P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
8.121e-24 | -53.17 | synapse | cellular component | GO:0045202 | 1473 | 32 | 19108 | 50 |
SYT1,CAMK2B,NRXN3,DNM1,PPFIA3,PCLO,STX1A,CAMKV,GRIN2B,GRIN1,GRM5,CACNA1G,HCN1,CPLX1,NRG3,GABRB2,RIMS1,SLC4A10,SLC8A3,LRRC7,NRXN2,DLG4,CACNA1C,DLGAP2,SNAP25,SPTBN2,IQSEC2,CACNA1A,SCN8A,CAMK2A,CACNA1E,PPFIA2 |
1.444e-23 | -52.59 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 22 | 10285 | 37 |
DLGAP2,CPLX1,CACNA2D1,SYT1,PPFIA3,GRIN1,CACNA1A,SNAP25,GRM5,CACNA1E,RIMS1,DLG4,CAMK2B,GRIN2B,HCN1,CAMK2A,PPFIA2,NRXN3,RASGRF1,GABRB2,STX1A,NRXN2 |
1.722e-22 | -50.11 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 22 | 18204 | 47 |
CAMK2B,SLC4A10,GRIN1,STX1A,IQSEC2,PPFIA2,CACNA1A,CAMK2A,GRM5,PPFIA3,RASGRF1,NRG3,SYT1,RIMS1,SNAP25,GRIN2B,DNM1,DLG4,SLC8A3,CAMKV,CPLX1,DLGAP2 |
1.799e-22 | -50.07 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 22 | 18204 | 47 |
CAMK2B,GRM5,CAMK2A,IQSEC2,CACNA1A,PPFIA2,GRIN1,STX1A,SLC4A10,DNM1,GRIN2B,SYT1,NRG3,SNAP25,RIMS1,PPFIA3,RASGRF1,CPLX1,DLGAP2,SLC8A3,CAMKV,DLG4 |
1.035e-20 | -46.02 | cell junction | cellular component | GO:0030054 | 2224 | 34 | 19108 | 50 |
SLC4A10,SLC8A3,LRRC7,CACNA1G,HCN1,CPLX1,NRG3,GABRB2,RIMS1,DLGAP2,SNAP25,CAMK2A,SCN8A,IQSEC2,SPTBN2,CACNA1A,PPFIA2,CACNA1E,NRXN2,SPTBN4,DLG4,CACNA1C,NRXN3,CAMK2B,SYT1,STX1A,CAMKV,GRIN2B,GRIN1,GRM5,PPFIA3,L1CAM,DNM1,PCLO |
1.901e-19 | -43.11 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 17 | 10285 | 37 |
PPFIA2,GRIN2B,CAMK2A,RASGRF1,STX1A,GABRB2,SYT1,PPFIA3,CACNA2D1,CPLX1,DLG4,CAMK2B,CACNA1A,SNAP25,GRIN1,RIMS1,CACNA1E |
2.152e-17 | -38.38 | cell projection | cellular component | GO:0042995 | 2398 | 32 | 19108 | 50 |
RASGRF1,SLC4A10,SLC8A3,LRRC7,HCN1,CPLX1,GABRB2,RIMS1,SNAP25,CACNA1A,SPTBN2,SCN8A,EPHA6,CAMK2A,PPFIA2,NRXN2,SPTBN4,DLG4,CACNA1C,BRINP1,CAMK2B,NRXN3,TMEM266,SYT1,STX1A,GRIN2B,ABLIM1,GRIN1,GRM5,DNM1,L1CAM,PCLO |
1.064e-16 | -36.78 | synaptic membrane | cellular component | GO:0097060 | 400 | 17 | 19108 | 50 |
NRXN3,LRRC7,HCN1,RIMS1,GABRB2,SYT1,SCN8A,STX1A,SNAP25,GRM5,GRIN1,GRIN2B,PPFIA2,NRXN2,DNM1,CACNA1C,DLG4 |
1.285e-16 | -36.59 | chemical synaptic transmission | biological process | GO:0007268 | 415 | 17 | 18204 | 47 |
GRM5,CACNA1A,GRIN1,STX1A,GABRB2,PCLO,CACNA1E,CACNA1G,NRXN2,CPLX1,DLGAP2,DLG4,GRIN2B,SYT1,RIMS1,SNAP25,PPFIA3 |
1.285e-16 | -36.59 | anterograde trans-synaptic signaling | biological process | GO:0098916 | 415 | 17 | 18204 | 47 |
DLG4,DLGAP2,NRXN2,CPLX1,RIMS1,SNAP25,SYT1,PPFIA3,GRIN2B,GRIN1,STX1A,GABRB2,GRM5,CACNA1A,CACNA1G,PCLO,CACNA1E |
1.802e-16 | -36.25 | cell-cell signaling | biological process | GO:0007267 | 822 | 21 | 18204 | 47 |
GRIN2B,SYT1,RIMS1,SNAP25,CACNA1C,PPFIA3,CPLX1,NRXN2,DLGAP2,FGF14,CACNA2D1,DLG4,PCLO,CACNA1E,RYR2,CACNA1G,GRM5,CACNA1A,STX1A,GRIN1,GABRB2 |
2.216e-16 | -36.05 | neuron projection | cellular component | GO:0043005 | 1331 | 25 | 19108 | 50 |
PCLO,L1CAM,GRIN2B,GRM5,GRIN1,STX1A,SYT1,TMEM266,BRINP1,CAMK2B,DLG4,CACNA1C,SPTBN4,PPFIA2,SNAP25,EPHA6,CAMK2A,SCN8A,GABRB2,HCN1,CPLX1,SLC8A3,LRRC7,RASGRF1,SLC4A10 |
2.413e-16 | -35.96 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 17 | 18204 | 47 |
GABRB2,STX1A,GRIN1,CACNA1A,GRM5,CACNA1G,CACNA1E,PCLO,DLG4,CPLX1,NRXN2,DLGAP2,PPFIA3,SYT1,RIMS1,SNAP25,GRIN2B |
6.862e-16 | -34.92 | synaptic signaling | biological process | GO:0099536 | 459 | 17 | 18204 | 47 |
CACNA1G,PCLO,CACNA1E,STX1A,GRIN1,GABRB2,GRM5,CACNA1A,SYT1,SNAP25,RIMS1,PPFIA3,GRIN2B,DLG4,NRXN2,CPLX1,DLGAP2 |
1.937e-15 | -33.88 | presynapse | cellular component | GO:0098793 | 569 | 18 | 19108 | 50 |
PCLO,DLG4,PPFIA3,NRXN2,DNM1,GRIN1,PPFIA2,SCN8A,SPTBN2,STX1A,SNAP25,RIMS1,SYT1,CPLX1,HCN1,NRXN3,SLC8A3,SLC4A10 |
2.297e-15 | -33.71 | regulation of biological quality | biological process | GO:0065008 | 2936 | 32 | 18204 | 47 |
CPLX1,CACNA2D1,CAMKV,DLG4,DNM1,SCN8A,RIMS1,CACNA1C,RASGRF1,PPFIA2,SLC4A10,PCLO,CAMK2B,RYR2,CACNA1G,SPTBN4,SLC8A3,GRIN2B,SNAP25,PPFIA3,GRM5,VSNL1,CAMK2A,IQSEC2,L1CAM,CACNA1A,STX1A,GRIN1,HCN1,GABRB2,SPTBN2,LRRC7 |
4.119e-15 | -33.12 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 16 | 19108 | 50 |
HCN1,CPLX1,NRG3,SYT1,DNM1,NRXN2,PPFIA3,DLG4,PCLO,SNAP25,DLGAP2,CAMKV,SCN8A,SPTBN2,PPFIA2,GRM5 |
7.584e-15 | -32.51 | regulation of synaptic plasticity | biological process | GO:0048167 | 219 | 13 | 18204 | 47 |
SLC8A3,DLG4,GRIN2B,RIMS1,SNAP25,RASGRF1,PPFIA3,CAMK2A,GRM5,IQSEC2,GRIN1,SLC4A10,CAMK2B |
1.733e-14 | -31.69 | postsynapse | cellular component | GO:0098794 | 646 | 18 | 19108 | 50 |
PCLO,CACNA1C,DLG4,SPTBN2,SCN8A,CAMK2A,DLGAP2,SNAP25,GRIN1,GRM5,PPFIA2,GRIN2B,CPLX1,HCN1,GABRB2,SLC4A10,LRRC7,SLC8A3 |
2.192e-14 | -31.45 | regulation of neuronal synaptic plasticity | biological process | GO:0048168 | 58 | 9 | 18204 | 47 |
GRIN1,SLC4A10,DLG4,GRM5,CAMK2A,RASGRF1,PPFIA3,CAMK2B,GRIN2B |
2.657e-14 | -31.26 | DGUOK (deoxyguanosine kinase) | protein interactions | 1716 | 91 | 10 | 19454 | 50 |
L1CAM,STX1A,SYT1,CAMKV,CAMK2A,EDIL3,CAMK2B,DNM1,VSNL1,SNAP25 |
5.715e-14 | -30.49 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 10 | 19454 | 50 |
STX1A,CAMK2A,SYT1,CAMKV,CACNA2D1,L1CAM,DNM1,SNAP25,VSNL1,CAMK2B |
6.701e-14 | -30.33 | GPM6A (glycoprotein M6A) | protein interactions | 2823 | 143 | 11 | 19454 | 50 |
CAMK2B,VSNL1,SNAP25,DNM1,CACNA2D1,L1CAM,CAMKV,CAMK2A,SYT1,EDIL3,STX1A |
8.097e-14 | -30.14 | Acetylcholine Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-264642 | 17 | 7 | 10285 | 37 |
SNAP25,STX1A,RIMS1,PPFIA2,CPLX1,SYT1,PPFIA3 |
1.184e-13 | -29.76 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 19 | 19108 | 50 |
L1CAM,SPTBN4,CACNA1C,DLG4,EPHA6,CAMK2A,CACNA1A,SPTBN2,SNAP25,GRM5,GRIN1,CACNA1E,PPFIA2,CPLX1,TMEM266,HCN1,SLC4A10,SLC8A3,BRINP1 |
1.322e-13 | -29.65 | Norepinephrine Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-181430 | 18 | 7 | 10285 | 37 |
PPFIA3,SYT1,CPLX1,PPFIA2,RIMS1,STX1A,SNAP25 |
1.322e-13 | -29.65 | Serotonin Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-181429 | 18 | 7 | 10285 | 37 |
CPLX1,PPFIA3,SYT1,PPFIA2,RIMS1,STX1A,SNAP25 |
1.508e-13 | -29.52 | monoatomic ion channel complex | cellular component | GO:0034702 | 344 | 14 | 19108 | 50 |
HCN1,CACNA1G,RYR2,GABRB2,SNAP25,STX1A,CACNA2D1,CACNA1A,SCN8A,GRIN2B,CACNA1E,GRIN1,DLG4,CACNA1C |
3.321e-13 | -28.73 | Interactions of neurexins and neuroligins at synapses | REACTOME pathways | R-HSA-6794361 | 58 | 9 | 10285 | 37 |
GRIN2B,DLGAP2,NRXN3,SYT1,GRM5,GRIN1,STX1A,DLG4,NRXN2 |
1.005e-12 | -27.63 | Dopamine Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-212676 | 23 | 7 | 10285 | 37 |
SNAP25,STX1A,RIMS1,PPFIA2,CPLX1,SYT1,PPFIA3 |
1.391e-12 | -27.30 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 10 | 19454 | 50 |
CAMK2B,VSNL1,SNAP25,DNM1,L1CAM,CAMKV,CAMK2A,SYT1,EDIL3,STX1A |
1.415e-12 | -27.28 | Glutamate Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-210500 | 24 | 7 | 10285 | 37 |
STX1A,RIMS1,SNAP25,CPLX1,SYT1,PPFIA3,PPFIA2 |
2.255e-12 | -26.82 | calcium ion transmembrane import into cytosol | biological process | GO:0097553 | 95 | 9 | 18204 | 47 |
CACNA2D1,SLC8A3,GRIN1,CACNA1A,RYR2,CACNA1G,CACNA1C,CACNA1E,GRIN2B |
2.564e-12 | -26.69 | Protein-protein interactions at synapses | REACTOME pathways | R-HSA-6794362 | 72 | 9 | 10285 | 37 |
SYT1,NRXN3,DLGAP2,GRIN2B,DLG4,NRXN2,STX1A,GRM5,GRIN1 |
3.364e-12 | -26.42 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 13 | 19108 | 50 |
LRRC7,GRIN1,GRM5,SLC8A3,GRIN2B,PPFIA2,CAMK2A,SCN8A,DLGAP2,GABRB2,CACNA1C,PCLO,DLG4 |
3.515e-12 | -26.37 | transmembrane transporter complex | cellular component | GO:1902495 | 434 | 14 | 19108 | 50 |
CACNA1A,SCN8A,SNAP25,STX1A,CACNA2D1,GRIN1,GRIN2B,CACNA1E,CACNA1C,DLG4,RYR2,HCN1,CACNA1G,GABRB2 |
4.291e-12 | -26.17 | cation channel complex | cellular component | GO:0034703 | 205 | 11 | 19108 | 50 |
CACNA1E,CACNA1A,SCN8A,SNAP25,CACNA2D1,STX1A,CACNA1C,DLG4,RYR2,CACNA1G,HCN1 |
4.498e-12 | -26.13 | axon | cellular component | GO:0030424 | 650 | 16 | 19108 | 50 |
HCN1,CPLX1,SYT1,RASGRF1,SLC4A10,SLC8A3,LRRC7,L1CAM,SPTBN4,DLG4,PCLO,STX1A,SNAP25,SCN8A,PPFIA2,GRIN1 |
6.168e-12 | -25.81 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 26 | 19108 | 50 |
SLC8A3,LRRC7,RASGRF1,SLC4A10,GABRB2,HCN1,CPLX1,PPFIA2,SNAP25,SCN8A,CAMK2A,EPHA6,DLG4,CACNA1C,SPTBN4,BRINP1,CAMK2B,SYT1,TMEM266,ABLIM1,GRIN2B,GRM5,GRIN1,STX1A,PCLO,L1CAM |
6.189e-12 | -25.81 | regulation of membrane potential | biological process | GO:0042391 | 463 | 14 | 18204 | 47 |
CACNA1C,RIMS1,SCN8A,GRIN2B,CACNA2D1,SLC8A3,DLG4,RYR2,CACNA1G,GRIN1,STX1A,HCN1,GABRB2,GRM5 |
7.895e-12 | -25.56 | transporter complex | cellular component | GO:1990351 | 461 | 14 | 19108 | 50 |
GABRB2,RYR2,CACNA1G,HCN1,CACNA1C,DLG4,GRIN1,CACNA1E,GRIN2B,CACNA1A,SCN8A,SNAP25,STX1A,CACNA2D1 |
1.587e-11 | -24.87 | Axon guidance | REACTOME pathways | R-HSA-422475 | 549 | 16 | 10285 | 37 |
SPTBN2,SCN8A,GRIN1,SPTBN4,NRG3,DLG4,EPHA6,CAMK2B,CACNA1G,ABLIM1,GRIN2B,CAMK2A,DNM1,RASGRF1,L1CAM,CACNA1C |
1.599e-11 | -24.86 | presynaptic membrane | cellular component | GO:0042734 | 168 | 10 | 19108 | 50 |
NRXN3,PPFIA2,SCN8A,STX1A,SNAP25,RIMS1,SYT1,NRXN2,DNM1,HCN1 |
2.769e-11 | -24.31 | presynaptic active zone | cellular component | GO:0048786 | 79 | 8 | 19108 | 50 |
HCN1,PPFIA3,PCLO,RIMS1,SCN8A,SNAP25,STX1A,PPFIA2 |
2.928e-11 | -24.25 | voltage-gated channel activity | molecular function | GO:0022832 | 173 | 10 | 18094 | 49 |
CACNA2D1,CACNA1A,CACNA1G,CACNA1E,HCN1,GRIN1,GRIN2B,SNAP25,CACNA1C,TMEM266 |
3.392e-11 | -24.11 | synapse organization | biological process | GO:0050808 | 333 | 12 | 18204 | 47 |
PPFIA2,L1CAM,GRM5,GABRB2,SPTBN2,PCLO,SPTBN4,NRXN2,DLG4,SLC8A3,PPFIA3,NRG3 |
3.715e-11 | -24.02 | Ras activation uopn Ca2+ infux through NMDA receptor | REACTOME pathways | R-HSA-442982 | 19 | 6 | 10285 | 37 |
RASGRF1,GRIN1,DLG4,CAMK2B,GRIN2B,CAMK2A |
3.916e-11 | -23.96 | gated channel activity | molecular function | GO:0022836 | 320 | 12 | 18094 | 49 |
RYR2,TMEM266,GRIN1,HCN1,GRIN2B,GABRB2,CACNA1C,SNAP25,CACNA1E,CACNA2D1,CACNA1A,CACNA1G |
5.810e-11 | -23.57 | neurotransmitter secretion | biological process | GO:0007269 | 88 | 8 | 18204 | 47 |
STX1A,CPLX1,NRXN2,PPFIA3,SYT1,RIMS1,SNAP25,PCLO |
5.810e-11 | -23.57 | signal release from synapse | biological process | GO:0099643 | 88 | 8 | 18204 | 47 |
SYT1,SNAP25,RIMS1,PPFIA3,PCLO,STX1A,CPLX1,NRXN2 |
7.677e-11 | -23.29 | calcium ion import across plasma membrane | biological process | GO:0098703 | 28 | 6 | 18204 | 47 |
CACNA1A,SLC8A3,CACNA2D1,CACNA1E,CACNA1G,CACNA1C |
9.334e-11 | -23.09 | calcium ion transmembrane transporter activity | molecular function | GO:0015085 | 136 | 9 | 18094 | 49 |
CACNA1C,RYR2,GRIN1,GRIN2B,CACNA1E,CACNA2D1,CACNA1A,SLC8A3,CACNA1G |
9.660e-11 | -23.06 | calcium ion import into cytosol | biological process | GO:1902656 | 29 | 6 | 18204 | 47 |
CACNA1A,CACNA1E,CACNA1C,CACNA1G,CACNA2D1,SLC8A3 |
1.093e-10 | -22.94 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 13 | 18094 | 49 |
CACNA1G,SLC8A3,CACNA1A,CACNA2D1,CACNA1E,SNAP25,CACNA1C,GRIN1,HCN1,GRIN2B,SCN8A,SLC4A10,RYR2 |
1.246e-10 | -22.81 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 12 | 19108 | 50 |
GRIN1,GRM5,GRIN2B,SCN8A,CAMK2A,DLGAP2,PCLO,CACNA1C,DLG4,LRRC7,SLC8A3,SYT1 |
1.738e-10 | -22.47 | plasma membrane region | cellular component | GO:0098590 | 1278 | 19 | 19108 | 50 |
GRM5,GRIN1,PPFIA2,GRIN2B,SCN8A,SPTBN2,SNAP25,STX1A,CACNA1C,DLG4,DNM1,NRXN2,LRRC7,NRXN3,SLC4A10,SYT1,GABRB2,RIMS1,HCN1 |
2.159e-10 | -22.26 | positive regulation of synaptic transmission | biological process | GO:0050806 | 157 | 9 | 18204 | 47 |
GRIN2B,RIMS1,SNAP25,SYT1,IQSEC2,DLG4,STX1A,GRIN1,SLC8A3 |
2.379e-10 | -22.16 | synaptic vesicle exocytosis | biological process | GO:0016079 | 63 | 7 | 18204 | 47 |
PCLO,SNAP25,RIMS1,SYT1,PPFIA3,CPLX1,STX1A |
2.894e-10 | -21.96 | behavior | biological process | GO:0007610 | 619 | 14 | 18204 | 47 |
BRINP1,DLG4,SLC4A10,HCN1,SLC8A3,GRIN1,SPTBN4,GRM5,NRXN2,RASGRF1,NRXN3,SNAP25,SPTBN2,GRIN2B |
3.643e-10 | -21.73 | metal ion transport | biological process | GO:0030001 | 630 | 14 | 18204 | 47 |
RYR2,CACNA1G,SNAP25,CACNA1C,CACNA1E,GRIN2B,SCN8A,SLC4A10,HCN1,SLC8A3,CACNA2D1,GRIN1,CACNA1A,CAMK2A |
4.418e-10 | -21.54 | Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-112310 | 51 | 7 | 10285 | 37 |
RIMS1,STX1A,SNAP25,SYT1,PPFIA3,CPLX1,PPFIA2 |
4.627e-10 | -21.49 | postsynaptic density | cellular component | GO:0014069 | 317 | 11 | 19108 | 50 |
CACNA1C,PCLO,DLG4,CAMK2A,SCN8A,DLGAP2,GRIN1,GRM5,LRRC7,SLC8A3,GRIN2B |
5.215e-10 | -21.37 | channel activity | molecular function | GO:0015267 | 502 | 13 | 18094 | 49 |
CACNA1C,GABRB2,SNAP25,CACNA1E,CACNA1G,CACNA1A,CACNA2D1,TMEM266,RYR2,SCN8A,GRIN1,GRIN2B,HCN1 |
5.343e-10 | -21.35 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 13 | 18094 | 49 |
CACNA1A,CACNA2D1,CACNA1G,CACNA1E,SNAP25,CACNA1C,GABRB2,GRIN1,HCN1,GRIN2B,SCN8A,RYR2,TMEM266 |
5.350e-10 | -21.35 | nervous system development | biological process | GO:0007399 | 2185 | 23 | 18204 | 47 |
RASGRF1,NRG3,SCN8A,BRINP1,DLG4,FGF14,NRXN2,CAMK2B,PCLO,SLC4A10,SNAP25,GRIN2B,MYT1L,SLC8A3,SPTBN4,NRXN3,SPTBN2,GABRB2,HCN1,GRIN1,EPHA6,L1CAM,CAMK2A |
6.338e-10 | -21.18 | CREB phosphorylation through the activation of Ras | REACTOME pathways | R-HSA-442742 | 29 | 6 | 10285 | 37 |
GRIN1,GRIN2B,RASGRF1,CAMK2A,DLG4,CAMK2B |
6.870e-10 | -21.10 | calcium ion transport | biological process | GO:0006816 | 251 | 10 | 18204 | 47 |
CAMK2A,CACNA1A,SLC8A3,CACNA2D1,GRIN1,CACNA1E,GRIN2B,RYR2,CACNA1C,CACNA1G |
7.231e-10 | -21.05 | voltage-gated monoatomic ion channel activity | molecular function | GO:0005244 | 171 | 9 | 18094 | 49 |
SNAP25,CACNA1C,CACNA1A,CACNA2D1,CACNA1G,CACNA1E,GRIN1,HCN1,GRIN2B |
7.642e-10 | -20.99 | calcium ion import | biological process | GO:0070509 | 40 | 6 | 18204 | 47 |
CACNA1E,CACNA1G,CACNA1C,CACNA1A,CACNA2D1,SLC8A3 |
7.782e-10 | -20.97 | asymmetric synapse | cellular component | GO:0032279 | 333 | 11 | 19108 | 50 |
PCLO,CACNA1C,DLG4,GRM5,LRRC7,GRIN1,GRIN2B,SLC8A3,SCN8A,CAMK2A,DLGAP2 |
8.674e-10 | -20.87 | calcium channel activity | molecular function | GO:0005262 | 117 | 8 | 18094 | 49 |
GRIN2B,GRIN1,CACNA1E,CACNA1G,CACNA1A,CACNA2D1,RYR2,CACNA1C |
1.020e-09 | -20.70 | monoatomic cation channel activity | molecular function | GO:0005261 | 331 | 11 | 18094 | 49 |
CACNA1G,CACNA2D1,CACNA1A,CACNA1E,HCN1,GRIN1,GRIN2B,SCN8A,SNAP25,CACNA1C,RYR2 |
1.237e-09 | -20.51 | Synaptic Vesicle Pathway | WikiPathways | WP2267 | 52 | 7 | 5310 | 23 |
CPLX1,STX1A,DNM1,SYT1,CACNA1A,SNAP25,RIMS1 |
1.314e-09 | -20.45 | regulation of system process | biological process | GO:0044057 | 571 | 13 | 18204 | 47 |
STX1A,GRIN1,CAMK2B,CACNA1G,RYR2,DLGAP2,SPTBN4,SLC8A3,CACNA2D1,DLG4,GRIN2B,CACNA1C,RIMS1 |
1.544e-09 | -20.29 | monoatomic ion channel activity | molecular function | GO:0005216 | 441 | 12 | 18094 | 49 |
CACNA1G,CACNA2D1,CACNA1A,GRIN2B,HCN1,GRIN1,CACNA1E,SCN8A,SNAP25,GABRB2,CACNA1C,RYR2 |
1.610e-09 | -20.25 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 10 | 7161 | 30 |
GRM5,GRIN1,CACNA1G,CAMK2A,CACNA1E,CAMK2B,SLC8A3,RYR2,CACNA1A,CACNA1C |
1.610e-09 | -20.25 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 10 | 7161 | 30 |
CAMK2A,CACNA1G,CACNA1E,GRM5,GRIN1,CACNA1A,CACNA1C,SLC8A3,CAMK2B,RYR2 |
1.723e-09 | -20.18 | learning or memory | biological process | GO:0007611 | 276 | 10 | 18204 | 47 |
SLC8A3,GRIN1,DLG4,BRINP1,GRM5,NRXN2,NRXN3,SNAP25,RASGRF1,GRIN2B |
1.880e-09 | -20.09 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 14 | 18204 | 47 |
GRIN2B,SCN8A,CACNA1C,SNAP25,CACNA2D1,SLC8A3,CACNA1E,CACNA1G,RYR2,CACNA1A,GABRB2,HCN1,SLC4A10,GRIN1 |
1.961e-09 | -20.05 | NCAM signaling for neurite out-growth | REACTOME pathways | R-HSA-375165 | 276 | 11 | 10285 | 37 |
RASGRF1,CACNA1C,GRIN2B,CACNA1G,CAMK2A,GRIN1,NRG3,SPTBN4,DLG4,CAMK2B,SPTBN2 |
2.299e-09 | -19.89 | calcium ion transmembrane transport | biological process | GO:0070588 | 205 | 9 | 18204 | 47 |
GRIN2B,CACNA1E,CACNA1C,CACNA1G,RYR2,CACNA1A,GRIN1,SLC8A3,CACNA2D1 |
2.443e-09 | -19.83 | neurotransmitter transport | biological process | GO:0006836 | 140 | 8 | 18204 | 47 |
SYT1,SNAP25,RIMS1,PPFIA3,PCLO,STX1A,NRXN2,CPLX1 |
2.701e-09 | -19.73 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 23 | 16828 | 47 |
CACNA1C,EDIL3,CAMK2B,SLC8A3,NRG3,GRIN2B,RYR2,CACNA1E,L1CAM,NRXN3,CACNA2D1,MCF2L2,PCLO,RIMS1,CAMK2A,LRRC7,DLGAP2,EPHA6,NRXN2,PPFIA2,CACNA1G,FGF14,HCN1 |
2.701e-09 | -19.73 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 23 | 16828 | 47 |
RYR2,HCN1,CACNA1E,L1CAM,CACNA2D1,NRXN3,PCLO,MCF2L2,RIMS1,CACNA1C,EDIL3,CAMK2A,DLGAP2,LRRC7,CAMK2B,EPHA6,NRXN2,NRG3,SLC8A3,FGF14,GRIN2B,PPFIA2,CACNA1G |
2.729e-09 | -19.72 | CREB phosphorylation through the activation of CaMKII | REACTOME pathways | R-HSA-442729 | 17 | 5 | 10285 | 37 |
DLG4,CAMK2B,GRIN1,GRIN2B,CAMK2A |
2.729e-09 | -19.72 | Unblocking of NMDA receptor, glutamate binding and activation | REACTOME pathways | R-HSA-438066 | 17 | 5 | 10285 | 37 |
CAMK2B,DLG4,CAMK2A,GRIN2B,GRIN1 |
2.736e-09 | -19.72 | modulation of excitatory postsynaptic potential | biological process | GO:0098815 | 49 | 6 | 18204 | 47 |
DLG4,STX1A,GRIN1,SLC8A3,RIMS1,GRIN2B |
3.038e-09 | -19.61 | Post NMDA receptor activation events | REACTOME pathways | R-HSA-438064 | 37 | 6 | 10285 | 37 |
CAMK2A,GRIN2B,GRIN1,RASGRF1,CAMK2B,DLG4 |
3.055e-09 | -19.61 | synaptic vesicle cycle | biological process | GO:0099504 | 144 | 8 | 18204 | 47 |
CPLX1,STX1A,DNM1,PCLO,PPFIA3,RIMS1,SNAP25,SYT1 |
3.202e-09 | -19.56 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 23 | 16828 | 47 |
HCN1,CAMK2A,LRRC7,DLGAP2,EPHA6,NRXN2,PPFIA2,CACNA1G,FGF14,RYR2,CACNA1E,L1CAM,NRXN3,CACNA2D1,MCF2L2,PCLO,RIMS1,CACNA1C,EDIL3,CAMK2B,SLC8A3,NRG3,GRIN2B |
3.414e-09 | -19.50 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 13 | 18204 | 47 |
HCN1,SLC4A10,GRIN1,SLC8A3,CACNA2D1,CACNA1A,CACNA1G,SNAP25,CACNA1C,RYR2,GRIN2B,CACNA1E,SCN8A |
3.463e-09 | -19.48 | neuronal cell body | cellular component | GO:0043025 | 489 | 12 | 19108 | 50 |
SLC4A10,SLC8A3,BRINP1,TMEM266,CPLX1,SPTBN2,CACNA1A,SNAP25,CACNA1E,SPTBN4,L1CAM,CACNA1C |
3.616e-09 | -19.44 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 13 | 18094 | 49 |
CACNA1A,CACNA2D1,SLC8A3,CACNA1G,CACNA1E,SNAP25,CACNA1C,HCN1,GRIN1,GRIN2B,SLC4A10,SCN8A,RYR2 |
3.664e-09 | -19.42 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 14 | 18094 | 49 |
RYR2,SLC4A10,SCN8A,GRIN2B,GRIN1,HCN1,GABRB2,CACNA1C,SNAP25,CACNA1E,CACNA2D1,CACNA1A,SLC8A3,CACNA1G |
4.133e-09 | -19.30 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 7 | 19454 | 50 |
DNM1,GRIN1,DLG4,CAMK2A,GRIN2B,CACNA2D1,GRM5 |
4.550e-09 | -19.21 | monoatomic cation transport | biological process | GO:0006812 | 766 | 14 | 18204 | 47 |
CAMK2A,CACNA1A,GRIN1,HCN1,SLC4A10,CACNA1E,CACNA1G,RYR2,CACNA2D1,SLC8A3,SCN8A,GRIN2B,CACNA1C,SNAP25 |
4.588e-09 | -19.20 | dendrite | cellular component | GO:0030425 | 620 | 13 | 19108 | 50 |
GRIN1,GRM5,PPFIA2,CAMK2A,EPHA6,CACNA1C,DLG4,L1CAM,BRINP1,SLC8A3,SLC4A10,TMEM266,HCN1 |
4.667e-09 | -19.18 | RIMS1 (regulating synaptic membrane exocytosis 1) | protein interactions | 22999 | 25 | 5 | 19454 | 50 |
CAMK2A,SYT1,SNAP25,CACNA1C,STX1A |
4.712e-09 | -19.17 | cell periphery | cellular component | GO:0071944 | 6020 | 36 | 19108 | 50 |
NRXN3,TMEM266,RYR2,SYT1,STX1A,CACNA2D1,CAMKV,GRIN2B,GRM5,GRIN1,DNM1,L1CAM,PPFIA3,PCLO,RASGRF1,SLC4A10,SLC8A3,LRRC7,HCN1,CACNA1G,NRG3,GABRB2,RIMS1,EDIL3,SNAP25,DLGAP2,CACNA1A,SPTBN2,SCN8A,EPHA6,PPFIA2,CACNA1E,SPTBN4,NRXN2,DLG4,CACNA1C |
4.769e-09 | -19.16 | dendritic tree | cellular component | GO:0097447 | 622 | 13 | 19108 | 50 |
L1CAM,DLG4,CACNA1C,EPHA6,CAMK2A,PPFIA2,GRIN1,GRM5,HCN1,TMEM266,SLC4A10,BRINP1,SLC8A3 |
4.820e-09 | -19.15 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 13 | 18204 | 47 |
SLC8A3,CACNA2D1,CACNA1C,SNAP25,GRIN2B,SCN8A,SLC4A10,HCN1,GRIN1,CACNA1A,RYR2,CACNA1G,CACNA1E |
5.034e-09 | -19.11 | Synaptic vesicle cycle | KEGG pathways | hsa04721 | 63 | 7 | 7161 | 30 |
SNAP25,RIMS1,SYT1,DNM1,STX1A,CPLX1,CACNA1A |
5.034e-09 | -19.11 | Synaptic vesicle cycle | KEGG pathways | ko04721 | 63 | 7 | 7161 | 30 |
RIMS1,SYT1,CPLX1,STX1A,CACNA1A,SNAP25,DNM1 |
5.101e-09 | -19.09 | GABA synthesis, release, reuptake and degradation | REACTOME pathways | R-HSA-888590 | 19 | 5 | 10285 | 37 |
SNAP25,RIMS1,STX1A,CPLX1,SYT1 |
5.196e-09 | -19.08 | vesicle-mediated transport in synapse | biological process | GO:0099003 | 154 | 8 | 18204 | 47 |
PPFIA3,SNAP25,RIMS1,SYT1,DNM1,PCLO,STX1A,CPLX1 |
5.394e-09 | -19.04 | VDCCAlpha1 | interpro domains | IPR002077 | 9 | 4 | 18521 | 49 |
CACNA1C,CACNA1G,CACNA1A,CACNA1E |
5.816e-09 | -18.96 | Activation of NMDA receptor upon glutamate binding and postsynaptic events | REACTOME pathways | R-HSA-442755 | 41 | 6 | 10285 | 37 |
GRIN2B,GRIN1,RASGRF1,CAMK2A,DLG4,CAMK2B |
6.917e-09 | -18.79 | cognition | biological process | GO:0050890 | 319 | 10 | 18204 | 47 |
GRIN2B,RASGRF1,SNAP25,NRXN3,NRXN2,GRM5,BRINP1,DLG4,GRIN1,SLC8A3 |
7.058e-09 | -18.77 | cell junction organization | biological process | GO:0034330 | 532 | 12 | 18204 | 47 |
SPTBN2,PCLO,PPFIA3,NRG3,L1CAM,PPFIA2,SPTBN4,NRXN2,GRM5,GABRB2,DLG4,SLC8A3 |
7.101e-09 | -18.76 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 14 | 18094 | 49 |
SNAP25,GABRB2,CACNA1C,SLC8A3,CACNA1A,CACNA2D1,CACNA1G,CACNA1E,SCN8A,SLC4A10,RYR2,GRIN2B,GRIN1,HCN1 |
7.729e-09 | -18.68 | GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) | protein interactions | 2904 | 58 | 6 | 19454 | 50 |
GRIN1,RASGRF1,CAMK2B,DLG4,GRIN2B,CAMK2A |
8.095e-09 | -18.63 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 13 | 18094 | 49 |
SNAP25,CACNA1C,CACNA1G,CACNA1A,SLC8A3,CACNA2D1,CACNA1E,SCN8A,SLC4A10,RYR2,HCN1,GRIN2B,GRIN1 |
8.155e-09 | -18.62 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 28 | 16828 | 47 |
NRG3,VSNL1,GRM5,CAMK2B,EDIL3,CACNA1C,SLC4A10,SPTBN2,CACNA2D1,NRXN3,CACNA1A,RIMS1,PCLO,GRIN1,MCF2L2,CACNA1E,SYT1,RYR2,PPFIA2,CACNA1G,NRXN2,GABRB2,CELF5,EPHA6,DNM1,SCN8A,HCN1,MYT1L |
8.155e-09 | -18.62 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 28 | 16828 | 47 |
MYT1L,HCN1,SCN8A,DNM1,EPHA6,GABRB2,CELF5,CACNA1G,PPFIA2,NRXN2,SYT1,CACNA1E,RYR2,CACNA1A,RIMS1,MCF2L2,GRIN1,PCLO,CACNA2D1,NRXN3,SPTBN2,CAMK2B,CACNA1C,SLC4A10,EDIL3,GRM5,VSNL1,NRG3 |
8.432e-09 | -18.59 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 14 | 18204 | 47 |
SCN8A,GRIN2B,SNAP25,CACNA1C,SLC8A3,CACNA2D1,CACNA1E,RYR2,CACNA1G,CACNA1A,GRIN1,SLC4A10,HCN1,GABRB2 |
9.873e-09 | -18.43 | monoatomic ion transport | biological process | GO:0006811 | 964 | 15 | 18204 | 47 |
CACNA2D1,SLC8A3,CACNA1C,SNAP25,GRIN2B,SCN8A,SLC4A10,HCN1,GABRB2,GRIN1,CACNA1A,CAMK2A,RYR2,CACNA1G,CACNA1E |
1.367e-08 | -18.11 | Phase 0 - rapid depolarisation | REACTOME pathways | R-HSA-5576892 | 47 | 6 | 10285 | 37 |
SCN8A,CACNA2D1,CAMK2A,FGF14,CAMK2B,CACNA1C |
1.369e-08 | -18.11 | Ion_trans | pfam domains | PF00520 | 109 | 7 | 17795 | 47 |
RYR2,CACNA1A,SCN8A,CACNA1G,CACNA1C,HCN1,CACNA1E |
1.403e-08 | -18.08 | establishment of localization | biological process | GO:0051234 | 3887 | 28 | 18204 | 47 |
SLC4A10,PPFIA2,RYR2,CACNA1G,PCLO,CACNA1E,CACNA2D1,DLG4,CPLX1,NRXN2,SYT1,RIMS1,CACNA1C,DNM1,SCN8A,STX1A,GRIN1,HCN1,GABRB2,CAMK2A,CACNA1A,LRRC7,SPTBN2,SLC8A3,SPTBN4,SNAP25,PPFIA3,GRIN2B |
1.410e-08 | -18.08 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 7 | 18521 | 49 |
CACNA1G,RYR2,CACNA1E,CACNA1A,HCN1,SCN8A,CACNA1C |
1.450e-08 | -18.05 | cell body | cellular component | GO:0044297 | 556 | 12 | 19108 | 50 |
CACNA1E,CACNA1A,SPTBN2,SNAP25,CACNA1C,L1CAM,SPTBN4,BRINP1,SLC8A3,SLC4A10,CPLX1,TMEM266 |
1.484e-08 | -18.03 | transport | biological process | GO:0006810 | 3615 | 27 | 18204 | 47 |
CACNA1A,CAMK2A,GABRB2,HCN1,STX1A,GRIN1,SPTBN2,LRRC7,SPTBN4,SLC8A3,GRIN2B,PPFIA3,SNAP25,PPFIA2,SLC4A10,CACNA1E,PCLO,RYR2,CACNA1G,CPLX1,NRXN2,CACNA2D1,DNM1,SCN8A,SYT1,RIMS1,CACNA1C |
1.514e-08 | -18.01 | Volt_channel_dom_sf | interpro domains | IPR027359 | 63 | 6 | 18521 | 49 |
CACNA1G,TMEM266,CACNA1E,CACNA1A,SCN8A,CACNA1C |
1.627e-08 | -17.93 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 37 | 16828 | 47 |
GRIN2B,NRG3,SLC8A3,GRM5,CCDC136,SLC4A10,EDIL3,CACNA1C,SPTBN2,CELF3,RIMS1,CACNA1A,PCLO,MCF2L2,RASGRF1,GRIN1,DLG4,CACNA1E,SYT1,RYR2,L1CAM,CACNA1G,PPFIA2,NRXN2,ABLIM1,DLGAP2,LRRC7,CELF5,CAMK2A,EPHA6,DNM1,PPFIA3,SCN8A,SNAP25,SPTBN4,HCN1,MYT1L |
1.761e-08 | -17.85 | positive regulation of excitatory postsynaptic potential | biological process | GO:2000463 | 32 | 5 | 18204 | 47 |
DLG4,RIMS1,GRIN1,STX1A,GRIN2B |
1.766e-08 | -17.85 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 16 | 18094 | 49 |
RYR2,TMEM266,SCN8A,SLC4A10,GRIN2B,HCN1,GRIN1,GABRB2,CACNA1C,SNAP25,CPLX1,CACNA1E,CACNA1A,SLC8A3,CACNA2D1,CACNA1G |
1.941e-08 | -17.76 | CACHANNEL | prints domains | PR00167 | 9 | 4 | 5227 | 20 |
CACNA1A,CACNA1G,CACNA1E,CACNA1C |
2.292e-08 | -17.59 | regulation of nervous system process | biological process | GO:0031644 | 120 | 7 | 18204 | 47 |
GRIN2B,RIMS1,DLGAP2,SLC8A3,STX1A,GRIN1,DLG4 |
2.484e-08 | -17.51 | signal release | biological process | GO:0023061 | 188 | 8 | 18204 | 47 |
NRXN2,CPLX1,STX1A,PCLO,SNAP25,RIMS1,SYT1,PPFIA3 |
2.645e-08 | -17.45 | - | gene3d domains | 1.10.287.70 | 148 | 8 | 14470 | 48 |
CACNA1A,CACNA1C,HCN1,SCN8A,CACNA1E,GRIN1,CACNA1G,RYR2 |
2.718e-08 | -17.42 | calcium channel complex | cellular component | GO:0034704 | 70 | 6 | 19108 | 50 |
CACNA1A,RYR2,CACNA1G,CACNA2D1,CACNA1C,CACNA1E |
2.903e-08 | -17.35 | GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A) | protein interactions | 2903 | 72 | 6 | 19454 | 50 |
CAMK2A,GRIN2B,GRM5,GRIN1,DLG4,CAMK2B |
2.983e-08 | -17.33 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 8 | 10285 | 37 |
FGF14,CAMK2B,CACNA1C,SCN8A,RYR2,CACNA2D1,CAMK2A,SLC8A3 |
3.359e-08 | -17.21 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 12 | 19108 | 50 |
CACNA1G,HCN1,GRIN1,CACNA1E,GRIN2B,CACNA1A,SCN8A,STX1A,CACNA2D1,SNAP25,CACNA1C,DLG4 |
3.510e-08 | -17.17 | system process | biological process | GO:0003008 | 2015 | 20 | 18204 | 47 |
NRXN3,RYR2,CACNA1G,GRM5,ABLIM1,SLC4A10,HCN1,GRIN1,GRIN2B,SCN8A,RASGRF1,SNAP25,CACNA1C,RIMS1,SPTBN4,NRXN2,BRINP1,DLG4,CACNA2D1,SLC8A3 |
3.542e-08 | -17.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 15 | 16828 | 47 |
EPHA6,EDIL3,CAMK2A,DLGAP2,GABRB2,NRG3,GRIN2B,FGF14,PPFIA2,RYR2,SYT1,PCLO,CACNA1A,NRXN3,CACNA2D1 |
3.905e-08 | -17.06 | Developmental Biology | REACTOME pathways | R-HSA-1266738 | 1075 | 17 | 10285 | 37 |
STX1A,L1CAM,DNM1,RASGRF1,CACNA1C,CAMK2A,GRIN2B,ABLIM1,CACNA1G,NRG3,SPTBN4,GRIN1,CAMK2B,DLG4,EPHA6,SPTBN2,SCN8A |
4.058e-08 | -17.02 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 9 | 19108 | 50 |
SCN8A,GRIN2B,GRIN1,LRRC7,GRM5,HCN1,DLG4,CACNA1C,GABRB2 |
4.176e-08 | -16.99 | regulation of transport | biological process | GO:0051049 | 1621 | 18 | 18204 | 47 |
SYT1,SNAP25,RIMS1,CACNA1C,GRIN2B,DLG4,CACNA2D1,SPTBN4,FGF14,CPLX1,RYR2,CAMK2B,PCLO,STX1A,GRIN1,PPFIA2,CAMK2A,VSNL1 |
4.220e-08 | -16.98 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 7 | 7161 | 30 |
SNAP25,CAMK2B,RYR2,CACNA1C,STX1A,CAMK2A,PCLO |
4.327e-08 | -16.96 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 27 | 16828 | 47 |
RIMS1,GRIN1,RASGRF1,MCF2L2,PCLO,NRXN3,CACNA1E,RYR2,GRM5,GRIN2B,SPTBN2,CELF3,CACNA1C,SLC4A10,PPFIA3,SCN8A,MYT1L,SPTBN4,HCN1,PPFIA2,CACNA1G,NRXN2,EPHA6,LRRC7,DLGAP2,CAMK2A,CELF5 |
4.657e-08 | -16.88 | high voltage-gated calcium channel activity | molecular function | GO:0008331 | 14 | 4 | 18094 | 49 |
CACNA1C,CACNA1E,CACNA1A,CACNA1G |
4.847e-08 | -16.84 | system development | biological process | GO:0048731 | 3533 | 26 | 18204 | 47 |
SNAP25,GRIN2B,SLC8A3,MYT1L,SPTBN4,NRXN3,SPTBN2,GRIN1,HCN1,GABRB2,CAMK2A,L1CAM,EPHA6,CACNA1C,NRG3,RASGRF1,SCN8A,BRINP1,DLG4,NRXN2,FGF14,CACNA1G,RYR2,PCLO,CAMK2B,SLC4A10 |
5.680e-08 | -16.68 | Voltage-gated potassium channels. Chain C | gene3d domains | 1.20.120.350 | 63 | 6 | 14470 | 48 |
CACNA1E,SCN8A,CACNA1A,TMEM266,CACNA1C,CACNA1G |
5.979e-08 | -16.63 | transporter activity | molecular function | GO:0005215 | 1211 | 16 | 18094 | 49 |
SNAP25,CACNA1C,GABRB2,CACNA2D1,SLC8A3,CACNA1A,CACNA1G,CACNA1E,CPLX1,SLC4A10,SCN8A,RYR2,TMEM266,GRIN2B,HCN1,GRIN1 |
6.243e-08 | -16.59 | plasma membrane | cellular component | GO:0005886 | 5538 | 33 | 19108 | 50 |
DNM1,L1CAM,GRIN2B,GRIN1,GRM5,CACNA2D1,CAMKV,STX1A,SYT1,TMEM266,RYR2,NRXN3,DLG4,CACNA1C,NRXN2,SPTBN4,CACNA1E,PPFIA2,DLGAP2,SNAP25,SPTBN2,CACNA1A,SCN8A,EPHA6,NRG3,RIMS1,GABRB2,HCN1,CACNA1G,SLC8A3,LRRC7,RASGRF1,SLC4A10 |
6.428e-08 | -16.56 | regulation of neurotransmitter secretion | biological process | GO:0046928 | 82 | 6 | 18204 | 47 |
SYT1,RIMS1,STX1A,CPLX1,CAMK2A,PPFIA2 |
6.813e-08 | -16.50 | membrane protein complex | cellular component | GO:0098796 | 1261 | 16 | 19108 | 50 |
DLG4,CACNA1C,DNM1,CACNA1E,GRIN2B,GRIN1,SNAP25,STX1A,CACNA2D1,CACNA1A,SCN8A,GABRB2,CACNA1G,HCN1,CPLX1,RYR2 |
7.445e-08 | -16.41 | calmodulin binding | molecular function | GO:0005516 | 206 | 8 | 18094 | 49 |
SLC8A3,CAMK2B,GRIN1,CAMKV,SYT1,CAMK2A,RYR2,CACNA1C |
8.081e-08 | -16.33 | regulated exocytosis | biological process | GO:0045055 | 144 | 7 | 18204 | 47 |
STX1A,CPLX1,SNAP25,RIMS1,SYT1,PPFIA3,PCLO |
8.158e-08 | -16.32 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 16 | 16828 | 47 |
EPHA6,EDIL3,CAMK2A,DLGAP2,GABRB2,NRG3,GRIN2B,FGF14,PPFIA2,RYR2,SPTBN4,SYT1,PCLO,CACNA1A,NRXN3,CACNA2D1 |
9.316e-08 | -16.19 | voltage-gated calcium channel activity | molecular function | GO:0005245 | 42 | 5 | 18094 | 49 |
CACNA1E,CACNA1C,CACNA1G,CACNA2D1,CACNA1A |
9.877e-08 | -16.13 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 7 | 7161 | 30 |
CACNA1C,CACNA1G,CAMK2A,GRIN1,RYR2,GRIN2B,CAMK2B |
9.877e-08 | -16.13 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 7 | 7161 | 30 |
GRIN1,CACNA1G,CAMK2A,GRIN2B,RYR2,CAMK2B,CACNA1C |
1.042e-07 | -16.08 | cardiac muscle cell action potential involved in contraction | biological process | GO:0086002 | 45 | 5 | 18204 | 47 |
SCN8A,CACNA2D1,RYR2,CACNA1G,CACNA1C |
1.082e-07 | -16.04 | voltage-gated monoatomic cation channel activity | molecular function | GO:0022843 | 143 | 7 | 18094 | 49 |
HCN1,CACNA1E,CACNA1G,CACNA1A,CACNA2D1,CACNA1C,SNAP25 |
1.096e-07 | -16.03 | multicellular organism development | biological process | GO:0007275 | 3957 | 27 | 18204 | 47 |
SLC4A10,CAMK2B,PCLO,RYR2,CACNA1G,FGF14,NRXN2,DLG4,BRINP1,SCN8A,RASGRF1,NRG3,CACNA1C,L1CAM,EPHA6,CAMK2A,GABRB2,HCN1,GRIN1,SPTBN2,LRRC7,NRXN3,SPTBN4,MYT1L,SLC8A3,GRIN2B,SNAP25 |
1.128e-07 | -16.00 | voltage-gated calcium channel complex | cellular component | GO:0005891 | 45 | 5 | 19108 | 50 |
CACNA1A,CACNA1G,CACNA2D1,CACNA1C,CACNA1E |
1.128e-07 | -16.00 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 38 | 16828 | 47 |
EPHA6,CAMK2A,STX1A,GABRB2,LRRC7,DLGAP2,NRXN2,PPFIA2,CACNA1G,FGF14,IQSEC2,MYT1L,HCN1,SPTBN4,PPFIA3,SCN8A,DNM1,SPTBN2,CACNA1C,EDIL3,SLC4A10,CAMK2B,CCDC136,GRM5,SLC8A3,NRG3,GRIN2B,L1CAM,RYR2,SYT1,CACNA1E,MCF2L2,RASGRF1,PCLO,CACNA1A,RIMS1,CACNA2D1,NRXN3 |
1.128e-07 | -16.00 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 38 | 16828 | 47 |
SLC4A10,CACNA1C,EDIL3,CAMK2B,SPTBN2,SLC8A3,NRG3,GRIN2B,CCDC136,GRM5,RYR2,SYT1,CACNA1E,L1CAM,NRXN3,CACNA2D1,RASGRF1,MCF2L2,PCLO,CACNA1A,RIMS1,CAMK2A,GABRB2,LRRC7,STX1A,DLGAP2,EPHA6,NRXN2,CACNA1G,PPFIA2,IQSEC2,FGF14,HCN1,SPTBN4,MYT1L,DNM1,SCN8A,PPFIA3 |
1.214e-07 | -15.92 | Effects of Botulinum toxin | Pathway Interaction DB | botulinumtoxinpathway | 9 | 4 | 2226 | 14 |
STX1A,SYT1,SNAP25,RIMS1 |
1.281e-07 | -15.87 | learning | biological process | GO:0007612 | 154 | 7 | 18204 | 47 |
DLG4,GRIN1,SLC8A3,GRM5,NRXN2,SNAP25,NRXN3 |
1.469e-07 | -15.73 | vocalization behavior | biological process | GO:0071625 | 19 | 4 | 18204 | 47 |
NRXN2,DLG4,BRINP1,NRXN3 |
1.482e-07 | -15.72 | GRB2 events in EGFR signaling | REACTOME pathways | R-HSA-179812 | 245 | 9 | 10285 | 37 |
SPTBN2,CAMK2A,GRIN2B,CAMK2B,DLG4,NRG3,SPTBN4,RASGRF1,GRIN1 |
1.482e-07 | -15.72 | RAF/MAP kinase cascade | REACTOME pathways | R-HSA-5673001 | 245 | 9 | 10285 | 37 |
SPTBN2,CAMK2A,GRIN2B,CAMK2B,DLG4,SPTBN4,NRG3,RASGRF1,GRIN1 |
1.482e-07 | -15.72 | SOS-mediated signalling | REACTOME pathways | R-HSA-112412 | 245 | 9 | 10285 | 37 |
CAMK2B,DLG4,NRG3,SPTBN4,RASGRF1,GRIN1,SPTBN2,CAMK2A,GRIN2B |
1.482e-07 | -15.72 | SHC1 events in EGFR signaling | REACTOME pathways | R-HSA-180336 | 245 | 9 | 10285 | 37 |
GRIN2B,CAMK2A,SPTBN2,RASGRF1,GRIN1,NRG3,SPTBN4,DLG4,CAMK2B |
1.583e-07 | -15.66 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 12 | 16828 | 47 |
EPHA6,CACNA1C,ABLIM1,GRM5,FGF14,PPFIA2,NRG3,MYT1L,RYR2,SCN8A,PCLO,NRXN3 |
1.609e-07 | -15.64 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 12 | 16828 | 47 |
PCLO,SCN8A,NRXN3,MYT1L,RYR2,ABLIM1,GRM5,NRG3,FGF14,PPFIA2,EPHA6,CACNA1C |
1.653e-07 | -15.62 | nervous system process | biological process | GO:0050877 | 1376 | 16 | 18204 | 47 |
GRIN1,SLC4A10,HCN1,ABLIM1,GRM5,NRXN3,SLC8A3,DLG4,BRINP1,NRXN2,SPTBN4,SNAP25,RIMS1,RASGRF1,SCN8A,GRIN2B |
1.661e-07 | -15.61 | neuron development | biological process | GO:0048666 | 859 | 13 | 18204 | 47 |
SNAP25,RASGRF1,BRINP1,DLG4,MYT1L,SPTBN4,NRXN3,SLC4A10,HCN1,GABRB2,CAMK2A,L1CAM,EPHA6 |
1.702e-07 | -15.59 | Signalling to p38 via RIT and RIN | REACTOME pathways | R-HSA-187706 | 249 | 9 | 10285 | 37 |
DLG4,CAMK2B,RASGRF1,GRIN1,NRG3,SPTBN4,SPTBN2,GRIN2B,CAMK2A |
1.702e-07 | -15.59 | ARMS-mediated activation | REACTOME pathways | R-HSA-170984 | 249 | 9 | 10285 | 37 |
DLG4,CAMK2B,GRIN1,RASGRF1,SPTBN4,NRG3,SPTBN2,GRIN2B,CAMK2A |
1.761e-07 | -15.55 | Frs2-mediated activation | REACTOME pathways | R-HSA-170968 | 250 | 9 | 10285 | 37 |
CAMK2A,GRIN2B,SPTBN2,NRG3,SPTBN4,GRIN1,RASGRF1,CAMK2B,DLG4 |
1.822e-07 | -15.52 | MAPK1/MAPK3 signaling | REACTOME pathways | R-HSA-5684996 | 251 | 9 | 10285 | 37 |
GRIN1,RASGRF1,SPTBN4,NRG3,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
1.859e-07 | -15.50 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | molecular function | GO:0086007 | 5 | 3 | 18094 | 49 |
CACNA2D1,CACNA1G,CACNA1C |
1.859e-07 | -15.50 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 3 | 18094 | 49 |
DLG4,NRXN2,NRXN3 |
1.885e-07 | -15.48 | Prolonged ERK activation events | REACTOME pathways | R-HSA-169893 | 252 | 9 | 10285 | 37 |
DLG4,CAMK2B,GRIN1,RASGRF1,NRG3,SPTBN4,SPTBN2,GRIN2B,CAMK2A |
1.949e-07 | -15.45 | Signaling by Leptin | REACTOME pathways | R-HSA-2586552 | 253 | 9 | 10285 | 37 |
DLG4,CAMK2B,RASGRF1,GRIN1,SPTBN4,NRG3,SPTBN2,GRIN2B,CAMK2A |
1.981e-07 | -15.43 | cardiac muscle cell contraction | biological process | GO:0086003 | 51 | 5 | 18204 | 47 |
CACNA2D1,RYR2,CACNA1G,CACNA1C,SCN8A |
1.990e-07 | -15.43 | regulation of neurotransmitter transport | biological process | GO:0051588 | 99 | 6 | 18204 | 47 |
RIMS1,SYT1,PPFIA2,CPLX1,CAMK2A,STX1A |
2.085e-07 | -15.38 | Interleukin receptor SHC signaling | REACTOME pathways | R-HSA-912526 | 255 | 9 | 10285 | 37 |
SPTBN2,GRIN2B,CAMK2A,DLG4,CAMK2B,RASGRF1,GRIN1,NRG3,SPTBN4 |
2.155e-07 | -15.35 | Signalling to RAS | REACTOME pathways | R-HSA-167044 | 256 | 9 | 10285 | 37 |
SPTBN2,CAMK2A,GRIN2B,CAMK2B,DLG4,NRG3,SPTBN4,RASGRF1,GRIN1 |
2.156e-07 | -15.35 | cell communication | biological process | GO:0007154 | 5010 | 30 | 18204 | 47 |
GABRB2,HCN1,STX1A,GRIN1,CACNA1A,EPHA6,CAMK2A,GRM5,SLC8A3,SPTBN4,PPFIA3,SNAP25,GRIN2B,RYR2,CACNA1G,CACNA1E,CAMK2B,PCLO,DLG4,CACNA2D1,FGF14,NRXN2,CPLX1,DLGAP2,RASGRF1,NRG3,SYT1,RIMS1,CACNA1C,SCN8A |
2.285e-07 | -15.29 | regulation of localization | biological process | GO:0032879 | 2028 | 19 | 18204 | 47 |
CPLX1,SPTBN4,FGF14,CACNA2D1,DLG4,GRIN2B,CACNA1C,SNAP25,RIMS1,SYT1,CAMK2A,VSNL1,PPFIA2,IQSEC2,STX1A,GRIN1,PCLO,CAMK2B,RYR2 |
2.303e-07 | -15.28 | VEGFR2 mediated cell proliferation | REACTOME pathways | R-HSA-5218921 | 258 | 9 | 10285 | 37 |
CAMK2A,GRIN2B,SPTBN2,SPTBN4,NRG3,RASGRF1,GRIN1,CAMK2B,DLG4 |
2.542e-07 | -15.19 | developmental process | biological process | GO:0032502 | 5716 | 32 | 18204 | 47 |
SNAP25,GRIN2B,CELF3,SLC8A3,MYT1L,SPTBN4,LRRC7,NRXN3,SPTBN2,GRIN1,GABRB2,HCN1,CAMK2A,ABLIM1,EPHA6,L1CAM,RIMS1,CACNA1C,NRG3,SYT1,RASGRF1,SCN8A,BRINP1,DLG4,NRXN2,FGF14,CACNA1G,RYR2,CCDC136,PCLO,CAMK2B,SLC4A10 |
2.615e-07 | -15.16 | regulation of exocytosis | biological process | GO:0017157 | 171 | 7 | 18204 | 47 |
PPFIA2,CPLX1,VSNL1,STX1A,PCLO,RIMS1,SYT1 |
2.624e-07 | -15.15 | Interleukin-2 signaling | REACTOME pathways | R-HSA-451927 | 262 | 9 | 10285 | 37 |
SPTBN2,CAMK2A,GRIN2B,CAMK2B,DLG4,SPTBN4,NRG3,GRIN1,RASGRF1 |
2.659e-07 | -15.14 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 6 | 7161 | 30 |
GRIN2B,CAMK2B,CACNA1C,GRIN1,GRM5,CAMK2A |
2.659e-07 | -15.14 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 6 | 7161 | 30 |
CAMK2B,GRIN2B,GRM5,GRIN1,CAMK2A,CACNA1C |
2.669e-07 | -15.14 | inorganic cation import across plasma membrane | biological process | GO:0098659 | 104 | 6 | 18204 | 47 |
SLC8A3,CACNA2D1,CACNA1G,CACNA1C,CACNA1E,CACNA1A |
2.669e-07 | -15.14 | inorganic ion import across plasma membrane | biological process | GO:0099587 | 104 | 6 | 18204 | 47 |
CACNA1G,CACNA1C,CACNA2D1,SLC8A3,CACNA1A,CACNA1E |
2.710e-07 | -15.12 | Signalling to ERKs | REACTOME pathways | R-HSA-187687 | 263 | 9 | 10285 | 37 |
CAMK2B,DLG4,SPTBN4,NRG3,GRIN1,RASGRF1,SPTBN2,CAMK2A,GRIN2B |
2.890e-07 | -15.06 | FCERI mediated MAPK activation | REACTOME pathways | R-HSA-2871796 | 265 | 9 | 10285 | 37 |
GRIN1,RASGRF1,SPTBN4,NRG3,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
2.908e-07 | -15.05 | Amphetamine addiction | KEGG pathways | hsa05031 | 68 | 6 | 7161 | 30 |
STX1A,CACNA1C,GRIN2B,CAMK2B,CAMK2A,GRIN1 |
2.908e-07 | -15.05 | Amphetamine addiction | KEGG pathways | ko05031 | 68 | 6 | 7161 | 30 |
CAMK2A,CACNA1C,STX1A,CAMK2B,GRIN2B,GRIN1 |
2.927e-07 | -15.04 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 27 | 16828 | 47 |
FGF14,CACNA1G,PPFIA2,DLGAP2,LRRC7,SCN8A,HCN1,SNAP25,CCDC136,NRG3,SLC8A3,GRIN2B,SPTBN2,EDIL3,SLC4A10,CACNA1C,CAMK2B,PCLO,MCF2L2,GRIN1,RIMS1,CACNA2D1,NRXN3,L1CAM,RYR2,CACNA1E,SYT1 |
2.927e-07 | -15.04 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 27 | 16828 | 47 |
GRIN2B,SLC8A3,NRG3,CCDC136,CAMK2B,EDIL3,CACNA1C,SLC4A10,SPTBN2,CACNA2D1,NRXN3,RIMS1,GRIN1,MCF2L2,PCLO,SYT1,CACNA1E,RYR2,L1CAM,PPFIA2,CACNA1G,FGF14,LRRC7,DLGAP2,SCN8A,SNAP25,HCN1 |
3.190e-07 | -14.96 | cardiac muscle cell action potential | biological process | GO:0086001 | 56 | 5 | 18204 | 47 |
SCN8A,CACNA1C,CACNA1G,RYR2,CACNA2D1 |
3.246e-07 | -14.94 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 28 | 16828 | 47 |
CACNA1C,SPTBN2,SLC8A3,GRIN2B,CCDC136,RYR2,SYT1,CACNA1E,L1CAM,NRXN3,MCF2L2,PCLO,RIMS1,CACNA1A,CAMK2A,CELF5,LRRC7,DLGAP2,EPHA6,NRXN2,CACNA1G,IQSEC2,HCN1,CAMKV,SPTBN4,MYT1L,DNM1,PPFIA3 |
3.386e-07 | -14.90 | RET signaling | REACTOME pathways | R-HSA-8853659 | 270 | 9 | 10285 | 37 |
DLG4,CAMK2B,GRIN1,RASGRF1,SPTBN4,NRG3,SPTBN2,GRIN2B,CAMK2A |
3.433e-07 | -14.88 | localization | biological process | GO:0051179 | 4474 | 28 | 18204 | 47 |
SPTBN4,SLC8A3,GRIN2B,PPFIA3,SNAP25,CACNA1A,CAMK2A,HCN1,GABRB2,GRIN1,STX1A,SPTBN2,LRRC7,NRXN2,CPLX1,DLG4,CACNA2D1,SCN8A,DNM1,RIMS1,CACNA1C,SYT1,PPFIA2,SLC4A10,CACNA1E,PCLO,CACNA1G,RYR2 |
3.493e-07 | -14.87 | Interleukin-3, 5 and GM-CSF signaling | REACTOME pathways | R-HSA-512988 | 271 | 9 | 10285 | 37 |
SPTBN2,GRIN2B,CAMK2A,DLG4,CAMK2B,GRIN1,RASGRF1,NRG3,SPTBN4 |
3.777e-07 | -14.79 | SNAP25 (synaptosome associated protein 25) | protein interactions | 6616 | 58 | 5 | 19454 | 50 |
RIMS1,STX1A,DNM1,SYT1,CPLX1 |
4.157e-07 | -14.69 | protein localization to synapse | biological process | GO:0035418 | 59 | 5 | 18204 | 47 |
DLG4,SNAP25,LRRC7,NRXN2,PCLO |
4.439e-07 | -14.63 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 16 | 16828 | 47 |
L1CAM,MYT1L,HCN1,RYR2,CACNA1E,SPTBN4,GRIN1,NRXN3,CACNA2D1,EPHA6,CAMK2B,LRRC7,CCDC136,GRM5,SLC8A3,PPFIA2 |
4.920e-07 | -14.52 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 8 | 10285 | 37 |
FGF14,CAMK2B,CACNA1C,SCN8A,CACNA2D1,RYR2,CAMK2A,SLC8A3 |
5.095e-07 | -14.49 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 16 | 16828 | 47 |
RYR2,HCN1,SPTBN4,CACNA1E,L1CAM,MYT1L,CACNA2D1,NRXN3,GRIN1,CAMK2B,LRRC7,EPHA6,SLC8A3,PPFIA2,CCDC136,GRM5 |
5.999e-07 | -14.33 | Ca_chan_IQ | pfam domains | PF08763 | 7 | 3 | 17795 | 47 |
CACNA1E,CACNA1C,CACNA1A |
5.999e-07 | -14.33 | GPHH | pfam domains | PF16905 | 7 | 3 | 17795 | 47 |
CACNA1A,CACNA1C,CACNA1E |
6.046e-07 | -14.32 | VDCC_a1su_IQ | interpro domains | IPR014873 | 7 | 3 | 18521 | 49 |
CACNA1A,CACNA1E,CACNA1C |
6.046e-07 | -14.32 | GPHH_dom | interpro domains | IPR031649 | 7 | 3 | 18521 | 49 |
CACNA1A,CACNA1E,CACNA1C |
6.185e-07 | -14.30 | MAPK family signaling cascades | REACTOME pathways | R-HSA-5683057 | 290 | 9 | 10285 | 37 |
CAMK2A,GRIN2B,SPTBN2,SPTBN4,NRG3,RASGRF1,GRIN1,CAMK2B,DLG4 |
6.552e-07 | -14.24 | cell-cell signaling involved in cardiac conduction | biological process | GO:0086019 | 27 | 4 | 18204 | 47 |
CACNA1C,CACNA1G,CACNA2D1,RYR2 |
6.704e-07 | -14.22 | HAX1 (HCLS1 associated protein X-1) | protein interactions | 10456 | 397 | 9 | 19454 | 50 |
CAMK2B,VSNL1,DNM1,L1CAM,EDIL3,SYT1,CAMK2A,CAMKV,STX1A |
6.939e-07 | -14.18 | IRS-mediated signalling | REACTOME pathways | R-HSA-112399 | 294 | 9 | 10285 | 37 |
DLG4,CAMK2B,GRIN1,RASGRF1,NRG3,SPTBN4,SPTBN2,GRIN2B,CAMK2A |
7.102e-07 | -14.16 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 10 | 10285 | 37 |
GRIN1,RASGRF1,DNM1,SPTBN4,NRG3,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
7.249e-07 | -14.14 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | REACTOME pathways | R-HSA-112314 | 146 | 7 | 10285 | 37 |
GRIN1,RASGRF1,GRIN2B,CAMK2A,GABRB2,DLG4,CAMK2B |
7.332e-07 | -14.13 | excitatory synapse | cellular component | GO:0060076 | 65 | 5 | 19108 | 50 |
SPTBN2,SCN8A,SYT1,GRIN1,DLG4 |
7.553e-07 | -14.10 | ERC2 (ELKS/RAB6-interacting/CAST family member 2) | protein interactions | 26059 | 28 | 4 | 19454 | 50 |
RIMS1,PCLO,PPFIA3,PPFIA2 |
7.556e-07 | -14.10 | Insulin receptor signalling cascade | REACTOME pathways | R-HSA-74751 | 297 | 9 | 10285 | 37 |
SPTBN2,GRIN2B,CAMK2A,DLG4,CAMK2B,RASGRF1,GRIN1,SPTBN4,NRG3 |
7.557e-07 | -14.10 | action potential | biological process | GO:0001508 | 124 | 6 | 18204 | 47 |
HCN1,CACNA2D1,SCN8A,RYR2,CACNA1C,CACNA1G |
7.772e-07 | -14.07 | IRS-related events triggered by IGF1R | REACTOME pathways | R-HSA-2428928 | 298 | 9 | 10285 | 37 |
GRIN1,RASGRF1,NRG3,SPTBN4,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
7.772e-07 | -14.07 | IGF1R signaling cascade | REACTOME pathways | R-HSA-2428924 | 298 | 9 | 10285 | 37 |
CAMK2A,GRIN2B,SPTBN2,SPTBN4,NRG3,RASGRF1,GRIN1,CAMK2B,DLG4 |
7.823e-07 | -14.06 | ARMC1 (armadillo repeat containing 1) | protein interactions | 55156 | 67 | 5 | 19454 | 50 |
CAMK2B,SYT1,CAMKV,VSNL1,CAMK2A |
7.993e-07 | -14.04 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | REACTOME pathways | R-HSA-2404192 | 299 | 9 | 10285 | 37 |
SPTBN2,GRIN2B,CAMK2A,DLG4,CAMK2B,GRIN1,RASGRF1,SPTBN4,NRG3 |
8.722e-07 | -13.95 | postsynaptic specialization membrane | cellular component | GO:0099634 | 125 | 6 | 19108 | 50 |
DLG4,GRIN2B,CACNA1C,GABRB2,GRM5,SCN8A |
9.087e-07 | -13.91 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 12 | 16828 | 47 |
PPFIA2,FGF14,NRG3,GRM5,ABLIM1,CACNA1C,EPHA6,NRXN3,SCN8A,PCLO,RYR2,MYT1L |
9.165e-07 | -13.90 | mouth | COSMIC cancer mutations | mouth | 9004 | 41 | 16828 | 47 |
EPHA6,CELF5,CAMK2A,DLGAP2,LRRC7,GABRB2,ABLIM1,NRXN2,IQSEC2,PPFIA2,CACNA1G,MYT1L,HCN1,SNAP25,SPTBN4,SCN8A,PPFIA3,DNM1,CELF3,SPTBN2,SLC4A10,CACNA1C,EDIL3,CCDC136,GRM5,NRG3,SLC8A3,GRIN2B,L1CAM,RYR2,CACNA1E,SYT1,PCLO,DLG4,RASGRF1,MCF2L2,GRIN1,CACNA1A,RIMS1,NRXN3,CACNA2D1 |
9.839e-07 | -13.83 | cardiac conduction | biological process | GO:0061337 | 70 | 5 | 18204 | 47 |
SPTBN4,RYR2,CACNA2D1,CACNA1C,CACNA1G |
1.002e-06 | -13.81 | neuron projection terminus | cellular component | GO:0044306 | 128 | 6 | 19108 | 50 |
SLC8A3,GRIN1,SLC4A10,DLG4,SYT1,CPLX1 |
1.180e-06 | -13.65 | regulation of cell communication | biological process | GO:0010646 | 3541 | 24 | 18204 | 47 |
SLC4A10,PPFIA2,RYR2,CAMK2B,DLG4,CAMKV,CPLX1,DLGAP2,RASGRF1,SYT1,NRG3,RIMS1,DNM1,STX1A,GRIN1,IQSEC2,CACNA1A,CAMK2A,GRM5,VSNL1,SLC8A3,PPFIA3,SNAP25,GRIN2B |
1.188e-06 | -13.64 | - | gene3d domains | 6.10.250.2180 | 7 | 3 | 14470 | 48 |
CACNA1C,CACNA1A,CACNA1E |
1.188e-06 | -13.64 | - | gene3d domains | 6.10.250.2500 | 7 | 3 | 14470 | 48 |
CACNA1E,CACNA1A,CACNA1C |
1.280e-06 | -13.57 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 14 | 16828 | 47 |
EDIL3,DLGAP2,LRRC7,NRG3,FGF14,PPFIA2,L1CAM,RYR2,HCN1,CACNA1E,PPFIA3,PCLO,CACNA2D1,NRXN3 |
1.327e-06 | -13.53 | CAMK2N1 (calcium/calmodulin dependent protein kinase II inhibitor 1) | protein interactions | 55450 | 9 | 3 | 19454 | 50 |
GRIN2B,CAMK2B,CAMK2A |
1.403e-06 | -13.48 | L1CAM interactions | REACTOME pathways | R-HSA-373760 | 101 | 6 | 10285 | 37 |
SPTBN2,SCN8A,L1CAM,SPTBN4,DNM1,DLG4 |
1.413e-06 | -13.47 | presynaptic active zone membrane | cellular component | GO:0048787 | 32 | 4 | 19108 | 50 |
STX1A,HCN1,SNAP25,SCN8A |
1.483e-06 | -13.42 | Signaling by Insulin receptor | REACTOME pathways | R-HSA-74752 | 322 | 9 | 10285 | 37 |
GRIN2B,CAMK2A,SPTBN2,GRIN1,RASGRF1,SPTBN4,NRG3,DLG4,CAMK2B |
1.485e-06 | -13.42 | actin-mediated cell contraction | biological process | GO:0070252 | 76 | 5 | 18204 | 47 |
SCN8A,CACNA2D1,RYR2,CACNA1C,CACNA1G |
1.585e-06 | -13.36 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 5 | 18204 | 47 |
SYT1,GRIN1,GRM5,IQSEC2,GRIN2B |
1.633e-06 | -13.32 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 27 | 16828 | 47 |
NRXN2,PPFIA2,FGF14,CAMK2A,CELF5,LRRC7,DLGAP2,SCN8A,HCN1,SPTBN4,GRM5,VSNL1,SLC8A3,NRG3,GRIN2B,SPTBN2,EDIL3,CACNA1C,CAMK2B,RASGRF1,PCLO,RIMS1,NRXN3,CACNA2D1,RYR2,SYT1,CACNA1E |
1.654e-06 | -13.31 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 32 | 16828 | 47 |
CAMK2B,CACNA1C,EDIL3,SLC4A10,SPTBN2,GRIN2B,NRG3,SLC8A3,GRM5,CCDC136,CACNA1E,RYR2,L1CAM,CACNA2D1,NRXN3,RIMS1,CACNA1A,PCLO,RASGRF1,MCF2L2,GRIN1,LRRC7,GABRB2,IQSEC2,PPFIA2,CACNA1G,NRXN2,CAMKV,HCN1,MYT1L,DNM1,SCN8A |
1.654e-06 | -13.31 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 32 | 16828 | 47 |
NRXN3,CACNA2D1,CACNA1A,RIMS1,GRIN1,RASGRF1,MCF2L2,PCLO,CACNA1E,RYR2,L1CAM,GRIN2B,SLC8A3,NRG3,GRM5,CCDC136,CAMK2B,CACNA1C,SLC4A10,EDIL3,SPTBN2,DNM1,SCN8A,HCN1,CAMKV,MYT1L,PPFIA2,CACNA1G,IQSEC2,NRXN2,GABRB2,LRRC7 |
1.742e-06 | -13.26 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 25 | 16828 | 47 |
HCN1,SCN8A,DLGAP2,LRRC7,CELF5,CAMK2A,FGF14,PPFIA2,NRXN2,SYT1,RYR2,NRXN3,CACNA2D1,RIMS1,PCLO,RASGRF1,CAMK2B,EDIL3,CACNA1C,SPTBN2,GRIN2B,NRG3,SLC8A3,VSNL1,GRM5 |
1.818e-06 | -13.22 | VEGFA-VEGFR2 Pathway | REACTOME pathways | R-HSA-4420097 | 330 | 9 | 10285 | 37 |
DLG4,CAMK2B,RASGRF1,GRIN1,NRG3,SPTBN4,SPTBN2,GRIN2B,CAMK2A |
1.868e-06 | -13.19 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 16 | 16828 | 47 |
RIMS1,NRXN3,CACNA2D1,CACNA1E,SYT1,RYR2,HCN1,VSNL1,CCDC136,FGF14,GRIN2B,CACNA1G,PPFIA2,NRG3,CELF3,EDIL3 |
1.868e-06 | -13.19 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 16 | 16828 | 47 |
NRXN3,CACNA2D1,RIMS1,SYT1,CACNA1E,HCN1,RYR2,CACNA1G,PPFIA2,FGF14,GRIN2B,NRG3,VSNL1,CCDC136,EDIL3,CELF3 |
1.893e-06 | -13.18 | GRIN3A (glutamate ionotropic receptor NMDA type subunit 3A) | protein interactions | 116443 | 10 | 3 | 19454 | 50 |
DLG4,GRIN1,GRIN2B |
2.163e-06 | -13.04 | Signaling by SCF-KIT | REACTOME pathways | R-HSA-1433557 | 337 | 9 | 10285 | 37 |
SPTBN2,CAMK2A,GRIN2B,CAMK2B,DLG4,NRG3,SPTBN4,RASGRF1,GRIN1 |
2.189e-06 | -13.03 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 7 | 5310 | 23 |
RYR2,CACNA1A,CACNA1C,CAMK2A,CAMK2B,SLC8A3,CACNA1E |
2.192e-06 | -13.03 | transmembrane transport | biological process | GO:0055085 | 1264 | 14 | 18204 | 47 |
CACNA1A,GABRB2,HCN1,SLC4A10,GRIN1,CACNA1E,CACNA1G,RYR2,CACNA2D1,SLC8A3,GRIN2B,SCN8A,SNAP25,CACNA1C |
2.217e-06 | -13.02 | Signaling by VEGF | REACTOME pathways | R-HSA-194138 | 338 | 9 | 10285 | 37 |
RASGRF1,GRIN1,SPTBN4,NRG3,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
2.236e-06 | -13.01 | Ca_chan_IQ | smart domains | SM01062 | 7 | 3 | 9717 | 40 |
CACNA1A,CACNA1C,CACNA1E |
2.250e-06 | -13.00 | neuron differentiation | biological process | GO:0030182 | 1081 | 13 | 18204 | 47 |
SPTBN4,BRINP1,DLG4,MYT1L,RASGRF1,SNAP25,L1CAM,EPHA6,CAMK2A,SLC4A10,GABRB2,HCN1,NRXN3 |
2.280e-06 | -12.99 | SYT1 (synaptotagmin 1) | protein interactions | 6857 | 83 | 5 | 19454 | 50 |
SYT1,SNAP25,RIMS1,STX1A,CACNA1A |
2.283e-06 | -12.99 | ACTN2 (actinin alpha 2) | protein interactions | 88 | 150 | 6 | 19454 | 50 |
CACNA1C,CAMK2A,GRIN1,GRIN2B,LRRC7,DLG4 |
2.302e-06 | -12.98 | cardiac muscle contraction | biological process | GO:0060048 | 83 | 5 | 18204 | 47 |
SCN8A,RYR2,CACNA2D1,CACNA1C,CACNA1G |
2.314e-06 | -12.98 | anatomical structure development | biological process | GO:0048856 | 5207 | 29 | 18204 | 47 |
SLC8A3,MYT1L,SPTBN4,SNAP25,GRIN2B,GRIN1,GABRB2,HCN1,ABLIM1,CAMK2A,EPHA6,L1CAM,NRXN3,LRRC7,SPTBN2,BRINP1,DLG4,NRXN2,FGF14,CACNA1C,NRG3,RASGRF1,SCN8A,SLC4A10,CACNA1G,RYR2,CCDC136,PCLO,CAMK2B |
2.426e-06 | -12.93 | Gastrin-CREB signalling pathway via PKC and MAPK | REACTOME pathways | R-HSA-881907 | 443 | 10 | 10285 | 37 |
GRM5,RASGRF1,GRIN1,NRG3,SPTBN4,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
2.509e-06 | -12.90 | regulation of monoatomic ion transport | biological process | GO:0043269 | 466 | 9 | 18204 | 47 |
CAMK2B,GRIN2B,RYR2,CACNA1C,CAMK2A,FGF14,SPTBN4,CACNA2D1,GRIN1 |
2.598e-06 | -12.86 | Caskin1 (CASK interacting protein 1) | protein interactions | 140722 | 11 | 3 | 19454 | 50 |
SYT1,NRXN2,L1CAM |
2.617e-06 | -12.85 | exocytosis | biological process | GO:0006887 | 241 | 7 | 18204 | 47 |
STX1A,CPLX1,PPFIA3,RIMS1,SNAP25,SYT1,PCLO |
2.745e-06 | -12.81 | protein localization to cell junction | biological process | GO:1902414 | 86 | 5 | 18204 | 47 |
DLG4,LRRC7,SNAP25,PCLO,NRXN2 |
3.042e-06 | -12.70 | thyroid-other-neoplasm | COSMIC cancer mutations | thyroid-other-neoplasm | 7637 | 37 | 16828 | 47 |
L1CAM,CACNA1E,SYT1,RYR2,CACNA1A,RIMS1,PCLO,DLG4,GRIN1,RASGRF1,CACNA2D1,NRXN3,SPTBN2,CELF3,CAMK2B,EDIL3,CACNA1C,GRM5,CCDC136,GRIN2B,NRG3,MYT1L,SPTBN4,CAMKV,SCN8A,PPFIA3,DNM1,EPHA6,DLGAP2,STX1A,LRRC7,CELF5,CAMK2A,ABLIM1,IQSEC2,CACNA1G,NRXN2 |
3.097e-06 | -12.69 | Downstream signal transduction | REACTOME pathways | R-HSA-186763 | 352 | 9 | 10285 | 37 |
GRIN1,RASGRF1,NRG3,SPTBN4,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
3.398e-06 | -12.59 | DAP12 signaling | REACTOME pathways | R-HSA-2424491 | 356 | 9 | 10285 | 37 |
CAMK2B,DLG4,NRG3,SPTBN4,GRIN1,RASGRF1,SPTBN2,CAMK2A,GRIN2B |
3.526e-06 | -12.56 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 17 | 16828 | 47 |
EPHA6,SPTBN2,SLC4A10,CCDC136,GRM5,NRG3,NRXN2,L1CAM,MYT1L,RYR2,HCN1,PCLO,SCN8A,GRIN1,CACNA1A,RIMS1,NRXN3 |
3.526e-06 | -12.56 | functioning | COSMIC cancer mutations | functioning | 1803 | 17 | 16828 | 47 |
NRG3,NRXN2,CCDC136,GRM5,SLC4A10,EPHA6,SPTBN2,NRXN3,SCN8A,PCLO,GRIN1,CACNA1A,RIMS1,RYR2,HCN1,L1CAM,MYT1L |
3.633e-06 | -12.53 | Interaction between L1 and Ankyrins | REACTOME pathways | R-HSA-445095 | 30 | 4 | 10285 | 37 |
SPTBN2,SCN8A,SPTBN4,L1CAM |
3.725e-06 | -12.50 | positive regulation of cytosolic calcium ion concentration | biological process | GO:0007204 | 163 | 6 | 18204 | 47 |
CACNA1C,RYR2,DLG4,GRIN1,CACNA2D1,CACNA1A |
3.997e-06 | -12.43 | import across plasma membrane | biological process | GO:0098739 | 165 | 6 | 18204 | 47 |
CACNA1E,CACNA1C,CACNA1G,CACNA1A,SLC8A3,CACNA2D1 |
4.023e-06 | -12.42 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 35 | 16828 | 47 |
L1CAM,CACNA1E,RYR2,RIMS1,MCF2L2,RASGRF1,DLG4,GRIN1,PCLO,CACNA2D1,NRXN3,SPTBN2,CACNA1C,SLC4A10,GRM5,CCDC136,GRIN2B,SLC8A3,NRG3,MYT1L,SPTBN4,SNAP25,HCN1,PPFIA3,SCN8A,DNM1,EPHA6,GABRB2,LRRC7,DLGAP2,ABLIM1,CACNA1G,PPFIA2,IQSEC2,NRXN2 |
4.077e-06 | -12.41 | Signaling by EGFR | REACTOME pathways | R-HSA-177929 | 364 | 9 | 10285 | 37 |
GRIN2B,CAMK2A,SPTBN2,RASGRF1,GRIN1,NRG3,SPTBN4,DLG4,CAMK2B |
4.128e-06 | -12.40 | neurogenesis | biological process | GO:0022008 | 1334 | 14 | 18204 | 47 |
SLC4A10,HCN1,GABRB2,CAMK2A,EPHA6,L1CAM,NRXN3,SLC8A3,DLG4,BRINP1,MYT1L,SPTBN4,SNAP25,RASGRF1 |
4.530e-06 | -12.30 | calcium ion transport into cytosol | biological process | GO:0060402 | 13 | 3 | 18204 | 47 |
CACNA2D1,RYR2,CACNA1C |
4.562e-06 | -12.30 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 42 | 16828 | 47 |
LRRC7,DLGAP2,CAMK2A,CELF5,EPHA6,CACNA1G,PPFIA2,FGF14,IQSEC2,NRXN2,ABLIM1,SNAP25,SPTBN4,CAMKV,HCN1,MYT1L,DNM1,SCN8A,PPFIA3,CAMK2B,CPLX1,SLC4A10,EDIL3,CACNA1C,SPTBN2,CELF3,GRIN2B,SLC8A3,NRG3,GRM5,VSNL1,SYT1,CACNA1E,RYR2,L1CAM,NRXN3,CACNA2D1,RIMS1,DLG4,MCF2L2,RASGRF1,PCLO |
4.644e-06 | -12.28 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 42 | 16828 | 47 |
GRIN2B,NRG3,SLC8A3,VSNL1,GRM5,CPLX1,CAMK2B,EDIL3,SLC4A10,CACNA1C,SPTBN2,CELF3,CACNA2D1,NRXN3,RIMS1,PCLO,RASGRF1,DLG4,MCF2L2,CACNA1E,SYT1,RYR2,L1CAM,IQSEC2,FGF14,PPFIA2,CACNA1G,NRXN2,ABLIM1,DLGAP2,LRRC7,CELF5,CAMK2A,EPHA6,DNM1,PPFIA3,SCN8A,SNAP25,SPTBN4,CAMKV,HCN1,MYT1L |
4.709e-06 | -12.27 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 10 | 10285 | 37 |
NRG3,SPTBN4,GRIN1,RASGRF1,DNM1,CAMK2B,DLG4,CAMK2A,GRIN2B,SPTBN2 |
4.764e-06 | -12.25 | DAP12 interactions | REACTOME pathways | R-HSA-2172127 | 371 | 9 | 10285 | 37 |
NRG3,SPTBN4,GRIN1,RASGRF1,CAMK2B,DLG4,CAMK2A,GRIN2B,SPTBN2 |
4.808e-06 | -12.25 | generation of neurons | biological process | GO:0048699 | 1158 | 13 | 18204 | 47 |
NRXN3,CAMK2A,EPHA6,L1CAM,SLC4A10,GABRB2,HCN1,SNAP25,RASGRF1,SPTBN4,BRINP1,DLG4,MYT1L |
4.857e-06 | -12.24 | regulation of signaling | biological process | GO:0023051 | 3534 | 23 | 18204 | 47 |
SLC8A3,GRIN2B,PPFIA3,SNAP25,CACNA1A,IQSEC2,CAMK2A,GRM5,VSNL1,STX1A,GRIN1,DLGAP2,CPLX1,DLG4,CAMKV,DNM1,RASGRF1,RIMS1,SYT1,NRG3,PPFIA2,SLC4A10,CAMK2B |
4.858e-06 | -12.23 | UNC13B (unc-13 homolog B) | protein interactions | 10497 | 44 | 4 | 19454 | 50 |
SNAP25,RIMS1,STX1A,SPTBN2 |
4.870e-06 | -12.23 | Fc epsilon receptor (FCERI) signaling | REACTOME pathways | R-HSA-2454202 | 372 | 9 | 10285 | 37 |
DLG4,CAMK2B,RASGRF1,GRIN1,SPTBN4,NRG3,SPTBN2,GRIN2B,CAMK2A |
5.031e-06 | -12.20 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 27 | 16828 | 47 |
CAMK2A,DLGAP2,LRRC7,EPHA6,NRXN2,FGF14,PPFIA2,CACNA1G,ABLIM1,CAMKV,HCN1,SPTBN4,MYT1L,PPFIA3,CACNA1C,CAMK2B,NRG3,GRM5,RYR2,CACNA1E,NRXN3,CACNA2D1,PCLO,RASGRF1,MCF2L2,CACNA1A,RIMS1 |
5.031e-06 | -12.20 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 27 | 16828 | 47 |
PPFIA3,SPTBN4,HCN1,CAMKV,MYT1L,PPFIA2,CACNA1G,FGF14,NRXN2,ABLIM1,LRRC7,DLGAP2,CAMK2A,EPHA6,CACNA2D1,NRXN3,RIMS1,CACNA1A,MCF2L2,RASGRF1,PCLO,CACNA1E,RYR2,NRG3,GRM5,CAMK2B,CACNA1C |
5.055e-06 | -12.20 | Neurotoxicity of clostridium toxins | REACTOME pathways | R-HSA-168799 | 10 | 3 | 10285 | 37 |
STX1A,SNAP25,SYT1 |
5.314e-06 | -12.15 | Signaling by PDGF | REACTOME pathways | R-HSA-186797 | 376 | 9 | 10285 | 37 |
SPTBN2,GRIN2B,CAMK2A,DLG4,CAMK2B,RASGRF1,GRIN1,NRG3,SPTBN4 |
5.377e-06 | -12.13 | cell communication involved in cardiac conduction | biological process | GO:0086065 | 45 | 4 | 18204 | 47 |
RYR2,CACNA2D1,CACNA1C,CACNA1G |
5.499e-06 | -12.11 | heart contraction | biological process | GO:0060047 | 99 | 5 | 18204 | 47 |
SCN8A,CACNA1G,CACNA1C,RYR2,CACNA2D1 |
5.579e-06 | -12.10 | dendritic spine | cellular component | GO:0043197 | 172 | 6 | 19108 | 50 |
DLG4,CAMK2A,GRIN1,GRM5,PPFIA2,SLC8A3 |
5.962e-06 | -12.03 | neuron spine | cellular component | GO:0044309 | 174 | 6 | 19108 | 50 |
SLC8A3,PPFIA2,GRM5,GRIN1,CAMK2A,DLG4 |
6.067e-06 | -12.01 | actin filament-based movement | biological process | GO:0030048 | 101 | 5 | 18204 | 47 |
SCN8A,RYR2,CACNA2D1,CACNA1C,CACNA1G |
6.202e-06 | -11.99 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 6 | 7161 | 30 |
DLG4,CACNA1A,CACNA1C,GRM5,GRIN2B,GRIN1 |
6.202e-06 | -11.99 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 6 | 7161 | 30 |
GRIN1,GRM5,GRIN2B,CACNA1C,DLG4,CACNA1A |
6.551e-06 | -11.94 | postsynaptic density membrane | cellular component | GO:0098839 | 101 | 5 | 19108 | 50 |
SCN8A,DLG4,GRIN2B,CACNA1C,GRM5 |
6.566e-06 | -11.93 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 33 | 16828 | 47 |
EPHA6,CELF5,CAMK2A,DLGAP2,GABRB2,ABLIM1,NRXN2,IQSEC2,PPFIA2,CACNA1G,MYT1L,CAMKV,SPTBN4,SCN8A,DNM1,CELF3,SPTBN2,SLC4A10,CACNA1C,CAMK2B,GRM5,NRG3,SLC8A3,GRIN2B,RYR2,CACNA1E,PCLO,RASGRF1,MCF2L2,RIMS1,CACNA1A,CACNA2D1,NRXN3 |
6.566e-06 | -11.93 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 33 | 16828 | 47 |
RYR2,CACNA1E,NRXN3,CACNA2D1,PCLO,MCF2L2,RASGRF1,CACNA1A,RIMS1,CACNA1C,SLC4A10,CAMK2B,CELF3,SPTBN2,NRG3,SLC8A3,GRIN2B,GRM5,CAMKV,SPTBN4,MYT1L,DNM1,SCN8A,CELF5,CAMK2A,DLGAP2,GABRB2,EPHA6,NRXN2,IQSEC2,CACNA1G,PPFIA2,ABLIM1 |
6.615e-06 | -11.93 | regulation of metal ion transport | biological process | GO:0010959 | 393 | 8 | 18204 | 47 |
CACNA1C,RYR2,CAMK2B,GRIN1,CACNA2D1,CAMK2A,FGF14,SPTBN4 |
6.649e-06 | -11.92 | distal axon | cellular component | GO:0150034 | 273 | 7 | 19108 | 50 |
SLC4A10,SNAP25,RASGRF1,GRIN1,SLC8A3,CPLX1,L1CAM |
6.679e-06 | -11.92 | regulation of heart rate | biological process | GO:0002027 | 103 | 5 | 18204 | 47 |
CACNA2D1,RYR2,CACNA1G,CACNA1C,SPTBN4 |
6.982e-06 | -11.87 | calcium-ion regulated exocytosis | biological process | GO:0017156 | 48 | 4 | 18204 | 47 |
SYT1,RIMS1,STX1A,SNAP25 |
7.169e-06 | -11.85 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 18 | 16828 | 47 |
EDIL3,CAMK2A,DLGAP2,LRRC7,CCDC136,NRG3,NRXN2,FGF14,GRIN2B,PPFIA2,RYR2,HCN1,SPTBN4,SYT1,PCLO,RIMS1,CACNA2D1,NRXN3 |
7.169e-06 | -11.85 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 18 | 16828 | 47 |
HCN1,RYR2,SYT1,SPTBN4,NRXN3,CACNA2D1,PCLO,RIMS1,CAMK2A,EDIL3,LRRC7,DLGAP2,NRG3,NRXN2,PPFIA2,FGF14,GRIN2B,CCDC136 |
7.221e-06 | -11.84 | multicellular organismal process | biological process | GO:0032501 | 6177 | 31 | 18204 | 47 |
GRIN1,HCN1,GABRB2,ABLIM1,CAMK2A,GRM5,EPHA6,L1CAM,LRRC7,NRXN3,SPTBN2,SLC8A3,MYT1L,SPTBN4,SNAP25,GRIN2B,SLC4A10,CACNA1G,RYR2,PCLO,CAMK2B,CACNA2D1,DLG4,BRINP1,NRXN2,FGF14,RIMS1,CACNA1C,NRG3,RASGRF1,SCN8A |
7.687e-06 | -11.78 | regulation of postsynaptic membrane potential | biological process | GO:0060078 | 106 | 5 | 18204 | 47 |
GABRB2,HCN1,GRIN1,GRIN2B,GRM5 |
8.021e-06 | -11.73 | import into cell | biological process | GO:0098657 | 687 | 10 | 18204 | 47 |
SYT1,CACNA1G,SNAP25,CACNA1C,DNM1,CACNA1E,CACNA2D1,SLC8A3,STX1A,CACNA1A |
8.068e-06 | -11.73 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 22 | 16828 | 47 |
FGF14,PPFIA2,DLGAP2,LRRC7,GABRB2,HCN1,SPTBN4,SNAP25,CCDC136,NRG3,SPTBN2,SLC4A10,EDIL3,CPLX1,CAMK2B,MCF2L2,CACNA1A,RIMS1,CACNA2D1,NRXN3,RYR2,SYT1 |
9.001e-06 | -11.62 | Regulation of insulin secretion | REACTOME pathways | R-HSA-422356 | 80 | 5 | 10285 | 37 |
CACNA1C,SNAP25,CACNA1A,STX1A,CACNA1E |
9.512e-06 | -11.56 | cortical cytoskeleton | cellular component | GO:0030863 | 109 | 5 | 19108 | 50 |
SPTBN4,SPTBN2,DLG4,PCLO,RIMS1 |
9.537e-06 | -11.56 | DLG3 (discs large MAGUK scaffold protein 3) | protein interactions | 1741 | 111 | 5 | 19454 | 50 |
GRIN2B,GRIN1,DLGAP2,DLG4,CAMK2A |
9.753e-06 | -11.54 | regulation of secretion by cell | biological process | GO:1903530 | 551 | 9 | 18204 | 47 |
PCLO,SNAP25,RIMS1,SYT1,PPFIA2,CAMK2A,VSNL1,CPLX1,STX1A |
1.020e-05 | -11.49 | SNARE binding | molecular function | GO:0000149 | 107 | 5 | 18094 | 49 |
SYT1,CACNA1A,SNAP25,STX1A,CPLX1 |
1.041e-05 | -11.47 | biological process involved in intraspecies interaction between organisms | biological process | GO:0051703 | 53 | 4 | 18204 | 47 |
DLG4,BRINP1,NRXN3,NRXN2 |
1.041e-05 | -11.47 | social behavior | biological process | GO:0035176 | 53 | 4 | 18204 | 47 |
NRXN3,BRINP1,DLG4,NRXN2 |
1.047e-05 | -11.47 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 35 | 16828 | 47 |
HCN1,SPTBN4,SNAP25,ABLIM1,NRXN2,PPFIA2,CACNA1G,FGF14,IQSEC2,EPHA6,CAMK2A,CELF5,GABRB2,LRRC7,DLGAP2,MCF2L2,RASGRF1,GRIN1,PCLO,RIMS1,NRXN3,CACNA2D1,RYR2,SYT1,CACNA1E,GRM5,VSNL1,SLC8A3,NRG3,GRIN2B,SPTBN2,EDIL3,CACNA1C,CAMK2B,CPLX1 |
1.051e-05 | -11.46 | heart process | biological process | GO:0003015 | 113 | 5 | 18204 | 47 |
SCN8A,CACNA1G,CACNA1C,CACNA2D1,RYR2 |
1.069e-05 | -11.45 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 3 | 18204 | 47 |
CACNA2D1,CACNA1G,CACNA1C |
1.074e-05 | -11.44 | secretion by cell | biological process | GO:0032940 | 420 | 8 | 18204 | 47 |
CPLX1,NRXN2,STX1A,PCLO,SYT1,RIMS1,SNAP25,PPFIA3 |
1.100e-05 | -11.42 | Signaling by Interleukins | REACTOME pathways | R-HSA-449147 | 525 | 10 | 10285 | 37 |
RASGRF1,GRIN1,NRG3,SPTBN4,STX1A,DLG4,CAMK2B,GRIN2B,CAMK2A,SPTBN2 |
1.117e-05 | -11.40 | presynaptic active zone cytoplasmic component | cellular component | GO:0098831 | 17 | 3 | 19108 | 50 |
PPFIA3,RIMS1,PCLO |
1.196e-05 | -11.33 | Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels | REACTOME pathways | R-HSA-112308 | 13 | 3 | 10285 | 37 |
CACNA1A,CACNA1E,CACNA2D1 |
1.281e-05 | -11.27 | calcium ion-regulated exocytosis of neurotransmitter | biological process | GO:0048791 | 18 | 3 | 18204 | 47 |
SYT1,SNAP25,RIMS1 |
1.297e-05 | -11.25 | synapse assembly | biological process | GO:0007416 | 118 | 5 | 18204 | 47 |
NRG3,GABRB2,PCLO,NRXN2,SPTBN2 |
1.298e-05 | -11.25 | vesicle docking | biological process | GO:0048278 | 56 | 4 | 18204 | 47 |
PPFIA3,STX1A,SNAP25,SYT1 |
1.309e-05 | -11.24 | cellular component organization | biological process | GO:0016043 | 5636 | 29 | 18204 | 47 |
SPTBN2,NRXN3,ABLIM1,CAMK2A,GRM5,EPHA6,L1CAM,IQSEC2,STX1A,GRIN1,GABRB2,HCN1,CELF5,GRIN2B,SNAP25,PPFIA3,SPTBN4,CELF3,SLC8A3,CCDC136,PCLO,PPFIA2,DNM1,RIMS1,SYT1,NRG3,RASGRF1,NRXN2,DLG4 |
1.407e-05 | -11.17 | striated muscle contraction | biological process | GO:0006941 | 120 | 5 | 18204 | 47 |
CACNA1G,CACNA1C,CACNA2D1,RYR2,SCN8A |
1.417e-05 | -11.16 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 9 | 16828 | 47 |
FGF14,PPFIA2,NRXN3,NRG3,RIMS1,DLGAP2,SYT1,EDIL3,HCN1 |
1.504e-05 | -11.10 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 3 | 19454 | 50 |
NRXN3,NRXN2,DLG4 |
1.504e-05 | -11.10 | regulation of heart contraction | biological process | GO:0008016 | 208 | 6 | 18204 | 47 |
CACNA1C,CACNA1G,RYR2,SPTBN4,CACNA2D1,SLC8A3 |
1.583e-05 | -11.05 | SYNGAP1 (synaptic Ras GTPase activating protein 1) | protein interactions | 8831 | 59 | 4 | 19454 | 50 |
DLG4,GRIN1,GRIN2B,CAMK2A |
1.616e-05 | -11.03 | cell cortex | cellular component | GO:0005938 | 313 | 7 | 19108 | 50 |
SPTBN4,PPFIA3,PCLO,RIMS1,DLG4,SPTBN2,SNAP25 |
1.691e-05 | -10.99 | humerus | COSMIC cancer mutations | humerus | 546 | 9 | 16828 | 47 |
EDIL3,RYR2,HCN1,DLGAP2,NRXN3,FGF14,PPFIA2,PCLO,RIMS1 |
1.729e-05 | -10.97 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 18 | 16828 | 47 |
NRG3,NRXN2,GRM5,CCDC136,SLC4A10,CACNA1C,SPTBN2,EPHA6,NRXN3,CACNA1A,RIMS1,GRIN1,SCN8A,PCLO,HCN1,RYR2,MYT1L,L1CAM |
1.861e-05 | -10.89 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 7 | 16828 | 47 |
DLGAP2,HCN1,EDIL3,PPFIA2,FGF14,NRXN3,RIMS1 |
1.926e-05 | -10.86 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 36 | 16828 | 47 |
CAMKV,HCN1,SNAP25,SPTBN4,SCN8A,PPFIA3,EPHA6,CELF5,CAMK2A,DLGAP2,GABRB2,STX1A,LRRC7,ABLIM1,NRXN2,FGF14,PPFIA2,RYR2,CACNA1E,SYT1,PCLO,GRIN1,MCF2L2,RIMS1,CACNA1A,NRXN3,CACNA2D1,SPTBN2,EDIL3,SLC4A10,CACNA1C,CAMK2B,VSNL1,NRG3,SLC8A3,GRIN2B |
1.930e-05 | -10.86 | DLG2 (discs large MAGUK scaffold protein 2) | protein interactions | 1740 | 62 | 4 | 19454 | 50 |
GRIN1,DLGAP2,GRIN2B,DLG4 |
1.954e-05 | -10.84 | calcium ion transmembrane transport via high voltage-gated calcium channel | biological process | GO:0061577 | 3 | 2 | 18204 | 47 |
CACNA2D1,CACNA1C |
2.038e-05 | -10.80 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 41 | 16828 | 47 |
SLC8A3,NRG3,GRIN2B,CCDC136,GRM5,SLC4A10,EDIL3,CACNA1C,CAMK2B,CELF3,SPTBN2,NRXN3,CACNA2D1,MCF2L2,GRIN1,DLG4,RASGRF1,PCLO,CACNA1A,RIMS1,RYR2,SYT1,CACNA1E,L1CAM,NRXN2,CACNA1G,IQSEC2,ABLIM1,CAMK2A,CELF5,STX1A,LRRC7,DLGAP2,EPHA6,DNM1,SCN8A,PPFIA3,CAMKV,HCN1,SPTBN4,MYT1L |
2.053e-05 | -10.79 | regulation of secretion | biological process | GO:0051046 | 605 | 9 | 18204 | 47 |
SYT1,RIMS1,SNAP25,PCLO,STX1A,CPLX1,VSNL1,CAMK2A,PPFIA2 |
2.060e-05 | -10.79 | Nicotine addiction | KEGG pathways | hsa05033 | 40 | 4 | 7161 | 30 |
GABRB2,GRIN2B,GRIN1,CACNA1A |
2.060e-05 | -10.79 | Nicotine addiction | KEGG pathways | ko05033 | 40 | 4 | 7161 | 30 |
CACNA1A,GRIN2B,GABRB2,GRIN1 |
2.070e-05 | -10.79 | syntaxin binding | molecular function | GO:0019905 | 60 | 4 | 18094 | 49 |
CPLX1,CACNA1A,SYT1,SNAP25 |
2.072e-05 | -10.78 | cellular component assembly | biological process | GO:0022607 | 2472 | 18 | 18204 | 47 |
SPTBN2,PCLO,CCDC136,ABLIM1,HCN1,GABRB2,GRIN1,GRIN2B,CELF5,DNM1,NRG3,SYT1,SNAP25,RIMS1,SPTBN4,NRXN2,DLG4,CELF3 |
2.093e-05 | -10.77 | trunk | COSMIC cancer mutations | trunk | 3554 | 23 | 16828 | 47 |
PPFIA2,IQSEC2,NRXN2,ABLIM1,CELF5,EPHA6,PPFIA3,SPTBN4,SNAP25,HCN1,MYT1L,GRIN2B,SLC8A3,NRG3,VSNL1,CACNA1C,EDIL3,SPTBN2,NRXN3,CACNA2D1,CACNA1E,RYR2,L1CAM |
2.152e-05 | -10.75 | voltage-gated calcium channel activity involved in AV node cell action potential | molecular function | GO:0086056 | 3 | 2 | 18094 | 49 |
CACNA1C,CACNA1G |
2.166e-05 | -10.74 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 19 | 16828 | 47 |
RYR2,HCN1,SYT1,CACNA2D1,NRXN3,MCF2L2,RIMS1,CACNA1A,EDIL3,SLC4A10,DLGAP2,CPLX1,LRRC7,GABRB2,CAMK2B,NRG3,FGF14,PPFIA2,CCDC136 |
2.169e-05 | -10.74 | axon initial segment | cellular component | GO:0043194 | 21 | 3 | 19108 | 50 |
SPTBN4,SCN8A,LRRC7 |
2.174e-05 | -10.74 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 39 | 16828 | 47 |
EDIL3,CACNA1C,SLC4A10,CAMK2B,CPLX1,CELF3,SPTBN2,SLC8A3,NRG3,GRIN2B,GRM5,VSNL1,RYR2,SYT1,CACNA1E,L1CAM,CACNA2D1,NRXN3,MCF2L2,RASGRF1,GRIN1,PCLO,RIMS1,CAMK2A,CELF5,LRRC7,GABRB2,DLGAP2,EPHA6,NRXN2,CACNA1G,PPFIA2,FGF14,IQSEC2,ABLIM1,HCN1,MYT1L,PPFIA3,SCN8A |
2.293e-05 | -10.68 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 42 | 16828 | 47 |
GRM5,VSNL1,CCDC136,GRIN2B,SLC8A3,NRG3,SPTBN2,CELF3,CAMK2B,EDIL3,CACNA1C,SLC4A10,CACNA1A,RIMS1,GRIN1,RASGRF1,DLG4,MCF2L2,PCLO,CACNA2D1,NRXN3,L1CAM,CACNA1E,RYR2,ABLIM1,PPFIA2,CACNA1G,IQSEC2,NRXN2,EPHA6,LRRC7,STX1A,GABRB2,DLGAP2,CELF5,PPFIA3,SCN8A,DNM1,MYT1L,SPTBN4,HCN1,CAMKV |
2.293e-05 | -10.68 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 42 | 16828 | 47 |
DLGAP2,STX1A,LRRC7,GABRB2,CELF5,EPHA6,IQSEC2,CACNA1G,PPFIA2,NRXN2,ABLIM1,SPTBN4,HCN1,CAMKV,MYT1L,DNM1,SCN8A,PPFIA3,CAMK2B,CACNA1C,EDIL3,SLC4A10,SPTBN2,CELF3,GRIN2B,NRG3,SLC8A3,VSNL1,GRM5,CCDC136,CACNA1E,RYR2,L1CAM,CACNA2D1,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,GRIN1,DLG4,MCF2L2 |
2.384e-05 | -10.64 | synaptic vesicle | cellular component | GO:0008021 | 222 | 6 | 19108 | 50 |
GRIN1,SYT1,PPFIA2,DLG4,SNAP25,STX1A |
2.400e-05 | -10.64 | membrane depolarization during action potential | biological process | GO:0086010 | 22 | 3 | 18204 | 47 |
CACNA2D1,CACNA1C,CACNA1G |
2.473e-05 | -10.61 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 14 | 16828 | 47 |
GRM5,SLC8A3,PPFIA2,EPHA6,CACNA1C,DLGAP2,LRRC7,PCLO,MCF2L2,RASGRF1,CACNA1A,RIMS1,MYT1L,RYR2 |
2.842e-05 | -10.47 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 13 | 16828 | 47 |
GRIN2B,NRG3,ABLIM1,LRRC7,CAMK2A,CACNA1C,CACNA1A,PCLO,SCN8A,CACNA1E,HCN1,RYR2,L1CAM |
2.842e-05 | -10.47 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 13 | 16828 | 47 |
CACNA1E,RYR2,HCN1,L1CAM,CACNA1A,SCN8A,PCLO,LRRC7,CACNA1C,CAMK2A,GRIN2B,NRG3,ABLIM1 |
2.894e-05 | -10.45 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 29 | 18204 | 47 |
DNM1,RIMS1,NRG3,SYT1,RASGRF1,NRXN2,DLG4,CCDC136,PCLO,PPFIA2,CELF5,GRIN2B,SNAP25,PPFIA3,SPTBN4,CELF3,SLC8A3,SPTBN2,NRXN3,GRM5,CAMK2A,ABLIM1,L1CAM,EPHA6,IQSEC2,STX1A,GRIN1,HCN1,GABRB2 |
2.986e-05 | -10.42 | main axon | cellular component | GO:0044304 | 68 | 4 | 19108 | 50 |
LRRC7,DLG4,SCN8A,SPTBN4 |
3.022e-05 | -10.41 | export from cell | biological process | GO:0140352 | 485 | 8 | 18204 | 47 |
NRXN2,CPLX1,STX1A,PCLO,SYT1,RIMS1,SNAP25,PPFIA3 |
3.115e-05 | -10.38 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 6 | 19454 | 50 |
LRRC7,CAMK2B,GRIN2B,GRIN1,RIMS1,CAMK2A |
3.565e-05 | -10.24 | regulation of long-term neuronal synaptic plasticity | biological process | GO:0048169 | 25 | 3 | 18204 | 47 |
DLG4,CAMK2B,GRM5 |
3.615e-05 | -10.23 | Type II diabetes mellitus | KEGG pathways | ko04930 | 46 | 4 | 7161 | 30 |
CACNA1E,CACNA1A,CACNA1G,CACNA1C |
3.615e-05 | -10.23 | Type II diabetes mellitus | KEGG pathways | hsa04930 | 46 | 4 | 7161 | 30 |
CACNA1C,CACNA1E,CACNA1G,CACNA1A |
3.671e-05 | -10.21 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 15 | 16828 | 47 |
MYT1L,SPTBN4,CACNA1E,RYR2,RIMS1,PCLO,RASGRF1,NRXN3,CACNA2D1,DLGAP2,LRRC7,CAMK2A,GRIN2B,PPFIA2,NRG3 |
3.742e-05 | -10.19 | biological regulation | biological process | GO:0065007 | 12501 | 44 | 18204 | 47 |
RASGRF1,NRG3,SYT1,CACNA1C,RIMS1,DNM1,SCN8A,BRINP1,DLG4,CACNA2D1,CAMKV,FGF14,CPLX1,NRXN2,DLGAP2,RYR2,CACNA1G,CACNA1E,CAMK2B,PCLO,SLC4A10,PPFIA2,EDIL3,PPFIA3,SNAP25,GRIN2B,CELF5,MYT1L,SLC8A3,CELF3,SPTBN4,LRRC7,SPTBN2,HCN1,GABRB2,GRIN1,STX1A,IQSEC2,EPHA6,CACNA1A,L1CAM,GRM5,VSNL1,CAMK2A |
3.769e-05 | -10.19 | Toxicity of botulinum toxin type C (BoNT/C) | REACTOME pathways | R-HSA-5250971 | 3 | 2 | 10285 | 37 |
STX1A,SNAP25 |
3.778e-05 | -10.18 | exocytic vesicle | cellular component | GO:0070382 | 241 | 6 | 19108 | 50 |
PPFIA2,DLG4,SYT1,GRIN1,SNAP25,STX1A |
3.869e-05 | -10.16 | regulation of synapse organization | biological process | GO:0050807 | 246 | 6 | 18204 | 47 |
CAMKV,PPFIA2,IQSEC2,SNAP25,GRIN2B,CAMK2B |
3.872e-05 | -10.16 | Rad23a (RAD23 homolog A, nucleotide excision repair protein) | protein interactions | 361381 | 4 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
3.872e-05 | -10.16 | Grin2a (glutamate receptor, ionotropic, NMDA2A (epsilon 1)) | protein interactions | 14811 | 4 | 2 | 19454 | 50 |
GRIN2B,GRIN1 |
3.931e-05 | -10.14 | organelle localization by membrane tethering | biological process | GO:0140056 | 74 | 4 | 18204 | 47 |
SYT1,SNAP25,STX1A,PPFIA3 |
4.006e-05 | -10.13 | large_intestine-caecum-adenoma | COSMIC cancer mutations | large_intestine-caecum-adenoma | 229 | 6 | 16828 | 47 |
PCLO,DLGAP2,CACNA1C,EDIL3,HCN1,MYT1L |
4.083e-05 | -10.11 | CaMKII_AD | pfam domains | PF08332 | 4 | 2 | 17795 | 47 |
CAMK2A,CAMK2B |
4.100e-05 | -10.10 | CELF3/4/5/6_RRM1 | interpro domains | IPR034648 | 4 | 2 | 18521 | 49 |
CELF3,CELF5 |
4.100e-05 | -10.10 | Liprin-alpha_SAM_rpt_2 | interpro domains | IPR037621 | 4 | 2 | 18521 | 49 |
PPFIA3,PPFIA2 |
4.100e-05 | -10.10 | Liprin-alpha_SAM_rpt_1 | interpro domains | IPR037620 | 4 | 2 | 18521 | 49 |
PPFIA3,PPFIA2 |
4.100e-05 | -10.10 | Spectrin_bsu | interpro domains | IPR016343 | 4 | 2 | 18521 | 49 |
SPTBN2,SPTBN4 |
4.100e-05 | -10.10 | Ca/CaM-dep_prot_kinase-assoc | interpro domains | IPR013543 | 4 | 2 | 18521 | 49 |
CAMK2A,CAMK2B |
4.100e-05 | -10.10 | Liprin-alpha_SAM_rpt_3 | interpro domains | IPR037622 | 4 | 2 | 18521 | 49 |
PPFIA3,PPFIA2 |
4.140e-05 | -10.09 | regulation of calcium ion transport | biological process | GO:0051924 | 249 | 6 | 18204 | 47 |
CACNA1C,RYR2,CAMK2B,GRIN1,CACNA2D1,CAMK2A |
4.425e-05 | -10.03 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 6 | 18204 | 47 |
CAMK2B,GRIN2B,SNAP25,IQSEC2,PPFIA2,CAMKV |
4.427e-05 | -10.03 | Integration of energy metabolism | REACTOME pathways | R-HSA-163685 | 111 | 5 | 10285 | 37 |
CACNA1E,STX1A,CACNA1A,SNAP25,CACNA1C |
4.516e-05 | -10.01 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 43 | 16828 | 47 |
CACNA1A,RIMS1,PCLO,DLG4,GRIN1,MCF2L2,RASGRF1,NRXN3,CACNA2D1,L1CAM,CACNA1E,SYT1,RYR2,VSNL1,GRM5,CCDC136,GRIN2B,NRG3,SPTBN2,CELF3,CPLX1,CAMK2B,EDIL3,CACNA1C,SLC4A10,PPFIA3,SCN8A,DNM1,MYT1L,SPTBN4,CAMKV,HCN1,ABLIM1,FGF14,IQSEC2,PPFIA2,CACNA1G,NRXN2,EPHA6,DLGAP2,LRRC7,CELF5,CAMK2A |
4.555e-05 | -10.00 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 4 | 10285 | 37 |
CAMK2A,SLC8A3,CAMK2B,RYR2 |
4.574e-05 | -9.99 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 34 | 16828 | 47 |
ABLIM1,NRXN2,FGF14,PPFIA2,CELF5,CAMK2A,DLGAP2,LRRC7,STX1A,GABRB2,PPFIA3,SCN8A,HCN1,SPTBN4,SNAP25,VSNL1,NRG3,SLC8A3,GRIN2B,SPTBN2,CACNA1C,EDIL3,SLC4A10,CAMK2B,PCLO,GRIN1,MCF2L2,CACNA1A,RIMS1,CACNA2D1,NRXN3,RYR2,CACNA1E,SYT1 |
4.588e-05 | -9.99 | perikaryon | cellular component | GO:0043204 | 151 | 5 | 19108 | 50 |
SLC8A3,CACNA1C,CPLX1,TMEM266,SLC4A10 |
4.601e-05 | -9.99 | signaling | biological process | GO:0023052 | 4968 | 26 | 18204 | 47 |
EPHA6,CACNA1A,GRM5,CAMK2A,GABRB2,GRIN1,STX1A,GRIN2B,PPFIA3,SNAP25,CACNA1E,CAMK2B,PCLO,RYR2,CACNA1G,RASGRF1,SYT1,NRG3,CACNA1C,RIMS1,FGF14,NRXN2,CPLX1,DLGAP2,DLG4,CACNA2D1 |
4.606e-05 | -9.99 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 8 | 16828 | 47 |
RASGRF1,RIMS1,NRXN3,NRG3,CACNA2D1,PPFIA2,MYT1L,DLGAP2 |
4.644e-05 | -9.98 | glutamate receptor activity | molecular function | GO:0008066 | 26 | 3 | 18094 | 49 |
GRIN1,GRIN2B,GRM5 |
4.644e-05 | -9.98 | structural constituent of synapse | molecular function | GO:0098918 | 26 | 3 | 18094 | 49 |
SPTBN2,PCLO,PPFIA2 |
4.690e-05 | -9.97 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 8 | 18204 | 47 |
PPFIA2,CPLX1,VSNL1,DLG4,STX1A,PCLO,RIMS1,SYT1 |
4.718e-05 | -9.96 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 11 | 16828 | 47 |
CACNA1E,MYT1L,NRXN3,CACNA2D1,MCF2L2,PCLO,CACNA1C,CAMK2B,SPTBN2,EPHA6,PPFIA2 |
4.718e-05 | -9.96 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 11 | 16828 | 47 |
EPHA6,SPTBN2,CAMK2B,CACNA1C,PPFIA2,MYT1L,CACNA1E,PCLO,MCF2L2,NRXN3,CACNA2D1 |
5.002e-05 | -9.90 | LRRC7 (leucine rich repeat containing 7) | protein interactions | 57554 | 28 | 3 | 19454 | 50 |
CAMK2A,DLG4,LRRC7 |
5.215e-05 | -9.86 | calmodulin-dependent protein kinase activity | molecular function | GO:0004683 | 27 | 3 | 18094 | 49 |
CAMK2B,CAMK2A,CAMKV |
5.291e-05 | -9.85 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 14 | 16828 | 47 |
NRXN3,CACNA2D1,RIMS1,MCF2L2,RASGRF1,PCLO,SPTBN4,HCN1,RYR2,PPFIA2,SLC8A3,NRG3,DLGAP2,EDIL3 |
5.379e-05 | -9.83 | regulation of blood circulation | biological process | GO:1903522 | 261 | 6 | 18204 | 47 |
RYR2,CACNA1G,CACNA1C,SPTBN4,CACNA2D1,SLC8A3 |
5.442e-05 | -9.82 | Retrograde endocannabinoid signaling | KEGG pathways | hsa04723 | 101 | 5 | 7161 | 30 |
CACNA1A,CACNA1C,GRM5,GABRB2,RIMS1 |
5.442e-05 | -9.82 | Retrograde endocannabinoid signaling | KEGG pathways | ko04723 | 101 | 5 | 7161 | 30 |
GABRB2,GRM5,RIMS1,CACNA1A,CACNA1C |
5.452e-05 | -9.82 | SALM protein interactions at the synapses | REACTOME pathways | R-HSA-8849932 | 21 | 3 | 10285 | 37 |
DLG4,GRIN1,GRIN2B |
5.554e-05 | -9.80 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 34 | 16828 | 47 |
DLGAP2,STX1A,LRRC7,CELF5,CAMK2A,ABLIM1,FGF14,PPFIA2,CACNA1G,NRXN2,MYT1L,SPTBN4,HCN1,SCN8A,SPTBN2,CPLX1,CAMK2B,CACNA1C,EDIL3,VSNL1,GRIN2B,NRG3,SLC8A3,CACNA1E,SYT1,RYR2,CACNA1A,RIMS1,PCLO,MCF2L2,RASGRF1,GRIN1,CACNA2D1,NRXN3 |
5.569e-05 | -9.80 | KCNB1 (potassium voltage-gated channel subfamily B member 1) | protein interactions | 3745 | 29 | 3 | 19454 | 50 |
SNAP25,CACNA1C,STX1A |
5.623e-05 | -9.79 | protein heterooligomerization | biological process | GO:0051291 | 29 | 3 | 18204 | 47 |
GRIN1,SYT1,GRIN2B |
5.703e-05 | -9.77 | membrane | cellular component | GO:0016020 | 9220 | 38 | 19108 | 50 |
GRIN2B,CCDC136,GRIN1,GRM5,CACNA2D1,CAMKV,STX1A,DNM1,L1CAM,CAMK2B,NRXN3,SYT1,TMEM266,RYR2,CACNA1E,PPFIA2,DLGAP2,SNAP25,SCN8A,CACNA1A,SPTBN2,EPHA6,CAMK2A,DLG4,CACNA1C,SPTBN4,NRXN2,SLC8A3,LRRC7,RASGRF1,VSNL1,SLC4A10,NRG3,GABRB2,RIMS1,CACNA1G,HCN1,CPLX1 |
5.927e-05 | -9.73 | regulation of biological process | biological process | GO:0050789 | 12079 | 43 | 18204 | 47 |
MYT1L,CELF3,SLC8A3,SPTBN4,PPFIA3,SNAP25,GRIN2B,CELF5,HCN1,GABRB2,GRIN1,STX1A,EPHA6,CACNA1A,L1CAM,IQSEC2,GRM5,VSNL1,CAMK2A,LRRC7,SPTBN2,DLG4,BRINP1,CAMKV,CACNA2D1,FGF14,DLGAP2,NRXN2,CPLX1,RASGRF1,RIMS1,CACNA1C,NRG3,SYT1,DNM1,SLC4A10,PPFIA2,EDIL3,CACNA1G,RYR2,CAMK2B,CACNA1E,PCLO |
6.067e-05 | -9.71 | DLG4 (discs large MAGUK scaffold protein 4) | protein interactions | 1742 | 163 | 5 | 19454 | 50 |
DLGAP2,GRIN1,GRIN2B,LRRC7,DLG4 |
6.129e-05 | -9.70 | secretion | biological process | GO:0046903 | 536 | 8 | 18204 | 47 |
NRXN2,CPLX1,STX1A,PCLO,RIMS1,SNAP25,SYT1,PPFIA3 |
6.442e-05 | -9.65 | CAMK2N2 (calcium/calmodulin dependent protein kinase II inhibitor 2) | protein interactions | 94032 | 5 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
6.468e-05 | -9.65 | membrane docking | biological process | GO:0022406 | 84 | 4 | 18204 | 47 |
SNAP25,STX1A,SYT1,PPFIA3 |
6.490e-05 | -9.64 | ligand-gated calcium channel activity | molecular function | GO:0099604 | 29 | 3 | 18094 | 49 |
GRIN1,GRIN2B,RYR2 |
6.492e-05 | -9.64 | membrane depolarization during AV node cell action potential | biological process | GO:0086045 | 5 | 2 | 18204 | 47 |
CACNA1C,CACNA1G |
6.610e-05 | -9.62 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 19 | 16828 | 47 |
RIMS1,SCN8A,PCLO,RASGRF1,CACNA2D1,NRXN3,MYT1L,SYT1,RYR2,FGF14,GRIN2B,PPFIA2,NRG3,SPTBN2,DLGAP2,LRRC7,CAMK2B,EDIL3,CELF5 |
6.677e-05 | -9.61 | synaptobrevin 2-SNAP-25-syntaxin-1a complex | cellular component | GO:0070044 | 5 | 2 | 19108 | 50 |
SNAP25,STX1A |
6.677e-05 | -9.61 | calcium- and calmodulin-dependent protein kinase complex | cellular component | GO:0005954 | 5 | 2 | 19108 | 50 |
CAMK2B,CAMK2A |
6.715e-05 | -9.61 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 22 | 16828 | 47 |
CACNA1C,SLC4A10,NRG3,GRM5,CACNA1E,RYR2,L1CAM,NRXN3,RIMS1,CACNA1A,DLG4,MCF2L2,RASGRF1,PCLO,LRRC7,DLGAP2,CAMK2A,PPFIA2,CACNA1G,ABLIM1,HCN1,SCN8A |
6.719e-05 | -9.61 | Spectrin/alpha-actinin | interpro domains | IPR018159 | 30 | 3 | 18521 | 49 |
MCF2L2,SPTBN2,SPTBN4 |
6.739e-05 | -9.61 | MAPK signaling pathway | KEGG pathways | ko04010 | 255 | 7 | 7161 | 30 |
CACNA1A,CACNA1C,CACNA2D1,RASGRF1,FGF14,CACNA1E,CACNA1G |
6.739e-05 | -9.61 | MAPK signaling pathway | KEGG pathways | hsa04010 | 255 | 7 | 7161 | 30 |
CACNA1G,CACNA1E,CACNA2D1,CACNA1C,CACNA1A,RASGRF1,FGF14 |
6.775e-05 | -9.60 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 22 | 16828 | 47 |
NRG3,GRM5,SLC4A10,CACNA1C,NRXN3,CACNA1A,RIMS1,RASGRF1,DLG4,MCF2L2,PCLO,CACNA1E,RYR2,L1CAM,PPFIA2,CACNA1G,ABLIM1,LRRC7,DLGAP2,CAMK2A,SCN8A,HCN1 |
6.892e-05 | -9.58 | protein localization to postsynaptic membrane | biological process | GO:1903539 | 31 | 3 | 18204 | 47 |
DLG4,LRRC7,SNAP25 |
6.910e-05 | -9.58 | PH_domain | interpro domains | IPR001849 | 266 | 6 | 18521 | 49 |
DNM1,IQSEC2,SPTBN4,SPTBN2,MCF2L2,RASGRF1 |
7.459e-05 | -9.50 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 18 | 18204 | 47 |
GRIN1,HCN1,GABRB2,ABLIM1,CCDC136,PCLO,SPTBN2,CELF3,DLG4,NRXN2,SPTBN4,RIMS1,SNAP25,SYT1,NRG3,DNM1,CELF5,GRIN2B |
7.555e-05 | -9.49 | bone | COSMIC cancer mutations | bone | 8157 | 36 | 16828 | 47 |
NRXN2,FGF14,CACNA1G,PPFIA2,ABLIM1,DLGAP2,GABRB2,LRRC7,EPHA6,PPFIA3,SCN8A,HCN1,CAMKV,SPTBN4,MYT1L,NRG3,SLC8A3,GRIN2B,CCDC136,CACNA1C,EDIL3,SLC4A10,CAMK2B,SPTBN2,NRXN3,CACNA2D1,PCLO,RASGRF1,DLG4,GRIN1,RIMS1,CACNA1A,RYR2,CACNA1E,SYT1,L1CAM |
7.591e-05 | -9.49 | protein localization to postsynapse | biological process | GO:0062237 | 32 | 3 | 18204 | 47 |
DLG4,SNAP25,LRRC7 |
8.422e-05 | -9.38 | secretory vesicle | cellular component | GO:0099503 | 1076 | 11 | 19108 | 50 |
GRIN1,CCDC136,PPFIA2,STX1A,CACNA2D1,SNAP25,DLG4,PPFIA3,DNM1,LRRC7,SYT1 |
8.981e-05 | -9.32 | voltage-gated potassium channel complex | cellular component | GO:0008076 | 90 | 4 | 19108 | 50 |
DLG4,SNAP25,HCN1,STX1A |
9.125e-05 | -9.30 | exploration behavior | biological process | GO:0035640 | 34 | 3 | 18204 | 47 |
BRINP1,DLG4,SLC4A10 |
9.227e-05 | -9.29 | protein tetramerization | biological process | GO:0051262 | 92 | 4 | 18204 | 47 |
GRIN1,HCN1,DNM1,GRIN2B |
9.527e-05 | -9.26 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 13 | 16828 | 47 |
PPFIA2,NRG3,SLC8A3,DLGAP2,EDIL3,CACNA2D1,NRXN3,RIMS1,PCLO,MCF2L2,RASGRF1,RYR2,HCN1 |
9.647e-05 | -9.25 | NLGN4X (neuroligin 4 X-linked) | protein interactions | 57502 | 6 | 2 | 19454 | 50 |
DLGAP2,DLG4 |
1.011e-04 | -9.20 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 11 | 19454 | 50 |
CPLX1,GRM5,DNM1,SLC4A10,CAMK2B,CAMK2A,SYT1,IQSEC2,L1CAM,ABLIM1,DLG4 |
1.022e-04 | -9.19 | Liprin | interpro domains | IPR029515 | 6 | 2 | 18521 | 49 |
PPFIA2,PPFIA3 |
1.022e-04 | -9.19 | PH_dom-spectrin-type | interpro domains | IPR001605 | 6 | 2 | 18521 | 49 |
SPTBN4,SPTBN2 |
1.040e-04 | -9.17 | cell cortex region | cellular component | GO:0099738 | 35 | 3 | 19108 | 50 |
PPFIA3,RIMS1,PCLO |
1.070e-04 | -9.14 | glutamate-gated calcium ion channel activity | molecular function | GO:0022849 | 6 | 2 | 18094 | 49 |
GRIN1,GRIN2B |
1.071e-04 | -9.14 | - | gene3d domains | 6.10.140.620 | 5 | 2 | 14470 | 48 |
CAMK2B,CAMK2A |
1.071e-04 | -9.14 | Nicotine Activity on Chromaffin Cells | WikiPathways | WP1603 | 4 | 2 | 5310 | 23 |
CACNA1G,CACNA1C |
1.085e-04 | -9.13 | positive regulation of synaptic transmission, glutamatergic | biological process | GO:0051968 | 36 | 3 | 18204 | 47 |
GRIN1,IQSEC2,GRIN2B |
1.118e-04 | -9.10 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 15 | 16828 | 47 |
EPHA6,CACNA1C,CAMK2A,CAMK2B,GRIN2B,MYT1L,RYR2,HCN1,CACNA1E,SNAP25,SPTBN4,SYT1,RIMS1,NRXN3,CACNA2D1 |
1.125e-04 | -9.09 | extremity | COSMIC cancer mutations | extremity | 1876 | 15 | 16828 | 47 |
RIMS1,NRXN3,CACNA2D1,MYT1L,SYT1,SPTBN4,CACNA1E,SNAP25,HCN1,RYR2,GRIN2B,EPHA6,CAMK2B,CAMK2A,CACNA1C |
1.154e-04 | -9.07 | sarcoplasm | cellular component | GO:0016528 | 96 | 4 | 19108 | 50 |
SLC8A3,CAMK2B,CACNA2D1,RYR2 |
1.155e-04 | -9.07 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 19 | 16828 | 47 |
PPFIA2,FGF14,GRIN2B,NRG3,SPTBN2,LRRC7,CAMK2B,DLGAP2,CELF5,EDIL3,RIMS1,RASGRF1,PCLO,SCN8A,NRXN3,CACNA2D1,MYT1L,SYT1,RYR2 |
1.167e-04 | -9.06 | GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D) | protein interactions | 2906 | 37 | 3 | 19454 | 50 |
DLG4,GRIN1,DNM1 |
1.190e-04 | -9.04 | STX1A (syntaxin 1A) | protein interactions | 6804 | 188 | 5 | 19454 | 50 |
CPLX1,SNAP25,SYT1,STX1A,RIMS1 |
1.249e-04 | -8.99 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 10 | 19454 | 50 |
RIMS1,SPTBN2,SYT1,CAMK2A,DNM1,SNAP25,PPFIA2,PPFIA3,CAMK2B,ABLIM1 |
1.260e-04 | -8.98 | ANF_receptor | pfam domains | PF01094 | 37 | 3 | 17795 | 47 |
GRIN2B,GRIN1,GRM5 |
1.269e-04 | -8.97 | ANF_lig-bd_rcpt | interpro domains | IPR001828 | 37 | 3 | 18521 | 49 |
GRIN2B,GRIN1,GRM5 |
1.276e-04 | -8.97 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 31 | 16828 | 47 |
NRG3,SLC8A3,GRIN2B,GRM5,EDIL3,SLC4A10,CACNA1C,CAMK2B,SPTBN2,NRXN3,CACNA2D1,PCLO,RASGRF1,DLG4,CACNA1A,RIMS1,RYR2,NRXN2,FGF14,CACNA1G,PPFIA2,ABLIM1,DLGAP2,GABRB2,LRRC7,EPHA6,PPFIA3,CAMKV,HCN1,SPTBN4,MYT1L |
1.296e-04 | -8.95 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 19 | 16828 | 47 |
EDIL3,CACNA1C,SLC4A10,DLGAP2,LRRC7,GABRB2,SPTBN2,SLC8A3,IQSEC2,FGF14,HCN1,CACNA1E,SYT1,MYT1L,NRXN3,CACNA2D1,PCLO,GRIN1,RASGRF1 |
1.320e-04 | -8.93 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 23 | 16828 | 47 |
HCN1,SPTBN4,MYT1L,SCN8A,CAMK2A,LRRC7,GABRB2,IQSEC2,PPFIA2,RYR2,CACNA1E,L1CAM,PCLO,MCF2L2,RASGRF1,CACNA1A,RIMS1,CACNA1C,SLC4A10,CELF3,SPTBN2,GRIN2B,GRM5 |
1.326e-04 | -8.93 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 23 | 16828 | 47 |
PPFIA2,IQSEC2,GABRB2,LRRC7,CAMK2A,SCN8A,SPTBN4,HCN1,MYT1L,GRIN2B,GRM5,CACNA1C,SLC4A10,SPTBN2,CELF3,CACNA1A,RIMS1,MCF2L2,RASGRF1,PCLO,CACNA1E,RYR2,L1CAM |
1.353e-04 | -8.91 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 29 | 16828 | 47 |
NRXN2,FGF14,CACNA1G,PPFIA2,EPHA6,CAMK2A,DLGAP2,GABRB2,LRRC7,MYT1L,HCN1,SPTBN4,NRG3,SLC8A3,GRIN2B,SPTBN2,EDIL3,CACNA1C,CAMK2B,PCLO,MCF2L2,DLG4,CACNA1A,RIMS1,NRXN3,CACNA2D1,L1CAM,RYR2,CACNA1E |
1.359e-04 | -8.90 | AV node cell to bundle of His cell signaling | biological process | GO:0086027 | 7 | 2 | 18204 | 47 |
CACNA1C,CACNA1G |
1.359e-04 | -8.90 | AV node cell action potential | biological process | GO:0086016 | 7 | 2 | 18204 | 47 |
CACNA1G,CACNA1C |
1.362e-04 | -8.90 | regulation of monoatomic cation transmembrane transport | biological process | GO:1904062 | 309 | 6 | 18204 | 47 |
GRIN2B,CACNA1C,RYR2,FGF14,GRIN1,CACNA2D1 |
1.363e-04 | -8.90 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 18 | 16828 | 47 |
L1CAM,MYT1L,RYR2,HCN1,SCN8A,PCLO,GRIN1,CACNA1A,RIMS1,NRXN3,EPHA6,SPTBN2,SLC4A10,CACNA1C,CCDC136,GRM5,NRG3,NRXN2 |
1.367e-04 | -8.90 | neurotransmitter receptor activity | molecular function | GO:0030594 | 97 | 4 | 18094 | 49 |
GRIN2B,GABRB2,GRIN1,GRM5 |
1.376e-04 | -8.89 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 17 | 19108 | 50 |
LRRC7,CAMK2B,SYT1,GABRB2,SNAP25,CAMKV,STX1A,CACNA2D1,SCN8A,CAMK2A,PPFIA2,GRIN2B,CCDC136,GRIN1,DNM1,PPFIA3,DLG4 |
1.405e-04 | -8.87 | potassium channel complex | cellular component | GO:0034705 | 101 | 4 | 19108 | 50 |
DLG4,STX1A,SNAP25,HCN1 |
1.413e-04 | -8.86 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 6 | 7161 | 30 |
GRIN2B,RYR2,CAMK2B,GRIN1,CAMK2A,CACNA1C |
1.413e-04 | -8.86 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 6 | 7161 | 30 |
CAMK2A,CACNA1C,RYR2,GRIN2B,CAMK2B,GRIN1 |
1.417e-04 | -8.86 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 17 | 19108 | 50 |
GABRB2,SYT1,LRRC7,CAMK2B,PPFIA3,DNM1,DLG4,CAMKV,CACNA2D1,STX1A,SNAP25,CAMK2A,SCN8A,CCDC136,PPFIA2,GRIN2B,GRIN1 |
1.424e-04 | -8.86 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 10 | 16828 | 47 |
CACNA2D1,RIMS1,CACNA1A,ABLIM1,GRIN1,CACNA1E,SPTBN4,LRRC7,MYT1L,EPHA6 |
1.437e-04 | -8.85 | ligand-gated monoatomic ion channel activity | molecular function | GO:0015276 | 186 | 5 | 18094 | 49 |
RYR2,GABRB2,HCN1,GRIN1,GRIN2B |
1.474e-04 | -8.82 | ligand-gated channel activity | molecular function | GO:0022834 | 187 | 5 | 18094 | 49 |
GABRB2,HCN1,GRIN1,GRIN2B,RYR2 |
1.487e-04 | -8.81 | Peripla_BP_I | interpro domains | IPR028082 | 39 | 3 | 18521 | 49 |
GRIN2B,GRM5,GRIN1 |
1.490e-04 | -8.81 | regulation of heart rate by cardiac conduction | biological process | GO:0086091 | 40 | 3 | 18204 | 47 |
CACNA2D1,CACNA1G,CACNA1C |
1.496e-04 | -8.81 | NMDA glutamate receptor activity | molecular function | GO:0004972 | 7 | 2 | 18094 | 49 |
GRIN1,GRIN2B |
1.496e-04 | -8.81 | locomotory behavior | biological process | GO:0007626 | 197 | 5 | 18204 | 47 |
SNAP25,SLC4A10,DLG4,GRM5,SPTBN4 |
1.498e-04 | -8.81 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 18 | 16828 | 47 |
L1CAM,MYT1L,RYR2,HCN1,CACNA1E,NRXN3,CACNA2D1,SPTBN2,EPHA6,EDIL3,CACNA1C,VSNL1,NRG3,NRXN2,SLC8A3,IQSEC2,GRIN2B,PPFIA2 |
1.521e-04 | -8.79 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 23 | 16828 | 47 |
HCN1,SPTBN4,MYT1L,SCN8A,CAMK2A,LRRC7,GABRB2,PPFIA2,IQSEC2,RYR2,CACNA1E,L1CAM,RASGRF1,MCF2L2,PCLO,CACNA1A,RIMS1,SLC4A10,CACNA1C,CELF3,SPTBN2,GRIN2B,GRM5 |
1.589e-04 | -8.75 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 10 | 16828 | 47 |
SPTBN4,CACNA1E,LRRC7,EPHA6,MYT1L,CACNA2D1,RIMS1,CACNA1A,ABLIM1,GRIN1 |
1.609e-04 | -8.73 | actin filament-based process | biological process | GO:0030029 | 616 | 8 | 18204 | 47 |
IQSEC2,SPTBN4,CACNA2D1,SPTBN2,SCN8A,RYR2,CACNA1C,CACNA1G |
1.676e-04 | -8.69 | ionotropic glutamate receptor complex | cellular component | GO:0008328 | 41 | 3 | 19108 | 50 |
GRIN1,GRIN2B,DLG4 |
1.743e-04 | -8.65 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 5 | 19454 | 50 |
DLG4,DLGAP2,ABLIM1,NRXN3,NRXN2 |
1.797e-04 | -8.62 | Uptake and actions of bacterial toxins | REACTOME pathways | R-HSA-5339562 | 31 | 3 | 10285 | 37 |
SYT1,SNAP25,STX1A |
1.807e-04 | -8.62 | Dopaminergic synapse | KEGG pathways | ko04728 | 130 | 5 | 7161 | 30 |
CACNA1C,CACNA1A,CAMK2A,CAMK2B,GRIN2B |
1.807e-04 | -8.62 | Dopaminergic synapse | KEGG pathways | hsa04728 | 130 | 5 | 7161 | 30 |
GRIN2B,CAMK2B,CACNA1C,CACNA1A,CAMK2A |
1.851e-04 | -8.59 | regulation of synaptic vesicle exocytosis | biological process | GO:2000300 | 43 | 3 | 18204 | 47 |
PPFIA2,RIMS1,SYT1 |
1.860e-04 | -8.59 | cytoskeleton of presynaptic active zone | cellular component | GO:0048788 | 8 | 2 | 19108 | 50 |
RIMS1,PCLO |
1.893e-04 | -8.57 | PH_9 | pfam domains | PF15410 | 8 | 2 | 17795 | 47 |
SPTBN4,SPTBN2 |
1.901e-04 | -8.57 | PH_9 | interpro domains | IPR041681 | 8 | 2 | 18521 | 49 |
SPTBN2,SPTBN4 |
1.902e-04 | -8.57 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 18 | 16828 | 47 |
RASGRF1,PCLO,SCN8A,RIMS1,CACNA1A,NRXN3,MYT1L,HCN1,RYR2,CACNA1E,GRM5,SLC8A3,NRXN2,NRG3,PPFIA2,GRIN2B,IQSEC2,STX1A |
1.977e-04 | -8.53 | RNF123 (ring finger protein 123) | protein interactions | 63891 | 812 | 9 | 19454 | 50 |
GRIN1,PPFIA2,PPFIA3,IQSEC2,LRRC7,SCN8A,HCN1,PCLO,SPTBN2 |
1.978e-04 | -8.53 | Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity | REACTOME pathways | R-HSA-399721 | 32 | 3 | 10285 | 37 |
CAMK2A,CAMK2B,DLG4 |
1.978e-04 | -8.53 | Trafficking of AMPA receptors | REACTOME pathways | R-HSA-399719 | 32 | 3 | 10285 | 37 |
DLG4,CAMK2B,CAMK2A |
1.983e-04 | -8.53 | cellular response to amyloid-beta | biological process | GO:1904646 | 44 | 3 | 18204 | 47 |
CACNA1A,CACNA2D1,GRIN1 |
1.983e-04 | -8.53 | receptor localization to synapse | biological process | GO:0097120 | 44 | 3 | 18204 | 47 |
DLG4,LRRC7,SNAP25 |
1.991e-04 | -8.52 | glutamate binding | molecular function | GO:0016595 | 8 | 2 | 18094 | 49 |
GRIN1,GRIN2B |
2.044e-04 | -8.50 | regulation of regulated secretory pathway | biological process | GO:1903305 | 113 | 4 | 18204 | 47 |
SYT1,STX1A,RIMS1,PPFIA2 |
2.050e-04 | -8.49 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 47 | 16828 | 47 |
CAMK2A,LRRC7,STX1A,GABRB2,EPHA6,NRXN2,PPFIA2,FGF14,IQSEC2,HCN1,SNAP25,MYT1L,DNM1,SCN8A,EDIL3,SLC4A10,CACNA1C,CAMK2B,CPLX1,CELF3,SPTBN2,SLC8A3,CCDC136,SYT1,L1CAM,CACNA2D1,GRIN1,MCF2L2,DLG4,CELF5,DLGAP2,CACNA1G,ABLIM1,CAMKV,SPTBN4,PPFIA3,NRG3,GRIN2B,GRM5,VSNL1,RYR2,CACNA1E,NRXN3,RASGRF1,PCLO,CACNA1A,RIMS1 |
2.059e-04 | -8.49 | CALM3 (calmodulin 3) | protein interactions | 808 | 334 | 6 | 19454 | 50 |
CAMK2A,CACNA1A,IQSEC2,GRM5,EPHA6,CAMK2B |
2.068e-04 | -8.48 | SPECTRINPH | prints domains | PR00683 | 6 | 2 | 5227 | 20 |
SPTBN2,SPTBN4 |
2.081e-04 | -8.48 | - | gene3d domains | 1.20.58.60 | 35 | 3 | 14470 | 48 |
SPTBN4,MCF2L2,SPTBN2 |
2.088e-04 | -8.47 | regulation of cellular process | biological process | GO:0050794 | 11468 | 41 | 18204 | 47 |
SPTBN4,MYT1L,CELF3,SLC8A3,GRIN2B,CELF5,PPFIA3,SNAP25,L1CAM,CACNA1A,EPHA6,IQSEC2,GRM5,VSNL1,CAMK2A,HCN1,STX1A,GRIN1,SPTBN2,LRRC7,FGF14,DLGAP2,CPLX1,NRXN2,BRINP1,DLG4,CAMKV,CACNA2D1,DNM1,RASGRF1,CACNA1C,RIMS1,NRG3,SYT1,PPFIA2,EDIL3,SLC4A10,CAMK2B,PCLO,CACNA1G,RYR2 |
2.093e-04 | -8.47 | axon terminus | cellular component | GO:0043679 | 112 | 4 | 19108 | 50 |
SLC8A3,GRIN1,CPLX1,SLC4A10 |
2.121e-04 | -8.46 | glutamate receptor signaling pathway | biological process | GO:0007215 | 45 | 3 | 18204 | 47 |
GRM5,GRIN2B,GRIN1 |
2.193e-04 | -8.43 | SPEC | smart domains | SM00150 | 29 | 3 | 9717 | 40 |
SPTBN2,SPTBN4,MCF2L2 |
2.254e-04 | -8.40 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 9 | 16828 | 47 |
SYT1,CAMK2B,RYR2,HCN1,RIMS1,PCLO,GRIN2B,PPFIA2,NRG3 |
2.265e-04 | -8.39 | receptor clustering | biological process | GO:0043113 | 46 | 3 | 18204 | 47 |
NRXN2,DLG4,LRRC7 |
2.273e-04 | -8.39 | CAMK2G (calcium/calmodulin dependent protein kinase II gamma) | protein interactions | 818 | 216 | 5 | 19454 | 50 |
GRIN2B,GRIN1,LRRC7,CAMK2B,CAMK2A |
2.281e-04 | -8.39 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 7 | 18204 | 47 |
GRIN2B,CACNA1C,RYR2,FGF14,GRIN1,CACNA2D1,DLG4 |
2.304e-04 | -8.38 | NETO1 (neuropilin and tolloid like 1) | protein interactions | 81832 | 9 | 2 | 19454 | 50 |
GRIN2B,GRIN1 |
2.322e-04 | -8.37 | synaptic vesicle docking | biological process | GO:0016081 | 9 | 2 | 18204 | 47 |
SNAP25,PPFIA3 |
2.364e-04 | -8.35 | neurotransmitter receptor complex | cellular component | GO:0098878 | 46 | 3 | 19108 | 50 |
GRIN1,DLG4,GRIN2B |
2.388e-04 | -8.34 | NMDA selective glutamate receptor complex | cellular component | GO:0017146 | 9 | 2 | 19108 | 50 |
GRIN2B,GRIN1 |
2.388e-04 | -8.34 | spectrin | cellular component | GO:0008091 | 9 | 2 | 19108 | 50 |
SPTBN4,SPTBN2 |
2.413e-04 | -8.33 | positive regulation of calcium ion transport | biological process | GO:0051928 | 118 | 4 | 18204 | 47 |
CAMK2A,RYR2,CACNA2D1,GRIN1 |
2.415e-04 | -8.33 | regulation of neuron migration | biological process | GO:2001222 | 47 | 3 | 18204 | 47 |
CAMK2A,CAMK2B,NRG3 |
2.434e-04 | -8.32 | Cytokine Signaling in Immune system | REACTOME pathways | R-HSA-1280215 | 756 | 10 | 10285 | 37 |
GRIN2B,CAMK2A,SPTBN2,GRIN1,RASGRF1,NRG3,SPTBN4,STX1A,DLG4,CAMK2B |
2.522e-04 | -8.29 | bladder | COSMIC cancer mutations | bladder | 14112 | 47 | 16828 | 47 |
DLGAP2,CELF5,ABLIM1,CACNA1G,SPTBN4,CAMKV,PPFIA3,VSNL1,GRM5,GRIN2B,NRG3,CACNA1E,RYR2,CACNA1A,RIMS1,PCLO,RASGRF1,NRXN3,EPHA6,GABRB2,LRRC7,STX1A,CAMK2A,IQSEC2,FGF14,PPFIA2,NRXN2,MYT1L,SNAP25,HCN1,SCN8A,DNM1,SPTBN2,CELF3,CPLX1,CAMK2B,CACNA1C,EDIL3,SLC4A10,CCDC136,SLC8A3,L1CAM,SYT1,GRIN1,DLG4,MCF2L2,CACNA2D1 |
2.522e-04 | -8.29 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 47 | 16828 | 47 |
ABLIM1,CACNA1G,DLGAP2,CELF5,PPFIA3,SPTBN4,CAMKV,GRM5,VSNL1,GRIN2B,NRG3,CACNA1A,RIMS1,RASGRF1,PCLO,NRXN3,CACNA1E,RYR2,PPFIA2,FGF14,IQSEC2,NRXN2,EPHA6,LRRC7,STX1A,GABRB2,CAMK2A,SCN8A,DNM1,MYT1L,SNAP25,HCN1,CCDC136,SLC8A3,SPTBN2,CELF3,CAMK2B,CPLX1,EDIL3,SLC4A10,CACNA1C,GRIN1,MCF2L2,DLG4,CACNA2D1,L1CAM,SYT1 |
2.552e-04 | -8.27 | regulation of monoatomic ion transmembrane transport | biological process | GO:0034765 | 347 | 6 | 18204 | 47 |
GRIN2B,RYR2,CACNA1C,FGF14,CACNA2D1,GRIN1 |
2.571e-04 | -8.27 | insulin secretion | biological process | GO:0030073 | 48 | 3 | 18204 | 47 |
STX1A,CPLX1,PCLO |
2.724e-04 | -8.21 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 33 | 16828 | 47 |
EPHA6,DLGAP2,LRRC7,GABRB2,ABLIM1,FGF14,CACNA1G,PPFIA2,NRXN2,MYT1L,SPTBN4,CAMKV,PPFIA3,SCN8A,SPTBN2,CAMK2B,EDIL3,SLC4A10,CACNA1C,CCDC136,GRIN2B,NRG3,SLC8A3,L1CAM,CACNA1E,RYR2,RIMS1,CACNA1A,PCLO,GRIN1,DLG4,NRXN3,CACNA2D1 |
2.728e-04 | -8.21 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 16 | 18204 | 47 |
DLG4,CAMKV,SPTBN4,CPLX1,SNAP25,RIMS1,NRG3,SYT1,GRIN2B,STX1A,PPFIA2,L1CAM,IQSEC2,LRRC7,CAMK2B,SPTBN2 |
2.783e-04 | -8.19 | glutamate receptor binding | molecular function | GO:0035254 | 47 | 3 | 18094 | 49 |
CAMK2A,RASGRF1,DLG4 |
2.914e-04 | -8.14 | Adrenergic signaling in cardiomyocytes | KEGG pathways | ko04261 | 144 | 5 | 7161 | 30 |
CAMK2B,RYR2,CACNA2D1,CACNA1C,CAMK2A |
2.914e-04 | -8.14 | Adrenergic signaling in cardiomyocytes | KEGG pathways | hsa04261 | 144 | 5 | 7161 | 30 |
RYR2,CAMK2B,CACNA1C,CACNA2D1,CAMK2A |
2.916e-04 | -8.14 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 7 | 18204 | 47 |
RYR2,GRIN1,CACNA2D1,HCN1,GABRB2,CAMK2A,CACNA1A |
2.986e-04 | -8.12 | PDZ | pfam domains | PF00595 | 122 | 4 | 17795 | 47 |
LRRC7,PCLO,RIMS1,DLG4 |
3.007e-04 | -8.11 | memory | biological process | GO:0007613 | 125 | 4 | 18204 | 47 |
BRINP1,RASGRF1,SNAP25,SLC8A3 |
3.030e-04 | -8.10 | SNARE complex | cellular component | GO:0031201 | 50 | 3 | 19108 | 50 |
CPLX1,SNAP25,STX1A |
3.143e-04 | -8.07 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 44 | 16828 | 47 |
CELF5,CAMK2A,DLGAP2,LRRC7,STX1A,GABRB2,EPHA6,NRXN2,FGF14,CACNA1G,PPFIA2,ABLIM1,CAMKV,HCN1,SPTBN4,SNAP25,MYT1L,DNM1,SCN8A,PPFIA3,CACNA1C,EDIL3,SLC4A10,CPLX1,CAMK2B,SPTBN2,NRG3,SLC8A3,GRIN2B,CCDC136,VSNL1,GRM5,RYR2,CACNA1E,SYT1,L1CAM,NRXN3,CACNA2D1,PCLO,GRIN1,MCF2L2,RASGRF1,CACNA1A,RIMS1 |
3.266e-04 | -8.03 | protein-containing complex assembly | biological process | GO:0065003 | 1279 | 11 | 18204 | 47 |
HCN1,GRIN1,CELF5,GRIN2B,DNM1,SYT1,SNAP25,RIMS1,SPTBN4,DLG4,CELF3 |
3.334e-04 | -8.01 | cell development | biological process | GO:0048468 | 2236 | 15 | 18204 | 47 |
RASGRF1,SNAP25,MYT1L,BRINP1,DLG4,SLC8A3,SPTBN4,NRXN3,CCDC136,GABRB2,HCN1,SLC4A10,L1CAM,EPHA6,CAMK2A |
3.355e-04 | -8.00 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 11 | 18204 | 47 |
SPTBN4,CPLX1,PPFIA3,SYT1,SNAP25,RIMS1,DNM1,STX1A,LRRC7,SPTBN2,PCLO |
3.489e-04 | -7.96 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 4 | 7161 | 30 |
CACNA1C,CACNA1G,CAMK2A,CAMK2B |
3.489e-04 | -7.96 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 4 | 7161 | 30 |
CAMK2B,CAMK2A,CACNA1G,CACNA1C |
3.508e-04 | -7.96 | CACNA1D (calcium voltage-gated channel subunit alpha1 D) | protein interactions | 776 | 11 | 2 | 19454 | 50 |
STX1A,RYR2 |
3.508e-04 | -7.96 | ITPKA (inositol-trisphosphate 3-kinase A) | protein interactions | 3706 | 11 | 2 | 19454 | 50 |
CAMK2B,CAMK2A |
3.508e-04 | -7.96 | Cobll1 (Cobl-like 1) | protein interactions | 319876 | 11 | 2 | 19454 | 50 |
ABLIM1,BRINP1 |
3.572e-04 | -7.94 | EPH-Ephrin signaling | REACTOME pathways | R-HSA-2682334 | 95 | 4 | 10285 | 37 |
EPHA6,DNM1,GRIN1,GRIN2B |
3.575e-04 | -7.94 | neuron projection development | biological process | GO:0031175 | 693 | 8 | 18204 | 47 |
EPHA6,L1CAM,SPTBN4,CAMK2A,DLG4,RASGRF1,SNAP25,NRXN3 |
3.591e-04 | -7.93 | muscle contraction | biological process | GO:0006936 | 238 | 5 | 18204 | 47 |
RYR2,CACNA2D1,CACNA1C,CACNA1G,SCN8A |
3.613e-04 | -7.93 | NOS1 (nitric oxide synthase 1) | protein interactions | 4842 | 54 | 3 | 19454 | 50 |
CAMK2A,DLG4,DLGAP2 |
3.636e-04 | -7.92 | presynaptic cytoskeleton | cellular component | GO:0099569 | 11 | 2 | 19108 | 50 |
PCLO,RIMS1 |
3.699e-04 | -7.90 | SBP_bac_3 | pfam domains | PF00497 | 11 | 2 | 17795 | 47 |
GRIN2B,GRIN1 |
3.714e-04 | -7.90 | Solute-binding_3/MltF_N | interpro domains | IPR001638 | 11 | 2 | 18521 | 49 |
GRIN2B,GRIN1 |
3.744e-04 | -7.89 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 5 | 7161 | 30 |
RYR2,CAMK2B,CACNA2D1,CACNA1C,CAMK2A |
3.744e-04 | -7.89 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 5 | 7161 | 30 |
CACNA2D1,CACNA1C,CAMK2A,CAMK2B,RYR2 |
3.851e-04 | -7.86 | membrane depolarization | biological process | GO:0051899 | 55 | 3 | 18204 | 47 |
CACNA1G,CACNA1C,CACNA2D1 |
3.851e-04 | -7.86 | synaptic vesicle endocytosis | biological process | GO:0048488 | 55 | 3 | 18204 | 47 |
DNM1,SYT1,STX1A |
3.890e-04 | -7.85 | glycine binding | molecular function | GO:0016594 | 11 | 2 | 18094 | 49 |
GRIN1,GRIN2B |
4.062e-04 | -7.81 | response to amyloid-beta | biological process | GO:1904645 | 56 | 3 | 18204 | 47 |
GRIN1,CACNA2D1,CACNA1A |
4.062e-04 | -7.81 | presynaptic endocytosis | biological process | GO:0140238 | 56 | 3 | 18204 | 47 |
STX1A,SYT1,DNM1 |
4.130e-04 | -7.79 | organelle localization | biological process | GO:0051640 | 535 | 7 | 18204 | 47 |
SYT1,SNAP25,STX1A,PPFIA3,DNM1,PCLO,PPFIA2 |
4.139e-04 | -7.79 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 47 |
GRM5,NRXN2,SLC8A3,GRIN2B,IQSEC2,PPFIA2,MYT1L,RYR2,CACNA1E,PCLO,RIMS1,CACNA1A |
4.139e-04 | -7.79 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 47 |
GRM5,PPFIA2,GRIN2B,IQSEC2,SLC8A3,NRXN2,CACNA1A,RIMS1,PCLO,MYT1L,CACNA1E,RYR2 |
4.175e-04 | -7.78 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 23 | 16828 | 47 |
L1CAM,MYT1L,RYR2,HCN1,CACNA1E,PCLO,PPFIA3,MCF2L2,DLG4,RASGRF1,RIMS1,CACNA1A,NRXN3,CACNA1C,SLC4A10,CAMK2B,LRRC7,GRM5,NRG3,GRIN2B,IQSEC2,CACNA1G,PPFIA2 |
4.236e-04 | -7.77 | positive regulation of catecholamine secretion | biological process | GO:0033605 | 12 | 2 | 18204 | 47 |
STX1A,SYT1 |
4.236e-04 | -7.77 | regulation of synaptic vesicle fusion to presynaptic active zone membrane | biological process | GO:0031630 | 12 | 2 | 18204 | 47 |
CPLX1,SYT1 |
4.236e-04 | -7.77 | excitatory chemical synaptic transmission | biological process | GO:0098976 | 12 | 2 | 18204 | 47 |
GRIN2B,GRIN1 |
4.236e-04 | -7.77 | synaptic vesicle fusion to presynaptic active zone membrane | biological process | GO:0031629 | 12 | 2 | 18204 | 47 |
STX1A,SNAP25 |
4.236e-04 | -7.77 | regulation of synaptic vesicle membrane organization | biological process | GO:1901632 | 12 | 2 | 18204 | 47 |
CPLX1,SYT1 |
4.236e-04 | -7.77 | regulation of ventricular cardiac muscle cell action potential | biological process | GO:0098911 | 12 | 2 | 18204 | 47 |
RYR2,CACNA1C |
4.236e-04 | -7.77 | AV node cell to bundle of His cell communication | biological process | GO:0086067 | 12 | 2 | 18204 | 47 |
CACNA1C,CACNA1G |
4.355e-04 | -7.74 | juxtaparanode region of axon | cellular component | GO:0044224 | 12 | 2 | 19108 | 50 |
DLG4,SPTBN4 |
4.355e-04 | -7.74 | L-type voltage-gated calcium channel complex | cellular component | GO:1990454 | 12 | 2 | 19108 | 50 |
CACNA2D1,CACNA1C |
4.379e-04 | -7.73 | sodium ion transmembrane transport | biological process | GO:0035725 | 138 | 4 | 18204 | 47 |
SCN8A,SLC4A10,HCN1,SLC8A3 |
4.463e-04 | -7.71 | positive regulation of cell communication | biological process | GO:0010647 | 1792 | 13 | 18204 | 47 |
IQSEC2,CAMK2A,VSNL1,GRM5,GRIN1,STX1A,DLG4,SLC8A3,GRIN2B,RASGRF1,RIMS1,SNAP25,SYT1 |
4.511e-04 | -7.70 | positive regulation of signaling | biological process | GO:0023056 | 1794 | 13 | 18204 | 47 |
STX1A,GRIN1,GRM5,CAMK2A,VSNL1,IQSEC2,SYT1,SNAP25,RIMS1,RASGRF1,GRIN2B,SLC8A3,DLG4 |
4.702e-04 | -7.66 | ARHGAP32 (Rho GTPase activating protein 32) | protein interactions | 9743 | 141 | 4 | 19454 | 50 |
CAMK2A,EPHA6,GRIN2B,DLG4 |
4.829e-04 | -7.64 | GIT1 (GIT ArfGAP 1) | protein interactions | 28964 | 142 | 4 | 19454 | 50 |
PPFIA2,PPFIA3,CAMK2A,PCLO |
4.841e-04 | -7.63 | ligand-gated monoatomic cation channel activity | molecular function | GO:0099094 | 135 | 4 | 18094 | 49 |
GRIN2B,HCN1,GRIN1,RYR2 |
4.853e-04 | -7.63 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 44 | 16828 | 47 |
CACNA1C,EDIL3,SLC4A10,CAMK2B,CPLX1,CELF3,SPTBN2,SLC8A3,NRG3,GRIN2B,CCDC136,GRM5,VSNL1,RYR2,SYT1,CACNA1E,L1CAM,CACNA2D1,NRXN3,GRIN1,DLG4,MCF2L2,RASGRF1,PCLO,CACNA1A,RIMS1,CAMK2A,CELF5,GABRB2,STX1A,LRRC7,DLGAP2,EPHA6,NRXN2,CACNA1G,PPFIA2,FGF14,ABLIM1,HCN1,SPTBN4,SNAP25,MYT1L,SCN8A,PPFIA3 |
4.959e-04 | -7.61 | CABP1 (calcium binding protein 1) | protein interactions | 9478 | 13 | 2 | 19454 | 50 |
CACNA1C,CACNA1A |
4.978e-04 | -7.61 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 3 | 18204 | 47 |
SCN8A,SPTBN4,HCN1 |
4.978e-04 | -7.61 | regulation of action potential | biological process | GO:0098900 | 60 | 3 | 18204 | 47 |
RYR2,CACNA2D1,CACNA1C |
4.998e-04 | -7.60 | positive regulation of calcium ion-dependent exocytosis | biological process | GO:0045956 | 13 | 2 | 18204 | 47 |
STX1A,SYT1 |
4.998e-04 | -7.60 | vesicle fusion to plasma membrane | biological process | GO:0099500 | 13 | 2 | 18204 | 47 |
SNAP25,STX1A |
4.998e-04 | -7.60 | detection of calcium ion | biological process | GO:0005513 | 13 | 2 | 18204 | 47 |
SYT1,RYR2 |
5.009e-04 | -7.60 | protein complex oligomerization | biological process | GO:0051259 | 256 | 5 | 18204 | 47 |
GRIN2B,DNM1,HCN1,GRIN1,SYT1 |
5.040e-04 | -7.59 | PRKCA (protein kinase C alpha) | protein interactions | 5578 | 395 | 6 | 19454 | 50 |
GRIN2B,GRIN1,DLG4,GRM5,SNAP25,DNM1 |
5.137e-04 | -7.57 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 5 | 19454 | 50 |
DLGAP2,GRIN1,GRIN2B,DNM1,CAMK2A |
5.164e-04 | -7.57 | sarcolemma | cellular component | GO:0042383 | 142 | 4 | 19108 | 50 |
CACNA1C,SLC8A3,RYR2,CACNA2D1 |
5.227e-04 | -7.56 | exocytic process | biological process | GO:0140029 | 61 | 3 | 18204 | 47 |
SNAP25,STX1A,PPFIA3 |
5.250e-04 | -7.55 | VGCC_Ca_Na | interpro domains | IPR043203 | 13 | 2 | 18521 | 49 |
SCN8A,CACNA1G |
5.382e-04 | -7.53 | human chr7q21.11 | chromosome location | human chr7q21.11 | 18 | 2 | 26134 | 50 |
CACNA2D1,PCLO |
5.418e-04 | -7.52 | adult behavior | biological process | GO:0030534 | 146 | 4 | 18204 | 47 |
NRXN3,NRXN2,SPTBN2,SPTBN4 |
5.454e-04 | -7.51 | transmitter-gated channel activity | molecular function | GO:0022835 | 59 | 3 | 18094 | 49 |
GABRB2,GRIN2B,GRIN1 |
5.454e-04 | -7.51 | transmitter-gated monoatomic ion channel activity | molecular function | GO:0022824 | 59 | 3 | 18094 | 49 |
GABRB2,GRIN2B,GRIN1 |
5.482e-04 | -7.51 | regulation of postsynaptic membrane neurotransmitter receptor levels | biological process | GO:0099072 | 62 | 3 | 18204 | 47 |
SNAP25,LRRC7,DLG4 |
5.691e-04 | -7.47 | NLGN2 (neuroligin 2) | protein interactions | 57555 | 63 | 3 | 19454 | 50 |
NRXN3,NRXN2,DLG4 |
5.746e-04 | -7.46 | synaptic vesicle recycling | biological process | GO:0036465 | 63 | 3 | 18204 | 47 |
STX1A,SYT1,DNM1 |
5.821e-04 | -7.45 | neurotransmitter receptor transport to postsynaptic membrane | biological process | GO:0098969 | 14 | 2 | 18204 | 47 |
LRRC7,SNAP25 |
5.879e-04 | -7.44 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 47 | 16828 | 47 |
NRG3,GRIN2B,VSNL1,GRM5,RYR2,CACNA1E,NRXN3,PCLO,RASGRF1,CACNA1A,RIMS1,CELF5,DLGAP2,CACNA1G,ABLIM1,CAMKV,SPTBN4,PPFIA3,SLC4A10,EDIL3,CACNA1C,CPLX1,CAMK2B,CELF3,SPTBN2,SLC8A3,CCDC136,SYT1,L1CAM,CACNA2D1,MCF2L2,GRIN1,DLG4,CAMK2A,LRRC7,STX1A,GABRB2,EPHA6,NRXN2,FGF14,IQSEC2,PPFIA2,HCN1,SNAP25,MYT1L,DNM1,SCN8A |
5.961e-04 | -7.43 | PDZ | interpro domains | IPR001478 | 146 | 4 | 18521 | 49 |
DLG4,RIMS1,PCLO,LRRC7 |
5.985e-04 | -7.42 | chromaffin granule | cellular component | GO:0042583 | 14 | 2 | 19108 | 50 |
SYT1,DNM1 |
6.018e-04 | -7.42 | - | gene3d domains | 3.40.50.2300 | 50 | 3 | 14470 | 48 |
GRIN1,GRM5,GRIN2B |
6.066e-04 | -7.41 | PH | smart domains | SM00233 | 259 | 6 | 9717 | 40 |
IQSEC2,MCF2L2,DNM1,SPTBN4,RASGRF1,SPTBN2 |
6.114e-04 | -7.40 | Neurexin-like | interpro domains | IPR003585 | 14 | 2 | 18521 | 49 |
NRXN3,NRXN2 |
6.136e-04 | -7.40 | SAM_1 | pfam domains | PF00536 | 63 | 3 | 17795 | 47 |
EPHA6,PPFIA2,PPFIA3 |
6.298e-04 | -7.37 | long-term synaptic potentiation | biological process | GO:0060291 | 65 | 3 | 18204 | 47 |
GRIN2B,SLC8A3,SNAP25 |
6.434e-04 | -7.35 | PDZ_sf | interpro domains | IPR036034 | 149 | 4 | 18521 | 49 |
LRRC7,PCLO,RIMS1,DLG4 |
6.444e-04 | -7.35 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 15 | 16828 | 47 |
DNM1,NRXN3,PCLO,PPFIA3,RASGRF1,SPTBN4,SYT1,CAMKV,L1CAM,PPFIA2,SLC8A3,CAMK2B,SLC4A10,CAMK2A,EPHA6 |
6.465e-04 | -7.34 | establishment of localization in cell | biological process | GO:0051649 | 1619 | 12 | 18204 | 47 |
STX1A,PPFIA2,RYR2,LRRC7,PCLO,NRXN2,CPLX1,PPFIA3,SYT1,RIMS1,SNAP25,DNM1 |
6.621e-04 | -7.32 | calcium-mediated signaling | biological process | GO:0019722 | 154 | 4 | 18204 | 47 |
GRIN1,CACNA1C,RYR2,GRIN2B |
6.651e-04 | -7.32 | membrane organization | biological process | GO:0061024 | 761 | 8 | 18204 | 47 |
DLG4,STX1A,SPTBN4,NRXN2,CAMK2A,SNAP25,RIMS1,DNM1 |
6.682e-04 | -7.31 | cellular response to nitrogen compound | biological process | GO:1901699 | 580 | 7 | 18204 | 47 |
RYR2,GABRB2,HCN1,GRIN1,CACNA2D1,CACNA1A,CAMK2A |
6.706e-04 | -7.31 | protein heterotetramerization | biological process | GO:0051290 | 15 | 2 | 18204 | 47 |
GRIN2B,GRIN1 |
6.706e-04 | -7.31 | establishment of protein localization to postsynaptic membrane | biological process | GO:1903540 | 15 | 2 | 18204 | 47 |
LRRC7,SNAP25 |
6.706e-04 | -7.31 | dense core granule localization | biological process | GO:0032253 | 15 | 2 | 18204 | 47 |
PPFIA2,SNAP25 |
6.706e-04 | -7.31 | neurotransmitter receptor transport to plasma membrane | biological process | GO:0098877 | 15 | 2 | 18204 | 47 |
SNAP25,LRRC7 |
6.894e-04 | -7.28 | ribbon synapse | cellular component | GO:0097470 | 15 | 2 | 19108 | 50 |
SNAP25,DNM1 |
6.959e-04 | -7.27 | Axon guidance | KEGG pathways | ko04360 | 174 | 5 | 7161 | 30 |
EPHA6,CAMK2A,ABLIM1,CAMK2B,L1CAM |
6.959e-04 | -7.27 | Axon guidance | KEGG pathways | hsa04360 | 174 | 5 | 7161 | 30 |
EPHA6,CAMK2A,ABLIM1,CAMK2B,L1CAM |
6.963e-04 | -7.27 | - | gene3d domains | 3.10.450.50 | 12 | 2 | 14470 | 48 |
CAMK2A,CAMK2B |
7.043e-04 | -7.26 | NTF2-like_dom_sf | interpro domains | IPR032710 | 15 | 2 | 18521 | 49 |
CAMK2B,CAMK2A |
7.301e-04 | -7.22 | Common Pathways Underlying Drug Addiction | WikiPathways | WP2636 | 42 | 3 | 5310 | 23 |
CAMK2A,GRM5,GRIN1 |
7.592e-04 | -7.18 | SYT4 (synaptotagmin 4) | protein interactions | 6860 | 16 | 2 | 19454 | 50 |
SYT1,STX1A |
7.592e-04 | -7.18 | TAMALIN (trafficking regulator and scaffold protein tamalin) | protein interactions | 160622 | 16 | 2 | 19454 | 50 |
GRM5,DLG4 |
7.651e-04 | -7.18 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 2 | 18204 | 47 |
DLG4,SLC4A10 |
7.651e-04 | -7.18 | regulation of short-term neuronal synaptic plasticity | biological process | GO:0048172 | 16 | 2 | 18204 | 47 |
SLC4A10,PPFIA3 |
7.651e-04 | -7.18 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 2 | 18204 | 47 |
NRXN2,NRXN3 |
7.747e-04 | -7.16 | DLGAP4 (DLG associated protein 4) | protein interactions | 22839 | 70 | 3 | 19454 | 50 |
DLG4,GRIN1,DLGAP2 |
7.866e-04 | -7.15 | node of Ranvier | cellular component | GO:0033268 | 16 | 2 | 19108 | 50 |
SCN8A,SPTBN4 |
8.136e-04 | -7.11 | cell junction assembly | biological process | GO:0034329 | 285 | 5 | 18204 | 47 |
SPTBN2,NRXN2,PCLO,GABRB2,NRG3 |
8.152e-04 | -7.11 | peptide hormone secretion | biological process | GO:0030072 | 71 | 3 | 18204 | 47 |
CPLX1,PCLO,STX1A |
8.276e-04 | -7.10 | PH_DOMAIN | prosite domains | PS50003 | 246 | 5 | 12186 | 37 |
RASGRF1,SPTBN2,MCF2L2,DNM1,SPTBN4 |
8.415e-04 | -7.08 | glutamate-gated receptor activity | molecular function | GO:0004970 | 16 | 2 | 18094 | 49 |
GRIN1,GRIN2B |
8.590e-04 | -7.06 | KRTAP19-3 (keratin associated protein 19-3) | protein interactions | 337970 | 17 | 2 | 19454 | 50 |
CAMK2B,CAMK2A |
8.590e-04 | -7.06 | GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C) | protein interactions | 2905 | 17 | 2 | 19454 | 50 |
DLG4,GRIN1 |
8.657e-04 | -7.05 | synaptic vesicle membrane organization | biological process | GO:0048499 | 17 | 2 | 18204 | 47 |
SNAP25,STX1A |
8.657e-04 | -7.05 | positive regulation of neurotransmitter secretion | biological process | GO:0001956 | 17 | 2 | 18204 | 47 |
STX1A,SYT1 |
8.657e-04 | -7.05 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 2 | 18204 | 47 |
RYR2,CACNA1C |
8.664e-04 | -7.05 | CALM1 (calmodulin 1) | protein interactions | 801 | 607 | 7 | 19454 | 50 |
SYT1,CACNA1C,RYR2,IQSEC2,GRIN1,CAMK2B,GRM5 |
8.735e-04 | -7.04 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 4 | 18094 | 49 |
SLC4A10,SCN8A,SLC8A3,HCN1 |
8.828e-04 | -7.03 | ErbB4 signaling events | Pathway Interaction DB | erbb4_pathway | 32 | 3 | 2226 | 14 |
GRIN2B,DLG4,NRG3 |
8.889e-04 | -7.03 | PDZ | prosite domains | PS50106 | 143 | 4 | 12186 | 37 |
DLG4,RIMS1,PCLO,LRRC7 |
8.993e-04 | -7.01 | postsynaptic neurotransmitter receptor activity | molecular function | GO:0098960 | 70 | 3 | 18094 | 49 |
GRM5,GABRB2,GRIN2B |
9.108e-04 | -7.00 | ADGRL1 (adhesion G protein-coupled receptor L1) | protein interactions | 22859 | 74 | 3 | 19454 | 50 |
DLG4,CACNA1A,EDIL3 |
9.163e-04 | -7.00 | positive regulation of developmental growth | biological process | GO:0048639 | 168 | 4 | 18204 | 47 |
SPTBN4,L1CAM,SYT1,RIMS1 |
9.198e-04 | -6.99 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 6 | 18521 | 49 |
SPTBN2,DNM1,RASGRF1,MCF2L2,SPTBN4,IQSEC2 |
9.262e-04 | -6.98 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 6 | 18204 | 47 |
DLG4,SPTBN4,EPHA6,L1CAM,NRXN3,SNAP25 |
9.377e-04 | -6.97 | transport vesicle | cellular component | GO:0030133 | 437 | 6 | 19108 | 50 |
DLG4,SYT1,SNAP25,STX1A,PPFIA2,GRIN1 |
9.561e-04 | -6.95 | peptide secretion | biological process | GO:0002790 | 75 | 3 | 18204 | 47 |
STX1A,CPLX1,PCLO |
9.575e-04 | -6.95 | regulation of calcium ion transmembrane transport | biological process | GO:1903169 | 170 | 4 | 18204 | 47 |
RYR2,CACNA2D1,GRIN1,CACNA1C |
9.723e-04 | -6.94 | secretory granule localization | biological process | GO:0032252 | 18 | 2 | 18204 | 47 |
PPFIA2,SNAP25 |
9.761e-04 | -6.93 | extracellular ligand-gated monoatomic ion channel activity | molecular function | GO:0005230 | 72 | 3 | 18094 | 49 |
GABRB2,GRIN1,GRIN2B |
9.785e-04 | -6.93 | muscle system process | biological process | GO:0003012 | 297 | 5 | 18204 | 47 |
SCN8A,CACNA1G,CACNA1C,CACNA2D1,RYR2 |
9.904e-04 | -6.92 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 8 | 16828 | 47 |
PCLO,RIMS1,CAMK2A,RYR2,LRRC7,GRIN2B,SPTBN4,CACNA1E |
9.936e-04 | -6.91 | positive regulation of exocytosis | biological process | GO:0045921 | 76 | 3 | 18204 | 47 |
SYT1,STX1A,VSNL1 |
1.017e-03 | -6.89 | Lig_chan | pfam domains | PF00060 | 18 | 2 | 17795 | 47 |
GRIN2B,GRIN1 |
1.017e-03 | -6.89 | Lig_chan-Glu_bd | pfam domains | PF10613 | 18 | 2 | 17795 | 47 |
GRIN1,GRIN2B |
1.021e-03 | -6.89 | Iontro_rcpt_C | interpro domains | IPR001320 | 18 | 2 | 18521 | 49 |
GRIN1,GRIN2B |
1.021e-03 | -6.89 | Iono_Glu_rcpt_met | interpro domains | IPR001508 | 18 | 2 | 18521 | 49 |
GRIN1,GRIN2B |
1.021e-03 | -6.89 | Glu/Gly-bd | interpro domains | IPR019594 | 18 | 2 | 18521 | 49 |
GRIN2B,GRIN1 |
1.021e-03 | -6.89 | Ionotropic_Glu_rcpt | interpro domains | IPR015683 | 18 | 2 | 18521 | 49 |
GRIN1,GRIN2B |
1.025e-03 | -6.88 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 40 | 16828 | 47 |
CCDC136,VSNL1,GRM5,NRG3,SLC8A3,GRIN2B,CELF3,SPTBN2,EDIL3,CACNA1C,SLC4A10,CAMK2B,PCLO,DLG4,RASGRF1,MCF2L2,RIMS1,CACNA1A,CACNA2D1,NRXN3,L1CAM,RYR2,CACNA1E,SYT1,NRXN2,FGF14,IQSEC2,CACNA1G,PPFIA2,EPHA6,CELF5,CAMK2A,DLGAP2,LRRC7,SCN8A,DNM1,MYT1L,HCN1,CAMKV,SPTBN4 |
1.036e-03 | -6.87 | sarcoplasmic reticulum | cellular component | GO:0016529 | 76 | 3 | 19108 | 50 |
CAMK2B,CACNA2D1,RYR2 |
1.055e-03 | -6.85 | Nitric Oxide Signaling Pathway | SMPDB pathways | SMP0063777 | 9 | 2 | 1369 | 8 |
GRIN1,DLG4 |
1.073e-03 | -6.84 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 14 | 18204 | 47 |
NRXN3,RYR2,SPTBN2,CCDC136,HCN1,SLC4A10,L1CAM,EPHA6,ABLIM1,CACNA1C,SNAP25,NRG3,DLG4,SPTBN4 |
1.074e-03 | -6.84 | Cocaine addiction | KEGG pathways | ko05030 | 49 | 3 | 7161 | 30 |
GRIN1,GRIN2B,DLG4 |
1.074e-03 | -6.84 | Cocaine addiction | KEGG pathways | hsa05030 | 49 | 3 | 7161 | 30 |
GRIN2B,GRIN1,DLG4 |
1.077e-03 | -6.83 | CFAP263 (cilia and flagella associated protein 263) | protein interactions | 29070 | 19 | 2 | 19454 | 50 |
PPFIA3,SPTBN2 |
1.077e-03 | -6.83 | ADRB1 (adrenoceptor beta 1) | protein interactions | 153 | 19 | 2 | 19454 | 50 |
DLG4,DLGAP2 |
1.077e-03 | -6.83 | DRD1 (dopamine receptor D1) | protein interactions | 1812 | 19 | 2 | 19454 | 50 |
DLG4,GRIN1 |
1.101e-03 | -6.81 | VAMP2 (vesicle associated membrane protein 2) | protein interactions | 6844 | 177 | 4 | 19454 | 50 |
STX1A,SNAP25,CPLX1,SYT1 |
1.115e-03 | -6.80 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 2 | 19108 | 50 |
SCN8A,SPTBN2 |
1.126e-03 | -6.79 | lobular_carcinoma | COSMIC cancer mutations | lobular_carcinoma | 763 | 8 | 16828 | 47 |
RIMS1,PPFIA3,DLG4,CACNA1E,CAMK2B,CAMK2A,CAMKV,EPHA6 |
1.126e-03 | -6.79 | breast-carcinoma-lobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-lobular_carcinoma | 763 | 8 | 16828 | 47 |
EPHA6,CAMK2B,CACNA1E,CAMK2A,CAMKV,RIMS1,DLG4,PPFIA3 |
1.136e-03 | -6.78 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 4 | 7161 | 30 |
CAMK2A,CACNA1A,CACNA1C,CAMK2B |
1.142e-03 | -6.78 | STX2 (syntaxin 2) | protein interactions | 2054 | 80 | 3 | 19454 | 50 |
STX1A,SYT1,SNAP25 |
1.193e-03 | -6.73 | syntaxin-1 binding | molecular function | GO:0017075 | 19 | 2 | 18094 | 49 |
SNAP25,SYT1 |
1.208e-03 | -6.72 | sodium ion transport | biological process | GO:0006814 | 181 | 4 | 18204 | 47 |
SCN8A,SLC8A3,HCN1,SLC4A10 |
1.208e-03 | -6.72 | cellular process | biological process | GO:0009987 | 14996 | 46 | 18204 | 47 |
CAMK2A,ABLIM1,L1CAM,EPHA6,CACNA1A,GRIN1,GABRB2,NRXN3,SLC8A3,CELF3,GRIN2B,SNAP25,PPFIA3,PPFIA2,CCDC136,CACNA1G,NRXN2,DLGAP2,FGF14,CACNA2D1,BRINP1,DLG4,DNM1,CACNA1C,RASGRF1,GRM5,IQSEC2,STX1A,HCN1,SPTBN2,LRRC7,SPTBN4,MYT1L,CELF5,EDIL3,SLC4A10,PCLO,CACNA1E,CAMK2B,RYR2,CPLX1,CAMKV,SCN8A,NRG3,SYT1,RIMS1 |
1.239e-03 | -6.69 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 33 | 16828 | 47 |
NRXN2,PPFIA2,CACNA1G,CELF5,CAMK2A,DLGAP2,LRRC7,GABRB2,EPHA6,SCN8A,PPFIA3,HCN1,SPTBN4,MYT1L,NRG3,GRIN2B,VSNL1,GRM5,SLC4A10,CACNA1C,CAMK2B,CELF3,SPTBN2,CACNA2D1,NRXN3,PCLO,GRIN1,RASGRF1,MCF2L2,RIMS1,CACNA1A,RYR2,CACNA1E |
1.267e-03 | -6.67 | Innate Immune System | REACTOME pathways | R-HSA-168249 | 1285 | 12 | 10285 | 37 |
SNAP25,GRIN1,NRG3,SPTBN4,DLG4,CAMK2B,LRRC7,SPTBN2,DNM1,RASGRF1,GRIN2B,CAMK2A |
1.282e-03 | -6.66 | peptide transport | biological process | GO:0015833 | 83 | 3 | 18204 | 47 |
STX1A,CPLX1,PCLO |
1.282e-03 | -6.66 | positive regulation of calcium ion transmembrane transport | biological process | GO:1904427 | 83 | 3 | 18204 | 47 |
RYR2,CACNA2D1,GRIN1 |
1.284e-03 | -6.66 | LGI-ADAM interactions | REACTOME pathways | R-HSA-5682910 | 15 | 2 | 10285 | 37 |
STX1A,DLG4 |
1.294e-03 | -6.65 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 12 | 16828 | 47 |
RYR2,LRRC7,SPTBN2,NRXN3,SLC8A3,IQSEC2,FGF14,CACNA1G,MCF2L2,ABLIM1,CACNA1A,RIMS1 |
1.294e-03 | -6.65 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 12 | 16828 | 47 |
RIMS1,CACNA1A,MCF2L2,NRXN3,RYR2,ABLIM1,FGF14,IQSEC2,CACNA1G,SLC8A3,SPTBN2,LRRC7 |
1.301e-03 | -6.64 | positive regulation of transport | biological process | GO:0051050 | 844 | 8 | 18204 | 47 |
SYT1,RYR2,SNAP25,CAMK2A,VSNL1,CACNA2D1,STX1A,GRIN1 |
1.309e-03 | -6.64 | vesicle localization | biological process | GO:0051648 | 185 | 4 | 18204 | 47 |
SNAP25,DNM1,PCLO,PPFIA2 |
1.315e-03 | -6.63 | RAB27A (RAB27A, member RAS oncogene family) | protein interactions | 5873 | 84 | 3 | 19454 | 50 |
RIMS1,STX1A,SYT1 |
1.318e-03 | -6.63 | STXBP6 (syntaxin binding protein 6) | protein interactions | 29091 | 21 | 2 | 19454 | 50 |
STX1A,SNAP25 |
1.328e-03 | -6.62 | regulation of receptor localization to synapse | biological process | GO:1902683 | 21 | 2 | 18204 | 47 |
IQSEC2,CPLX1 |
1.329e-03 | -6.62 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 17 | 18204 | 47 |
SLC8A3,CACNA2D1,DLG4,BRINP1,DLGAP2,SPTBN4,CACNA1C,RIMS1,GRIN2B,STX1A,GRIN1,GRM5,IQSEC2,L1CAM,RYR2,CACNA1G,CAMK2B |
1.331e-03 | -6.62 | IQ_motif_EF-hand-BS | interpro domains | IPR000048 | 82 | 3 | 18521 | 49 |
RASGRF1,SCN8A,IQSEC2 |
1.421e-03 | -6.56 | central nervous system neuron development | biological process | GO:0021954 | 86 | 3 | 18204 | 47 |
SPTBN4,SLC4A10,BRINP1 |
1.447e-03 | -6.54 | CPLX2 (complexin 2) | protein interactions | 10814 | 22 | 2 | 19454 | 50 |
STX1A,CPLX1 |
1.457e-03 | -6.53 | 4.1m | smart domains | SM00294 | 14 | 2 | 9717 | 40 |
NRXN3,NRXN2 |
1.458e-03 | -6.53 | cell communication by electrical coupling | biological process | GO:0010644 | 22 | 2 | 18204 | 47 |
RYR2,CACNA1C |
1.458e-03 | -6.53 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | biological process | GO:0010881 | 22 | 2 | 18204 | 47 |
CACNA1C,RYR2 |
1.464e-03 | -6.53 | femur | COSMIC cancer mutations | femur | 1197 | 10 | 16828 | 47 |
HCN1,CACNA1E,DLGAP2,SYT1,LRRC7,NRXN3,NRG3,FGF14,PPFIA2,DLG4 |
1.478e-03 | -6.52 | - | gene3d domains | 2.30.42.10 | 149 | 4 | 14470 | 48 |
RIMS1,DLG4,PCLO,LRRC7 |
1.490e-03 | -6.51 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 6 | 18204 | 47 |
DLG4,SNAP25,NRXN3,EPHA6,L1CAM,SPTBN4 |
1.497e-03 | -6.50 | SAM_DOMAIN | prosite domains | PS50105 | 75 | 3 | 12186 | 37 |
EPHA6,PPFIA2,PPFIA3 |
1.499e-03 | -6.50 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 39 | 16828 | 47 |
LRRC7,DLGAP2,CAMK2A,CELF5,EPHA6,CACNA1G,PPFIA2,IQSEC2,FGF14,NRXN2,ABLIM1,SPTBN4,HCN1,MYT1L,DNM1,PPFIA3,SCN8A,CAMK2B,CPLX1,CACNA1C,EDIL3,SLC4A10,SPTBN2,CELF3,GRIN2B,NRG3,GRM5,SYT1,CACNA1E,RYR2,NRXN3,CACNA2D1,CACNA1A,RIMS1,MCF2L2,RASGRF1,GRIN1,DLG4,PCLO |
1.499e-03 | -6.50 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 39 | 16828 | 47 |
SPTBN4,HCN1,MYT1L,DNM1,SCN8A,PPFIA3,LRRC7,DLGAP2,CAMK2A,CELF5,EPHA6,PPFIA2,CACNA1G,IQSEC2,FGF14,NRXN2,ABLIM1,SYT1,CACNA1E,RYR2,NRXN3,CACNA2D1,RIMS1,CACNA1A,RASGRF1,GRIN1,MCF2L2,DLG4,PCLO,CAMK2B,CPLX1,EDIL3,SLC4A10,CACNA1C,SPTBN2,CELF3,GRIN2B,NRG3,GRM5 |
1.503e-03 | -6.50 | NLGN3 (neuroligin 3) | protein interactions | 54413 | 88 | 3 | 19454 | 50 |
NRXN2,NRXN3,DLG4 |
1.570e-03 | -6.46 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 6 | 18204 | 47 |
SNAP25,NRXN3,DLG4,L1CAM,EPHA6,SPTBN4 |
1.578e-03 | -6.45 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 42 | 16828 | 47 |
DNM1,SCN8A,PPFIA3,HCN1,SPTBN4,MYT1L,NRXN2,PPFIA2,CACNA1G,FGF14,IQSEC2,ABLIM1,CAMK2A,CELF5,LRRC7,GABRB2,DLGAP2,EPHA6,CACNA2D1,NRXN3,RASGRF1,MCF2L2,DLG4,GRIN1,PCLO,RIMS1,CACNA1A,RYR2,SYT1,CACNA1E,L1CAM,SLC8A3,NRG3,GRIN2B,GRM5,SLC4A10,CACNA1C,EDIL3,CAMK2B,CPLX1,CELF3,SPTBN2 |
1.582e-03 | -6.45 | TSPOAP1 (TSPO associated protein 1) | protein interactions | 9256 | 23 | 2 | 19454 | 50 |
CACNA1A,DLGAP2 |
1.595e-03 | -6.44 | ionotropic glutamate receptor signaling pathway | biological process | GO:0035235 | 23 | 2 | 18204 | 47 |
GRIN2B,GRIN1 |
1.595e-03 | -6.44 | regulation of vesicle fusion | biological process | GO:0031338 | 23 | 2 | 18204 | 47 |
SYT1,CPLX1 |
1.595e-03 | -6.44 | positive regulation of neurotransmitter transport | biological process | GO:0051590 | 23 | 2 | 18204 | 47 |
STX1A,SYT1 |
1.595e-03 | -6.44 | cervix | COSMIC cancer mutations | cervix | 11793 | 42 | 16828 | 47 |
GRM5,SLC8A3,NRG3,GRIN2B,CELF3,SPTBN2,EDIL3,SLC4A10,CACNA1C,CAMK2B,CPLX1,DLG4,GRIN1,MCF2L2,RASGRF1,PCLO,RIMS1,CACNA1A,CACNA2D1,NRXN3,L1CAM,RYR2,SYT1,CACNA1E,ABLIM1,NRXN2,CACNA1G,PPFIA2,FGF14,IQSEC2,EPHA6,CAMK2A,CELF5,GABRB2,LRRC7,DLGAP2,SCN8A,PPFIA3,DNM1,MYT1L,HCN1,SPTBN4 |
1.653e-03 | -6.41 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 6 | 18204 | 47 |
L1CAM,EPHA6,SPTBN4,SNAP25,NRXN3,DLG4 |
1.674e-03 | -6.39 | Actinin_actin-bd_CS | interpro domains | IPR001589 | 23 | 2 | 18521 | 49 |
SPTBN2,SPTBN4 |
1.712e-03 | -6.37 | vesicle organization | biological process | GO:0016050 | 337 | 5 | 18204 | 47 |
DNM1,CCDC136,DLG4,SNAP25,STX1A |
1.723e-03 | -6.36 | CNKSR2 (connector enhancer of kinase suppressor of Ras 2) | protein interactions | 22866 | 24 | 2 | 19454 | 50 |
DLG4,LRRC7 |
1.724e-03 | -6.36 | hormone secretion | biological process | GO:0046879 | 92 | 3 | 18204 | 47 |
PCLO,CPLX1,STX1A |
1.728e-03 | -6.36 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 7 | 18204 | 47 |
PPFIA2,L1CAM,DLG4,GRIN2B,CAMK2B,SNAP25,LRRC7 |
1.737e-03 | -6.36 | positive regulation of dendrite extension | biological process | GO:1903861 | 24 | 2 | 18204 | 47 |
SYT1,RIMS1 |
1.737e-03 | -6.36 | neurotransmitter receptor transport | biological process | GO:0099637 | 24 | 2 | 18204 | 47 |
SNAP25,LRRC7 |
1.753e-03 | -6.35 | voltage-gated sodium channel activity | molecular function | GO:0005248 | 23 | 2 | 18094 | 49 |
HCN1,SCN8A |
1.800e-03 | -6.32 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 3 | 18094 | 49 |
CACNA1A,GRIN1,GRIN2B |
1.816e-03 | -6.31 | Spectrin | pfam domains | PF00435 | 24 | 2 | 17795 | 47 |
SPTBN2,SPTBN4 |
1.817e-03 | -6.31 | TANC1 (tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1) | protein interactions | 85461 | 94 | 3 | 19454 | 50 |
GRIN2B,DLG4,CAMK2A |
1.823e-03 | -6.31 | Spectrin_repeat | interpro domains | IPR002017 | 24 | 2 | 18521 | 49 |
SPTBN4,SPTBN2 |
1.852e-03 | -6.29 | SAM | interpro domains | IPR001660 | 92 | 3 | 18521 | 49 |
PPFIA2,PPFIA3,EPHA6 |
1.854e-03 | -6.29 | Schaffer collateral - CA1 synapse | cellular component | GO:0098685 | 93 | 3 | 19108 | 50 |
CPLX1,IQSEC2,GRM5 |
1.868e-03 | -6.28 | IQ | prosite domains | PS50096 | 81 | 3 | 12186 | 37 |
RASGRF1,IQSEC2,SCN8A |
1.870e-03 | -6.28 | PPFIA2 (PTPRF interacting protein alpha 2) | protein interactions | 8499 | 25 | 2 | 19454 | 50 |
PPFIA2,PPFIA3 |
1.870e-03 | -6.28 | SLC6A3 (solute carrier family 6 member 3) | protein interactions | 6531 | 25 | 2 | 19454 | 50 |
STX1A,CAMK2A |
1.884e-03 | -6.27 | GnRH Signaling Pathway | SMPDB pathways | SMP0063811 | 47 | 3 | 1369 | 8 |
CAMK2A,LRRC7,CACNA1C |
1.885e-03 | -6.27 | presynapse organization | biological process | GO:0099172 | 25 | 2 | 18204 | 47 |
PCLO,PPFIA2 |
1.913e-03 | -6.26 | human chr14q24.3-q31.1 | chromosome location | human chr14q24.3-q31.1 | 1 | 1 | 26134 | 50 |
NRXN3 |
1.913e-03 | -6.26 | human chr11q14.2-q14.3 | chromosome location | human chr11q14.2-q14.3 | 1 | 1 | 26134 | 50 |
GRM5 |
1.929e-03 | -6.25 | HOMER1 (homer scaffold protein 1) | protein interactions | 9456 | 96 | 3 | 19454 | 50 |
RYR2,SPTBN4,GRM5 |
1.944e-03 | -6.24 | endocytic vesicle membrane | cellular component | GO:0030666 | 203 | 4 | 19108 | 50 |
CAMK2A,CAMK2B,SYT1,DLG4 |
2.023e-03 | -6.20 | PDE4A (phosphodiesterase 4A) | protein interactions | 5141 | 26 | 2 | 19454 | 50 |
CAMK2B,CAMK2A |
2.047e-03 | -6.19 | KRTAP19-5 (keratin associated protein 19-5) | protein interactions | 337972 | 98 | 3 | 19454 | 50 |
CAMK2A,CELF5,CAMK2B |
2.052e-03 | -6.19 | NMDARECEPTOR | prints domains | PR00177 | 18 | 2 | 5227 | 20 |
GRIN1,GRIN2B |
2.082e-03 | -6.17 | cellular localization | biological process | GO:0051641 | 2660 | 15 | 18204 | 47 |
STX1A,HCN1,PPFIA2,RYR2,LRRC7,PCLO,DLG4,NRXN2,CPLX1,SPTBN4,SYT1,SNAP25,RIMS1,PPFIA3,DNM1 |
2.118e-03 | -6.16 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 40 | 16828 | 47 |
CACNA1E,SYT1,RYR2,L1CAM,CACNA2D1,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,MCF2L2,DLG4,CAMK2B,SLC4A10,CACNA1C,EDIL3,SPTBN2,CELF3,GRIN2B,NRG3,SLC8A3,VSNL1,GRM5,CCDC136,SPTBN4,HCN1,CAMKV,MYT1L,DNM1,SCN8A,DLGAP2,LRRC7,CELF5,CAMK2A,EPHA6,FGF14,IQSEC2,PPFIA2,CACNA1G,NRXN2 |
2.127e-03 | -6.15 | regulation of striated muscle contraction | biological process | GO:0006942 | 99 | 3 | 18204 | 47 |
CACNA1C,SLC8A3,RYR2 |
2.133e-03 | -6.15 | endocytic vesicle | cellular component | GO:0030139 | 349 | 5 | 19108 | 50 |
CAMK2B,SYT1,DLG4,CAMK2A,DNM1 |
2.155e-03 | -6.14 | ovary | COSMIC cancer mutations | ovary | 14770 | 47 | 16828 | 47 |
ABLIM1,CACNA1G,CELF5,DLGAP2,PPFIA3,CAMKV,SPTBN4,VSNL1,GRM5,NRG3,GRIN2B,PCLO,RASGRF1,RIMS1,CACNA1A,NRXN3,RYR2,CACNA1E,NRXN2,IQSEC2,FGF14,PPFIA2,EPHA6,CAMK2A,STX1A,GABRB2,LRRC7,SCN8A,DNM1,MYT1L,HCN1,SNAP25,CCDC136,SLC8A3,CELF3,SPTBN2,SLC4A10,EDIL3,CACNA1C,CPLX1,CAMK2B,MCF2L2,DLG4,GRIN1,CACNA2D1,L1CAM,SYT1 |
2.155e-03 | -6.14 | positive regulation of monoatomic ion transport | biological process | GO:0043270 | 212 | 4 | 18204 | 47 |
CAMK2A,RYR2,CACNA2D1,GRIN1 |
2.168e-03 | -6.13 | APBA1 (amyloid beta precursor protein binding family A member 1) | protein interactions | 320 | 100 | 3 | 19454 | 50 |
DLG4,ABLIM1,STX1A |
2.170e-03 | -6.13 | DCAF6 (DDB1 and CUL4 associated factor 6) | protein interactions | 55827 | 213 | 4 | 19454 | 50 |
CAMK2B,DLG4,GRIN1,DNM1 |
2.180e-03 | -6.13 | ACTININ_2 | prosite domains | PS00020 | 23 | 2 | 12186 | 37 |
SPTBN4,SPTBN2 |
2.180e-03 | -6.13 | ACTININ_1 | prosite domains | PS00019 | 23 | 2 | 12186 | 37 |
SPTBN4,SPTBN2 |
2.181e-03 | -6.13 | KCNJ12 (potassium inwardly rectifying channel subfamily J member 12) | protein interactions | 3768 | 27 | 2 | 19454 | 50 |
DLG4,ABLIM1 |
2.181e-03 | -6.13 | DLGAP1 (DLG associated protein 1) | protein interactions | 9229 | 27 | 2 | 19454 | 50 |
DLG4,DLGAP2 |
2.198e-03 | -6.12 | regulation of dendrite extension | biological process | GO:1903859 | 27 | 2 | 18204 | 47 |
SYT1,RIMS1 |
2.198e-03 | -6.12 | regulation of cardiac muscle contraction by calcium ion signaling | biological process | GO:0010882 | 27 | 2 | 18204 | 47 |
RYR2,CACNA1C |
2.198e-03 | -6.12 | positive regulation of protein tyrosine kinase activity | biological process | GO:0061098 | 27 | 2 | 18204 | 47 |
GRM5,DLG4 |
2.207e-03 | -6.12 | DLG1 (discs large MAGUK scaffold protein 1) | protein interactions | 1739 | 214 | 4 | 19454 | 50 |
DLGAP2,GRIN1,GRIN2B,CAMK2A |
2.230e-03 | -6.11 | regulation of monoatomic ion transmembrane transporter activity | biological process | GO:0032412 | 214 | 4 | 18204 | 47 |
CACNA2D1,RYR2,DLG4,FGF14 |
2.230e-03 | -6.11 | PRKCG (protein kinase C gamma) | protein interactions | 5582 | 101 | 3 | 19454 | 50 |
GRM5,GRIN1,GRIN2B |
2.259e-03 | -6.09 | axonal growth cone | cellular component | GO:0044295 | 27 | 2 | 19108 | 50 |
L1CAM,SNAP25 |
2.289e-03 | -6.08 | calcium ion binding | molecular function | GO:0005509 | 683 | 7 | 18094 | 49 |
PCLO,SYT1,RYR2,VSNL1,EDIL3,CACNA1E,GRIN1 |
2.307e-03 | -6.07 | T_SNARE_dom | interpro domains | IPR000727 | 27 | 2 | 18521 | 49 |
SNAP25,STX1A |
2.315e-03 | -6.07 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 7 | 16828 | 47 |
CAMK2A,CAMKV,CELF5,LRRC7,CAMK2B,EPHA6,MCF2L2 |
2.363e-03 | -6.05 | dendritic spine development | biological process | GO:0060996 | 28 | 2 | 18204 | 47 |
DLG4,CAMK2A |
2.363e-03 | -6.05 | regulation of cardiac conduction | biological process | GO:1903779 | 28 | 2 | 18204 | 47 |
SLC8A3,RYR2 |
2.363e-03 | -6.05 | regulation of calcium ion-dependent exocytosis | biological process | GO:0017158 | 28 | 2 | 18204 | 47 |
SYT1,STX1A |
2.381e-03 | -6.04 | hormone transport | biological process | GO:0009914 | 103 | 3 | 18204 | 47 |
CPLX1,PCLO,STX1A |
2.395e-03 | -6.03 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 7 | 16828 | 47 |
LRRC7,CAMK2B,CELF5,CAMKV,CAMK2A,EPHA6,MCF2L2 |
2.422e-03 | -6.02 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 9 | 18204 | 47 |
RASGRF1,NRXN3,SNAP25,DLG4,SPTBN4,EPHA6,L1CAM,CAMK2A,ABLIM1 |
2.425e-03 | -6.02 | PBPe | smart domains | SM00079 | 18 | 2 | 9717 | 40 |
GRIN1,GRIN2B |
2.425e-03 | -6.02 | Lig_chan-Glu_bd | smart domains | SM00918 | 18 | 2 | 9717 | 40 |
GRIN1,GRIN2B |
2.452e-03 | -6.01 | axonogenesis | biological process | GO:0007409 | 366 | 5 | 18204 | 47 |
SNAP25,NRXN3,L1CAM,EPHA6,SPTBN4 |
2.514e-03 | -5.99 | CACNG2 (calcium voltage-gated channel auxiliary subunit gamma 2) | protein interactions | 10369 | 29 | 2 | 19454 | 50 |
GRIN1,DLG4 |
2.515e-03 | -5.99 | regulation of postsynapse organization | biological process | GO:0099175 | 105 | 3 | 18204 | 47 |
CAMK2B,GRIN2B,PPFIA2 |
2.534e-03 | -5.98 | regulation of cardiac muscle cell action potential | biological process | GO:0098901 | 29 | 2 | 18204 | 47 |
RYR2,CACNA1C |
2.534e-03 | -5.98 | postsynaptic membrane organization | biological process | GO:0001941 | 29 | 2 | 18204 | 47 |
DLG4,NRXN2 |
2.547e-03 | -5.97 | regulation of transmembrane transporter activity | biological process | GO:0022898 | 222 | 4 | 18204 | 47 |
CACNA2D1,RYR2,DLG4,FGF14 |
2.569e-03 | -5.96 | vesicle | cellular component | GO:0031982 | 4141 | 20 | 19108 | 50 |
CAMK2B,LRRC7,GABRB2,SYT1,CCDC136,PPFIA2,GRIN2B,GRIN1,CAMKV,CACNA2D1,STX1A,SNAP25,EDIL3,CAMK2A,SCN8A,DLG4,PCLO,PPFIA3,SPTBN4,DNM1 |
2.570e-03 | -5.96 | Cript (CXXC repeat containing interactor of PDZ3 domain) | protein interactions | 56725 | 1 | 1 | 19454 | 50 |
DLG4 |
2.570e-03 | -5.96 | Epha3 (Eph receptor A3) | protein interactions | 13837 | 1 | 1 | 19454 | 50 |
L1CAM |
2.570e-03 | -5.96 | Septin1 (Septin 1) | protein interactions | 33114 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | Kcna4 (potassium voltage-gated channel subfamily A member 4) | protein interactions | 25469 | 1 | 1 | 19454 | 50 |
DLG4 |
2.570e-03 | -5.96 | Ank3 (ankyrin 3) | protein interactions | 361833 | 1 | 1 | 19454 | 50 |
L1CAM |
2.570e-03 | -5.96 | pnut (peanut) | protein interactions | 35801 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | HEM15 (ferrochelatase HEM15) | protein interactions | 854347 | 1 | 1 | 19454 | 50 |
CAMK2B |
2.570e-03 | -5.96 | Epha7 (Eph receptor A7) | protein interactions | 171287 | 1 | 1 | 19454 | 50 |
L1CAM |
2.570e-03 | -5.96 | Vps16 (VPS16 core subunit of CORVET and HOPS complexes) | protein interactions | 296159 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | Vps18 (VPS18 core subunit of CORVET and HOPS complexes) | protein interactions | 296083 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | SEC9 (Sec9p) | protein interactions | 852892 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | SLA1 (cytoskeletal protein-binding protein SLA1) | protein interactions | 852276 | 1 | 1 | 19454 | 50 |
DNM1 |
2.570e-03 | -5.96 | EPHB2 (EPH receptor B2) | protein interactions | 396513 | 1 | 1 | 19454 | 50 |
L1CAM |
2.570e-03 | -5.96 | Vps11 (VPS11 core subunit of CORVET and HOPS complexes) | protein interactions | 315600 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | Shank1 (SH3 and multiple ankyrin repeat domains 1) | protein interactions | 78957 | 1 | 1 | 19454 | 50 |
DLG4 |
2.570e-03 | -5.96 | Ephb1 (Eph receptor B1) | protein interactions | 270190 | 1 | 1 | 19454 | 50 |
L1CAM |
2.570e-03 | -5.96 | SNC1 (SNAP receptor SNC1) | protein interactions | 851203 | 1 | 1 | 19454 | 50 |
STX1A |
2.570e-03 | -5.96 | Rnf138 (ring finger protein 138) | protein interactions | 94196 | 1 | 1 | 19454 | 50 |
CACNA1A |
2.570e-03 | -5.96 | EPHA4 (EPH receptor A4) | protein interactions | 395559 | 1 | 1 | 19454 | 50 |
L1CAM |
2.570e-03 | -5.96 | Ephb3 (Eph receptor B3) | protein interactions | 13845 | 1 | 1 | 19454 | 50 |
L1CAM |
2.575e-03 | -5.96 | T_SNARE | prosite domains | PS50192 | 25 | 2 | 12186 | 37 |
STX1A,SNAP25 |
2.582e-03 | -5.96 | chemorepulsion involved in interneuron migration from the subpallium to the cortex | biological process | GO:0021842 | 1 | 1 | 18204 | 47 |
NRG3 |
2.582e-03 | -5.96 | peptidyl-threonine autophosphorylation | biological process | GO:1990443 | 1 | 1 | 18204 | 47 |
CAMK2A |
2.582e-03 | -5.96 | regulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane | biological process | GO:0099145 | 1 | 1 | 18204 | 47 |
CPLX1 |
2.582e-03 | -5.96 | fast, calcium ion-dependent exocytosis of neurotransmitter | biological process | GO:0098746 | 1 | 1 | 18204 | 47 |
SYT1 |
2.582e-03 | -5.96 | propylene metabolic process | biological process | GO:0018964 | 1 | 1 | 18204 | 47 |
GRIN1 |
2.582e-03 | -5.96 | positive regulation of calcium ion-dependent exocytosis of neurotransmitter | biological process | GO:1903235 | 1 | 1 | 18204 | 47 |
SYT1 |
2.582e-03 | -5.96 | directional guidance of interneurons involved in migration from the subpallium to the cortex | biological process | GO:0021840 | 1 | 1 | 18204 | 47 |
NRG3 |
2.582e-03 | -5.96 | clathrin coat assembly involved in endocytosis | biological process | GO:0099049 | 1 | 1 | 18204 | 47 |
DNM1 |
2.582e-03 | -5.96 | synchronous neurotransmitter secretion | biological process | GO:0071911 | 1 | 1 | 18204 | 47 |
SYT1 |
2.608e-03 | -5.95 | Periplasmic binding protein-like II | gene3d domains | 3.40.190.10 | 23 | 2 | 14470 | 48 |
GRIN1,GRIN2B |
2.617e-03 | -5.95 | postsynaptic spectrin-associated cytoskeleton | cellular component | GO:0099189 | 1 | 1 | 19108 | 50 |
SPTBN2 |
2.617e-03 | -5.95 | epididymosome | cellular component | GO:0098875 | 1 | 1 | 19108 | 50 |
PPFIA3 |
2.646e-03 | -5.93 | VDCC_L_a1csu | interpro domains | IPR005451 | 1 | 1 | 18521 | 49 |
CACNA1C |
2.646e-03 | -5.93 | SRRM3_cwf21 | interpro domains | IPR047489 | 1 | 1 | 18521 | 49 |
SRRM3 |
2.646e-03 | -5.93 | EPH-A6_SAM | interpro domains | IPR042746 | 1 | 1 | 18521 | 49 |
EPHA6 |
2.646e-03 | -5.93 | Na_channel_a8su | interpro domains | IPR008054 | 1 | 1 | 18521 | 49 |
SCN8A |
2.646e-03 | -5.93 | PCLO_FYVE1 | interpro domains | IPR042720 | 1 | 1 | 18521 | 49 |
PCLO |
2.646e-03 | -5.93 | GPCR_3_mGluR5 | interpro domains | IPR000202 | 1 | 1 | 18521 | 49 |
GRM5 |
2.646e-03 | -5.93 | SNAP-25_N_SNARE_chord | interpro domains | IPR039077 | 1 | 1 | 18521 | 49 |
SNAP25 |
2.646e-03 | -5.93 | EphA6_rcpt_lig-bd | interpro domains | IPR034280 | 1 | 1 | 18521 | 49 |
EPHA6 |
2.646e-03 | -5.93 | TMEM266 | interpro domains | IPR042857 | 1 | 1 | 18521 | 49 |
TMEM266 |
2.646e-03 | -5.93 | CACNA1A | interpro domains | IPR005448 | 1 | 1 | 18521 | 49 |
CACNA1A |
2.646e-03 | -5.93 | VDCC_R_a1su | interpro domains | IPR005449 | 1 | 1 | 18521 | 49 |
CACNA1E |
2.690e-03 | -5.92 | UBTFL1 (upstream binding transcription factor like 1) | protein interactions | 642623 | 30 | 2 | 19454 | 50 |
CCDC136,STX1A |
2.690e-03 | -5.92 | GRIN3B (glutamate ionotropic receptor NMDA type subunit 3B) | protein interactions | 116444 | 30 | 2 | 19454 | 50 |
DLG4,GRIN1 |
2.708e-03 | -5.91 | structural constituent of presynapse | molecular function | GO:0099181 | 1 | 1 | 18094 | 49 |
PPFIA2 |
2.708e-03 | -5.91 | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | molecular function | GO:0099580 | 1 | 1 | 18094 | 49 |
SLC8A3 |
2.708e-03 | -5.91 | P2Y1 nucleotide receptor binding | molecular function | GO:0031812 | 1 | 1 | 18094 | 49 |
DLG4 |
2.708e-03 | -5.91 | G protein-coupled nucleotide receptor binding | molecular function | GO:0031811 | 1 | 1 | 18094 | 49 |
DLG4 |
2.708e-03 | -5.91 | intracellular cAMP-activated cation channel activity involved in regulation of presynaptic membrane potential | molecular function | GO:0140232 | 1 | 1 | 18094 | 49 |
HCN1 |
2.708e-03 | -5.91 | voltage-gated calcium channel activity involved in bundle of His cell action potential | molecular function | GO:0086057 | 1 | 1 | 18094 | 49 |
CACNA2D1 |
2.710e-03 | -5.91 | neuronal action potential | biological process | GO:0019228 | 30 | 2 | 18204 | 47 |
SCN8A,HCN1 |
2.725e-03 | -5.91 | PDZ | smart domains | SM00228 | 143 | 4 | 9717 | 40 |
LRRC7,RIMS1,DLG4,PCLO |
2.796e-03 | -5.88 | postsynapse organization | biological process | GO:0099173 | 109 | 3 | 18204 | 47 |
DLG4,SPTBN2,NRXN2 |
2.830e-03 | -5.87 | EGF_3 | prosite domains | PS50026 | 196 | 4 | 12186 | 37 |
NRXN2,NRG3,NRXN3,EDIL3 |
2.870e-03 | -5.85 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 6 | 14470 | 48 |
SPTBN4,IQSEC2,MCF2L2,DNM1,SPTBN2,RASGRF1 |
2.870e-03 | -5.85 | GRM5 (glutamate metabotropic receptor 5) | protein interactions | 2915 | 31 | 2 | 19454 | 50 |
GRIN1,GRM5 |
2.892e-03 | -5.85 | positive regulation of calcium ion transmembrane transporter activity | biological process | GO:1901021 | 31 | 2 | 18204 | 47 |
CACNA2D1,RYR2 |
2.892e-03 | -5.85 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0010880 | 31 | 2 | 18204 | 47 |
RYR2,CACNA1C |
2.922e-03 | -5.84 | cell differentiation | biological process | GO:0030154 | 3645 | 18 | 18204 | 47 |
CAMK2B,CCDC136,NRXN3,EPHA6,L1CAM,CAMK2A,HCN1,GABRB2,SLC4A10,RASGRF1,SNAP25,RIMS1,SYT1,SPTBN4,MYT1L,DLG4,BRINP1,SLC8A3 |
2.939e-03 | -5.83 | calcium ion homeostasis | biological process | GO:0055074 | 231 | 4 | 18204 | 47 |
GRIN1,RYR2,SLC8A3,GRM5 |
2.950e-03 | -5.83 | cellular developmental process | biological process | GO:0048869 | 3648 | 18 | 18204 | 47 |
SLC4A10,HCN1,GABRB2,CAMK2A,EPHA6,L1CAM,NRXN3,CCDC136,CAMK2B,SLC8A3,DLG4,BRINP1,MYT1L,SPTBN4,SYT1,RIMS1,SNAP25,RASGRF1 |
3.038e-03 | -5.80 | HSF1-dependent transactivation | REACTOME pathways | R-HSA-3371571 | 23 | 2 | 10285 | 37 |
CAMK2B,CAMK2A |
3.046e-03 | -5.79 | PRKCB (protein kinase C beta) | protein interactions | 5579 | 234 | 4 | 19454 | 50 |
GRIN1,GRIN2B,GRM5,GABRB2 |
3.074e-03 | -5.78 | Brain-Derived Neurotrophic Factor (BDNF) signaling pathway | WikiPathways | WP2380 | 144 | 4 | 5310 | 23 |
GRIN2B,CAMK2A,RASGRF1,GRIN1 |
3.080e-03 | -5.78 | ligand-gated ion channel signaling pathway | biological process | GO:1990806 | 32 | 2 | 18204 | 47 |
GRIN2B,GRIN1 |
3.177e-03 | -5.75 | intracellularly ligand-gated monoatomic ion channel activity | molecular function | GO:0005217 | 31 | 2 | 18094 | 49 |
RYR2,HCN1 |
3.191e-03 | -5.75 | cell projection organization | biological process | GO:0030030 | 1200 | 9 | 18204 | 47 |
RASGRF1,NRXN3,SNAP25,DLG4,SPTBN4,EPHA6,L1CAM,ABLIM1,CAMK2A |
3.202e-03 | -5.74 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 46 | 16828 | 47 |
CACNA1G,ABLIM1,CELF5,DLGAP2,PPFIA3,CAMKV,SPTBN4,NRG3,GRIN2B,GRM5,VSNL1,NRXN3,RASGRF1,PCLO,CACNA1A,RIMS1,RYR2,CACNA1E,NRXN2,PPFIA2,FGF14,IQSEC2,CAMK2A,GABRB2,LRRC7,EPHA6,DNM1,SCN8A,HCN1,SNAP25,MYT1L,SLC8A3,CCDC136,EDIL3,CACNA1C,SLC4A10,CAMK2B,CPLX1,CELF3,SPTBN2,CACNA2D1,GRIN1,MCF2L2,DLG4,SYT1,L1CAM |
3.249e-03 | -5.73 | ADGRB1 (adhesion G protein-coupled receptor B1) | protein interactions | 575 | 33 | 2 | 19454 | 50 |
LRRC7,DLG4 |
3.257e-03 | -5.73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | KEGG pathways | hsa05412 | 72 | 3 | 7161 | 30 |
CACNA2D1,CACNA1C,RYR2 |
3.257e-03 | -5.73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | KEGG pathways | ko05412 | 72 | 3 | 7161 | 30 |
RYR2,CACNA2D1,CACNA1C |
3.269e-03 | -5.72 | EGF-like_dom | interpro domains | IPR000742 | 232 | 4 | 18521 | 49 |
EDIL3,NRXN3,NRG3,NRXN2 |
3.271e-03 | -5.72 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 4 | 18204 | 47 |
SNAP25,LRRC7,DLG4,SPTBN4 |
3.305e-03 | -5.71 | Metipranolol Action Pathway | SMPDB pathways | SMP0000667 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Amlodipine Action Pathway | SMPDB pathways | SMP0000376 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Bopindolol Action Pathway | SMPDB pathways | SMP0000657 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Muscle/Heart Contraction | SMPDB pathways | SMP0000588 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Nimodipine Action Pathway | SMPDB pathways | SMP0000380 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Disopyramide Action Pathway | SMPDB pathways | SMP0000325 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Propranolol Action Pathway | SMPDB pathways | SMP0000307 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Ibutilide Action Pathway | SMPDB pathways | SMP0000332 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Flecainide Action Pathway | SMPDB pathways | SMP0000331 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Arbutamine Action Pathway | SMPDB pathways | SMP0000664 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Verapamil Action Pathway | SMPDB pathways | SMP0000375 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Oxprenolol Action Pathway | SMPDB pathways | SMP0000304 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Practolol Action Pathway | SMPDB pathways | SMP0000669 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Timolol Action Pathway | SMPDB pathways | SMP0000659 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Fosphenytoin (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000326 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Nifedipine Action Pathway | SMPDB pathways | SMP0000379 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Penbutolol Action Pathway | SMPDB pathways | SMP0000305 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Metoprolol Action Pathway | SMPDB pathways | SMP0000302 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Bupranolol Action Pathway | SMPDB pathways | SMP0000670 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Esmolol Action Pathway | SMPDB pathways | SMP0000301 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Epinephrine Action Pathway | SMPDB pathways | SMP0000661 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Atenolol Action Pathway | SMPDB pathways | SMP0000298 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Amiodarone Action Pathway | SMPDB pathways | SMP0000665 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Dobutamine Action Pathway | SMPDB pathways | SMP0000662 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Procainamide (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000324 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Pindolol Action Pathway | SMPDB pathways | SMP0000306 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Felodipine Action Pathway | SMPDB pathways | SMP0000377 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Levobunolol Action Pathway | SMPDB pathways | SMP0000666 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Mexiletine Action Pathway | SMPDB pathways | SMP0000329 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Sotalol Action Pathway | SMPDB pathways | SMP0000660 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Isradipine Action Pathway | SMPDB pathways | SMP0000378 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Diltiazem Action Pathway | SMPDB pathways | SMP0000359 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Betaxolol Action Pathway | SMPDB pathways | SMP0000299 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Bisoprolol Action Pathway | SMPDB pathways | SMP0000300 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Alprenolol Action Pathway | SMPDB pathways | SMP0000297 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Quinidine Action Pathway | SMPDB pathways | SMP0000323 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Nisoldipine Action Pathway | SMPDB pathways | SMP0000381 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Nebivolol Action Pathway | SMPDB pathways | SMP0000366 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Nitrendipine Action Pathway | SMPDB pathways | SMP0000382 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Acebutolol Action Pathway | SMPDB pathways | SMP0000296 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Nadolol Action Pathway | SMPDB pathways | SMP0000303 | 57 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.305e-03 | -5.71 | Isoprenaline Action Pathway | SMPDB pathways | SMP0000663 | 57 | 3 | 1369 | 8 |
CACNA1G,RYR2,CACNA1C |
3.305e-03 | -5.71 | Carteolol Action Pathway | SMPDB pathways | SMP0000658 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.305e-03 | -5.71 | Tocainide Action Pathway | SMPDB pathways | SMP0000330 | 57 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.305e-03 | -5.71 | Bevantolol Action Pathway | SMPDB pathways | SMP0000668 | 57 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
3.383e-03 | -5.69 | ETS1 (ETS proto-oncogene 1, transcription factor) | protein interactions | 2113 | 117 | 3 | 19454 | 50 |
CAMK2B,SPTBN4,CAMK2A |
3.383e-03 | -5.69 | protein tyrosine kinase activator activity | molecular function | GO:0030296 | 32 | 2 | 18094 | 49 |
GRM5,NRG3 |
3.446e-03 | -5.67 | SHANK2 (SH3 and multiple ankyrin repeat domains 2) | protein interactions | 22941 | 34 | 2 | 19454 | 50 |
DLGAP2,DLG4 |
3.465e-03 | -5.67 | DNM1 (dynamin 1) | protein interactions | 1759 | 118 | 3 | 19454 | 50 |
GRIN1,SNAP25,DNM1 |
3.473e-03 | -5.66 | vesicle docking involved in exocytosis | biological process | GO:0006904 | 34 | 2 | 18204 | 47 |
SNAP25,PPFIA3 |
3.476e-03 | -5.66 | Labetalol Action Pathway | SMPDB pathways | SMP0000368 | 58 | 3 | 1369 | 8 |
RYR2,CACNA1G,CACNA1C |
3.476e-03 | -5.66 | Carvedilol Action Pathway | SMPDB pathways | SMP0000367 | 58 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.520e-03 | -5.65 | Cardiac muscle contraction | KEGG pathways | hsa04260 | 74 | 3 | 7161 | 30 |
RYR2,CACNA1C,CACNA2D1 |
3.520e-03 | -5.65 | Cardiac muscle contraction | KEGG pathways | ko04260 | 74 | 3 | 7161 | 30 |
RYR2,CACNA1C,CACNA2D1 |
3.623e-03 | -5.62 | t_SNARE | smart domains | SM00397 | 22 | 2 | 9717 | 40 |
STX1A,SNAP25 |
3.638e-03 | -5.62 | central nervous system development | biological process | GO:0007417 | 995 | 8 | 18204 | 47 |
GRIN2B,SPTBN2,NRG3,SPTBN4,BRINP1,SLC4A10,GRIN1,SLC8A3 |
3.649e-03 | -5.61 | ABRA (actin binding Rho activating protein) | protein interactions | 137735 | 35 | 2 | 19454 | 50 |
ABLIM1,SPTBN2 |
3.652e-03 | -5.61 | Lidocaine (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000328 | 59 | 3 | 1369 | 8 |
CACNA1C,RYR2,CACNA1G |
3.676e-03 | -5.61 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 13 | 16828 | 47 |
SLC8A3,SLC4A10,CAMK2A,CAMK2B,EPHA6,DNM1,PCLO,PPFIA3,RASGRF1,CAMKV,SPTBN4,SYT1,L1CAM |
3.677e-03 | -5.61 | actin filament capping | biological process | GO:0051693 | 35 | 2 | 18204 | 47 |
SPTBN4,SPTBN2 |
3.677e-03 | -5.61 | regulation of cardiac muscle cell contraction | biological process | GO:0086004 | 35 | 2 | 18204 | 47 |
RYR2,CACNA1C |
3.681e-03 | -5.60 | regulation of cell morphogenesis | biological process | GO:0022604 | 246 | 4 | 18204 | 47 |
DLG4,SYT1,RIMS1,CAMK2B |
3.826e-03 | -5.57 | PQVDCCALPHA1 | prints domains | PR01632 | 1 | 1 | 5227 | 20 |
CACNA1A |
3.826e-03 | -5.57 | RVDCCALPHA1 | prints domains | PR01633 | 1 | 1 | 5227 | 20 |
CACNA1E |
3.826e-03 | -5.57 | NACHANNEL8 | prints domains | PR01667 | 1 | 1 | 5227 | 20 |
SCN8A |
3.826e-03 | -5.57 | LVDCCALPHA1C | prints domains | PR01635 | 1 | 1 | 5227 | 20 |
CACNA1C |
3.826e-03 | -5.57 | MTABOTROPC5R | prints domains | PR01055 | 1 | 1 | 5227 | 20 |
GRM5 |
3.843e-03 | -5.56 | regulation of muscle system process | biological process | GO:0090257 | 249 | 4 | 18204 | 47 |
CACNA1C,SLC8A3,RYR2,CAMK2B |
3.857e-03 | -5.56 | RAB33A (RAB33A, member RAS oncogene family) | protein interactions | 9363 | 36 | 2 | 19454 | 50 |
CCDC136,SYT1 |
3.857e-03 | -5.56 | SCN5A (sodium voltage-gated channel alpha subunit 5) | protein interactions | 6331 | 36 | 2 | 19454 | 50 |
DLG4,FGF14 |
3.893e-03 | -5.55 | PTPRD (protein tyrosine phosphatase receptor type D) | protein interactions | 5789 | 123 | 3 | 19454 | 50 |
PPFIA3,PPFIA2,ABLIM1 |
3.934e-03 | -5.54 | SAM/pointed_sf | interpro domains | IPR013761 | 120 | 3 | 18521 | 49 |
EPHA6,PPFIA3,PPFIA2 |
4.062e-03 | -5.51 | Arrhythmogenic Right Ventricular Cardiomyopathy | WikiPathways | WP2118 | 76 | 3 | 5310 | 23 |
RYR2,CACNA1C,CACNA2D1 |
4.062e-03 | -5.51 | Laminin_G_2 | pfam domains | PF02210 | 36 | 2 | 17795 | 47 |
NRXN3,NRXN2 |
4.067e-03 | -5.50 | regulation of transporter activity | biological process | GO:0032409 | 253 | 4 | 18204 | 47 |
CACNA2D1,RYR2,DLG4,FGF14 |
4.161e-03 | -5.48 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia | 739 | 7 | 16828 | 47 |
PCLO,RASGRF1,CACNA1A,SPTBN2,RYR2,CAMKV,HCN1 |
4.161e-03 | -5.48 | acute_lymphoblastic_T_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_T_cell_leukaemia | 739 | 7 | 16828 | 47 |
CAMKV,HCN1,RYR2,RASGRF1,PCLO,SPTBN2,CACNA1A |
4.187e-03 | -5.48 | C2 | pfam domains | PF00168 | 123 | 3 | 17795 | 47 |
RIMS1,PCLO,SYT1 |
4.209e-03 | -5.47 | cytoplasmic vesicle membrane | cellular component | GO:0030659 | 1230 | 9 | 19108 | 50 |
GABRB2,SYT1,DLG4,CAMK2B,CCDC136,CAMK2A,STX1A,CAMKV,SNAP25 |
4.241e-03 | -5.46 | positive regulation of growth | biological process | GO:0045927 | 256 | 4 | 18204 | 47 |
SPTBN4,L1CAM,SYT1,RIMS1 |
4.287e-03 | -5.45 | SAM_2 | pfam domains | PF07647 | 37 | 2 | 17795 | 47 |
PPFIA3,PPFIA2 |
4.290e-03 | -5.45 | ZNF440 (zinc finger protein 440) | protein interactions | 126070 | 38 | 2 | 19454 | 50 |
CCDC136,STX1A |
4.290e-03 | -5.45 | AOC3 (amine oxidase copper containing 3) | protein interactions | 8639 | 38 | 2 | 19454 | 50 |
CAMK2A,STX1A |
4.303e-03 | -5.45 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 6 | 16828 | 47 |
CACNA1A,CCDC136,PCLO,CACNA1E,RYR2,CACNA2D1 |
4.323e-03 | -5.44 | mRNA splice site recognition | biological process | GO:0006376 | 38 | 2 | 18204 | 47 |
CELF3,CELF5 |
4.328e-03 | -5.44 | blood circulation | biological process | GO:0008015 | 418 | 5 | 18204 | 47 |
CACNA1C,CACNA1G,CACNA2D1,RYR2,SCN8A |
4.352e-03 | -5.44 | CDCA8 (cell division cycle associated 8) | protein interactions | 55143 | 128 | 3 | 19454 | 50 |
CAMK2A,SYT1,VSNL1 |
4.379e-03 | -5.43 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 6 | 16828 | 47 |
PCLO,CCDC136,CACNA1A,CACNA2D1,RYR2,CACNA1E |
4.416e-03 | -5.42 | axon development | biological process | GO:0061564 | 420 | 5 | 18204 | 47 |
SPTBN4,L1CAM,EPHA6,NRXN3,SNAP25 |
4.442e-03 | -5.42 | dense core granule | cellular component | GO:0031045 | 38 | 2 | 19108 | 50 |
CACNA2D1,SYT1 |
4.488e-03 | -5.41 | Phase 2 - plateau phase | REACTOME pathways | R-HSA-5576893 | 28 | 2 | 10285 | 37 |
CACNA1C,CACNA2D1 |
4.488e-03 | -5.41 | Recycling pathway of L1 | REACTOME pathways | R-HSA-437239 | 28 | 2 | 10285 | 37 |
L1CAM,DNM1 |
4.504e-03 | -5.40 | SNAP receptor activity | molecular function | GO:0005484 | 37 | 2 | 18094 | 49 |
SNAP25,STX1A |
4.506e-03 | -5.40 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 44 | 16828 | 47 |
PPFIA3,SCN8A,DNM1,MYT1L,CAMKV,HCN1,SPTBN4,SNAP25,ABLIM1,NRXN2,CACNA1G,PPFIA2,IQSEC2,EPHA6,CAMK2A,CELF5,STX1A,LRRC7,GABRB2,DLGAP2,RASGRF1,GRIN1,MCF2L2,DLG4,PCLO,RIMS1,CACNA1A,NRXN3,CACNA2D1,L1CAM,RYR2,SYT1,CACNA1E,CCDC136,GRM5,SLC8A3,NRG3,GRIN2B,CELF3,SPTBN2,EDIL3,SLC4A10,CACNA1C,CAMK2B |
4.515e-03 | -5.40 | E (envelope protein) | protein interactions | 14254599 | 39 | 2 | 19454 | 50 |
RIMS1,LRRC7 |
4.549e-03 | -5.39 | long-term memory | biological process | GO:0007616 | 39 | 2 | 18204 | 47 |
SNAP25,RASGRF1 |
4.549e-03 | -5.39 | negative regulation of actin filament depolymerization | biological process | GO:0030835 | 39 | 2 | 18204 | 47 |
SPTBN4,SPTBN2 |
4.643e-03 | -5.37 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 9 | 16828 | 47 |
GRIN2B,NRG3,GRM5,RIMS1,CAMK2B,HCN1,CAMK2A,CAMKV,EPHA6 |
4.643e-03 | -5.37 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 9 | 16828 | 47 |
EPHA6,CAMK2B,CAMK2A,HCN1,CAMKV,RIMS1,GRM5,GRIN2B,NRG3 |
4.703e-03 | -5.36 | vesicle membrane | cellular component | GO:0012506 | 1251 | 9 | 19108 | 50 |
CAMK2A,STX1A,CAMKV,SNAP25,CAMK2B,CCDC136,GABRB2,SYT1,DLG4 |
4.729e-03 | -5.35 | SAM | smart domains | SM00454 | 83 | 3 | 9717 | 40 |
EPHA6,PPFIA3,PPFIA2 |
4.744e-03 | -5.35 | PPFIA3 (PTPRF interacting protein alpha 3) | protein interactions | 8541 | 40 | 2 | 19454 | 50 |
PPFIA2,PPFIA3 |
4.744e-03 | -5.35 | CPLX1 (complexin 1) | protein interactions | 10815 | 40 | 2 | 19454 | 50 |
SNAP25,STX1A |
4.771e-03 | -5.35 | kinase binding | molecular function | GO:0019900 | 780 | 7 | 18094 | 49 |
DNM1,GRM5,NRG3,LRRC7,DLG4,RYR2,STX1A |
4.776e-03 | -5.34 | Z disc | cellular component | GO:0030018 | 130 | 3 | 19108 | 50 |
RYR2,SCN8A,CACNA1C |
4.788e-03 | -5.34 | protein secretion | biological process | GO:0009306 | 132 | 3 | 18204 | 47 |
PCLO,CPLX1,STX1A |
4.808e-03 | -5.34 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 26 | 16828 | 47 |
GRIN2B,SLC8A3,NRG3,SPTBN2,CAMK2B,SLC4A10,CACNA1C,EDIL3,RIMS1,CACNA1A,DLG4,PCLO,NRXN3,L1CAM,CACNA1E,RYR2,ABLIM1,CACNA1G,FGF14,NRXN2,GABRB2,DLGAP2,SCN8A,MYT1L,SPTBN4,CAMKV |
4.812e-03 | -5.34 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 35 | 16828 | 47 |
CCDC136,GRM5,SLC8A3,GRIN2B,CELF3,CACNA1C,EDIL3,SLC4A10,CAMK2B,PCLO,MCF2L2,DLG4,RASGRF1,CACNA1A,CACNA2D1,NRXN3,L1CAM,RYR2,SYT1,NRXN2,IQSEC2,CACNA1G,PPFIA2,EPHA6,CAMK2A,DLGAP2,STX1A,LRRC7,GABRB2,SCN8A,PPFIA3,DNM1,HCN1,CAMKV,SPTBN4 |
4.827e-03 | -5.33 | chondrosarcoma | COSMIC cancer mutations | chondrosarcoma | 1181 | 9 | 16828 | 47 |
RIMS1,RASGRF1,PCLO,LRRC7,DLGAP2,CACNA1E,SLC8A3,HCN1,RYR2 |
4.865e-03 | -5.33 | Hypertrophic cardiomyopathy (HCM) | KEGG pathways | hsa05410 | 83 | 3 | 7161 | 30 |
CACNA1C,CACNA2D1,RYR2 |
4.865e-03 | -5.33 | Hypertrophic cardiomyopathy (HCM) | KEGG pathways | ko05410 | 83 | 3 | 7161 | 30 |
CACNA1C,CACNA2D1,RYR2 |
4.889e-03 | -5.32 | establishment of protein localization to extracellular region | biological process | GO:0035592 | 133 | 3 | 18204 | 47 |
STX1A,CPLX1,PCLO |
4.897e-03 | -5.32 | amide binding | molecular function | GO:0033218 | 254 | 4 | 18094 | 49 |
GRIN1,GRIN2B,RYR2,CACNA1A |
4.980e-03 | -5.30 | LIN7B (lin-7 homolog B, crumbs cell polarity complex component) | protein interactions | 64130 | 41 | 2 | 19454 | 50 |
DLG4,GRIN2B |
4.985e-03 | -5.30 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 43 | 16828 | 47 |
SYT1,CACNA1E,RYR2,L1CAM,CACNA2D1,NRXN3,RIMS1,CACNA1A,GRIN1,DLG4,MCF2L2,RASGRF1,PCLO,CAMK2B,CPLX1,CACNA1C,EDIL3,SPTBN2,CELF3,GRIN2B,SLC8A3,NRG3,GRM5,VSNL1,CCDC136,SPTBN4,SNAP25,HCN1,MYT1L,SCN8A,PPFIA3,STX1A,GABRB2,LRRC7,DLGAP2,CAMK2A,CELF5,EPHA6,PPFIA2,IQSEC2,FGF14,NRXN2,ABLIM1 |
4.998e-03 | -5.30 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 4 | 16828 | 47 |
GRM5,NRG3,CAMK2B,SYT1 |
4.998e-03 | -5.30 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 4 | 16828 | 47 |
NRG3,CAMK2B,SYT1,GRM5 |
5.011e-03 | -5.30 | LAM_G_DOMAIN | prosite domains | PS50025 | 35 | 2 | 12186 | 37 |
NRXN2,NRXN3 |
5.018e-03 | -5.29 | regulation of actin filament-based movement | biological process | GO:1903115 | 41 | 2 | 18204 | 47 |
CACNA1C,RYR2 |
5.018e-03 | -5.29 | positive regulation of amine transport | biological process | GO:0051954 | 41 | 2 | 18204 | 47 |
SYT1,STX1A |
5.049e-03 | -5.29 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 3 | 19454 | 50 |
GRIN1,ABLIM1,RASGRF1 |
5.134e-03 | -5.27 | ACTB (actin, beta) | protein interactions | 396526 | 2 | 1 | 19454 | 50 |
VSNL1 |
5.134e-03 | -5.27 | Dlgap1 (DLG associated protein 1) | protein interactions | 65040 | 2 | 1 | 19454 | 50 |
DLG4 |
5.134e-03 | -5.27 | fem-2 (Protein phosphatase fem-2) | protein interactions | 175217 | 2 | 1 | 19454 | 50 |
CAMK2A |
5.134e-03 | -5.27 | Grin2b (glutamate ionotropic receptor NMDA type subunit 2B) | protein interactions | 24410 | 2 | 1 | 19454 | 50 |
DLG4 |
5.134e-03 | -5.27 | Dyrk1a (dual specificity tyrosine phosphorylation regulated kinase 1A) | protein interactions | 25255 | 2 | 1 | 19454 | 50 |
DNM1 |
5.134e-03 | -5.27 | ZNF233 (zinc finger protein 233) | protein interactions | 353355 | 2 | 1 | 19454 | 50 |
CACNA1A |
5.157e-03 | -5.27 | neurotransmitter receptor transport postsynaptic membrane to endosome | biological process | GO:0098968 | 2 | 1 | 18204 | 47 |
LRRC7 |
5.157e-03 | -5.27 | presynapse to nucleus signaling pathway | biological process | GO:0099526 | 2 | 1 | 18204 | 47 |
PCLO |
5.157e-03 | -5.27 | vesicle scission | biological process | GO:0099050 | 2 | 1 | 18204 | 47 |
DNM1 |
5.157e-03 | -5.27 | response to nickel cation | biological process | GO:0010045 | 2 | 1 | 18204 | 47 |
CACNA1G |
5.157e-03 | -5.27 | cellular alkene metabolic process | biological process | GO:0043449 | 2 | 1 | 18204 | 47 |
GRIN1 |
5.157e-03 | -5.27 | olefin metabolic process | biological process | GO:1900673 | 2 | 1 | 18204 | 47 |
GRIN1 |
5.157e-03 | -5.27 | presynaptic signal transduction | biological process | GO:0098928 | 2 | 1 | 18204 | 47 |
PCLO |
5.200e-03 | -5.26 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 3 | 7161 | 30 |
NRG3,CAMK2A,CAMK2B |
5.200e-03 | -5.26 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 3 | 7161 | 30 |
CAMK2B,CAMK2A,NRG3 |
5.220e-03 | -5.26 | PPFIBP2 (PPFIA binding protein 2) | protein interactions | 8495 | 42 | 2 | 19454 | 50 |
PPFIA3,PPFIA2 |
5.220e-03 | -5.26 | RYR2 (ryanodine receptor 2) | protein interactions | 6262 | 42 | 2 | 19454 | 50 |
RYR2,CACNA1C |
5.227e-03 | -5.25 | CA3 pyramidal cell dendrite | cellular component | GO:0097442 | 2 | 1 | 19108 | 50 |
SLC4A10 |
5.227e-03 | -5.25 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex | cellular component | GO:0070554 | 2 | 1 | 19108 | 50 |
CPLX1 |
5.259e-03 | -5.25 | USP53 (ubiquitin specific peptidase 53) | protein interactions | 54532 | 137 | 3 | 19454 | 50 |
CAMK2A,SPTBN2,DNM1 |
5.260e-03 | -5.25 | regulation of catecholamine secretion | biological process | GO:0050433 | 42 | 2 | 18204 | 47 |
SYT1,STX1A |
5.260e-03 | -5.25 | positive regulation of regulated secretory pathway | biological process | GO:1903307 | 42 | 2 | 18204 | 47 |
SYT1,STX1A |
5.260e-03 | -5.25 | regulation of neurotransmitter receptor activity | biological process | GO:0099601 | 42 | 2 | 18204 | 47 |
DLG4,DLGAP2 |
5.265e-03 | -5.25 | Laminin_G | interpro domains | IPR001791 | 41 | 2 | 18521 | 49 |
NRXN3,NRXN2 |
5.276e-03 | -5.24 | GluR_Homer-bdg | pfam domains | PF10606 | 2 | 1 | 17795 | 47 |
GRM5 |
5.276e-03 | -5.24 | SRRM_C | pfam domains | PF15230 | 2 | 1 | 17795 | 47 |
SRRM3 |
5.276e-03 | -5.24 | zf-piccolo | pfam domains | PF05715 | 2 | 1 | 17795 | 47 |
PCLO |
5.276e-03 | -5.24 | SNAP-25 | pfam domains | PF00835 | 2 | 1 | 17795 | 47 |
SNAP25 |
5.284e-03 | -5.24 | Znf_piccolo | interpro domains | IPR008899 | 2 | 1 | 18521 | 49 |
PCLO |
5.284e-03 | -5.24 | Metabotropic_Glu_rcpt_Homer-bd | interpro domains | IPR019588 | 2 | 1 | 18521 | 49 |
GRM5 |
5.284e-03 | -5.24 | SRRM_C | interpro domains | IPR029360 | 2 | 1 | 18521 | 49 |
SRRM3 |
5.284e-03 | -5.24 | SNAP-25_dom | interpro domains | IPR000928 | 2 | 1 | 18521 | 49 |
SNAP25 |
5.409e-03 | -5.22 | suramin binding | molecular function | GO:0043924 | 2 | 1 | 18094 | 49 |
RYR2 |
5.409e-03 | -5.22 | voltage-gated calcium channel activity involved SA node cell action potential | molecular function | GO:0086059 | 2 | 1 | 18094 | 49 |
CACNA1G |
5.409e-03 | -5.22 | low voltage-gated calcium channel activity | molecular function | GO:0008332 | 2 | 1 | 18094 | 49 |
CACNA1G |
5.409e-03 | -5.22 | syntaxin-3 binding | molecular function | GO:0030348 | 2 | 1 | 18094 | 49 |
SYT1 |
5.502e-03 | -5.20 | pseudomyxoma_peritonei | COSMIC cancer mutations | pseudomyxoma_peritonei | 585 | 6 | 16828 | 47 |
EDIL3,GRIN2B,DLGAP2,CACNA1E,GRM5,RIMS1 |
5.502e-03 | -5.20 | peritoneum-appendix-other-pseudomyxoma_peritonei | COSMIC cancer mutations | peritoneum-appendix-other-pseudomyxoma_peritonei | 585 | 6 | 16828 | 47 |
GRM5,RIMS1,CACNA1E,DLGAP2,GRIN2B,EDIL3 |
5.524e-03 | -5.20 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 5 | 18204 | 47 |
SNAP25,LRRC7,PPFIA2,L1CAM,CAMK2B |
5.527e-03 | -5.20 | positive regulation of cation transmembrane transport | biological process | GO:1904064 | 139 | 3 | 18204 | 47 |
RYR2,CACNA2D1,GRIN1 |
5.547e-03 | -5.19 | appendix | COSMIC cancer mutations | appendix | 586 | 6 | 16828 | 47 |
EDIL3,CACNA1E,DLGAP2,GRIN2B,GRM5,RIMS1 |
5.585e-03 | -5.19 | STX3 (syntaxin 3) | protein interactions | 6809 | 140 | 3 | 19454 | 50 |
STX1A,SYT1,SNAP25 |
5.592e-03 | -5.19 | peritoneum | COSMIC cancer mutations | peritoneum | 587 | 6 | 16828 | 47 |
CACNA1E,GRIN2B,DLGAP2,EDIL3,RIMS1,GRM5 |
5.658e-03 | -5.17 | sarcoplasmic reticulum membrane | cellular component | GO:0033017 | 43 | 2 | 19108 | 50 |
RYR2,CAMK2B |
5.717e-03 | -5.16 | CACNA1C (calcium voltage-gated channel subunit alpha1 C) | protein interactions | 775 | 44 | 2 | 19454 | 50 |
RYR2,RIMS1 |
5.717e-03 | -5.16 | TMEM254 (transmembrane protein 254) | protein interactions | 80195 | 44 | 2 | 19454 | 50 |
SYT1,STX1A |
5.729e-03 | -5.16 | GABAergic synapse | KEGG pathways | ko04727 | 88 | 3 | 7161 | 30 |
GABRB2,CACNA1A,CACNA1C |
5.729e-03 | -5.16 | GABAergic synapse | KEGG pathways | hsa04727 | 88 | 3 | 7161 | 30 |
GABRB2,CACNA1A,CACNA1C |
5.750e-03 | -5.16 | protein localization to extracellular region | biological process | GO:0071692 | 141 | 3 | 18204 | 47 |
PCLO,CPLX1,STX1A |
5.760e-03 | -5.16 | regulation of dendritic spine morphogenesis | biological process | GO:0061001 | 44 | 2 | 18204 | 47 |
PPFIA2,CAMK2B |
5.760e-03 | -5.16 | synaptic vesicle localization | biological process | GO:0097479 | 44 | 2 | 18204 | 47 |
PCLO,DNM1 |
5.773e-03 | -5.15 | metal cation:monoatomic cation antiporter activity | molecular function | GO:0140828 | 42 | 2 | 18094 | 49 |
SLC8A3,SLC4A10 |
5.912e-03 | -5.13 | Dilated cardiomyopathy | KEGG pathways | ko05414 | 89 | 3 | 7161 | 30 |
CACNA1C,CACNA2D1,RYR2 |
5.912e-03 | -5.13 | Dilated cardiomyopathy | KEGG pathways | hsa05414 | 89 | 3 | 7161 | 30 |
RYR2,CACNA1C,CACNA2D1 |
5.950e-03 | -5.12 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 10 | 18094 | 49 |
CAMK2A,SYT1,FGF14,NRXN2,NRXN3,NRG3,GRM5,RASGRF1,DLG4,EDIL3 |
5.973e-03 | -5.12 | CELSR3 (cadherin EGF LAG seven-pass G-type receptor 3) | protein interactions | 1951 | 45 | 2 | 19454 | 50 |
SPTBN4,SPTBN2 |
6.032e-03 | -5.11 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 12 | 16828 | 47 |
GRIN2B,PPFIA2,NRXN2,NRXN3,RIMS1,PCLO,CACNA1E,SNAP25,LRRC7,CACNA1C,RYR2,HCN1 |
6.044e-03 | -5.11 | sodium channel activity | molecular function | GO:0005272 | 43 | 2 | 18094 | 49 |
SCN8A,HCN1 |
6.082e-03 | -5.10 | larynx | COSMIC cancer mutations | larynx | 1948 | 12 | 16828 | 47 |
CACNA1E,SNAP25,HCN1,RYR2,NRXN3,RIMS1,PCLO,LRRC7,CACNA1C,PPFIA2,GRIN2B,NRXN2 |
6.095e-03 | -5.10 | amide transport | biological process | GO:0042886 | 144 | 3 | 18204 | 47 |
CPLX1,PCLO,STX1A |
6.130e-03 | -5.09 | central_nervous_system-brain-glioma-astrocytoma_Grade_II | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_II | 420 | 5 | 16828 | 47 |
CACNA1G,SPTBN4,DLGAP2,CACNA1C,CACNA2D1 |
6.140e-03 | -5.09 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 47 |
SLC4A10,RYR2,HCN1,SPTBN2 |
6.230e-03 | -5.08 | regulation of nervous system development | biological process | GO:0051960 | 456 | 5 | 18204 | 47 |
BRINP1,CAMK2B,L1CAM,IQSEC2,GRM5 |
6.342e-03 | -5.06 | I band | cellular component | GO:0031674 | 144 | 3 | 19108 | 50 |
CACNA1C,RYR2,SCN8A |
6.406e-03 | -5.05 | C2_dom | interpro domains | IPR000008 | 143 | 3 | 18521 | 49 |
RIMS1,SYT1,PCLO |
6.441e-03 | -5.05 | ion channel regulator activity | molecular function | GO:0099106 | 140 | 3 | 18094 | 49 |
NRXN2,STX1A,FGF14 |
6.453e-03 | -5.04 | terminal bouton | cellular component | GO:0043195 | 46 | 2 | 19108 | 50 |
CPLX1,GRIN1 |
6.474e-03 | -5.04 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 4 | 10285 | 37 |
GABRB2,CAMK2A,CAMK2B,RYR2 |
6.483e-03 | -5.04 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 3 | 7161 | 30 |
CAMK2A,CACNA1C,CAMK2B |
6.483e-03 | -5.04 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 3 | 7161 | 30 |
CAMK2B,CAMK2A,CACNA1C |
6.492e-03 | -5.04 | positive regulation of secretion by cell | biological process | GO:1903532 | 289 | 4 | 18204 | 47 |
SYT1,SNAP25,STX1A,VSNL1 |
6.500e-03 | -5.04 | SEMA4G (semaphorin 4G) | protein interactions | 57715 | 47 | 2 | 19454 | 50 |
DLG4,CAMK2B |
6.522e-03 | -5.03 | Transcription Factor, Ets-1 | gene3d domains | 1.10.150.50 | 115 | 3 | 14470 | 48 |
EPHA6,PPFIA3,PPFIA2 |
6.577e-03 | -5.02 | protein localization to membrane | biological process | GO:0072657 | 462 | 5 | 18204 | 47 |
NRXN2,SPTBN4,LRRC7,SNAP25,DLG4 |
6.587e-03 | -5.02 | Laminin | gene3d domains | 2.10.25.10 | 226 | 4 | 14470 | 48 |
NRG3,NRXN2,NRXN3,EDIL3 |
6.624e-03 | -5.02 | - | gene3d domains | 6.10.140.420 | 2 | 1 | 14470 | 48 |
SRRM3 |
6.772e-03 | -4.99 | NAPB (NSF attachment protein beta) | protein interactions | 63908 | 48 | 2 | 19454 | 50 |
SYT1,STX1A |
6.824e-03 | -4.99 | regulation of membrane depolarization | biological process | GO:0003254 | 48 | 2 | 18204 | 47 |
CACNA1G,HCN1 |
6.868e-03 | -4.98 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 12 | 16828 | 47 |
SLC4A10,DLGAP2,CELF3,MYT1L,SLC8A3,NRXN3,DNM1,CACNA1G,RASGRF1,PCLO,GRM5,CACNA1A |
6.868e-03 | -4.98 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 12 | 16828 | 47 |
SLC4A10,DLGAP2,CELF3,MYT1L,NRXN3,DNM1,SLC8A3,CACNA1G,PCLO,RASGRF1,CACNA1A,GRM5 |
6.892e-03 | -4.98 | pre-mRNA binding | molecular function | GO:0036002 | 46 | 2 | 18094 | 49 |
CELF5,CELF3 |
6.975e-03 | -4.97 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 10 | 16828 | 47 |
NRXN3,NRG3,GRIN2B,SCN8A,PCLO,RASGRF1,GRM5,RYR2,HCN1,STX1A |
6.999e-03 | -4.96 | prostate | COSMIC cancer mutations | prostate | 13883 | 45 | 16828 | 47 |
NRXN2,IQSEC2,FGF14,PPFIA2,CACNA1G,ABLIM1,CELF5,CAMK2A,DLGAP2,LRRC7,STX1A,GABRB2,EPHA6,SCN8A,PPFIA3,HCN1,SNAP25,SPTBN4,MYT1L,NRG3,SLC8A3,GRIN2B,CCDC136,VSNL1,GRM5,EDIL3,SLC4A10,CACNA1C,CPLX1,CAMK2B,CELF3,SPTBN2,NRXN3,CACNA2D1,PCLO,GRIN1,DLG4,RASGRF1,MCF2L2,CACNA1A,RIMS1,RYR2,CACNA1E,SYT1,L1CAM |
7.007e-03 | -4.96 | CAMK2B (calcium/calmodulin dependent protein kinase II beta) | protein interactions | 816 | 152 | 3 | 19454 | 50 |
CAMK2B,GRIN2B,CAMK2A |
7.026e-03 | -4.96 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 6 | 18204 | 47 |
L1CAM,PPFIA2,CAMK2B,GRIN2B,LRRC7,SNAP25 |
7.049e-03 | -4.95 | WDR5B (WD repeat domain 5B) | protein interactions | 54554 | 49 | 2 | 19454 | 50 |
TMEM266,CAMK2B |
7.049e-03 | -4.95 | ZNF490 (zinc finger protein 490) | protein interactions | 57474 | 49 | 2 | 19454 | 50 |
STX1A,CCDC136 |
7.055e-03 | -4.95 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 4 | 18204 | 47 |
GRM5,L1CAM,CAMK2B,IQSEC2 |
7.095e-03 | -4.95 | channel regulator activity | molecular function | GO:0016247 | 145 | 3 | 18094 | 49 |
NRXN2,STX1A,FGF14 |
7.125e-03 | -4.94 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 47 | 16828 | 47 |
NRXN2,PPFIA2,IQSEC2,FGF14,EPHA6,CAMK2A,STX1A,GABRB2,LRRC7,SCN8A,DNM1,MYT1L,HCN1,SNAP25,CCDC136,SLC8A3,CELF3,SPTBN2,EDIL3,SLC4A10,CACNA1C,CAMK2B,CPLX1,MCF2L2,GRIN1,DLG4,CACNA2D1,L1CAM,SYT1,ABLIM1,CACNA1G,CELF5,DLGAP2,PPFIA3,CAMKV,SPTBN4,GRM5,VSNL1,NRG3,GRIN2B,RASGRF1,PCLO,CACNA1A,RIMS1,NRXN3,RYR2,CACNA1E |
7.196e-03 | -4.93 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 23 | 16828 | 47 |
PCLO,RASGRF1,MCF2L2,CACNA2D1,L1CAM,SYT1,RYR2,CCDC136,GRIN2B,CAMK2B,EDIL3,SLC4A10,PPFIA3,DNM1,SNAP25,CAMKV,ABLIM1,IQSEC2,PPFIA2,NRXN2,EPHA6,LRRC7,CAMK2A |
7.196e-03 | -4.93 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 23 | 16828 | 47 |
EPHA6,LRRC7,CAMK2A,ABLIM1,PPFIA2,IQSEC2,NRXN2,SNAP25,CAMKV,PPFIA3,DNM1,CAMK2B,SLC4A10,EDIL3,CCDC136,GRIN2B,L1CAM,SYT1,RYR2,RASGRF1,MCF2L2,PCLO,CACNA2D1 |
7.230e-03 | -4.93 | transporter regulator activity | molecular function | GO:0141108 | 146 | 3 | 18094 | 49 |
NRXN2,STX1A,FGF14 |
7.254e-03 | -4.93 | Huntington's disease | KEGG pathways | ko05016 | 187 | 4 | 7161 | 30 |
GRIN1,GRIN2B,GRM5,DLG4 |
7.254e-03 | -4.93 | Huntington's disease | KEGG pathways | hsa05016 | 187 | 4 | 7161 | 30 |
DLG4,GRIN1,GRIN2B,GRM5 |
7.464e-03 | -4.90 | positive regulation of monoatomic ion transmembrane transport | biological process | GO:0034767 | 155 | 3 | 18204 | 47 |
GRIN1,RYR2,CACNA2D1 |
7.617e-03 | -4.88 | APLP1 (amyloid beta precursor like protein 1) | protein interactions | 333 | 51 | 2 | 19454 | 50 |
GRIN2B,GRIN1 |
7.675e-03 | -4.87 | regulation of protein tyrosine kinase activity | biological process | GO:0061097 | 51 | 2 | 18204 | 47 |
GRM5,DLG4 |
7.691e-03 | -4.87 | POM121L1P (POM121 transmembrane nucleoporin like 1, pseudogene) | protein interactions | 25812 | 3 | 1 | 19454 | 50 |
SPTBN4 |
7.691e-03 | -4.87 | Akt2 (thymoma viral proto-oncogene 2) | protein interactions | 11652 | 3 | 1 | 19454 | 50 |
BRINP1 |
7.691e-03 | -4.87 | Lrrc7 (leucine rich repeat containing 7) | protein interactions | 117284 | 3 | 1 | 19454 | 50 |
CAMK2A |
7.691e-03 | -4.87 | Ephb2 (Eph receptor B2) | protein interactions | 13844 | 3 | 1 | 19454 | 50 |
L1CAM |
7.691e-03 | -4.87 | Ap2a1 (adaptor related protein complex 2 subunit alpha 1) | protein interactions | 308578 | 3 | 1 | 19454 | 50 |
DNM1 |
7.691e-03 | -4.87 | BCO1 (beta-carotene oxygenase 1) | protein interactions | 53630 | 3 | 1 | 19454 | 50 |
ABLIM1 |
7.691e-03 | -4.87 | SMPDL3A (sphingomyelin phosphodiesterase acid like 3A) | protein interactions | 10924 | 3 | 1 | 19454 | 50 |
BRINP1 |
7.691e-03 | -4.87 | Baiap2 (brain-specific angiogenesis inhibitor 1-associated protein 2) | protein interactions | 108100 | 3 | 1 | 19454 | 50 |
DLG4 |
7.691e-03 | -4.87 | Dlgap2 (DLG associated protein 2) | protein interactions | 116681 | 3 | 1 | 19454 | 50 |
GRIN2B |
7.691e-03 | -4.87 | GOLGA6L5P (golgin A6 family like 5, pseudogene) | protein interactions | 374650 | 3 | 1 | 19454 | 50 |
CACNA1A |
7.703e-03 | -4.87 | mixed | COSMIC cancer mutations | mixed | 145 | 3 | 16828 | 47 |
CAMK2B,PCLO,MYT1L |
7.726e-03 | -4.86 | type B pancreatic cell apoptotic process | biological process | GO:0097050 | 3 | 1 | 18204 | 47 |
RYR2 |
7.726e-03 | -4.86 | membrane depolarization during bundle of His cell action potential | biological process | GO:0086048 | 3 | 1 | 18204 | 47 |
CACNA2D1 |
7.726e-03 | -4.86 | phospholipase C-activating G protein-coupled glutamate receptor signaling pathway | biological process | GO:0007206 | 3 | 1 | 18204 | 47 |
GRM5 |
7.726e-03 | -4.86 | regulation of SA node cell action potential | biological process | GO:0098907 | 3 | 1 | 18204 | 47 |
RYR2 |
7.726e-03 | -4.86 | positive regulation of synaptic vesicle exocytosis | biological process | GO:2000302 | 3 | 1 | 18204 | 47 |
SYT1 |
7.726e-03 | -4.86 | presynaptic active zone assembly | biological process | GO:1904071 | 3 | 1 | 18204 | 47 |
PCLO |
7.726e-03 | -4.86 | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission | biological process | GO:0099553 | 3 | 1 | 18204 | 47 |
GRM5 |
7.726e-03 | -4.86 | protein localization to early endosome | biological process | GO:1902946 | 3 | 1 | 18204 | 47 |
LRRC7 |
7.726e-03 | -4.86 | positive regulation of ATPase-coupled calcium transmembrane transporter activity | biological process | GO:1901896 | 3 | 1 | 18204 | 47 |
RYR2 |
7.726e-03 | -4.86 | trans-synaptic signaling by lipid, modulating synaptic transmission | biological process | GO:0099552 | 3 | 1 | 18204 | 47 |
GRM5 |
7.726e-03 | -4.86 | mammary placode formation | biological process | GO:0060596 | 3 | 1 | 18204 | 47 |
NRG3 |
7.726e-03 | -4.86 | neuroligin clustering involved in postsynaptic membrane assembly | biological process | GO:0097118 | 3 | 1 | 18204 | 47 |
NRXN2 |
7.726e-03 | -4.86 | membrane depolarization during atrial cardiac muscle cell action potential | biological process | GO:0098912 | 3 | 1 | 18204 | 47 |
CACNA1C |
7.726e-03 | -4.86 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane | biological process | GO:0098967 | 3 | 1 | 18204 | 47 |
SNAP25 |
7.726e-03 | -4.86 | regulation of endocannabinoid signaling pathway | biological process | GO:2000124 | 3 | 1 | 18204 | 47 |
CAMK2A |
7.726e-03 | -4.86 | response to glycine | biological process | GO:1905429 | 3 | 1 | 18204 | 47 |
GRIN1 |
7.731e-03 | -4.86 | protein-containing complex localization | biological process | GO:0031503 | 157 | 3 | 18204 | 47 |
SNAP25,LRRC7,DLG4 |
7.731e-03 | -4.86 | membrane fusion | biological process | GO:0061025 | 157 | 3 | 18204 | 47 |
RIMS1,STX1A,SNAP25 |
7.748e-03 | -4.86 | NCAM1 interactions | REACTOME pathways | R-HSA-419037 | 37 | 2 | 10285 | 37 |
CACNA1G,CACNA1C |
7.764e-03 | -4.86 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 12 | 16828 | 47 |
SYT1,SNAP25,GRM5,VSNL1,ABLIM1,NRG3,GRIN2B,CELF3,SPTBN2,EDIL3,CAMK2B,LRRC7 |
7.764e-03 | -4.86 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 12 | 16828 | 47 |
GRM5,ABLIM1,VSNL1,NRG3,GRIN2B,CELF3,SPTBN2,EDIL3,LRRC7,CAMK2B,SYT1,SNAP25 |
7.790e-03 | -4.85 | calcium channel regulator activity | molecular function | GO:0005246 | 49 | 2 | 18094 | 49 |
NRXN2,STX1A |
7.800e-03 | -4.85 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 47 |
SPTBN4,CAMKV,HCN1,MYT1L,DNM1,SCN8A,PPFIA3,DLGAP2,LRRC7,STX1A,CELF5,CAMK2A,EPHA6,FGF14,IQSEC2,PPFIA2,CACNA1G,NRXN2,ABLIM1,CACNA1E,SYT1,RYR2,L1CAM,NRXN3,CACNA2D1,CACNA1A,RIMS1,PCLO,DLG4,GRIN1,MCF2L2,RASGRF1,CPLX1,CAMK2B,EDIL3,SLC4A10,CACNA1C,SPTBN2,CELF3,GRIN2B,NRG3,SLC8A3,VSNL1,GRM5,CCDC136 |
7.800e-03 | -4.85 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 47 |
EPHA6,STX1A,LRRC7,CAMK2A,PPFIA2,IQSEC2,FGF14,NRXN2,MYT1L,HCN1,SCN8A,DNM1,SPTBN2,CELF3,CAMK2B,CPLX1,EDIL3,SLC4A10,CACNA1C,CCDC136,SLC8A3,L1CAM,SYT1,DLG4,MCF2L2,GRIN1,CACNA2D1,DLGAP2,CELF5,ABLIM1,CACNA1G,SPTBN4,CAMKV,PPFIA3,GRM5,VSNL1,GRIN2B,NRG3,CACNA1E,RYR2,RIMS1,CACNA1A,RASGRF1,PCLO,NRXN3 |
7.810e-03 | -4.85 | Phenytoin (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000327 | 77 | 3 | 1369 | 8 |
CACNA1C,CACNA1G,RYR2 |
7.830e-03 | -4.85 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex | cellular component | GO:0070032 | 3 | 1 | 19108 | 50 |
SNAP25 |
7.830e-03 | -4.85 | clathrin-sculpted acetylcholine transport vesicle membrane | cellular component | GO:0060201 | 3 | 1 | 19108 | 50 |
SYT1 |
7.830e-03 | -4.85 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex | cellular component | GO:0070033 | 3 | 1 | 19108 | 50 |
SNAP25 |
7.830e-03 | -4.85 | clathrin-sculpted acetylcholine transport vesicle | cellular component | GO:0060200 | 3 | 1 | 19108 | 50 |
SYT1 |
7.884e-03 | -4.84 | pleura | COSMIC cancer mutations | pleura | 4914 | 22 | 16828 | 47 |
SLC4A10,EDIL3,CAMK2A,CAMK2B,EPHA6,NRXN2,GRIN2B,IQSEC2,PPFIA2,RYR2,CAMKV,CACNA1E,SPTBN4,SYT1,L1CAM,DNM1,PPFIA3,PCLO,MCF2L2,RASGRF1,RIMS1,CACNA1A |
7.888e-03 | -4.84 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 15 | 16828 | 47 |
RIMS1,CACNA1A,SCN8A,PCLO,RASGRF1,CACNA2D1,SNAP25,SPTBN4,HCN1,IQSEC2,FGF14,CACNA1G,NRG3,EPHA6,CAMK2B |
7.888e-03 | -4.84 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 15 | 16828 | 47 |
HCN1,SPTBN4,SNAP25,CACNA2D1,PCLO,SCN8A,RASGRF1,CACNA1A,RIMS1,CAMK2B,EPHA6,NRG3,IQSEC2,FGF14,CACNA1G |
7.903e-03 | -4.84 | NMDAR2_C | pfam domains | PF10565 | 3 | 1 | 17795 | 47 |
GRIN2B |
7.903e-03 | -4.84 | Na_Ca_ex_C | pfam domains | PF16494 | 3 | 1 | 17795 | 47 |
SLC8A3 |
7.903e-03 | -4.84 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 47 |
RYR2 |
7.903e-03 | -4.84 | MYT1 | pfam domains | PF08474 | 3 | 1 | 17795 | 47 |
MYT1L |
7.903e-03 | -4.84 | MAGUK_N_PEST | pfam domains | PF10608 | 3 | 1 | 17795 | 47 |
DLG4 |
7.903e-03 | -4.84 | CAC1F_C | pfam domains | PF16885 | 3 | 1 | 17795 | 47 |
CACNA1C |
7.903e-03 | -4.84 | cwf21 | pfam domains | PF08312 | 3 | 1 | 17795 | 47 |
SRRM3 |
7.903e-03 | -4.84 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 47 |
RYR2 |
7.903e-03 | -4.84 | BRINP | pfam domains | PF19052 | 3 | 1 | 17795 | 47 |
BRINP1 |
7.903e-03 | -4.84 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 47 |
RYR2 |
7.903e-03 | -4.84 | IQ_SEC7_PH | pfam domains | PF16453 | 3 | 1 | 17795 | 47 |
IQSEC2 |
7.916e-03 | -4.84 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | mRNA_splic_Cwf21_dom | interpro domains | IPR013170 | 3 | 1 | 18521 | 49 |
SRRM3 |
7.916e-03 | -4.84 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | CAC1F_C | interpro domains | IPR031688 | 3 | 1 | 18521 | 49 |
CACNA1C |
7.916e-03 | -4.84 | IQSEC_PH | interpro domains | IPR033742 | 3 | 1 | 18521 | 49 |
IQSEC2 |
7.916e-03 | -4.84 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | Na_Ca_Ex_C-exten | interpro domains | IPR032452 | 3 | 1 | 18521 | 49 |
SLC8A3 |
7.916e-03 | -4.84 | NMDAR2_C | interpro domains | IPR018884 | 3 | 1 | 18521 | 49 |
GRIN2B |
7.916e-03 | -4.84 | BRINP | interpro domains | IPR033237 | 3 | 1 | 18521 | 49 |
BRINP1 |
7.916e-03 | -4.84 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | Na_Ca_Ex | interpro domains | IPR004836 | 3 | 1 | 18521 | 49 |
SLC8A3 |
7.916e-03 | -4.84 | Neuregulin | interpro domains | IPR040180 | 3 | 1 | 18521 | 49 |
NRG3 |
7.916e-03 | -4.84 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | GABAAb_rcpt | interpro domains | IPR002289 | 3 | 1 | 18521 | 49 |
GABRB2 |
7.916e-03 | -4.84 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 49 |
RYR2 |
7.916e-03 | -4.84 | VDCC_T_a1 | interpro domains | IPR005445 | 3 | 1 | 18521 | 49 |
CACNA1G |
7.916e-03 | -4.84 | Myelin_TF | interpro domains | IPR013681 | 3 | 1 | 18521 | 49 |
MYT1L |
8.103e-03 | -4.82 | beta-1 adrenergic receptor binding | molecular function | GO:0031697 | 3 | 1 | 18094 | 49 |
DLG4 |
8.103e-03 | -4.82 | A2A adenosine receptor binding | molecular function | GO:0031687 | 3 | 1 | 18094 | 49 |
GRM5 |
8.103e-03 | -4.82 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | molecular function | GO:0099583 | 3 | 1 | 18094 | 49 |
GRM5 |
8.103e-03 | -4.82 | sodium,bicarbonate:chloride antiporter activity | molecular function | GO:0140892 | 3 | 1 | 18094 | 49 |
SLC4A10 |
8.127e-03 | -4.81 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 9 | 18204 | 47 |
SYT1,RIMS1,CAMK2B,BRINP1,DLG4,IQSEC2,SPTBN4,L1CAM,GRM5 |
8.134e-03 | -4.81 | cell morphogenesis | biological process | GO:0000902 | 687 | 6 | 18204 | 47 |
DLG4,NRXN3,SNAP25,SPTBN4,EPHA6,L1CAM |
8.142e-03 | -4.81 | peptidyl-serine phosphorylation | biological process | GO:0018105 | 160 | 3 | 18204 | 47 |
CAMK2B,CAMK2A,CAMKV |
8.186e-03 | -4.81 | T-tubule | cellular component | GO:0030315 | 52 | 2 | 19108 | 50 |
CACNA2D1,CACNA1C |
8.203e-03 | -4.80 | KRTAP6-3 (keratin associated protein 6-3) | protein interactions | 337968 | 161 | 3 | 19454 | 50 |
CAMK2A,CAMK2B,CELF5 |
8.206e-03 | -4.80 | LIN7A (lin-7 homolog A, crumbs cell polarity complex component) | protein interactions | 8825 | 53 | 2 | 19454 | 50 |
GRIN2B,DLG4 |
8.216e-03 | -4.80 | GluR_Homer-bdg | smart domains | SM01229 | 2 | 1 | 9717 | 40 |
GRM5 |
8.216e-03 | -4.80 | cwf21 | smart domains | SM01115 | 2 | 1 | 9717 | 40 |
SRRM3 |
8.268e-03 | -4.80 | regulation of actin filament depolymerization | biological process | GO:0030834 | 53 | 2 | 18204 | 47 |
SPTBN4,SPTBN2 |
8.281e-03 | -4.79 | positive regulation of cell growth | biological process | GO:0030307 | 161 | 3 | 18204 | 47 |
L1CAM,RIMS1,SYT1 |
8.368e-03 | -4.78 | positive regulation of secretion | biological process | GO:0051047 | 311 | 4 | 18204 | 47 |
VSNL1,STX1A,SNAP25,SYT1 |
8.373e-03 | -4.78 | ACTN1 (actinin alpha 1) | protein interactions | 87 | 312 | 4 | 19454 | 50 |
CACNA1C,CAMK2A,CACNA1A,GRM5 |
8.417e-03 | -4.78 | amino acid binding | molecular function | GO:0016597 | 51 | 2 | 18094 | 49 |
GRIN1,GRIN2B |
8.418e-03 | -4.78 | secretory granule | cellular component | GO:0030141 | 897 | 7 | 19108 | 50 |
SNAP25,CACNA2D1,LRRC7,CCDC136,DNM1,PPFIA3,SYT1 |
8.423e-03 | -4.78 | cytoplasmic region | cellular component | GO:0099568 | 307 | 4 | 19108 | 50 |
PCLO,RIMS1,DLG4,PPFIA3 |
8.558e-03 | -4.76 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 9 | 16828 | 47 |
RYR2,MYT1L,CACNA1G,IQSEC2,SLC8A3,NRXN3,CACNA1A,RIMS1,RASGRF1 |
8.591e-03 | -4.76 | response to organonitrogen compound | biological process | GO:0010243 | 915 | 7 | 18204 | 47 |
RYR2,CAMK2A,CACNA1A,GRIN1,CACNA2D1,HCN1,GABRB2 |
8.591e-03 | -4.76 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 17 | 16828 | 47 |
PCLO,GRIN1,CACNA1A,RYR2,CACNA1E,SYT1,NRXN2,NRG3,SLC8A3,FGF14,PPFIA2,EPHA6,SPTBN2,CELF5,CACNA1C,EDIL3,CAMK2B |
8.649e-03 | -4.75 | regulation of developmental growth | biological process | GO:0048638 | 314 | 4 | 18204 | 47 |
RIMS1,SYT1,L1CAM,SPTBN4 |
8.734e-03 | -4.74 | BDNF-TrkB Signaling | WikiPathways | WP3676 | 33 | 2 | 5310 | 23 |
GRIN1,DLG4 |
8.814e-03 | -4.73 | BEGAIN (brain enriched guanylate kinase associated) | protein interactions | 57596 | 55 | 2 | 19454 | 50 |
DLG4,ABLIM1 |
8.881e-03 | -4.72 | establishment or maintenance of epithelial cell apical/basal polarity | biological process | GO:0045197 | 55 | 2 | 18204 | 47 |
DLG4,LRRC7 |
8.881e-03 | -4.72 | regulation of alternative mRNA splicing, via spliceosome | biological process | GO:0000381 | 55 | 2 | 18204 | 47 |
CELF3,CELF5 |
9.011e-03 | -4.71 | C2 | prosite domains | PS50004 | 142 | 3 | 12186 | 37 |
RIMS1,PCLO,SYT1 |
9.057e-03 | -4.70 | Buprenorphine Action Pathway | SMPDB pathways | SMP0000684 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Carfentanil Action Pathway | SMPDB pathways | SMP0000414 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Dihydromorphine Action Pathway | SMPDB pathways | SMP0000689 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Proparacaine Action Pathway | SMPDB pathways | SMP0000403 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Sufentanil Action Pathway | SMPDB pathways | SMP0000417 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Naltrexone Action Pathway | SMPDB pathways | SMP0000687 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Methadyl Acetate Action Pathway | SMPDB pathways | SMP0000678 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Levorphanol Action Pathway | SMPDB pathways | SMP0000673 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Remifentanil Action Pathway | SMPDB pathways | SMP0000416 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Pentazocine Action Pathway | SMPDB pathways | SMP0000686 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Bupivacaine Action Pathway | SMPDB pathways | SMP0000393 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Oxybuprocaine Action Pathway | SMPDB pathways | SMP0000400 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Hydrocodone Action Pathway | SMPDB pathways | SMP0000411 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Alvimopan Action Pathway | SMPDB pathways | SMP0000685 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Fentanyl Action Pathway | SMPDB pathways | SMP0000415 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Oxymorphone Action Pathway | SMPDB pathways | SMP0000412 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Ethylmorphine Action Pathway | SMPDB pathways | SMP0000681 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Chloroprocaine Action Pathway | SMPDB pathways | SMP0000394 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Propoxyphene Action Pathway | SMPDB pathways | SMP0000672 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Diphenoxylate Action Pathway | SMPDB pathways | SMP0000675 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Ketobemidone Action Pathway | SMPDB pathways | SMP0000690 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Tramadol Action Action Pathway | SMPDB pathways | SMP0000671 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Mepivacaine Action Pathway | SMPDB pathways | SMP0000399 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Hydromorphone Action Pathway | SMPDB pathways | SMP0000410 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Dimethylthiambutene Action Pathway | SMPDB pathways | SMP0000680 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Levobupivacaine Action Pathway | SMPDB pathways | SMP0000397 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Procaine Action Pathway | SMPDB pathways | SMP0000402 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Dezocine Action Pathway | SMPDB pathways | SMP0000676 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Prilocaine Action Pathway | SMPDB pathways | SMP0000401 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Ropivacaine Action Pathway | SMPDB pathways | SMP0000404 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Levomethadyl Acetate Action Action Pathway | SMPDB pathways | SMP0000677 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Naloxone Action Pathway | SMPDB pathways | SMP0000688 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Alfentanil Action Pathway | SMPDB pathways | SMP0000413 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Dibucaine Action Pathway | SMPDB pathways | SMP0000396 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Levallorphan Action Pathway | SMPDB pathways | SMP0000683 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Oxycodone Action Pathway | SMPDB pathways | SMP0000409 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Anileridine Action Pathway | SMPDB pathways | SMP0000674 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Escitalopram Action Pathway | SMPDB pathways | SMP0000425 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | Benzocaine Action Pathway | SMPDB pathways | SMP0000392 | 26 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
9.057e-03 | -4.70 | Cocaine Action Pathway | SMPDB pathways | SMP0000395 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.057e-03 | -4.70 | 3-Methylthiofentanyl Action Pathway | SMPDB pathways | SMP0000679 | 26 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.066e-03 | -4.70 | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | molecular function | GO:1904315 | 53 | 2 | 18094 | 49 |
GABRB2,GRIN2B |
9.125e-03 | -4.70 | RAB3IL1 (RAB3A interacting protein like 1) | protein interactions | 5866 | 56 | 2 | 19454 | 50 |
PPFIA3,STX1A |
9.125e-03 | -4.70 | MIP (major intrinsic protein of lens fiber) | protein interactions | 4284 | 56 | 2 | 19454 | 50 |
STX1A,SYT1 |
9.150e-03 | -4.69 | regulation of insulin secretion | biological process | GO:0050796 | 167 | 3 | 18204 | 47 |
STX1A,SNAP25,VSNL1 |
9.208e-03 | -4.69 | growth cone | cellular component | GO:0030426 | 165 | 3 | 19108 | 50 |
RASGRF1,L1CAM,SNAP25 |
9.212e-03 | -4.69 | RALBP1 (ralA binding protein 1) | protein interactions | 10928 | 168 | 3 | 19454 | 50 |
ABLIM1,DLG4,CCDC136 |
9.442e-03 | -4.66 | ZBTB32 (zinc finger and BTB domain containing 32) | protein interactions | 27033 | 57 | 2 | 19454 | 50 |
CAMK2B,CAMK2A |
9.450e-03 | -4.66 | regulation of muscle contraction | biological process | GO:0006937 | 169 | 3 | 18204 | 47 |
RYR2,SLC8A3,CACNA1C |
9.472e-03 | -4.66 | monoatomic cation homeostasis | biological process | GO:0055080 | 505 | 5 | 18204 | 47 |
GRM5,RYR2,SLC8A3,GRIN1,SLC4A10 |
9.476e-03 | -4.66 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 26 | 16828 | 47 |
CACNA1E,RYR2,CACNA1A,RIMS1,PCLO,RASGRF1,MCF2L2,CACNA2D1,NRXN3,SPTBN2,CAMK2B,CACNA1C,VSNL1,GRM5,GRIN2B,NRG3,MYT1L,SPTBN4,HCN1,EPHA6,DLGAP2,GABRB2,LRRC7,CELF5,CACNA1G,NRXN2 |
9.611e-03 | -4.64 | protein localization | biological process | GO:0008104 | 1954 | 11 | 18204 | 47 |
CPLX1,NRXN2,SPTBN4,STX1A,DLG4,HCN1,PCLO,RYR2,LRRC7,SNAP25,RIMS1 |
9.702e-03 | -4.64 | circulatory system process | biological process | GO:0003013 | 508 | 5 | 18204 | 47 |
RYR2,CACNA2D1,CACNA1G,CACNA1C,SCN8A |
9.737e-03 | -4.63 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | molecular function | GO:0099529 | 55 | 2 | 18094 | 49 |
GABRB2,GRIN2B |
9.741e-03 | -4.63 | - | gene3d domains | 1.10.287.1490 | 45 | 2 | 14470 | 48 |
PPFIA3,CCDC136 |
9.753e-03 | -4.63 | Nalbuphine Action Pathway | SMPDB pathways | SMP0000691 | 27 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.753e-03 | -4.63 | Desipramine Action Pathway | SMPDB pathways | SMP0000423 | 27 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
9.757e-03 | -4.63 | establishment of vesicle localization | biological process | GO:0051650 | 171 | 3 | 18204 | 47 |
DNM1,PPFIA2,SNAP25 |
9.766e-03 | -4.63 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 7 | 16828 | 47 |
PCLO,EPHA6,CAMK2A,CAMKV,CACNA2D1,LRRC7,CAMK2B |
9.899e-03 | -4.62 | cellular macromolecule localization | biological process | GO:0070727 | 1962 | 11 | 18204 | 47 |
PCLO,RYR2,LRRC7,STX1A,HCN1,RIMS1,SNAP25,CPLX1,NRXN2,SPTBN4,DLG4 |
9.905e-03 | -4.61 | EPHB-mediated forward signaling | REACTOME pathways | R-HSA-3928662 | 42 | 2 | 10285 | 37 |
GRIN1,GRIN2B |
9.912e-03 | -4.61 | peptidyl-serine modification | biological process | GO:0018209 | 172 | 3 | 18204 | 47 |
CAMKV,CAMK2B,CAMK2A |
9.919e-03 | -4.61 | Single Helix bin | gene3d domains | 1.20.5.580 | 3 | 1 | 14470 | 48 |
CPLX1 |
9.919e-03 | -4.61 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 48 |
RYR2 |
9.985e-03 | -4.61 | site of polarized growth | cellular component | GO:0030427 | 170 | 3 | 19108 | 50 |
SNAP25,RASGRF1,L1CAM |
9.999e-03 | -4.61 | cell adhesion | biological process | GO:0007155 | 942 | 7 | 18204 | 47 |
NRXN3,LRRC7,L1CAM,PPFIA2,NRXN2,EDIL3,DLG4 |
1.008e-02 | -4.60 | calcium-dependent phospholipid binding | molecular function | GO:0005544 | 56 | 2 | 18094 | 49 |
PCLO,SYT1 |
1.013e-02 | -4.59 | SLC1A1 (solute carrier family 1 member 1) | protein interactions | 6505 | 174 | 3 | 19454 | 50 |
DLG4,GRIN1,GRIN2B |
1.013e-02 | -4.59 | phospholipid binding | molecular function | GO:0005543 | 489 | 5 | 18094 | 49 |
SPTBN4,SPTBN2,PCLO,SYT1,DNM1 |
1.017e-02 | -4.59 | establishment or maintenance of apical/basal cell polarity | biological process | GO:0035088 | 59 | 2 | 18204 | 47 |
DLG4,LRRC7 |
1.017e-02 | -4.59 | establishment or maintenance of bipolar cell polarity | biological process | GO:0061245 | 59 | 2 | 18204 | 47 |
DLG4,LRRC7 |
1.017e-02 | -4.59 | negative regulation of actin filament polymerization | biological process | GO:0030837 | 59 | 2 | 18204 | 47 |
SPTBN2,SPTBN4 |
1.017e-02 | -4.59 | regulation of dendritic spine development | biological process | GO:0060998 | 59 | 2 | 18204 | 47 |
CAMK2B,PPFIA2 |
1.024e-02 | -4.58 | Snap25 (synaptosome associated protein 25) | protein interactions | 25012 | 4 | 1 | 19454 | 50 |
STX1A |
1.024e-02 | -4.58 | Psmc5 (proteasome 26S subunit, ATPase 5) | protein interactions | 81827 | 4 | 1 | 19454 | 50 |
CAMK2A |
1.024e-02 | -4.58 | Stxbp1 (syntaxin binding protein 1) | protein interactions | 25558 | 4 | 1 | 19454 | 50 |
STX1A |
1.024e-02 | -4.58 | SRL (sarcalumenin) | protein interactions | 6345 | 4 | 1 | 19454 | 50 |
VSNL1 |
1.024e-02 | -4.58 | HCN4 (hyperpolarization activated cyclic nucleotide gated potassium channel 4) | protein interactions | 10021 | 4 | 1 | 19454 | 50 |
HCN1 |
1.024e-02 | -4.58 | Grb2 (growth factor receptor bound protein 2) | protein interactions | 81504 | 4 | 1 | 19454 | 50 |
DNM1 |
1.024e-02 | -4.58 | Amph (amphiphysin) | protein interactions | 60668 | 4 | 1 | 19454 | 50 |
DNM1 |
1.024e-02 | -4.58 | Baz2b (bromodomain adjacent to zinc finger domain, 2B) | protein interactions | 407823 | 4 | 1 | 19454 | 50 |
CACNA2D1 |
1.024e-02 | -4.58 | SLC6A2 (solute carrier family 6 member 2) | protein interactions | 6530 | 4 | 1 | 19454 | 50 |
STX1A |
1.025e-02 | -4.58 | monoatomic ion homeostasis | biological process | GO:0050801 | 515 | 5 | 18204 | 47 |
GRIN1,RYR2,SLC8A3,SLC4A10,GRM5 |
1.029e-02 | -4.58 | regulation of atrial cardiac muscle cell action potential | biological process | GO:0098910 | 4 | 1 | 18204 | 47 |
RYR2 |
1.029e-02 | -4.58 | regulation of grooming behavior | biological process | GO:2000821 | 4 | 1 | 18204 | 47 |
DLG4 |
1.029e-02 | -4.58 | regulation of calcium ion-dependent exocytosis of neurotransmitter | biological process | GO:1903233 | 4 | 1 | 18204 | 47 |
SYT1 |
1.029e-02 | -4.58 | maintenance of presynaptic active zone structure | biological process | GO:0048790 | 4 | 1 | 18204 | 47 |
PCLO |
1.029e-02 | -4.58 | regulation of AV node cell action potential | biological process | GO:0098904 | 4 | 1 | 18204 | 47 |
RYR2 |
1.029e-02 | -4.58 | positive regulation of norepinephrine secretion | biological process | GO:0010701 | 4 | 1 | 18204 | 47 |
STX1A |
1.029e-02 | -4.58 | calcium-dependent activation of synaptic vesicle fusion | biological process | GO:0099502 | 4 | 1 | 18204 | 47 |
SYT1 |
1.029e-02 | -4.58 | positive regulation of high voltage-gated calcium channel activity | biological process | GO:1901843 | 4 | 1 | 18204 | 47 |
CACNA2D1 |
1.029e-02 | -4.58 | trans-synaptic signaling by endocannabinoid | biological process | GO:0099542 | 4 | 1 | 18204 | 47 |
GRM5 |
1.029e-02 | -4.58 | trans-synaptic signaling by lipid | biological process | GO:0099541 | 4 | 1 | 18204 | 47 |
GRM5 |
1.029e-02 | -4.58 | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | biological process | GO:0031632 | 4 | 1 | 18204 | 47 |
SYT1 |
1.029e-02 | -4.58 | left ventricular cardiac muscle tissue morphogenesis | biological process | GO:0003220 | 4 | 1 | 18204 | 47 |
RYR2 |
1.029e-02 | -4.58 | positive regulation of synaptic vesicle membrane organization | biological process | GO:1901634 | 4 | 1 | 18204 | 47 |
SYT1 |
1.029e-02 | -4.58 | negative regulation of dendritic spine maintenance | biological process | GO:1902951 | 4 | 1 | 18204 | 47 |
GRIN2B |
1.039e-02 | -4.57 | brain development | biological process | GO:0007420 | 724 | 6 | 18204 | 47 |
SPTBN2,GRIN2B,NRG3,SLC4A10,BRINP1,GRIN1 |
1.043e-02 | -4.56 | clathrin-sculpted glutamate transport vesicle | cellular component | GO:0060199 | 4 | 1 | 19108 | 50 |
SYT1 |
1.043e-02 | -4.56 | HCN channel complex | cellular component | GO:0098855 | 4 | 1 | 19108 | 50 |
HCN1 |
1.043e-02 | -4.56 | clathrin-sculpted glutamate transport vesicle membrane | cellular component | GO:0060203 | 4 | 1 | 19108 | 50 |
SYT1 |
1.044e-02 | -4.56 | C2_domain_sf | interpro domains | IPR035892 | 171 | 3 | 18521 | 49 |
PCLO,SYT1,RIMS1 |
1.047e-02 | -4.56 | Lidocaine (Local Anaesthetic) Action Pathway | SMPDB pathways | SMP0000398 | 28 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
1.050e-02 | -4.56 | protein homotetramerization | biological process | GO:0051289 | 60 | 2 | 18204 | 47 |
HCN1,DNM1 |
1.050e-02 | -4.56 | regulation of cytosolic calcium ion concentration | biological process | GO:0051480 | 60 | 2 | 18204 | 47 |
RYR2,GRM5 |
1.052e-02 | -4.55 | Synaphin | pfam domains | PF05835 | 4 | 1 | 17795 | 47 |
CPLX1 |
1.052e-02 | -4.55 | AbLIM_anchor | pfam domains | PF16182 | 4 | 1 | 17795 | 47 |
ABLIM1 |
1.052e-02 | -4.55 | Ion_trans_N | pfam domains | PF08412 | 4 | 1 | 17795 | 47 |
HCN1 |
1.052e-02 | -4.55 | VWA_N | pfam domains | PF08399 | 4 | 1 | 17795 | 47 |
CACNA2D1 |
1.052e-02 | -4.55 | VGCC_alpha2 | pfam domains | PF08473 | 4 | 1 | 17795 | 47 |
CACNA2D1 |
1.052e-02 | -4.55 | PDZ_assoc | pfam domains | PF10600 | 4 | 1 | 17795 | 47 |
DLG4 |
1.052e-02 | -4.55 | Bravo_FIGEY | pfam domains | PF13882 | 4 | 1 | 17795 | 47 |
L1CAM |
1.054e-02 | -4.55 | Rim-like | interpro domains | IPR039032 | 4 | 1 | 18521 | 49 |
RIMS1 |
1.054e-02 | -4.55 | Synaphin | interpro domains | IPR008849 | 4 | 1 | 18521 | 49 |
CPLX1 |
1.054e-02 | -4.55 | VDCC_a2/dsu | interpro domains | IPR013680 | 4 | 1 | 18521 | 49 |
CACNA2D1 |
1.054e-02 | -4.55 | DLG1_PEST_dom | interpro domains | IPR019590 | 4 | 1 | 18521 | 49 |
DLG4 |
1.054e-02 | -4.55 | Neurofascin/L1/NrCAM_C | interpro domains | IPR026966 | 4 | 1 | 18521 | 49 |
L1CAM |
1.054e-02 | -4.55 | AbLIM_anchor | interpro domains | IPR032402 | 4 | 1 | 18521 | 49 |
ABLIM1 |
1.054e-02 | -4.55 | DLG1-like | interpro domains | IPR016313 | 4 | 1 | 18521 | 49 |
DLG4 |
1.054e-02 | -4.55 | VWA_N | interpro domains | IPR013608 | 4 | 1 | 18521 | 49 |
CACNA2D1 |
1.054e-02 | -4.55 | DLG1-4_PDZ_assoc | interpro domains | IPR019583 | 4 | 1 | 18521 | 49 |
DLG4 |
1.054e-02 | -4.55 | Ion_trans_N | interpro domains | IPR013621 | 4 | 1 | 18521 | 49 |
HCN1 |
1.054e-02 | -4.55 | VDCC_L_a1su | interpro domains | IPR005446 | 4 | 1 | 18521 | 49 |
CACNA1C |
1.055e-02 | -4.55 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 3 | 18204 | 47 |
SPTBN4,BRINP1,SLC4A10 |
1.057e-02 | -4.55 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 8 | 18204 | 47 |
GRM5,CAMK2A,CACNA2D1,DLG4,GRIN2B,CACNA1C,RYR2,RASGRF1 |
1.065e-02 | -4.54 | pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 6 | 16828 | 47 |
LRRC7,CACNA1G,GRIN2B,RYR2,GRM5,SPTBN2 |
1.065e-02 | -4.54 | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | COSMIC cancer mutations | pancreas-pancreatic_intraepithelial_neoplasia_(PanIN) | 673 | 6 | 16828 | 47 |
CACNA1G,LRRC7,GRIN2B,RYR2,GRM5,SPTBN2 |
1.075e-02 | -4.53 | Toxicity of botulinum toxin type E (BoNT/E) | REACTOME pathways | R-HSA-5250992 | 3 | 1 | 10285 | 37 |
SNAP25 |
1.075e-02 | -4.53 | Toxicity of botulinum toxin type B (BoNT/B) | REACTOME pathways | R-HSA-5250958 | 3 | 1 | 10285 | 37 |
SYT1 |
1.075e-02 | -4.53 | Toxicity of botulinum toxin type G (BoNT/G) | REACTOME pathways | R-HSA-5250989 | 3 | 1 | 10285 | 37 |
SYT1 |
1.076e-02 | -4.53 | TTC5 (tetratricopeptide repeat domain 5) | protein interactions | 91875 | 61 | 2 | 19454 | 50 |
CAMK2B,CAMK2A |
1.077e-02 | -4.53 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 3 | 19454 | 50 |
NRG3,LRRC7,DLG4 |
1.079e-02 | -4.53 | structural constituent of presynaptic active zone | molecular function | GO:0098882 | 4 | 1 | 18094 | 49 |
PCLO |
1.079e-02 | -4.53 | calcium ion sensor activity | molecular function | GO:0061891 | 4 | 1 | 18094 | 49 |
SYT1 |
1.079e-02 | -4.53 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 49 |
RYR2 |
1.079e-02 | -4.53 | cytoskeletal protein-membrane anchor activity | molecular function | GO:0106006 | 4 | 1 | 18094 | 49 |
SPTBN4 |
1.079e-02 | -4.53 | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | molecular function | GO:0099530 | 4 | 1 | 18094 | 49 |
GRM5 |
1.103e-02 | -4.51 | - | gene3d domains | 1.20.5.110 | 48 | 2 | 14470 | 48 |
SNAP25,STX1A |
1.110e-02 | -4.50 | FAM9C (family with sequence similarity 9 member C) | protein interactions | 171484 | 62 | 2 | 19454 | 50 |
CCDC136,STX1A |
1.112e-02 | -4.50 | Serotonergic synapse | KEGG pathways | hsa04726 | 112 | 3 | 7161 | 30 |
GABRB2,CACNA1A,CACNA1C |
1.121e-02 | -4.49 | Codeine Action Pathway | SMPDB pathways | SMP0000405 | 29 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
1.122e-02 | -4.49 | protein kinase binding | molecular function | GO:0019901 | 701 | 6 | 18094 | 49 |
DLG4,LRRC7,NRG3,RYR2,GRM5,DNM1 |
1.123e-02 | -4.49 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 5 | 16828 | 47 |
CAMKV,CAMK2A,CACNA2D1,CAMK2B,EPHA6 |
1.126e-02 | -4.49 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 25 | 16828 | 47 |
GRIN2B,NRG3,SLC8A3,GRM5,SPTBN2,CELF3,NRXN3,CACNA2D1,RIMS1,GRIN1,MCF2L2,RASGRF1,SYT1,L1CAM,IQSEC2,NRXN2,ABLIM1,LRRC7,GABRB2,STX1A,CELF5,DNM1,PPFIA3,SPTBN4,HCN1 |
1.131e-02 | -4.48 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 25 | 16828 | 47 |
GRM5,NRG3,SLC8A3,GRIN2B,CELF3,SPTBN2,MCF2L2,RASGRF1,GRIN1,RIMS1,NRXN3,CACNA2D1,L1CAM,SYT1,ABLIM1,NRXN2,IQSEC2,CELF5,GABRB2,LRRC7,STX1A,PPFIA3,DNM1,HCN1,SPTBN4 |
1.139e-02 | -4.47 | primary_central_nervous_system_lymphoma | COSMIC cancer mutations | primary_central_nervous_system_lymphoma | 683 | 6 | 16828 | 47 |
SPTBN2,PPFIA2,SPTBN4,RYR2,NRG3,CACNA2D1 |
1.139e-02 | -4.47 | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | 683 | 6 | 16828 | 47 |
SPTBN2,RYR2,NRG3,CACNA2D1,SPTBN4,PPFIA2 |
1.144e-02 | -4.47 | GABAARBETA | prints domains | PR01160 | 3 | 1 | 5227 | 20 |
GABRB2 |
1.144e-02 | -4.47 | TVDCCALPHA1 | prints domains | PR01629 | 3 | 1 | 5227 | 20 |
CACNA1G |
1.144e-02 | -4.47 | NACAEXCHNGR | prints domains | PR01259 | 3 | 1 | 5227 | 20 |
SLC8A3 |
1.144e-02 | -4.47 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 20 |
RYR2 |
1.157e-02 | -4.46 | regulation of molecular function | biological process | GO:0065009 | 2005 | 11 | 18204 | 47 |
DLG4,SLC8A3,CACNA2D1,FGF14,CAMK2A,GRM5,DLGAP2,RASGRF1,RYR2,CACNA1C,GRIN2B |
1.157e-02 | -4.46 | human chr7q11.23 | chromosome location | human chr7q11.23 | 85 | 2 | 26134 | 50 |
SRRM3,STX1A |
1.165e-02 | -4.45 | metal ion binding | molecular function | GO:0046872 | 4239 | 19 | 18094 | 49 |
NRXN3,GRIN1,GRIN2B,RIMS1,RYR2,ABLIM1,SYT1,PCLO,SCN8A,CACNA1E,NRXN2,CACNA1A,SLC8A3,EDIL3,CACNA2D1,CACNA1C,CAMK2A,VSNL1,MYT1L |
1.168e-02 | -4.45 | LamG | smart domains | SM00282 | 40 | 2 | 9717 | 40 |
NRXN2,NRXN3 |
1.168e-02 | -4.45 | response to metal ion | biological process | GO:0010038 | 343 | 4 | 18204 | 47 |
RYR2,SYT1,CACNA1G,DLG4 |
1.169e-02 | -4.45 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 5 | 16828 | 47 |
EPHA6,CAMK2B,CACNA2D1,CAMK2A,CAMKV |
1.179e-02 | -4.44 | MAP3K10 (mitogen-activated protein kinase kinase kinase 10) | protein interactions | 4294 | 64 | 2 | 19454 | 50 |
DLG4,DNM1 |
1.179e-02 | -4.44 | TMEM14C (transmembrane protein 14C) | protein interactions | 51522 | 64 | 2 | 19454 | 50 |
SYT1,STX1A |
1.198e-02 | -4.42 | Imipramine Action Pathway | SMPDB pathways | SMP0000422 | 30 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
1.222e-02 | -4.40 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 46 | 16828 | 47 |
DNM1,SCN8A,SNAP25,HCN1,MYT1L,IQSEC2,FGF14,PPFIA2,NRXN2,LRRC7,STX1A,GABRB2,CAMK2A,EPHA6,CACNA2D1,DLG4,MCF2L2,GRIN1,SYT1,L1CAM,SLC8A3,CCDC136,CAMK2B,CACNA1C,EDIL3,SLC4A10,SPTBN2,CELF3,PPFIA3,SPTBN4,CAMKV,CACNA1G,ABLIM1,DLGAP2,CELF5,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,CACNA1E,RYR2,GRIN2B,NRG3,VSNL1,GRM5 |
1.230e-02 | -4.40 | KRTAP6-2 (keratin associated protein 6-2) | protein interactions | 337967 | 187 | 3 | 19454 | 50 |
CAMK2A,CELF5,CAMK2B |
1.259e-02 | -4.37 | face | COSMIC cancer mutations | face | 2139 | 12 | 16828 | 47 |
SLC8A3,NRXN2,CACNA2D1,NRG3,GRIN2B,MCF2L2,PPFIA3,GRM5,ABLIM1,HCN1,LRRC7,EPHA6 |
1.260e-02 | -4.37 | negative regulation of protein depolymerization | biological process | GO:1901880 | 66 | 2 | 18204 | 47 |
SPTBN4,SPTBN2 |
1.267e-02 | -4.37 | lung-carcinoid-endocrine_tumour | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour | 502 | 5 | 16828 | 47 |
CAMK2A,CAMKV,NRXN3,CAMK2B,EPHA6 |
1.268e-02 | -4.37 | regulation of hormone levels | biological process | GO:0010817 | 543 | 5 | 18204 | 47 |
SNAP25,STX1A,CPLX1,VSNL1,PCLO |
1.269e-02 | -4.37 | liver-carcinoma | COSMIC cancer mutations | liver-carcinoma | 15337 | 47 | 16828 | 47 |
ABLIM1,CACNA1G,DLGAP2,CELF5,PPFIA3,SPTBN4,CAMKV,GRM5,VSNL1,GRIN2B,NRG3,RIMS1,CACNA1A,RASGRF1,PCLO,NRXN3,CACNA1E,RYR2,PPFIA2,IQSEC2,FGF14,NRXN2,EPHA6,STX1A,GABRB2,LRRC7,CAMK2A,SCN8A,DNM1,MYT1L,SNAP25,HCN1,CCDC136,SLC8A3,SPTBN2,CELF3,CAMK2B,CPLX1,EDIL3,SLC4A10,CACNA1C,MCF2L2,GRIN1,DLG4,CACNA2D1,L1CAM,SYT1 |
1.275e-02 | -4.36 | regulation of cellular component size | biological process | GO:0032535 | 352 | 4 | 18204 | 47 |
DNM1,L1CAM,SPTBN4,SPTBN2 |
1.277e-02 | -4.36 | Fluoxetine Action Pathway | SMPDB pathways | SMP0000426 | 31 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
1.279e-02 | -4.36 | Snap23 (synaptosomal-associated protein 23) | protein interactions | 20619 | 5 | 1 | 19454 | 50 |
STX1A |
1.279e-02 | -4.36 | CDK5R2 (cyclin dependent kinase 5 regulatory subunit 2) | protein interactions | 8941 | 5 | 1 | 19454 | 50 |
CAMK2A |
1.279e-02 | -4.36 | SETD6 (SET domain containing 6, protein lysine methyltransferase) | protein interactions | 79918 | 5 | 1 | 19454 | 50 |
PPFIA2 |
1.279e-02 | -4.36 | HCN3 (hyperpolarization activated cyclic nucleotide gated potassium channel 3) | protein interactions | 57657 | 5 | 1 | 19454 | 50 |
HCN1 |
1.279e-02 | -4.36 | CCM2L (CCM2 like scaffold protein) | protein interactions | 140706 | 5 | 1 | 19454 | 50 |
CAMK2B |
1.279e-02 | -4.36 | CACNA1E (calcium voltage-gated channel subunit alpha1 E) | protein interactions | 777 | 5 | 1 | 19454 | 50 |
CACNA1E |
1.279e-02 | -4.36 | Calu (calumenin) | protein interactions | 12321 | 5 | 1 | 19454 | 50 |
CACNA2D1 |
1.280e-02 | -4.36 | EPH-ephrin mediated repulsion of cells | REACTOME pathways | R-HSA-3928665 | 48 | 2 | 10285 | 37 |
DNM1,EPHA6 |
1.284e-02 | -4.35 | Purkinje myocyte to ventricular cardiac muscle cell signaling | biological process | GO:0086029 | 5 | 1 | 18204 | 47 |
RYR2 |
1.284e-02 | -4.35 | presynaptic dense core vesicle exocytosis | biological process | GO:0099525 | 5 | 1 | 18204 | 47 |
SNAP25 |
1.284e-02 | -4.35 | general adaptation syndrome, behavioral process | biological process | GO:0051867 | 5 | 1 | 18204 | 47 |
HCN1 |
1.284e-02 | -4.35 | bundle of His cell action potential | biological process | GO:0086043 | 5 | 1 | 18204 | 47 |
CACNA2D1 |
1.284e-02 | -4.35 | gephyrin clustering involved in postsynaptic density assembly | biological process | GO:0097116 | 5 | 1 | 18204 | 47 |
NRXN2 |
1.284e-02 | -4.35 | glutamate receptor clustering | biological process | GO:0097688 | 5 | 1 | 18204 | 47 |
DLG4 |
1.284e-02 | -4.35 | neuronal dense core vesicle exocytosis | biological process | GO:0099011 | 5 | 1 | 18204 | 47 |
SNAP25 |
1.284e-02 | -4.35 | regulation of postsynaptic neurotransmitter receptor activity | biological process | GO:0098962 | 5 | 1 | 18204 | 47 |
DLGAP2 |
1.284e-02 | -4.35 | membrane depolarization during SA node cell action potential | biological process | GO:0086046 | 5 | 1 | 18204 | 47 |
CACNA1G |
1.284e-02 | -4.35 | AMPA glutamate receptor clustering | biological process | GO:0097113 | 5 | 1 | 18204 | 47 |
DLG4 |
1.284e-02 | -4.35 | positive regulation of the force of heart contraction | biological process | GO:0098735 | 5 | 1 | 18204 | 47 |
RYR2 |
1.284e-02 | -4.35 | bundle of His cell to Purkinje myocyte signaling | biological process | GO:0086028 | 5 | 1 | 18204 | 47 |
CACNA2D1 |
1.287e-02 | -4.35 | ZNF696 (zinc finger protein 696) | protein interactions | 79943 | 67 | 2 | 19454 | 50 |
STX1A,CCDC136 |
1.296e-02 | -4.35 | cell-cell adhesion | biological process | GO:0098609 | 546 | 5 | 18204 | 47 |
L1CAM,NRXN2,DLG4,NRXN3,LRRC7 |
1.297e-02 | -4.35 | excitatory postsynaptic potential | biological process | GO:0060079 | 67 | 2 | 18204 | 47 |
GRIN2B,GRIN1 |
1.299e-02 | -4.34 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 43 | 16828 | 47 |
CACNA2D1,MCF2L2,GRIN1,SYT1,L1CAM,SLC8A3,CCDC136,EDIL3,CACNA1C,SLC4A10,CPLX1,CAMK2B,CELF3,SPTBN2,SCN8A,HCN1,SNAP25,MYT1L,NRXN2,FGF14,IQSEC2,PPFIA2,CAMK2A,GABRB2,STX1A,LRRC7,EPHA6,NRXN3,PCLO,RASGRF1,CACNA1A,RIMS1,RYR2,CACNA1E,NRG3,GRIN2B,VSNL1,GRM5,PPFIA3,SPTBN4,CACNA1G,CELF5,DLGAP2 |
1.302e-02 | -4.34 | clathrin-sculpted monoamine transport vesicle membrane | cellular component | GO:0070083 | 5 | 1 | 19108 | 50 |
SYT1 |
1.302e-02 | -4.34 | clathrin-sculpted monoamine transport vesicle | cellular component | GO:0070081 | 5 | 1 | 19108 | 50 |
SYT1 |
1.309e-02 | -4.34 | adherens junction | cellular component | GO:0005912 | 188 | 3 | 19108 | 50 |
SPTBN4,LRRC7,DLG4 |
1.314e-02 | -4.33 | GKAP | pfam domains | PF03359 | 5 | 1 | 17795 | 47 |
DLGAP2 |
1.316e-02 | -4.33 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 49 |
SLC4A10 |
1.316e-02 | -4.33 | Znf_C2H2C_sf | interpro domains | IPR036060 | 5 | 1 | 18521 | 49 |
MYT1L |
1.316e-02 | -4.33 | SAPAP | interpro domains | IPR005026 | 5 | 1 | 18521 | 49 |
DLGAP2 |
1.322e-02 | -4.33 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_associated_with_MDS | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_associated_with_MDS | 177 | 3 | 16828 | 47 |
CACNA1E,GRIN2B,L1CAM |
1.322e-02 | -4.33 | acute_myeloid_leukaemia_associated_with_MDS | COSMIC cancer mutations | acute_myeloid_leukaemia_associated_with_MDS | 177 | 3 | 16828 | 47 |
CACNA1E,GRIN2B,L1CAM |
1.324e-02 | -4.32 | ZNF835 (zinc finger protein 835) | protein interactions | 90485 | 68 | 2 | 19454 | 50 |
STX1A,CCDC136 |
1.325e-02 | -4.32 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 47 |
NRXN2,SPTBN4,SNAP25,LRRC7,DLG4 |
1.330e-02 | -4.32 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 10 | 16828 | 47 |
SPTBN2,SYT1,GABRB2,LRRC7,GRIN1,RASGRF1,SLC8A3,NRXN3,FGF14,IQSEC2 |
1.347e-02 | -4.31 | metal ion sensor activity | molecular function | GO:0140784 | 5 | 1 | 18094 | 49 |
SYT1 |
1.354e-02 | -4.30 | CH | pfam domains | PF00307 | 67 | 2 | 17795 | 47 |
SPTBN2,SPTBN4 |
1.358e-02 | -4.30 | Methadone Action Pathway | SMPDB pathways | SMP0000408 | 32 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
1.358e-02 | -4.30 | Citalopram Action Pathway | SMPDB pathways | SMP0000424 | 32 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
1.358e-02 | -4.30 | Nicotine Action Pathway | SMPDB pathways | SMP0000431 | 32 | 2 | 1369 | 8 |
GRIN1,CACNA1A |
1.361e-02 | -4.30 | C2 | smart domains | SM00239 | 122 | 3 | 9717 | 40 |
RIMS1,SYT1,PCLO |
1.361e-02 | -4.30 | BAGE2 (BAGE family member 2 (pseudogene)) | protein interactions | 85319 | 69 | 2 | 19454 | 50 |
EPHA6,CACNA2D1 |
1.366e-02 | -4.29 | plasma membrane signaling receptor complex | cellular component | GO:0098802 | 191 | 3 | 19108 | 50 |
GRIN2B,DLG4,GRIN1 |
1.366e-02 | -4.29 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 47 | 16828 | 47 |
FGF14,IQSEC2,PPFIA2,NRXN2,STX1A,GABRB2,LRRC7,CAMK2A,EPHA6,DNM1,SCN8A,SNAP25,HCN1,MYT1L,SLC8A3,CCDC136,CPLX1,CAMK2B,EDIL3,CACNA1C,SLC4A10,SPTBN2,CELF3,CACNA2D1,GRIN1,DLG4,MCF2L2,SYT1,L1CAM,CACNA1G,ABLIM1,DLGAP2,CELF5,PPFIA3,SPTBN4,CAMKV,GRIN2B,NRG3,VSNL1,GRM5,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,CACNA1E,RYR2 |
1.388e-02 | -4.28 | positive regulation of cell projection organization | biological process | GO:0031346 | 361 | 4 | 18204 | 47 |
LRRC7,DLG4,CAMK2B,L1CAM |
1.390e-02 | -4.28 | Ras signaling pathway | KEGG pathways | hsa04014 | 226 | 4 | 7161 | 30 |
GRIN1,RASGRF1,GRIN2B,FGF14 |
1.399e-02 | -4.27 | ACTN4 (actinin alpha 4) | protein interactions | 81 | 363 | 4 | 19454 | 50 |
GRIN1,LRRC7,CAMK2B,CAMK2A |
1.399e-02 | -4.27 | Signaling by GPCR | REACTOME pathways | R-HSA-372790 | 1299 | 10 | 10285 | 37 |
SPTBN2,GRIN2B,CAMK2A,DLG4,CAMK2B,GRM5,GRIN1,RASGRF1,SPTBN4,NRG3 |
1.410e-02 | -4.26 | head development | biological process | GO:0060322 | 774 | 6 | 18204 | 47 |
GRIN1,NRG3,BRINP1,SLC4A10,GRIN2B,SPTBN2 |
1.423e-02 | -4.25 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 7 | 16828 | 47 |
EDIL3,CAMK2A,CAMKV,CAMK2B,SYT1,EPHA6,NRXN3 |
1.427e-02 | -4.25 | regulation of peptide hormone secretion | biological process | GO:0090276 | 197 | 3 | 18204 | 47 |
VSNL1,STX1A,SNAP25 |
1.431e-02 | -4.25 | HCN channels | REACTOME pathways | R-HSA-1296061 | 4 | 1 | 10285 | 37 |
HCN1 |
1.431e-02 | -4.25 | Toxicity of botulinum toxin type A (BoNT/A) | REACTOME pathways | R-HSA-5250968 | 4 | 1 | 10285 | 37 |
SNAP25 |
1.433e-02 | -4.25 | CAMK2D (calcium/calmodulin dependent protein kinase II delta) | protein interactions | 817 | 198 | 3 | 19454 | 50 |
CAMK2B,GRIN2B,CAMK2A |
1.435e-02 | -4.24 | protein-containing complex organization | biological process | GO:0043933 | 2067 | 11 | 18204 | 47 |
GRIN2B,CELF5,DNM1,SYT1,RIMS1,SNAP25,SPTBN4,DLG4,HCN1,GRIN1,CELF3 |
1.445e-02 | -4.24 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 3 | 16828 | 47 |
NRG3,FGF14,SYT1 |
1.447e-02 | -4.24 | fertilization | biological process | GO:0009566 | 198 | 3 | 18204 | 47 |
SPTBN4,CCDC136,RIMS1 |
1.448e-02 | -4.23 | kidney | COSMIC cancer mutations | kidney | 15380 | 47 | 16828 | 47 |
CACNA2D1,MCF2L2,DLG4,GRIN1,SYT1,L1CAM,SLC8A3,CCDC136,CACNA1C,SLC4A10,EDIL3,CAMK2B,CPLX1,CELF3,SPTBN2,DNM1,SCN8A,HCN1,SNAP25,MYT1L,NRXN2,PPFIA2,FGF14,IQSEC2,CAMK2A,LRRC7,GABRB2,STX1A,EPHA6,NRXN3,RASGRF1,PCLO,CACNA1A,RIMS1,RYR2,CACNA1E,NRG3,GRIN2B,GRM5,VSNL1,PPFIA3,CAMKV,SPTBN4,CACNA1G,ABLIM1,CELF5,DLGAP2 |
1.453e-02 | -4.23 | DAPK1 (death associated protein kinase 1) | protein interactions | 1612 | 199 | 3 | 19454 | 50 |
ABLIM1,SPTBN2,STX1A |
1.471e-02 | -4.22 | RhoGEF | pfam domains | PF00621 | 70 | 2 | 17795 | 47 |
RASGRF1,MCF2L2 |
1.477e-02 | -4.22 | DH-domain | interpro domains | IPR000219 | 70 | 2 | 18521 | 49 |
MCF2L2,RASGRF1 |
1.486e-02 | -4.21 | regulation of peptide secretion | biological process | GO:0002791 | 200 | 3 | 18204 | 47 |
STX1A,SNAP25,VSNL1 |
1.486e-02 | -4.21 | regulation of peptide transport | biological process | GO:0090087 | 200 | 3 | 18204 | 47 |
VSNL1,STX1A,SNAP25 |
1.486e-02 | -4.21 | photoreceptor inner segment | cellular component | GO:0001917 | 71 | 2 | 19108 | 50 |
DNM1,SNAP25 |
1.492e-02 | -4.21 | C2 domain | gene3d domains | 2.60.40.150 | 156 | 3 | 14470 | 48 |
RIMS1,SYT1,PCLO |
1.500e-02 | -4.20 | cation binding | molecular function | GO:0043169 | 4341 | 19 | 18094 | 49 |
EDIL3,CACNA2D1,CACNA1A,SLC8A3,NRXN2,CACNA1E,MYT1L,CAMK2A,VSNL1,CACNA1C,RIMS1,GRIN2B,GRIN1,NRXN3,SCN8A,PCLO,ABLIM1,SYT1,RYR2 |
1.509e-02 | -4.19 | response to nitrogen compound | biological process | GO:1901698 | 1021 | 7 | 18204 | 47 |
GABRB2,HCN1,CACNA2D1,GRIN1,CACNA1A,CAMK2A,RYR2 |
1.517e-02 | -4.19 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 2 | 18521 | 49 |
RASGRF1,MCF2L2 |
1.522e-02 | -4.19 | LVDCCALPHA1 | prints domains | PR01630 | 4 | 1 | 5227 | 20 |
CACNA1C |
1.526e-02 | -4.18 | intracellular calcium ion homeostasis | biological process | GO:0006874 | 202 | 3 | 18204 | 47 |
GRM5,SLC8A3,RYR2 |
1.526e-02 | -4.18 | receptor internalization | biological process | GO:0031623 | 73 | 2 | 18204 | 47 |
SNAP25,DNM1 |
1.526e-02 | -4.18 | negative regulation of protein polymerization | biological process | GO:0032272 | 73 | 2 | 18204 | 47 |
SPTBN2,SPTBN4 |
1.526e-02 | -4.18 | chemical synaptic transmission, postsynaptic | biological process | GO:0099565 | 73 | 2 | 18204 | 47 |
GRIN1,GRIN2B |
1.532e-02 | -4.18 | CIBAR2 (CBY1 interacting BAR domain containing 2) | protein interactions | 339145 | 6 | 1 | 19454 | 50 |
CAMK2B |
1.532e-02 | -4.18 | Nos1 (nitric oxide synthase 1) | protein interactions | 24598 | 6 | 1 | 19454 | 50 |
DLG4 |
1.539e-02 | -4.17 | Purkinje myocyte to ventricular cardiac muscle cell communication | biological process | GO:0086068 | 6 | 1 | 18204 | 47 |
RYR2 |
1.539e-02 | -4.17 | acrosomal vesicle exocytosis | biological process | GO:0060478 | 6 | 1 | 18204 | 47 |
RIMS1 |
1.539e-02 | -4.17 | imitative learning | biological process | GO:0098596 | 6 | 1 | 18204 | 47 |
NRXN2 |
1.539e-02 | -4.17 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 47 |
NRXN2 |
1.539e-02 | -4.17 | positive regulation of inhibitory postsynaptic potential | biological process | GO:0097151 | 6 | 1 | 18204 | 47 |
RIMS1 |
1.539e-02 | -4.17 | clustering of voltage-gated sodium channels | biological process | GO:0045162 | 6 | 1 | 18204 | 47 |
SPTBN4 |
1.539e-02 | -4.17 | general adaptation syndrome | biological process | GO:0051866 | 6 | 1 | 18204 | 47 |
HCN1 |
1.539e-02 | -4.17 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 1 | 18204 | 47 |
NRG3 |
1.539e-02 | -4.17 | vocal learning | biological process | GO:0042297 | 6 | 1 | 18204 | 47 |
NRXN2 |
1.539e-02 | -4.17 | presynaptic active zone organization | biological process | GO:1990709 | 6 | 1 | 18204 | 47 |
PCLO |
1.539e-02 | -4.17 | cellular response to histamine | biological process | GO:0071420 | 6 | 1 | 18204 | 47 |
GABRB2 |
1.539e-02 | -4.17 | positive regulation of dopamine secretion | biological process | GO:0033603 | 6 | 1 | 18204 | 47 |
SYT1 |
1.539e-02 | -4.17 | mammary gland formation | biological process | GO:0060592 | 6 | 1 | 18204 | 47 |
NRG3 |
1.543e-02 | -4.17 | scaffold protein binding | molecular function | GO:0097110 | 70 | 2 | 18094 | 49 |
DLG4,CACNA1G |
1.554e-02 | -4.16 | GIMAP5 (GTPase, IMAP family member 5) | protein interactions | 55340 | 74 | 2 | 19454 | 50 |
STX1A,SYT1 |
1.560e-02 | -4.16 | basal dendrite | cellular component | GO:0097441 | 6 | 1 | 19108 | 50 |
SLC4A10 |
1.560e-02 | -4.16 | extrinsic component of presynaptic membrane | cellular component | GO:0098888 | 6 | 1 | 19108 | 50 |
SNAP25 |
1.571e-02 | -4.15 | testis | COSMIC cancer mutations | testis | 733 | 6 | 16828 | 47 |
CACNA2D1,LRRC7,CAMK2B,CAMK2A,CAMKV,EPHA6 |
1.575e-02 | -4.15 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 47 |
RYR2 |
1.575e-02 | -4.15 | Na_trans_cytopl | pfam domains | PF11933 | 6 | 1 | 17795 | 47 |
SCN8A |
1.575e-02 | -4.15 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 47 |
RYR2 |
1.575e-02 | -4.15 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 47 |
RYR2 |
1.575e-02 | -4.15 | Syndecan | pfam domains | PF01034 | 6 | 1 | 17795 | 47 |
NRXN3 |
1.575e-02 | -4.15 | GED | pfam domains | PF02212 | 6 | 1 | 17795 | 47 |
DNM1 |
1.575e-02 | -4.15 | zf-C2HC | pfam domains | PF01530 | 6 | 1 | 17795 | 47 |
MYT1L |
1.575e-02 | -4.15 | Dynamin_M | pfam domains | PF01031 | 6 | 1 | 17795 | 47 |
DNM1 |
1.577e-02 | -4.15 | GED_dom | interpro domains | IPR020850 | 6 | 1 | 18521 | 49 |
DNM1 |
1.577e-02 | -4.15 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 1 | 18521 | 49 |
NRXN3 |
1.577e-02 | -4.15 | GED | interpro domains | IPR003130 | 6 | 1 | 18521 | 49 |
DNM1 |
1.577e-02 | -4.15 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 49 |
RYR2 |
1.577e-02 | -4.15 | Na_trans_cytopl | interpro domains | IPR024583 | 6 | 1 | 18521 | 49 |
SCN8A |
1.577e-02 | -4.15 | Dynamin_GTPase_CS | interpro domains | IPR019762 | 6 | 1 | 18521 | 49 |
DNM1 |
1.577e-02 | -4.15 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 49 |
RYR2 |
1.577e-02 | -4.15 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 49 |
RYR2 |
1.577e-02 | -4.15 | Dynamin_stalk | interpro domains | IPR000375 | 6 | 1 | 18521 | 49 |
DNM1 |
1.577e-02 | -4.15 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 49 |
RYR2 |
1.577e-02 | -4.15 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 49 |
RYR2 |
1.578e-02 | -4.15 | ion binding | molecular function | GO:0043167 | 6007 | 24 | 18094 | 49 |
CACNA1A,CACNA2D1,CACNA1E,DNM1,MYT1L,VSNL1,NRXN3,EPHA6,HCN1,GRIN1,ABLIM1,PCLO,SCN8A,RYR2,SLC8A3,EDIL3,NRXN2,CAMKV,CACNA1C,CAMK2A,RIMS1,CAMK2B,GRIN2B,SYT1 |
1.603e-02 | -4.13 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 47 |
GRM5,L1CAM,CAMK2B,BRINP1 |
1.606e-02 | -4.13 | regulation of calcium ion transmembrane transporter activity | biological process | GO:1901019 | 75 | 2 | 18204 | 47 |
CACNA2D1,RYR2 |
1.614e-02 | -4.13 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 49 |
RYR2 |
1.614e-02 | -4.13 | D1 dopamine receptor binding | molecular function | GO:0031748 | 6 | 1 | 18094 | 49 |
DLG4 |
1.614e-02 | -4.13 | chloride channel inhibitor activity | molecular function | GO:0019869 | 6 | 1 | 18094 | 49 |
STX1A |
1.614e-02 | -4.13 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 49 |
SLC4A10 |
1.631e-02 | -4.12 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 46 | 16828 | 47 |
SPTBN4,PPFIA3,DLGAP2,CELF5,ABLIM1,CACNA1G,CACNA1E,RYR2,CACNA1A,RIMS1,PCLO,RASGRF1,NRXN3,VSNL1,GRM5,GRIN2B,NRG3,MYT1L,SNAP25,HCN1,SCN8A,DNM1,EPHA6,LRRC7,STX1A,GABRB2,CAMK2A,IQSEC2,FGF14,PPFIA2,NRXN2,L1CAM,SYT1,DLG4,MCF2L2,GRIN1,CACNA2D1,SPTBN2,CELF3,CPLX1,CAMK2B,EDIL3,SLC4A10,CACNA1C,CCDC136,SLC8A3 |
1.635e-02 | -4.11 | SRI (sorcin) | protein interactions | 6717 | 76 | 2 | 19454 | 50 |
RYR2,CACNA1C |
1.637e-02 | -4.11 | MAGUK_N_PEST | smart domains | SM01277 | 4 | 1 | 9717 | 40 |
DLG4 |
1.641e-02 | -4.11 | Galactose-bd-like_sf | interpro domains | IPR008979 | 74 | 2 | 18521 | 49 |
EDIL3,EPHA6 |
1.647e-02 | -4.11 | negative regulation of protein-containing complex disassembly | biological process | GO:0043242 | 76 | 2 | 18204 | 47 |
SPTBN4,SPTBN2 |
1.647e-02 | -4.11 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 7 | 18094 | 49 |
DNM1,CAMK2B,CACNA1C,ABLIM1,SPTBN2,SNAP25,SPTBN4 |
1.649e-02 | -4.11 | neuromuscular junction | cellular component | GO:0031594 | 75 | 2 | 19108 | 50 |
DLG4,SLC8A3 |
1.653e-02 | -4.10 | establishment of protein localization | biological process | GO:0045184 | 1291 | 8 | 18204 | 47 |
DLG4,STX1A,CPLX1,LRRC7,RYR2,SNAP25,RIMS1,PCLO |
1.675e-02 | -4.09 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 9 | 16828 | 47 |
MYT1L,CELF5,RYR2,EDIL3,GRM5,PCLO,PPFIA2,NRXN2,SLC8A3 |
1.675e-02 | -4.09 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 9 | 16828 | 47 |
MYT1L,RYR2,CELF5,EDIL3,GRM5,PCLO,PPFIA2,NRXN2,SLC8A3 |
1.676e-02 | -4.09 | LITAF (lipopolysaccharide induced TNF factor) | protein interactions | 9516 | 77 | 2 | 19454 | 50 |
CACNA1C,VSNL1 |
1.676e-02 | -4.09 | Htt (huntingtin) | protein interactions | 15194 | 77 | 2 | 19454 | 50 |
STX1A,SNAP25 |
1.691e-02 | -4.08 | cortical actin cytoskeleton | cellular component | GO:0030864 | 76 | 2 | 19108 | 50 |
SPTBN2,SPTBN4 |
1.696e-02 | -4.08 | EPHB2 (EPH receptor B2) | protein interactions | 2048 | 211 | 3 | 19454 | 50 |
GRIN2B,EPHA6,GRIN1 |
1.704e-02 | -4.07 | regulation of actin filament-based process | biological process | GO:0032970 | 384 | 4 | 18204 | 47 |
SPTBN2,SPTBN4,CACNA1C,RYR2 |
1.708e-02 | -4.07 | neoplasm | COSMIC cancer mutations | neoplasm | 14787 | 46 | 16828 | 47 |
GRIN2B,NRG3,SLC8A3,VSNL1,GRM5,CCDC136,CPLX1,CAMK2B,CACNA1C,EDIL3,SPTBN2,CELF3,NRXN3,CACNA2D1,RIMS1,CACNA1A,PCLO,RASGRF1,GRIN1,DLG4,MCF2L2,CACNA1E,SYT1,RYR2,L1CAM,FGF14,IQSEC2,PPFIA2,CACNA1G,NRXN2,ABLIM1,DLGAP2,LRRC7,STX1A,GABRB2,CELF5,CAMK2A,EPHA6,DNM1,SCN8A,PPFIA3,SNAP25,SPTBN4,CAMKV,HCN1,MYT1L |
1.717e-02 | -4.06 | LRP8 (LDL receptor related protein 8) | protein interactions | 7804 | 78 | 2 | 19454 | 50 |
DLG4,GRIN1 |
1.730e-02 | -4.06 | regulation of cardiac muscle contraction | biological process | GO:0055117 | 78 | 2 | 18204 | 47 |
RYR2,CACNA1C |
1.744e-02 | -4.05 | Felodipine Metabolism Pathway | SMPDB pathways | SMP0000619 | 3 | 1 | 1369 | 8 |
CACNA1C |
1.759e-02 | -4.04 | TRAF3IP3 (TRAF3 interacting protein 3) | protein interactions | 80342 | 79 | 2 | 19454 | 50 |
CCDC136,STX1A |
1.776e-02 | -4.03 | GABA-ergic synapse | cellular component | GO:0098982 | 78 | 2 | 19108 | 50 |
GABRB2,PCLO |
1.777e-02 | -4.03 | positive regulation of transmembrane transport | biological process | GO:0034764 | 214 | 3 | 18204 | 47 |
RYR2,CACNA2D1,GRIN1 |
1.786e-02 | -4.03 | HCN2 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2) | protein interactions | 610 | 7 | 1 | 19454 | 50 |
HCN1 |
1.786e-02 | -4.03 | ABCC9 (ATP binding cassette subfamily C member 9) | protein interactions | 10060 | 7 | 1 | 19454 | 50 |
STX1A |
1.786e-02 | -4.03 | Dlg4 (discs large MAGUK scaffold protein 4) | protein interactions | 13385 | 7 | 1 | 19454 | 50 |
GRIN1 |
1.786e-02 | -4.03 | ATP4B (ATPase H+/K+ transporting subunit beta) | protein interactions | 496 | 7 | 1 | 19454 | 50 |
STX1A |
1.786e-02 | -4.03 | RIMBP2 (RIMS binding protein 2) | protein interactions | 23504 | 7 | 1 | 19454 | 50 |
CACNA1A |
1.786e-02 | -4.03 | SV2B (synaptic vesicle glycoprotein 2B) | protein interactions | 9899 | 7 | 1 | 19454 | 50 |
SYT1 |
1.786e-02 | -4.03 | ZNF479 (zinc finger protein 479) | protein interactions | 90827 | 7 | 1 | 19454 | 50 |
STX1A |
1.786e-02 | -4.03 | FRMPD4 (FERM and PDZ domain containing 4) | protein interactions | 9758 | 7 | 1 | 19454 | 50 |
GRM5 |
1.786e-02 | -4.03 | KCNE2 (potassium voltage-gated channel subfamily E regulatory subunit 2) | protein interactions | 9992 | 7 | 1 | 19454 | 50 |
CACNA1C |
1.794e-02 | -4.02 | modulation of inhibitory postsynaptic potential | biological process | GO:0098828 | 7 | 1 | 18204 | 47 |
RIMS1 |
1.794e-02 | -4.02 | regulation of synaptic vesicle priming | biological process | GO:0010807 | 7 | 1 | 18204 | 47 |
STX1A |
1.794e-02 | -4.02 | interneuron migration from the subpallium to the cortex | biological process | GO:0021830 | 7 | 1 | 18204 | 47 |
NRG3 |
1.794e-02 | -4.02 | observational learning | biological process | GO:0098597 | 7 | 1 | 18204 | 47 |
NRXN2 |
1.794e-02 | -4.02 | SA node cell to atrial cardiac muscle cell signaling | biological process | GO:0086018 | 7 | 1 | 18204 | 47 |
CACNA1G |
1.794e-02 | -4.02 | dense core granule exocytosis | biological process | GO:1990504 | 7 | 1 | 18204 | 47 |
SNAP25 |
1.794e-02 | -4.02 | spontaneous neurotransmitter secretion | biological process | GO:0061669 | 7 | 1 | 18204 | 47 |
SYT1 |
1.794e-02 | -4.02 | hydrocarbon metabolic process | biological process | GO:0120252 | 7 | 1 | 18204 | 47 |
GRIN1 |
1.794e-02 | -4.02 | SA node cell action potential | biological process | GO:0086015 | 7 | 1 | 18204 | 47 |
CACNA1G |
1.794e-02 | -4.02 | positive regulation of voltage-gated calcium channel activity | biological process | GO:1901387 | 7 | 1 | 18204 | 47 |
CACNA2D1 |
1.794e-02 | -4.02 | positive regulation of long-term synaptic depression | biological process | GO:1900454 | 7 | 1 | 18204 | 47 |
IQSEC2 |
1.794e-02 | -4.02 | regulation of ATPase-coupled calcium transmembrane transporter activity | biological process | GO:1901894 | 7 | 1 | 18204 | 47 |
RYR2 |
1.801e-02 | -4.02 | BLOC1S6 (biogenesis of lysosomal organelles complex 1 subunit 6) | protein interactions | 26258 | 80 | 2 | 19454 | 50 |
STX1A,CCDC136 |
1.808e-02 | -4.01 | G_DYNAMIN_1 | prosite domains | PS00410 | 6 | 1 | 12186 | 37 |
DNM1 |
1.808e-02 | -4.01 | GED | prosite domains | PS51388 | 6 | 1 | 12186 | 37 |
DNM1 |
1.818e-02 | -4.01 | axon hillock | cellular component | GO:0043203 | 7 | 1 | 19108 | 50 |
SPTBN4 |
1.818e-02 | -4.01 | cerebellar mossy fiber | cellular component | GO:0044300 | 7 | 1 | 19108 | 50 |
DLG4 |
1.834e-02 | -4.00 | Ion transport by P-type ATPases | REACTOME pathways | R-HSA-936837 | 58 | 2 | 10285 | 37 |
CAMK2B,CAMK2A |
1.838e-02 | -4.00 | Dynamin_GTPase | interpro domains | IPR001401 | 7 | 1 | 18521 | 49 |
DNM1 |
1.838e-02 | -4.00 | Dynamin | interpro domains | IPR022812 | 7 | 1 | 18521 | 49 |
DNM1 |
1.838e-02 | -4.00 | Znf_C2H2C | interpro domains | IPR002515 | 7 | 1 | 18521 | 49 |
MYT1L |
1.844e-02 | -3.99 | visual perception | biological process | GO:0007601 | 217 | 3 | 18204 | 47 |
SLC4A10,RIMS1,ABLIM1 |
1.849e-02 | -3.99 | organic acid binding | molecular function | GO:0043177 | 207 | 3 | 18094 | 49 |
GRIN1,GRIN2B,RYR2 |
1.882e-02 | -3.97 | cytoplasm | cellular component | GO:0005737 | 12081 | 39 | 19108 | 50 |
MCF2L2,CAMK2B,BRINP1,SYT1,FGF14,CELF5,RYR2,TMEM266,GRM5,GRIN1,CCDC136,GRIN2B,ABLIM1,STX1A,CAMKV,CACNA2D1,PCLO,PPFIA3,DNM1,LRRC7,SLC8A3,VSNL1,RASGRF1,GABRB2,RIMS1,CELF3,CPLX1,CACNA1G,PPFIA2,CAMK2A,SCN8A,CACNA1A,SPTBN2,IQSEC2,SNAP25,DLGAP2,CACNA1C,DLG4,SPTBN4 |
1.886e-02 | -3.97 | LINC00839 (long intergenic non-protein coding RNA 839) | protein interactions | 84856 | 82 | 2 | 19454 | 50 |
L1CAM,RYR2 |
1.886e-02 | -3.97 | VPS11 (VPS11 core subunit of CORVET and HOPS complexes) | protein interactions | 55823 | 82 | 2 | 19454 | 50 |
TMEM266,STX1A |
1.893e-02 | -3.97 | CDK5 (cyclin dependent kinase 5) | protein interactions | 1020 | 220 | 3 | 19454 | 50 |
GRM5,DNM1,STX1A |
1.897e-02 | -3.96 | human chr2p24.2 | chromosome location | human chr2p24.2 | 10 | 1 | 26134 | 50 |
VSNL1 |
1.899e-02 | -3.96 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 20 |
SLC4A10 |
1.901e-02 | -3.96 | thyroid-carcinoma-Hurthle_cell_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-Hurthle_cell_carcinoma | 203 | 3 | 16828 | 47 |
SCN8A,RIMS1,SPTBN4 |
1.901e-02 | -3.96 | Hurthle_cell_carcinoma | COSMIC cancer mutations | Hurthle_cell_carcinoma | 203 | 3 | 16828 | 47 |
SPTBN4,RIMS1,SCN8A |
1.903e-02 | -3.96 | DH_2 | prosite domains | PS50010 | 70 | 2 | 12186 | 37 |
MCF2L2,RASGRF1 |
1.905e-02 | -3.96 | Amyotrophic lateral sclerosis (ALS) | KEGG pathways | hsa05014 | 51 | 2 | 7161 | 30 |
GRIN2B,GRIN1 |
1.905e-02 | -3.96 | Amyotrophic lateral sclerosis (ALS) | KEGG pathways | ko05014 | 51 | 2 | 7161 | 30 |
GRIN1,GRIN2B |
1.913e-02 | -3.96 | regulation of growth | biological process | GO:0040008 | 603 | 5 | 18204 | 47 |
NRG3,SYT1,RIMS1,SPTBN4,L1CAM |
1.934e-02 | -3.95 | sensory perception of light stimulus | biological process | GO:0050953 | 221 | 3 | 18204 | 47 |
SLC4A10,RIMS1,ABLIM1 |
1.937e-02 | -3.94 | sarcomere | cellular component | GO:0030017 | 218 | 3 | 19108 | 50 |
SCN8A,RYR2,CACNA1C |
1.939e-02 | -3.94 | calcium-dependent protein binding | molecular function | GO:0048306 | 79 | 2 | 18094 | 49 |
SNAP25,SYT1 |
1.944e-02 | -3.94 | actin filament binding | molecular function | GO:0051015 | 211 | 3 | 18094 | 49 |
SPTBN2,SPTBN4,ABLIM1 |
1.944e-02 | -3.94 | positive regulation of ion transmembrane transporter activity | biological process | GO:0032414 | 83 | 2 | 18204 | 47 |
RYR2,CACNA2D1 |
1.944e-02 | -3.94 | regulation of amine transport | biological process | GO:0051952 | 83 | 2 | 18204 | 47 |
SYT1,STX1A |
1.944e-02 | -3.94 | spliceosomal complex assembly | biological process | GO:0000245 | 83 | 2 | 18204 | 47 |
CELF3,CELF5 |
1.945e-02 | -3.94 | CH_dom | interpro domains | IPR001715 | 81 | 2 | 18521 | 49 |
SPTBN2,SPTBN4 |
1.954e-02 | -3.94 | BSG (basigin (Ok blood group)) | protein interactions | 682 | 608 | 5 | 19454 | 50 |
DNM1,CACNA1C,CAMK2A,SPTBN4,ABLIM1 |
1.964e-02 | -3.93 | regulation of cell growth | biological process | GO:0001558 | 401 | 4 | 18204 | 47 |
RIMS1,SYT1,NRG3,L1CAM |
1.974e-02 | -3.93 | IQSEC1 (IQ motif and Sec7 domain ArfGEF 1) | protein interactions | 9922 | 84 | 2 | 19454 | 50 |
BRINP1,IQSEC2 |
1.974e-02 | -3.93 | SPTA1 (spectrin alpha, erythrocytic 1) | protein interactions | 6708 | 84 | 2 | 19454 | 50 |
SPTBN2,SPTBN4 |
1.974e-02 | -3.92 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 48 |
RYR2 |
1.974e-02 | -3.92 | - | gene3d domains | 4.10.320.30 | 6 | 1 | 14470 | 48 |
MYT1L |
1.974e-02 | -3.92 | Dynamin, middle domain | gene3d domains | 1.20.120.1240 | 6 | 1 | 14470 | 48 |
DNM1 |
1.976e-02 | -3.92 | FBXO2 (F-box protein 2) | protein interactions | 26232 | 403 | 4 | 19454 | 50 |
EDIL3,L1CAM,CACNA2D1,GRIN1 |
1.986e-02 | -3.92 | other | COSMIC cancer mutations | other | 14843 | 46 | 16828 | 47 |
SYT1,L1CAM,CACNA2D1,GRIN1,DLG4,MCF2L2,CPLX1,CAMK2B,CACNA1C,EDIL3,SPTBN2,CELF3,SLC8A3,CCDC136,SNAP25,HCN1,MYT1L,DNM1,SCN8A,GABRB2,STX1A,LRRC7,CAMK2A,EPHA6,FGF14,IQSEC2,PPFIA2,NRXN2,CACNA1E,RYR2,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,GRIN2B,NRG3,VSNL1,GRM5,SPTBN4,CAMKV,PPFIA3,DLGAP2,CELF5,CACNA1G,ABLIM1 |
1.989e-02 | -3.92 | regulation of release of sequestered calcium ion into cytosol | biological process | GO:0051279 | 84 | 2 | 18204 | 47 |
CACNA1C,RYR2 |
1.989e-02 | -3.92 | regulation of sodium ion transport | biological process | GO:0002028 | 84 | 2 | 18204 | 47 |
FGF14,SPTBN4 |
1.991e-02 | -3.92 | CH_dom_sf | interpro domains | IPR036872 | 82 | 2 | 18521 | 49 |
SPTBN4,SPTBN2 |
1.992e-02 | -3.92 | EF_hand_dom | interpro domains | IPR002048 | 218 | 3 | 18521 | 49 |
VSNL1,RYR2,CACNA1E |
2.004e-02 | -3.91 | axon guidance | biological process | GO:0007411 | 224 | 3 | 18204 | 47 |
L1CAM,EPHA6,NRXN3 |
2.004e-02 | -3.91 | neuron projection guidance | biological process | GO:0097485 | 224 | 3 | 18204 | 47 |
EPHA6,L1CAM,NRXN3 |
2.016e-02 | -3.90 | ConA-like_dom_sf | interpro domains | IPR013320 | 219 | 3 | 18521 | 49 |
NRXN2,RYR2,NRXN3 |
2.038e-02 | -3.89 | RASSF4 (Ras association domain family member 4) | protein interactions | 83937 | 8 | 1 | 19454 | 50 |
DLG4 |
2.038e-02 | -3.89 | PEX5L (peroxisomal biogenesis factor 5 like) | protein interactions | 51555 | 8 | 1 | 19454 | 50 |
HCN1 |
2.038e-02 | -3.89 | C18orf32 (chromosome 18 open reading frame 32) | protein interactions | 497661 | 8 | 1 | 19454 | 50 |
CACNA1C |
2.038e-02 | -3.89 | PKD1L1-AS1 (PKD1L1 antisense RNA 1) | protein interactions | 80099 | 8 | 1 | 19454 | 50 |
CACNA2D1 |
2.038e-02 | -3.89 | Bod1 (biorientation of chromosomes in cell division 1) | protein interactions | 69556 | 8 | 1 | 19454 | 50 |
SPTBN2 |
2.038e-02 | -3.89 | PRSS33 (serine protease 33) | protein interactions | 260429 | 8 | 1 | 19454 | 50 |
CACNA2D1 |
2.038e-02 | -3.89 | TAFA1 (TAFA chemokine like family member 1) | protein interactions | 407738 | 8 | 1 | 19454 | 50 |
NRXN3 |
2.038e-02 | -3.89 | ZNF441 (zinc finger protein 441) | protein interactions | 126068 | 8 | 1 | 19454 | 50 |
STX1A |
2.038e-02 | -3.89 | KRTAP23-1 (keratin associated protein 23-1) | protein interactions | 337963 | 8 | 1 | 19454 | 50 |
CAMK2A |
2.047e-02 | -3.89 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 6 | 16828 | 47 |
EPHA6,SPTBN4,SYT1,CAMK2B,CAMK2A,CAMKV |
2.047e-02 | -3.89 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 6 | 16828 | 47 |
CAMK2A,CAMKV,SPTBN4,CAMK2B,SYT1,EPHA6 |
2.047e-02 | -3.89 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 1 | 18204 | 47 |
NRG3 |
2.047e-02 | -3.89 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 47 |
CAMK2B |
2.047e-02 | -3.89 | positive regulation of vesicle fusion | biological process | GO:0031340 | 8 | 1 | 18204 | 47 |
SYT1 |
2.047e-02 | -3.89 | dense core granule transport | biological process | GO:1901950 | 8 | 1 | 18204 | 47 |
PPFIA2 |
2.047e-02 | -3.89 | positive regulation of neuron projection arborization | biological process | GO:0150012 | 8 | 1 | 18204 | 47 |
DLG4 |
2.047e-02 | -3.89 | dense core granule cytoskeletal transport | biological process | GO:0099519 | 8 | 1 | 18204 | 47 |
PPFIA2 |
2.047e-02 | -3.89 | neuron-neuron synaptic transmission | biological process | GO:0007270 | 8 | 1 | 18204 | 47 |
DLGAP2 |
2.075e-02 | -3.88 | clathrin-sculpted gamma-aminobutyric acid transport vesicle | cellular component | GO:0061200 | 8 | 1 | 19108 | 50 |
SYT1 |
2.075e-02 | -3.88 | presynaptic endocytic zone membrane | cellular component | GO:0098835 | 8 | 1 | 19108 | 50 |
DNM1 |
2.075e-02 | -3.88 | cell body fiber | cellular component | GO:0070852 | 8 | 1 | 19108 | 50 |
SPTBN4 |
2.075e-02 | -3.88 | clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane | cellular component | GO:0061202 | 8 | 1 | 19108 | 50 |
SYT1 |
2.075e-02 | -3.88 | paranodal junction | cellular component | GO:0033010 | 8 | 1 | 19108 | 50 |
SPTBN2 |
2.078e-02 | -3.87 | positive regulation of insulin secretion | biological process | GO:0032024 | 86 | 2 | 18204 | 47 |
VSNL1,SNAP25 |
2.086e-02 | -3.87 | Morphine Action Pathway | SMPDB pathways | SMP0000406 | 40 | 2 | 1369 | 8 |
CACNA1A,GRIN1 |
2.094e-02 | -3.87 | Syntaxin | pfam domains | PF00804 | 8 | 1 | 17795 | 47 |
STX1A |
2.094e-02 | -3.87 | VHP | pfam domains | PF02209 | 8 | 1 | 17795 | 47 |
ABLIM1 |
2.097e-02 | -3.86 | GPCR_3_mtglu_rcpt | interpro domains | IPR000162 | 8 | 1 | 18521 | 49 |
GRM5 |
2.097e-02 | -3.86 | Villin_headpiece_dom_sf | interpro domains | IPR036886 | 8 | 1 | 18521 | 49 |
ABLIM1 |
2.097e-02 | -3.86 | Villin_headpiece | interpro domains | IPR003128 | 8 | 1 | 18521 | 49 |
ABLIM1 |
2.103e-02 | -3.86 | PCNT (pericentrin) | protein interactions | 5116 | 229 | 3 | 19454 | 50 |
MYT1L,DNM1,SPTBN2 |
2.107e-02 | -3.86 | ZF_CCHHC | prosite domains | PS51802 | 7 | 1 | 12186 | 37 |
MYT1L |
2.124e-02 | -3.85 | regulation of protein depolymerization | biological process | GO:1901879 | 87 | 2 | 18204 | 47 |
SPTBN2,SPTBN4 |
2.124e-02 | -3.85 | associative learning | biological process | GO:0008306 | 87 | 2 | 18204 | 47 |
SNAP25,GRIN1 |
2.135e-02 | -3.85 | Cell adhesion molecules (CAMs) | KEGG pathways | ko04514 | 143 | 3 | 7161 | 30 |
NRXN3,L1CAM,NRXN2 |
2.135e-02 | -3.85 | Cell adhesion molecules (CAMs) | KEGG pathways | hsa04514 | 143 | 3 | 7161 | 30 |
L1CAM,NRXN2,NRXN3 |
2.146e-02 | -3.84 | CDC37 (cell division cycle 37, HSP90 cochaperone) | protein interactions | 11140 | 623 | 5 | 19454 | 50 |
EPHA6,CAMK2B,SPTBN4,CAMK2A,STX1A |
2.146e-02 | -3.84 | adenosine receptor binding | molecular function | GO:0031685 | 8 | 1 | 18094 | 49 |
GRM5 |
2.146e-02 | -3.84 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 49 |
SCN8A |
2.153e-02 | -3.84 | HSPG2 (heparan sulfate proteoglycan 2) | protein interactions | 3339 | 88 | 2 | 19454 | 50 |
CAMKV,CACNA1A |
2.153e-02 | -3.84 | BTN2A2 (butyrophilin subfamily 2 member A2) | protein interactions | 10385 | 88 | 2 | 19454 | 50 |
SYT1,STX1A |
2.175e-02 | -3.83 | phosphatidylinositol-4,5-bisphosphate binding | molecular function | GO:0005546 | 84 | 2 | 18094 | 49 |
SYT1,DNM1 |
2.197e-02 | -3.82 | receptor complex | cellular component | GO:0043235 | 409 | 4 | 19108 | 50 |
GRIN1,GABRB2,GRIN2B,DLG4 |
2.213e-02 | -3.81 | bone-knee-chondrosarcoma-synovial | COSMIC cancer mutations | bone-knee-chondrosarcoma-synovial | 8 | 1 | 16828 | 47 |
RYR2 |
2.213e-02 | -3.81 | synovial | COSMIC cancer mutations | synovial | 8 | 1 | 16828 | 47 |
RYR2 |
2.216e-02 | -3.81 | multicellular organismal response to stress | biological process | GO:0033555 | 89 | 2 | 18204 | 47 |
BRINP1,HCN1 |
2.216e-02 | -3.81 | multicellular organism growth | biological process | GO:0035264 | 89 | 2 | 18204 | 47 |
SPTBN2,SLC4A10 |
2.219e-02 | -3.81 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 11 | 16828 | 47 |
HCN1,LRRC7,MCF2L2,PPFIA3,GRM5,ABLIM1,SLC8A3,NRXN2,NRG3,CACNA2D1,GRIN2B |
2.240e-02 | -3.80 | ErbB Signaling Pathway | WikiPathways | WP673 | 54 | 2 | 5310 | 23 |
NRG3,CAMK2A |
2.246e-02 | -3.80 | TMEM60 (transmembrane protein 60) | protein interactions | 85025 | 90 | 2 | 19454 | 50 |
STX1A,SYT1 |
2.261e-02 | -3.79 | nodular | COSMIC cancer mutations | nodular | 1515 | 9 | 16828 | 47 |
SPTBN2,CELF5,HCN1,SPTBN4,SNAP25,PPFIA3,ABLIM1,DNM1,GRIN2B |
2.290e-02 | -3.78 | RDH8 (retinol dehydrogenase 8) | protein interactions | 50700 | 9 | 1 | 19454 | 50 |
CAMK2B |
2.290e-02 | -3.78 | Plk2 (polo like kinase 2) | protein interactions | 20620 | 9 | 1 | 19454 | 50 |
CACNA2D1 |
2.290e-02 | -3.78 | HYAL3 (hyaluronidase 3) | protein interactions | 8372 | 9 | 1 | 19454 | 50 |
CAMK2A |
2.290e-02 | -3.78 | PMFBP1 (polyamine modulated factor 1 binding protein 1) | protein interactions | 83449 | 9 | 1 | 19454 | 50 |
CAMK2A |
2.290e-02 | -3.78 | ZNF599 (zinc finger protein 599) | protein interactions | 148103 | 9 | 1 | 19454 | 50 |
CCDC136 |
2.290e-02 | -3.78 | MPND (MPN domain containing) | protein interactions | 84954 | 9 | 1 | 19454 | 50 |
DLG4 |
2.290e-02 | -3.78 | SOBP (sine oculis binding protein homolog) | protein interactions | 55084 | 9 | 1 | 19454 | 50 |
CELF3 |
2.292e-02 | -3.78 | MAP1A (microtubule associated protein 1A) | protein interactions | 4130 | 91 | 2 | 19454 | 50 |
DLG4,GRIN2B |
2.300e-02 | -3.77 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 47 |
RYR2 |
2.300e-02 | -3.77 | receptor diffusion trapping | biological process | GO:0098953 | 9 | 1 | 18204 | 47 |
DLG4 |
2.300e-02 | -3.77 | neurotransmitter receptor diffusion trapping | biological process | GO:0099628 | 9 | 1 | 18204 | 47 |
DLG4 |
2.300e-02 | -3.77 | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | biological process | GO:0007196 | 9 | 1 | 18204 | 47 |
GRM5 |
2.300e-02 | -3.77 | positive regulation of long-term neuronal synaptic plasticity | biological process | GO:0048170 | 9 | 1 | 18204 | 47 |
GRM5 |
2.300e-02 | -3.77 | spontaneous synaptic transmission | biological process | GO:0098814 | 9 | 1 | 18204 | 47 |
SYT1 |
2.300e-02 | -3.77 | postsynaptic neurotransmitter receptor diffusion trapping | biological process | GO:0098970 | 9 | 1 | 18204 | 47 |
DLG4 |
2.300e-02 | -3.77 | SA node cell to atrial cardiac muscle cell communication | biological process | GO:0086070 | 9 | 1 | 18204 | 47 |
CACNA1G |
2.300e-02 | -3.77 | positive regulation of synapse maturation | biological process | GO:0090129 | 9 | 1 | 18204 | 47 |
CAMK2B |
2.315e-02 | -3.77 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 2 | 14470 | 48 |
MCF2L2,RASGRF1 |
2.331e-02 | -3.76 | presynaptic endocytic zone | cellular component | GO:0098833 | 9 | 1 | 19108 | 50 |
DNM1 |
2.331e-02 | -3.76 | chromaffin granule membrane | cellular component | GO:0042584 | 9 | 1 | 19108 | 50 |
SYT1 |
2.331e-02 | -3.76 | photoreceptor ribbon synapse | cellular component | GO:0098684 | 9 | 1 | 19108 | 50 |
DNM1 |
2.331e-02 | -3.76 | spectrin-associated cytoskeleton | cellular component | GO:0014731 | 9 | 1 | 19108 | 50 |
SPTBN2 |
2.331e-02 | -3.76 | junctional sarcoplasmic reticulum membrane | cellular component | GO:0014701 | 9 | 1 | 19108 | 50 |
RYR2 |
2.332e-02 | -3.76 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 47 |
MYT1L,PCLO,CAMK2B,GRIN2B,CACNA1E |
2.333e-02 | -3.76 | small molecule binding | molecular function | GO:0036094 | 6197 | 24 | 18094 | 49 |
CACNA1A,CACNA2D1,CACNA1E,DNM1,MYT1L,VSNL1,NRXN3,EPHA6,HCN1,GRIN1,ABLIM1,PCLO,SCN8A,RYR2,SLC8A3,EDIL3,NRXN2,CAMKV,CACNA1C,CAMK2A,RIMS1,GRIN2B,CAMK2B,SYT1 |
2.339e-02 | -3.76 | RLN1 (relaxin 1) | protein interactions | 6013 | 92 | 2 | 19454 | 50 |
CACNA2D1,EPHA6 |
2.339e-02 | -3.76 | KDM5B (lysine demethylase 5B) | protein interactions | 10765 | 92 | 2 | 19454 | 50 |
GRIN2B,CACNA1A |
2.353e-02 | -3.75 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 47 |
SLC4A10 |
2.353e-02 | -3.75 | Na_Ca_ex | pfam domains | PF01699 | 9 | 1 | 17795 | 47 |
SLC8A3 |
2.353e-02 | -3.75 | Calx-beta | pfam domains | PF03160 | 9 | 1 | 17795 | 47 |
SLC8A3 |
2.357e-02 | -3.75 | CalX-like_sf | interpro domains | IPR038081 | 9 | 1 | 18521 | 49 |
SLC8A3 |
2.357e-02 | -3.75 | NaCa_Exmemb | interpro domains | IPR004837 | 9 | 1 | 18521 | 49 |
SLC8A3 |
2.357e-02 | -3.75 | Calx_beta | interpro domains | IPR003644 | 9 | 1 | 18521 | 49 |
SLC8A3 |
2.357e-02 | -3.75 | NCX_ion-bd_dom_sf | interpro domains | IPR044880 | 9 | 1 | 18521 | 49 |
SLC8A3 |
2.357e-02 | -3.75 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 49 |
SLC4A10 |
2.357e-02 | -3.75 | positive regulation of transporter activity | biological process | GO:0032411 | 92 | 2 | 18204 | 47 |
RYR2,CACNA2D1 |
2.378e-02 | -3.74 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 3 | 18094 | 49 |
IQSEC2,RASGRF1,MCF2L2 |
2.384e-02 | -3.74 | DISC1 (DISC1 scaffold protein) | protein interactions | 27185 | 427 | 4 | 19454 | 50 |
PPFIA3,SPTBN4,MYT1L,CCDC136 |
2.404e-02 | -3.73 | HP | prosite domains | PS51089 | 8 | 1 | 12186 | 37 |
ABLIM1 |
2.412e-02 | -3.72 | G protein-coupled glutamate receptor activity | molecular function | GO:0098988 | 9 | 1 | 18094 | 49 |
GRM5 |
2.412e-02 | -3.72 | 7SK snRNA binding | molecular function | GO:0097322 | 9 | 1 | 18094 | 49 |
CELF3 |
2.412e-02 | -3.72 | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | molecular function | GO:0001640 | 9 | 1 | 18094 | 49 |
GRM5 |
2.412e-02 | -3.72 | intracellularly cAMP-activated cation channel activity | molecular function | GO:0005222 | 9 | 1 | 18094 | 49 |
HCN1 |
2.412e-02 | -3.72 | calcium-dependent protein serine/threonine kinase activity | molecular function | GO:0009931 | 9 | 1 | 18094 | 49 |
CAMK2B |
2.427e-02 | -3.72 | intracellular monoatomic cation homeostasis | biological process | GO:0030003 | 428 | 4 | 18204 | 47 |
GRM5,SLC4A10,SLC8A3,RYR2 |
2.429e-02 | -3.72 | stomach | COSMIC cancer mutations | stomach | 15550 | 47 | 16828 | 47 |
GRIN2B,NRG3,VSNL1,GRM5,CACNA1E,RYR2,NRXN3,RIMS1,CACNA1A,PCLO,RASGRF1,DLGAP2,CELF5,CACNA1G,ABLIM1,SPTBN4,CAMKV,PPFIA3,CPLX1,CAMK2B,SLC4A10,CACNA1C,EDIL3,SPTBN2,CELF3,SLC8A3,CCDC136,SYT1,L1CAM,CACNA2D1,DLG4,GRIN1,MCF2L2,GABRB2,LRRC7,STX1A,CAMK2A,EPHA6,FGF14,IQSEC2,PPFIA2,NRXN2,SNAP25,HCN1,MYT1L,DNM1,SCN8A |
2.435e-02 | -3.72 | ZNF785 (zinc finger protein 785) | protein interactions | 146540 | 94 | 2 | 19454 | 50 |
STX1A,CCDC136 |
2.445e-02 | -3.71 | GED | smart domains | SM00302 | 6 | 1 | 9717 | 40 |
DNM1 |
2.461e-02 | -3.70 | myofibril | cellular component | GO:0030016 | 239 | 3 | 19108 | 50 |
CACNA1C,SCN8A,RYR2 |
2.492e-02 | -3.69 | NrCAM interactions | REACTOME pathways | R-HSA-447038 | 7 | 1 | 10285 | 37 |
DLG4 |
2.497e-02 | -3.69 | Alzheimers Disease | WikiPathways | WP2059 | 148 | 3 | 5310 | 23 |
GRIN2B,CACNA1C,GRIN1 |
2.500e-02 | -3.69 | IFN-gamma pathway | Pathway Interaction DB | ifngpathway | 40 | 2 | 2226 | 14 |
CAMK2B,CAMK2A |
2.501e-02 | -3.69 | CH | prosite domains | PS50021 | 81 | 2 | 12186 | 37 |
SPTBN2,SPTBN4 |
2.505e-02 | -3.69 | ITSN1 (intersectin 1) | protein interactions | 6453 | 245 | 3 | 19454 | 50 |
SNAP25,DNM1,PPFIA2 |
2.519e-02 | -3.68 | regulation of protein transport | biological process | GO:0051223 | 433 | 4 | 18204 | 47 |
SNAP25,STX1A,VSNL1,CPLX1 |
2.519e-02 | -3.68 | inorganic ion homeostasis | biological process | GO:0098771 | 433 | 4 | 18204 | 47 |
GRM5,SLC8A3,RYR2,GRIN1 |
2.525e-02 | -3.68 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 8 | 16828 | 47 |
ABLIM1,PPFIA3,GRIN2B,SPTBN2,SPTBN4,SNAP25,CELF5,HCN1 |
2.532e-02 | -3.68 | CAST (calpastatin) | protein interactions | 831 | 96 | 2 | 19454 | 50 |
PPFIA2,PPFIA3 |
2.532e-02 | -3.68 | VAMP8 (vesicle associated membrane protein 8) | protein interactions | 8673 | 96 | 2 | 19454 | 50 |
STX1A,SNAP25 |
2.541e-02 | -3.67 | ALKAL2 (ALK and LTK ligand 2) | protein interactions | 285016 | 10 | 1 | 19454 | 50 |
CACNA2D1 |
2.541e-02 | -3.67 | Eps15 (epidermal growth factor receptor pathway substrate 15) | protein interactions | 13858 | 10 | 1 | 19454 | 50 |
DNM1 |
2.541e-02 | -3.67 | SCN8A (sodium voltage-gated channel alpha subunit 8) | protein interactions | 6334 | 10 | 1 | 19454 | 50 |
FGF14 |
2.541e-02 | -3.67 | RAB37 (RAB37, member RAS oncogene family) | protein interactions | 326624 | 10 | 1 | 19454 | 50 |
RIMS1 |
2.541e-02 | -3.67 | SLC8A2 (solute carrier family 8 member A2) | protein interactions | 6543 | 10 | 1 | 19454 | 50 |
SLC8A3 |
2.541e-02 | -3.67 | SDHAF1 (succinate dehydrogenase complex assembly factor 1) | protein interactions | 644096 | 10 | 1 | 19454 | 50 |
CCDC136 |
2.541e-02 | -3.67 | ASIC3 (acid sensing ion channel subunit 3) | protein interactions | 9311 | 10 | 1 | 19454 | 50 |
DLG4 |
2.541e-02 | -3.67 | Vbp1 (von Hippel-Lindau binding protein 1) | protein interactions | 22327 | 10 | 1 | 19454 | 50 |
ABLIM1 |
2.543e-02 | -3.67 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 7 | 18204 | 47 |
RYR2,HCN1,GABRB2,GRIN1,CACNA2D1,CACNA1A,CAMK2A |
2.550e-02 | -3.67 | astrocytoma_Grade_II | COSMIC cancer mutations | astrocytoma_Grade_II | 601 | 5 | 16828 | 47 |
CACNA2D1,CACNA1C,CACNA1G,DLGAP2,SPTBN4 |
2.551e-02 | -3.67 | vesicle fusion | biological process | GO:0006906 | 96 | 2 | 18204 | 47 |
STX1A,SNAP25 |
2.551e-02 | -3.67 | CCDC8 (coiled-coil domain containing 8) | protein interactions | 83987 | 652 | 5 | 19454 | 50 |
CACNA2D1,ABLIM1,IQSEC2,SPTBN2,EDIL3 |
2.553e-02 | -3.67 | trans-synaptic signaling, modulating synaptic transmission | biological process | GO:0099550 | 10 | 1 | 18204 | 47 |
GRM5 |
2.553e-02 | -3.67 | response to histamine | biological process | GO:0034776 | 10 | 1 | 18204 | 47 |
GABRB2 |
2.553e-02 | -3.67 | neurotransmitter receptor transport, endosome to postsynaptic membrane | biological process | GO:0098887 | 10 | 1 | 18204 | 47 |
LRRC7 |
2.553e-02 | -3.67 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 47 |
RYR2 |
2.553e-02 | -3.67 | regulation of atrial cardiac muscle cell membrane depolarization | biological process | GO:0060371 | 10 | 1 | 18204 | 47 |
CACNA1G |
2.553e-02 | -3.67 | regulation of modification of postsynaptic structure | biological process | GO:0099159 | 10 | 1 | 18204 | 47 |
CAMKV |
2.553e-02 | -3.67 | synaptic vesicle budding from presynaptic endocytic zone membrane | biological process | GO:0016185 | 10 | 1 | 18204 | 47 |
DNM1 |
2.553e-02 | -3.67 | substrate-independent telencephalic tangential migration | biological process | GO:0021826 | 10 | 1 | 18204 | 47 |
NRG3 |
2.553e-02 | -3.67 | learned vocalization behavior or vocal learning | biological process | GO:0098598 | 10 | 1 | 18204 | 47 |
NRXN2 |
2.553e-02 | -3.67 | substrate-independent telencephalic tangential interneuron migration | biological process | GO:0021843 | 10 | 1 | 18204 | 47 |
NRG3 |
2.553e-02 | -3.67 | neurotransmitter receptor transport, endosome to plasma membrane | biological process | GO:0099639 | 10 | 1 | 18204 | 47 |
LRRC7 |
2.553e-02 | -3.67 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 1 | 18204 | 47 |
NRXN2 |
2.553e-02 | -3.67 | regulation of high voltage-gated calcium channel activity | biological process | GO:1901841 | 10 | 1 | 18204 | 47 |
CACNA2D1 |
2.553e-02 | -3.67 | regulation of postsynaptic cytosolic calcium ion concentration | biological process | GO:0099566 | 10 | 1 | 18204 | 47 |
GRM5 |
2.553e-02 | -3.67 | postsynaptic density assembly | biological process | GO:0097107 | 10 | 1 | 18204 | 47 |
NRXN2 |
2.553e-02 | -3.67 | regulation of voltage-gated sodium channel activity | biological process | GO:1905150 | 10 | 1 | 18204 | 47 |
FGF14 |
2.555e-02 | -3.67 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 3 | 18204 | 47 |
GRM5,L1CAM,CAMK2B |
2.568e-02 | -3.66 | SPTAN1 (spectrin alpha, non-erythrocytic 1) | protein interactions | 6709 | 437 | 4 | 19454 | 50 |
GRIN1,GRIN2B,SPTBN4,SPTBN2 |
2.581e-02 | -3.66 | LIN7C (lin-7 homolog C, crumbs cell polarity complex component) | protein interactions | 55327 | 97 | 2 | 19454 | 50 |
ABLIM1,DLG4 |
2.583e-02 | -3.66 | abdomen | COSMIC cancer mutations | abdomen | 603 | 5 | 16828 | 47 |
RIMS1,EPHA6,NRXN3,SNAP25,SPTBN4 |
2.587e-02 | -3.65 | postsynaptic cytoskeleton | cellular component | GO:0099571 | 10 | 1 | 19108 | 50 |
SPTBN2 |
2.587e-02 | -3.65 | neurofilament | cellular component | GO:0005883 | 10 | 1 | 19108 | 50 |
DLGAP2 |
2.594e-02 | -3.65 | skin-abdomen-malignant_melanoma | COSMIC cancer mutations | skin-abdomen-malignant_melanoma | 404 | 4 | 16828 | 47 |
NRXN3,SPTBN4,SNAP25,EPHA6 |
2.594e-02 | -3.65 | intracellular monoatomic ion homeostasis | biological process | GO:0006873 | 437 | 4 | 18204 | 47 |
GRM5,SLC8A3,RYR2,SLC4A10 |
2.600e-02 | -3.65 | nerve development | biological process | GO:0021675 | 97 | 2 | 18204 | 47 |
SCN8A,GABRB2 |
2.611e-02 | -3.65 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 47 |
RYR2 |
2.611e-02 | -3.65 | Na_trans_assoc | pfam domains | PF06512 | 10 | 1 | 17795 | 47 |
SCN8A |
2.611e-02 | -3.65 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 47 |
SLC4A10 |
2.615e-02 | -3.64 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 49 |
SLC4A10 |
2.615e-02 | -3.64 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 49 |
RYR2 |
2.615e-02 | -3.64 | Na_trans_assoc_dom | interpro domains | IPR010526 | 10 | 1 | 18521 | 49 |
SCN8A |
2.615e-02 | -3.64 | Na_chnl_inactivation_gate | interpro domains | IPR044564 | 10 | 1 | 18521 | 49 |
SCN8A |
2.615e-02 | -3.64 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 49 |
RYR2 |
2.615e-02 | -3.64 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 49 |
SLC4A10 |
2.615e-02 | -3.64 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 49 |
SLC4A10 |
2.615e-02 | -3.64 | Na_channel_asu | interpro domains | IPR001696 | 10 | 1 | 18521 | 49 |
SCN8A |
2.619e-02 | -3.64 | EGF-type_Asp/Asn_hydroxyl_site | interpro domains | IPR000152 | 95 | 2 | 18521 | 49 |
EDIL3,NRXN3 |
2.624e-02 | -3.64 | Guanylate Kinase phosphate binding domain | gene3d domains | 3.30.63.10 | 8 | 1 | 14470 | 48 |
DLG4 |
2.624e-02 | -3.64 | Villin headpiece domain | gene3d domains | 1.10.950.10 | 8 | 1 | 14470 | 48 |
ABLIM1 |
2.631e-02 | -3.64 | PTK2B (protein tyrosine kinase 2 beta) | protein interactions | 2185 | 98 | 2 | 19454 | 50 |
DLG4,DNM1 |
2.631e-02 | -3.64 | GNAO1 (G protein subunit alpha o1) | protein interactions | 2775 | 98 | 2 | 19454 | 50 |
SCN8A,CAMK2A |
2.631e-02 | -3.64 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 47 |
PCLO,MYT1L,GRIN2B,CACNA1E,CAMK2B |
2.646e-02 | -3.63 | human chr9q33.1 | chromosome location | human chr9q33.1 | 14 | 1 | 26134 | 50 |
BRINP1 |
2.649e-02 | -3.63 | DYNAMIN | prints domains | PR00195 | 7 | 1 | 5227 | 20 |
DNM1 |
2.650e-02 | -3.63 | organelle membrane fusion | biological process | GO:0090174 | 98 | 2 | 18204 | 47 |
SNAP25,STX1A |
2.662e-02 | -3.63 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 6 | 18204 | 47 |
CAMK2B,RIMS1,SYT1,PPFIA2,L1CAM,DLG4 |
2.676e-02 | -3.62 | calcium:sodium antiporter activity | molecular function | GO:0005432 | 10 | 1 | 18094 | 49 |
SLC8A3 |
2.676e-02 | -3.62 | calcium-dependent protein kinase activity | molecular function | GO:0010857 | 10 | 1 | 18094 | 49 |
CAMK2B |
2.676e-02 | -3.62 | profilin binding | molecular function | GO:0005522 | 10 | 1 | 18094 | 49 |
PCLO |
2.680e-02 | -3.62 | EFNA1 (ephrin A1) | protein interactions | 1942 | 99 | 2 | 19454 | 50 |
VSNL1,EPHA6 |
2.688e-02 | -3.62 | Neuroactive ligand-receptor interaction | KEGG pathways | hsa04080 | 276 | 4 | 7161 | 30 |
GRIN1,GABRB2,GRIN2B,GRM5 |
2.688e-02 | -3.62 | Neuroactive ligand-receptor interaction | KEGG pathways | ko04080 | 276 | 4 | 7161 | 30 |
GRIN2B,GRM5,GABRB2,GRIN1 |
2.691e-02 | -3.62 | Immune System | REACTOME pathways | R-HSA-168256 | 2101 | 13 | 10285 | 37 |
CAMK2A,GRIN2B,STX1A,DNM1,RASGRF1,LRRC7,SPTBN2,SPTBN4,NRG3,GRIN1,SNAP25,CAMK2B,DLG4 |
2.701e-02 | -3.61 | regulation of signaling receptor activity | biological process | GO:0010469 | 99 | 2 | 18204 | 47 |
DLGAP2,DLG4 |
2.701e-02 | -3.61 | G_PROTEIN_RECEP_F3_1 | prosite domains | PS00979 | 9 | 1 | 12186 | 37 |
GRM5 |
2.701e-02 | -3.61 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 47 |
PCLO,DLG4,MCF2L2,RIMS1,CACNA1A,RYR2,CACNA1E,SPTBN4,MYT1L,NRXN2,PPFIA2,DLGAP2,EPHA6 |
2.701e-02 | -3.61 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 47 |
PPFIA2,NRXN2,DLGAP2,EPHA6,CACNA1A,RIMS1,MCF2L2,DLG4,PCLO,SPTBN4,CACNA1E,RYR2,MYT1L |
2.712e-02 | -3.61 | EF-hand_7 | pfam domains | PF13499 | 97 | 2 | 17795 | 47 |
RYR2,VSNL1 |
2.715e-02 | -3.61 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 19 | 16828 | 47 |
L1CAM,RYR2,CAMKV,CACNA1E,SYT1,PCLO,PPFIA3,RASGRF1,MCF2L2,DNM1,EPHA6,SLC4A10,EDIL3,CAMK2A,CAMK2B,NRXN2,GRIN2B,IQSEC2,PPFIA2 |
2.721e-02 | -3.60 | STX5 (syntaxin 5) | protein interactions | 6811 | 253 | 3 | 19454 | 50 |
STX1A,SNAP25,TMEM266 |
2.734e-02 | -3.60 | contractile muscle fiber | cellular component | GO:0043292 | 249 | 3 | 19108 | 50 |
CACNA1C,RYR2,SCN8A |
2.781e-02 | -3.58 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 46 | 16828 | 47 |
SLC8A3,CCDC136,CPLX1,CAMK2B,SLC4A10,EDIL3,CACNA1C,SPTBN2,CELF3,CACNA2D1,DLG4,MCF2L2,GRIN1,SYT1,L1CAM,IQSEC2,FGF14,PPFIA2,NRXN2,LRRC7,GABRB2,STX1A,CAMK2A,EPHA6,SCN8A,SNAP25,HCN1,MYT1L,GRIN2B,NRG3,VSNL1,GRM5,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,CACNA1E,RYR2,CACNA1G,ABLIM1,DLGAP2,CELF5,PPFIA3,SPTBN4,CAMKV |
2.783e-02 | -3.58 | myelofibrosis | COSMIC cancer mutations | myelofibrosis | 413 | 4 | 16828 | 47 |
MCF2L2,RIMS1,GRIN2B,CACNA1E |
2.783e-02 | -3.58 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | 413 | 4 | 16828 | 47 |
GRIN2B,CACNA1E,RIMS1,MCF2L2 |
2.792e-02 | -3.58 | SV2C (synaptic vesicle glycoprotein 2C) | protein interactions | 22987 | 11 | 1 | 19454 | 50 |
SYT1 |
2.792e-02 | -3.58 | CELF3 (CUGBP Elav-like family member 3) | protein interactions | 11189 | 11 | 1 | 19454 | 50 |
CELF5 |
2.792e-02 | -3.58 | PLA2G5 (phospholipase A2 group V) | protein interactions | 5322 | 11 | 1 | 19454 | 50 |
CACNA2D1 |
2.792e-02 | -3.58 | ZNF230 (zinc finger protein 230) | protein interactions | 7773 | 11 | 1 | 19454 | 50 |
CCDC136 |
2.792e-02 | -3.58 | RIMS3 (regulating synaptic membrane exocytosis 3) | protein interactions | 9783 | 11 | 1 | 19454 | 50 |
RIMS1 |
2.792e-02 | -3.58 | PIP5K1P1 (phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 1) | protein interactions | 206426 | 11 | 1 | 19454 | 50 |
NRXN3 |
2.792e-02 | -3.58 | Katna1 (katanin p60 (ATPase-containing) subunit A1) | protein interactions | 23924 | 11 | 1 | 19454 | 50 |
RIMS1 |
2.792e-02 | -3.58 | Fcho2 (FCH domain only 2) | protein interactions | 218503 | 11 | 1 | 19454 | 50 |
DNM1 |
2.792e-02 | -3.58 | DUS4L (dihydrouridine synthase 4 like) | protein interactions | 11062 | 11 | 1 | 19454 | 50 |
CAMK2B |
2.795e-02 | -3.58 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 49 |
DNM1,SPTBN4,SPTBN2,SNAP25,SYT1,PCLO |
2.804e-02 | -3.57 | ectodermal placode formation | biological process | GO:0060788 | 11 | 1 | 18204 | 47 |
NRG3 |
2.804e-02 | -3.57 | negative regulation of neuron migration | biological process | GO:2001223 | 11 | 1 | 18204 | 47 |
NRG3 |
2.804e-02 | -3.57 | short-term memory | biological process | GO:0007614 | 11 | 1 | 18204 | 47 |
BRINP1 |
2.804e-02 | -3.57 | synaptic vesicle budding | biological process | GO:0070142 | 11 | 1 | 18204 | 47 |
DNM1 |
2.804e-02 | -3.57 | cellular response to epinephrine stimulus | biological process | GO:0071872 | 11 | 1 | 18204 | 47 |
RYR2 |
2.804e-02 | -3.57 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 47 |
SLC4A10 |
2.804e-02 | -3.57 | retinal cone cell development | biological process | GO:0046549 | 11 | 1 | 18204 | 47 |
HCN1 |
2.804e-02 | -3.57 | ectodermal placode morphogenesis | biological process | GO:0071697 | 11 | 1 | 18204 | 47 |
NRG3 |
2.804e-02 | -3.57 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 47 |
RYR2 |
2.804e-02 | -3.57 | regulation of membrane repolarization during action potential | biological process | GO:0098903 | 11 | 1 | 18204 | 47 |
CACNA2D1 |
2.804e-02 | -3.57 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0098696 | 11 | 1 | 18204 | 47 |
IQSEC2 |
2.804e-02 | -3.57 | synaptic vesicle clustering | biological process | GO:0097091 | 11 | 1 | 18204 | 47 |
PCLO |
2.822e-02 | -3.57 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 2 | 19108 | 50 |
DLG4,SNAP25 |
2.823e-02 | -3.57 | - | gene3d domains | 2.80.10.50 | 79 | 2 | 14470 | 48 |
RYR2,FGF14 |
2.823e-02 | -3.57 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 2 | 14470 | 48 |
SPTBN4,SPTBN2 |
2.832e-02 | -3.56 | human chr12q21.2 | chromosome location | human chr12q21.2 | 15 | 1 | 26134 | 50 |
SYT1 |
2.832e-02 | -3.56 | KRTAP6-1 (keratin associated protein 6-1) | protein interactions | 337966 | 102 | 2 | 19454 | 50 |
CELF5,CAMK2A |
2.832e-02 | -3.56 | PATJ (PATJ crumbs cell polarity complex component) | protein interactions | 10207 | 102 | 2 | 19454 | 50 |
GRIN2B,NRXN2 |
2.842e-02 | -3.56 | microvesicle | cellular component | GO:1990742 | 11 | 1 | 19108 | 50 |
PPFIA3 |
2.847e-02 | -3.56 | DYNc | smart domains | SM00053 | 7 | 1 | 9717 | 40 |
DNM1 |
2.858e-02 | -3.55 | regulation of hormone secretion | biological process | GO:0046883 | 257 | 3 | 18204 | 47 |
VSNL1,STX1A,SNAP25 |
2.868e-02 | -3.55 | MACPF | pfam domains | PF01823 | 11 | 1 | 17795 | 47 |
BRINP1 |
2.873e-02 | -3.55 | Syntaxin_N | interpro domains | IPR006011 | 11 | 1 | 18521 | 49 |
STX1A |
2.884e-02 | -3.55 | CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) | protein interactions | 55454 | 103 | 2 | 19454 | 50 |
SLC8A3,SYT1 |
2.884e-02 | -3.55 | C1orf94 (chromosome 1 open reading frame 94) | protein interactions | 84970 | 103 | 2 | 19454 | 50 |
CAMK2A,RIMS1 |
2.892e-02 | -3.54 | Gliclazide Action Pathway | SMPDB pathways | SMP0000461 | 5 | 1 | 1369 | 8 |
CACNA1A |
2.892e-02 | -3.54 | Repaglinide Action Pathway | SMPDB pathways | SMP0000454 | 5 | 1 | 1369 | 8 |
CACNA1A |
2.892e-02 | -3.54 | Pancreas Function | SMPDB pathways | SMP0000643 | 5 | 1 | 1369 | 8 |
CACNA1A |
2.892e-02 | -3.54 | Nateglinide Action Pathway | SMPDB pathways | SMP0000453 | 5 | 1 | 1369 | 8 |
CACNA1A |
2.892e-02 | -3.54 | Glibenclamide Action Pathway | SMPDB pathways | SMP0000460 | 5 | 1 | 1369 | 8 |
CACNA1A |
2.899e-02 | -3.54 | MECP2 and Associated Rett Syndrome | WikiPathways | WP3584 | 62 | 2 | 5310 | 23 |
CAMK2A,GRIN1 |
2.913e-02 | -3.54 | Glioma | KEGG pathways | hsa05214 | 64 | 2 | 7161 | 30 |
CAMK2A,CAMK2B |
2.913e-02 | -3.54 | Glioma | KEGG pathways | ko05214 | 64 | 2 | 7161 | 30 |
CAMK2B,CAMK2A |
2.913e-02 | -3.54 | bone-femur-chondrosarcoma | COSMIC cancer mutations | bone-femur-chondrosarcoma | 419 | 4 | 16828 | 47 |
HCN1,CACNA1E,DLGAP2,LRRC7 |
2.936e-02 | -3.53 | RRP7A (ribosomal RNA processing 7 homolog A) | protein interactions | 27341 | 104 | 2 | 19454 | 50 |
SYT1,CAMK2A |
2.936e-02 | -3.53 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 2 | 19454 | 50 |
VSNL1,ABLIM1 |
2.940e-02 | -3.53 | axon guidance receptor activity | molecular function | GO:0008046 | 11 | 1 | 18094 | 49 |
L1CAM |
2.940e-02 | -3.53 | cyclic nucleotide-activated monoatomic ion channel activity | molecular function | GO:0043855 | 11 | 1 | 18094 | 49 |
HCN1 |
2.940e-02 | -3.53 | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | molecular function | GO:0005221 | 11 | 1 | 18094 | 49 |
HCN1 |
2.940e-02 | -3.53 | acetylcholine receptor binding | molecular function | GO:0033130 | 11 | 1 | 18094 | 49 |
DLG4 |
2.947e-02 | -3.52 | NCX, central ion-binding region | gene3d domains | 1.20.1420.30 | 9 | 1 | 14470 | 48 |
SLC8A3 |
2.947e-02 | -3.52 | - | gene3d domains | 2.60.40.2030 | 9 | 1 | 14470 | 48 |
SLC8A3 |
2.950e-02 | -3.52 | voltage-gated potassium channel activity | molecular function | GO:0005249 | 99 | 2 | 18094 | 49 |
SNAP25,HCN1 |
2.952e-02 | -3.52 | anchoring junction | cellular component | GO:0070161 | 902 | 6 | 19108 | 50 |
SPTBN2,LRRC7,SLC8A3,SPTBN4,L1CAM,DLG4 |
2.958e-02 | -3.52 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 3 | 5310 | 23 |
RYR2,CAMK2A,CAMK2B |
2.962e-02 | -3.52 | actin binding | molecular function | GO:0003779 | 434 | 4 | 18094 | 49 |
SPTBN4,SPTBN2,ABLIM1,CAMK2B |
2.964e-02 | -3.52 | basolateral plasma membrane | cellular component | GO:0016323 | 257 | 3 | 19108 | 50 |
SLC4A10,LRRC7,DLG4 |
2.985e-02 | -3.51 | large_cell_carcinoma | COSMIC cancer mutations | large_cell_carcinoma | 849 | 6 | 16828 | 47 |
NRXN3,EPHA6,CAMK2A,CAMKV,CAMK2B,SYT1 |
2.985e-02 | -3.51 | lung-carcinoma-large_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-large_cell_carcinoma | 849 | 6 | 16828 | 47 |
NRXN3,CAMKV,CAMK2A,CAMK2B,SYT1,EPHA6 |
2.988e-02 | -3.51 | CEP72 (centrosomal protein 72) | protein interactions | 55722 | 105 | 2 | 19454 | 50 |
PCLO,SLC4A10 |
2.996e-02 | -3.51 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 37 |
RYR2 |
3.003e-02 | -3.51 | CH | smart domains | SM00033 | 66 | 2 | 9717 | 40 |
SPTBN4,SPTBN2 |
3.005e-02 | -3.50 | amino acid transmembrane transporter activity | molecular function | GO:0015171 | 100 | 2 | 18094 | 49 |
GRIN2B,GRIN1 |
3.018e-02 | -3.50 | human chr20p12.2 | chromosome location | human chr20p12.2 | 16 | 1 | 26134 | 50 |
SNAP25 |
3.022e-02 | -3.50 | MTABOTROPICR | prints domains | PR00593 | 8 | 1 | 5227 | 20 |
GRM5 |
3.025e-02 | -3.50 | oesophagus-upper_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-upper_third-carcinoma-squamous_cell_carcinoma | 629 | 5 | 16828 | 47 |
PCLO,RYR2,SLC4A10,LRRC7,CACNA1E |
3.025e-02 | -3.50 | upper_third | COSMIC cancer mutations | upper_third | 629 | 5 | 16828 | 47 |
CACNA1E,LRRC7,RYR2,SLC4A10,PCLO |
3.040e-02 | -3.49 | CWC22 (CWC22 spliceosome associated protein homolog) | protein interactions | 57703 | 106 | 2 | 19454 | 50 |
SYT1,CAMKV |
3.042e-02 | -3.49 | ZNF843 (zinc finger protein 843) | protein interactions | 283933 | 12 | 1 | 19454 | 50 |
CAMK2B |
3.042e-02 | -3.49 | MATN3 (matrilin 3) | protein interactions | 4148 | 12 | 1 | 19454 | 50 |
EDIL3 |
3.042e-02 | -3.49 | PDC (phosducin) | protein interactions | 5132 | 12 | 1 | 19454 | 50 |
CAMK2A |
3.042e-02 | -3.49 | VSTM4 (V-set and transmembrane domain containing 4) | protein interactions | 196740 | 12 | 1 | 19454 | 50 |
STX1A |
3.042e-02 | -3.49 | MATCAP2 (microtubule associated tyrosine carboxypeptidase 2) | protein interactions | 23366 | 12 | 1 | 19454 | 50 |
CAMK2A |
3.048e-02 | -3.49 | protein-containing complex | cellular component | GO:0032991 | 6542 | 24 | 19108 | 50 |
GABRB2,CELF3,CPLX1,HCN1,CACNA1G,CACNA1C,DLG4,NRXN2,SPTBN4,CACNA1E,CAMK2A,SCN8A,CACNA1A,SPTBN2,SNAP25,CELF5,RYR2,CAMK2B,DNM1,GRIN1,GRIN2B,CACNA2D1,STX1A,MYT1L |
3.056e-02 | -3.49 | negative regulation of heart rate | biological process | GO:0010459 | 12 | 1 | 18204 | 47 |
SPTBN4 |
3.056e-02 | -3.49 | maternal behavior | biological process | GO:0042711 | 12 | 1 | 18204 | 47 |
BRINP1 |
3.056e-02 | -3.49 | neuronal ion channel clustering | biological process | GO:0045161 | 12 | 1 | 18204 | 47 |
SPTBN4 |
3.056e-02 | -3.49 | SNARE complex assembly | biological process | GO:0035493 | 12 | 1 | 18204 | 47 |
SNAP25 |
3.056e-02 | -3.49 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 47 |
NRXN2 |
3.056e-02 | -3.49 | sinoatrial node development | biological process | GO:0003163 | 12 | 1 | 18204 | 47 |
CACNA1G |
3.056e-02 | -3.49 | neurotransmitter-gated ion channel clustering | biological process | GO:0072578 | 12 | 1 | 18204 | 47 |
DLG4 |
3.091e-02 | -3.48 | regulation of protein secretion | biological process | GO:0050708 | 265 | 3 | 18204 | 47 |
STX1A,SNAP25,VSNL1 |
3.093e-02 | -3.48 | Alzheimer's disease | KEGG pathways | hsa05010 | 165 | 3 | 7161 | 30 |
GRIN1,GRIN2B,CACNA1C |
3.093e-02 | -3.48 | Alzheimer's disease | KEGG pathways | ko05010 | 165 | 3 | 7161 | 30 |
CACNA1C,GRIN1,GRIN2B |
3.093e-02 | -3.48 | APLP2 (amyloid beta precursor like protein 2) | protein interactions | 334 | 107 | 2 | 19454 | 50 |
GRIN2B,GRIN1 |
3.096e-02 | -3.48 | paranode region of axon | cellular component | GO:0033270 | 12 | 1 | 19108 | 50 |
SPTBN4 |
3.096e-02 | -3.48 | clathrin-sculpted vesicle | cellular component | GO:0060198 | 12 | 1 | 19108 | 50 |
SYT1 |
3.130e-02 | -3.46 | MACPF | interpro domains | IPR020864 | 12 | 1 | 18521 | 49 |
BRINP1 |
3.130e-02 | -3.46 | Rab_BD | interpro domains | IPR010911 | 12 | 1 | 18521 | 49 |
RIMS1 |
3.130e-02 | -3.46 | K_chnl_volt-dep_EAG/ELK/ERG | interpro domains | IPR003938 | 12 | 1 | 18521 | 49 |
HCN1 |
3.148e-02 | -3.46 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 18 | 16828 | 47 |
RIMS1,CACNA1A,DLG4,MCF2L2,PCLO,SPTBN4,CACNA1E,HCN1,RYR2,MYT1L,PPFIA2,NRXN2,LRRC7,GABRB2,DLGAP2,CACNA1C,SPTBN2,EPHA6 |
3.155e-02 | -3.46 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways | WikiPathways | WP706 | 162 | 3 | 5310 | 23 |
RYR2,SNAP25,GRIN1 |
3.162e-02 | -3.45 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 47 |
EPHA6,CAMK2B,CAMK2A,CAMKV |
3.162e-02 | -3.45 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 47 |
EPHA6,CAMKV,CAMK2A,CAMK2B |
3.173e-02 | -3.45 | RhoGEF | smart domains | SM00325 | 68 | 2 | 9717 | 40 |
MCF2L2,RASGRF1 |
3.178e-02 | -3.45 | eye-uveal_tract-malignant_melanoma-mixed | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-mixed | 100 | 2 | 16828 | 47 |
MYT1L,CAMK2B |
3.193e-02 | -3.44 | Formation of annular gap junctions | REACTOME pathways | R-HSA-196025 | 9 | 1 | 10285 | 37 |
DNM1 |
3.203e-02 | -3.44 | bicarbonate:monoatomic anion antiporter activity | molecular function | GO:0140829 | 12 | 1 | 18094 | 49 |
SLC4A10 |
3.203e-02 | -3.44 | calcium channel inhibitor activity | molecular function | GO:0019855 | 12 | 1 | 18094 | 49 |
STX1A |
3.203e-02 | -3.44 | chloride:bicarbonate antiporter activity | molecular function | GO:0140900 | 12 | 1 | 18094 | 49 |
SLC4A10 |
3.221e-02 | -3.44 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 6 | 10285 | 37 |
CAMK2B,SLC4A10,GABRB2,RYR2,SLC8A3,CAMK2A |
3.239e-02 | -3.43 | breast-carcinoma-ER-PR-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-ER-PR-positive_carcinoma | 1881 | 10 | 16828 | 47 |
NRG3,FGF14,RASGRF1,CACNA1A,GRM5,RYR2,CACNA1E,LRRC7,EPHA6,MYT1L |
3.239e-02 | -3.43 | ER-PR-positive_carcinoma | COSMIC cancer mutations | ER-PR-positive_carcinoma | 1881 | 10 | 16828 | 47 |
EPHA6,MYT1L,CACNA1E,LRRC7,RYR2,CACNA1A,GRM5,RASGRF1,FGF14,NRG3 |
3.247e-02 | -3.43 | VHP | smart domains | SM00153 | 8 | 1 | 9717 | 40 |
ABLIM1 |
3.247e-02 | -3.43 | Calx_beta | smart domains | SM00237 | 8 | 1 | 9717 | 40 |
SLC8A3 |
3.254e-02 | -3.43 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 46 | 16828 | 47 |
CELF3,SPTBN2,EDIL3,CACNA1C,SLC4A10,CAMK2B,CCDC136,SLC8A3,L1CAM,SYT1,GRIN1,DLG4,MCF2L2,CACNA2D1,EPHA6,CAMK2A,STX1A,LRRC7,GABRB2,NRXN2,PPFIA2,FGF14,IQSEC2,MYT1L,HCN1,SNAP25,SCN8A,DNM1,GRM5,VSNL1,NRG3,GRIN2B,RYR2,CACNA1E,RASGRF1,PCLO,CACNA1A,RIMS1,NRXN3,CELF5,DLGAP2,ABLIM1,CACNA1G,CAMKV,SPTBN4,PPFIA3 |
3.262e-02 | -3.42 | COPI-mediated anterograde transport | REACTOME pathways | R-HSA-6807878 | 79 | 2 | 10285 | 37 |
SPTBN2,SPTBN4 |
3.263e-02 | -3.42 | peptide binding | molecular function | GO:0042277 | 258 | 3 | 18094 | 49 |
GRIN1,GRIN2B,CACNA1A |
3.269e-02 | -3.42 | Helix hairpin bin | gene3d domains | 1.10.287.630 | 10 | 1 | 14470 | 48 |
HCN1 |
3.269e-02 | -3.42 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 48 |
SLC4A10 |
3.291e-02 | -3.41 | G_PROTEIN_RECEP_F3_3 | prosite domains | PS00981 | 11 | 1 | 12186 | 37 |
GRM5 |
3.291e-02 | -3.41 | IGLC6 (immunoglobulin lambda constant 6) | protein interactions | 3542 | 13 | 1 | 19454 | 50 |
HCN1 |
3.291e-02 | -3.41 | PCAT1 (prostate cancer associated transcript 1) | protein interactions | 100750225 | 13 | 1 | 19454 | 50 |
PCLO |
3.291e-02 | -3.41 | NCAN (neurocan) | protein interactions | 1463 | 13 | 1 | 19454 | 50 |
L1CAM |
3.291e-02 | -3.41 | SNPH (syntaphilin) | protein interactions | 9751 | 13 | 1 | 19454 | 50 |
STX1A |
3.291e-02 | -3.41 | CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4) | protein interactions | 785 | 13 | 1 | 19454 | 50 |
CACNA1A |
3.306e-02 | -3.41 | regulation of translational elongation | biological process | GO:0006448 | 13 | 1 | 18204 | 47 |
GRM5 |
3.306e-02 | -3.41 | regulation of dendritic spine maintenance | biological process | GO:1902950 | 13 | 1 | 18204 | 47 |
GRIN2B |
3.306e-02 | -3.41 | postsynaptic specialization assembly | biological process | GO:0098698 | 13 | 1 | 18204 | 47 |
NRXN2 |
3.306e-02 | -3.41 | regulation of norepinephrine secretion | biological process | GO:0014061 | 13 | 1 | 18204 | 47 |
STX1A |
3.306e-02 | -3.41 | positive regulation of calcium ion transport into cytosol | biological process | GO:0010524 | 13 | 1 | 18204 | 47 |
GRIN1 |
3.306e-02 | -3.41 | parental behavior | biological process | GO:0060746 | 13 | 1 | 18204 | 47 |
BRINP1 |
3.306e-02 | -3.41 | retinal cone cell differentiation | biological process | GO:0042670 | 13 | 1 | 18204 | 47 |
HCN1 |
3.306e-02 | -3.41 | cellular response to potassium ion | biological process | GO:0035865 | 13 | 1 | 18204 | 47 |
DLG4 |
3.306e-02 | -3.41 | ectodermal placode development | biological process | GO:0071696 | 13 | 1 | 18204 | 47 |
NRG3 |
3.333e-02 | -3.40 | regulation of mRNA splicing, via spliceosome | biological process | GO:0048024 | 111 | 2 | 18204 | 47 |
CELF5,CELF3 |
3.333e-02 | -3.40 | positive regulation of peptide hormone secretion | biological process | GO:0090277 | 111 | 2 | 18204 | 47 |
SNAP25,VSNL1 |
3.363e-02 | -3.39 | VAMP7 (vesicle associated membrane protein 7) | protein interactions | 6845 | 112 | 2 | 19454 | 50 |
SNAP25,STX1A |
3.363e-02 | -3.39 | ITPR2 (inositol 1,4,5-trisphosphate receptor type 2) | protein interactions | 3709 | 112 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
3.375e-02 | -3.39 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 4 | 16828 | 47 |
EPHA6,CAMKV,CAMK2A,CAMK2B |
3.381e-02 | -3.39 | NCD3G | pfam domains | PF07562 | 13 | 1 | 17795 | 47 |
GRM5 |
3.381e-02 | -3.39 | SNARE | pfam domains | PF05739 | 13 | 1 | 17795 | 47 |
STX1A |
3.386e-02 | -3.39 | GPCR_3_9-Cys_sf | interpro domains | IPR038550 | 13 | 1 | 18521 | 49 |
GRM5 |
3.386e-02 | -3.39 | GPCR_3_9-Cys_dom | interpro domains | IPR011500 | 13 | 1 | 18521 | 49 |
GRM5 |
3.389e-02 | -3.38 | human chr13q33.1 | chromosome location | human chr13q33.1 | 18 | 1 | 26134 | 50 |
FGF14 |
3.389e-02 | -3.38 | human chr8p23.3 | chromosome location | human chr8p23.3 | 18 | 1 | 26134 | 50 |
DLGAP2 |
3.418e-02 | -3.38 | GFI1B (growth factor independent 1B transcriptional repressor) | protein interactions | 8328 | 113 | 2 | 19454 | 50 |
VSNL1,CCDC136 |
3.425e-02 | -3.37 | ZDHHC17 (zinc finger DHHC-type palmitoyltransferase 17) | protein interactions | 23390 | 277 | 3 | 19454 | 50 |
DLG4,SYT1,SNAP25 |
3.444e-02 | -3.37 | positive regulation of peptide secretion | biological process | GO:0002793 | 113 | 2 | 18204 | 47 |
VSNL1,SNAP25 |
3.444e-02 | -3.37 | dendrite development | biological process | GO:0016358 | 113 | 2 | 18204 | 47 |
DLG4,CAMK2A |
3.460e-02 | -3.36 | phosphatidylinositol bisphosphate binding | molecular function | GO:1902936 | 108 | 2 | 18094 | 49 |
SYT1,DNM1 |
3.465e-02 | -3.36 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 1 | 18094 | 49 |
SLC4A10 |
3.465e-02 | -3.36 | chloride channel regulator activity | molecular function | GO:0017081 | 13 | 1 | 18094 | 49 |
STX1A |
3.465e-02 | -3.36 | calcium:monoatomic cation antiporter activity | molecular function | GO:0015368 | 13 | 1 | 18094 | 49 |
SLC8A3 |
3.465e-02 | -3.36 | GABA-gated chloride ion channel activity | molecular function | GO:0022851 | 13 | 1 | 18094 | 49 |
GABRB2 |
3.474e-02 | -3.36 | ITPRID2 (ITPR interacting domain containing 2) | protein interactions | 6744 | 114 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
3.475e-02 | -3.36 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 2 | 16828 | 47 |
NRG3,FGF14 |
3.507e-02 | -3.35 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 7 | 16828 | 47 |
GRIN2B,RYR2,SLC4A10,CACNA1C,LRRC7,CACNA1E,L1CAM |
3.530e-02 | -3.34 | CDH2 (cadherin 2) | protein interactions | 1000 | 115 | 2 | 19454 | 50 |
LRRC7,GRIN1 |
3.540e-02 | -3.34 | TMEM41A (transmembrane protein 41A) | protein interactions | 90407 | 14 | 1 | 19454 | 50 |
STX1A |
3.540e-02 | -3.34 | KRTAP22-1 (keratin associated protein 22-1) | protein interactions | 337979 | 14 | 1 | 19454 | 50 |
CAMK2A |
3.540e-02 | -3.34 | TIMD4 (T cell immunoglobulin and mucin domain containing 4) | protein interactions | 91937 | 14 | 1 | 19454 | 50 |
SPTBN4 |
3.540e-02 | -3.34 | Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain1) | protein interactions | 13196 | 14 | 1 | 19454 | 50 |
DNM1 |
3.540e-02 | -3.34 | SYT5 (synaptotagmin 5) | protein interactions | 6861 | 14 | 1 | 19454 | 50 |
SYT1 |
3.540e-02 | -3.34 | KCNC1 (potassium voltage-gated channel subfamily C member 1) | protein interactions | 3746 | 14 | 1 | 19454 | 50 |
CAMK2A |
3.540e-02 | -3.34 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 1 | 19454 | 50 |
CAMK2A |
3.540e-02 | -3.34 | CHGA (chromogranin A) | protein interactions | 1113 | 14 | 1 | 19454 | 50 |
SYT1 |
3.540e-02 | -3.34 | Pkm (pyruvate kinase, muscle) | protein interactions | 18746 | 14 | 1 | 19454 | 50 |
BRINP1 |
3.540e-02 | -3.34 | GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2) | protein interactions | 2977 | 14 | 1 | 19454 | 50 |
DLG4 |
3.540e-02 | -3.34 | C20orf96 (chromosome 20 open reading frame 96) | protein interactions | 140680 | 14 | 1 | 19454 | 50 |
CAMK2B |
3.540e-02 | -3.34 | SLC38A6 (solute carrier family 38 member 6) | protein interactions | 145389 | 14 | 1 | 19454 | 50 |
EDIL3 |
3.541e-02 | -3.34 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 37 |
SLC4A10 |
3.541e-02 | -3.34 | Gap junction degradation | REACTOME pathways | R-HSA-190873 | 10 | 1 | 10285 | 37 |
DNM1 |
3.541e-02 | -3.34 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 1 | 10285 | 37 |
NRG3 |
3.556e-02 | -3.34 | regulation of skeletal muscle adaptation | biological process | GO:0014733 | 14 | 1 | 18204 | 47 |
CAMK2B |
3.556e-02 | -3.34 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 47 |
NRXN2 |
3.556e-02 | -3.34 | neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0099645 | 14 | 1 | 18204 | 47 |
DLG4 |
3.556e-02 | -3.34 | protein localization to endosome | biological process | GO:0036010 | 14 | 1 | 18204 | 47 |
LRRC7 |
3.556e-02 | -3.34 | atrial cardiac muscle cell to AV node cell signaling | biological process | GO:0086026 | 14 | 1 | 18204 | 47 |
CACNA1C |
3.556e-02 | -3.34 | synaptic vesicle priming | biological process | GO:0016082 | 14 | 1 | 18204 | 47 |
SNAP25 |
3.556e-02 | -3.34 | regulation of NMDA receptor activity | biological process | GO:2000310 | 14 | 1 | 18204 | 47 |
DLG4 |
3.556e-02 | -3.34 | protein localization to postsynaptic specialization membrane | biological process | GO:0099633 | 14 | 1 | 18204 | 47 |
DLG4 |
3.556e-02 | -3.34 | G protein-coupled glutamate receptor signaling pathway | biological process | GO:0007216 | 14 | 1 | 18204 | 47 |
GRM5 |
3.556e-02 | -3.34 | response to epinephrine | biological process | GO:0071871 | 14 | 1 | 18204 | 47 |
RYR2 |
3.556e-02 | -3.34 | regulation of modification of synaptic structure | biological process | GO:1905244 | 14 | 1 | 18204 | 47 |
CAMKV |
3.556e-02 | -3.34 | atrial cardiac muscle cell action potential | biological process | GO:0086014 | 14 | 1 | 18204 | 47 |
CACNA1C |
3.556e-02 | -3.34 | regulation of long-term synaptic depression | biological process | GO:1900452 | 14 | 1 | 18204 | 47 |
IQSEC2 |
3.556e-02 | -3.34 | bundle of His cell to Purkinje myocyte communication | biological process | GO:0086069 | 14 | 1 | 18204 | 47 |
CACNA2D1 |
3.556e-02 | -3.34 | response to redox state | biological process | GO:0051775 | 14 | 1 | 18204 | 47 |
RYR2 |
3.556e-02 | -3.34 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 47 |
RYR2 |
3.578e-02 | -3.33 | structural constituent of cytoskeleton | molecular function | GO:0005200 | 110 | 2 | 18094 | 49 |
SPTBN2,SPTBN4 |
3.585e-02 | -3.33 | RABBD | prosite domains | PS50916 | 12 | 1 | 12186 | 37 |
RIMS1 |
3.586e-02 | -3.33 | KRTAP19-7 (keratin associated protein 19-7) | protein interactions | 337974 | 116 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
3.590e-02 | -3.33 | - | gene3d domains | 1.10.220.20 | 11 | 1 | 14470 | 48 |
IQSEC2 |
3.592e-02 | -3.33 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 3 | 18094 | 49 |
GRIN2B,GRIN1,SLC4A10 |
3.592e-02 | -3.33 | PRKACA (protein kinase cAMP-activated catalytic subunit alpha) | protein interactions | 5566 | 486 | 4 | 19454 | 50 |
RYR2,SNAP25,CACNA1C,RASGRF1 |
3.595e-02 | -3.33 | endometrium-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-endometrioid_carcinoma | 15680 | 47 | 16828 | 47 |
L1CAM,SYT1,GRIN1,DLG4,MCF2L2,CACNA2D1,SPTBN2,CELF3,CAMK2B,CPLX1,EDIL3,CACNA1C,SLC4A10,CCDC136,SLC8A3,MYT1L,SNAP25,HCN1,SCN8A,DNM1,EPHA6,LRRC7,GABRB2,STX1A,CAMK2A,PPFIA2,IQSEC2,FGF14,NRXN2,CACNA1E,RYR2,CACNA1A,RIMS1,RASGRF1,PCLO,NRXN3,GRM5,VSNL1,GRIN2B,NRG3,SPTBN4,CAMKV,PPFIA3,DLGAP2,CELF5,ABLIM1,CACNA1G |
3.603e-02 | -3.32 | extrinsic component of synaptic membrane | cellular component | GO:0099243 | 14 | 1 | 19108 | 50 |
SNAP25 |
3.603e-02 | -3.32 | voltage-gated sodium channel complex | cellular component | GO:0001518 | 14 | 1 | 19108 | 50 |
SCN8A |
3.612e-02 | -3.32 | regulation of cation channel activity | biological process | GO:2001257 | 116 | 2 | 18204 | 47 |
CACNA2D1,FGF14 |
3.635e-02 | -3.31 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 6 | 19454 | 50 |
RASGRF1,ABLIM1,CAMK2B,SLC8A3,IQSEC2,CAMK2A |
3.636e-02 | -3.31 | Ephrin_lbd | pfam domains | PF01404 | 14 | 1 | 17795 | 47 |
EPHA6 |
3.636e-02 | -3.31 | EphA2_TM | pfam domains | PF14575 | 14 | 1 | 17795 | 47 |
EPHA6 |
3.636e-02 | -3.31 | Ephrin_rec_like | pfam domains | PF07699 | 14 | 1 | 17795 | 47 |
EPHA6 |
3.642e-02 | -3.31 | Eph_TM | interpro domains | IPR027936 | 14 | 1 | 18521 | 49 |
EPHA6 |
3.642e-02 | -3.31 | Tyr_kinase_rcpt_V_CS | interpro domains | IPR001426 | 14 | 1 | 18521 | 49 |
EPHA6 |
3.642e-02 | -3.31 | Tyr_kinase_ephrin_rcpt | interpro domains | IPR016257 | 14 | 1 | 18521 | 49 |
EPHA6 |
3.642e-02 | -3.31 | Ras_G-nucl-exch_fac_CS | interpro domains | IPR019804 | 14 | 1 | 18521 | 49 |
RASGRF1 |
3.642e-02 | -3.31 | GPCR_3 | interpro domains | IPR000337 | 14 | 1 | 18521 | 49 |
GRM5 |
3.642e-02 | -3.31 | GPCR_3_CS | interpro domains | IPR017979 | 14 | 1 | 18521 | 49 |
GRM5 |
3.642e-02 | -3.31 | Tyr-kin_ephrin_A/B_rcpt-like | interpro domains | IPR011641 | 14 | 1 | 18521 | 49 |
EPHA6 |
3.642e-02 | -3.31 | Ephrin_rcpt_lig-bd_dom | interpro domains | IPR001090 | 14 | 1 | 18521 | 49 |
EPHA6 |
3.642e-02 | -3.31 | G_DYNAMIN_dom | interpro domains | IPR030381 | 14 | 1 | 18521 | 49 |
DNM1 |
3.642e-02 | -3.31 | Recoverin | interpro domains | IPR028846 | 14 | 1 | 18521 | 49 |
VSNL1 |
3.642e-02 | -3.31 | EFEMP1 (EGF containing fibulin extracellular matrix protein 1) | protein interactions | 2202 | 117 | 2 | 19454 | 50 |
CACNA1C,CACNA1A |
3.646e-02 | -3.31 | SynN | smart domains | SM00503 | 9 | 1 | 9717 | 40 |
STX1A |
3.651e-02 | -3.31 | macromolecule localization | biological process | GO:0033036 | 2376 | 11 | 18204 | 47 |
SNAP25,RIMS1,CPLX1,NRXN2,SPTBN4,DLG4,PCLO,RYR2,LRRC7,STX1A,HCN1 |
3.669e-02 | -3.31 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 2 | 18204 | 47 |
IQSEC2,SNAP25 |
3.686e-02 | -3.30 | ASX_HYDROXYL | prosite domains | PS00010 | 100 | 2 | 12186 | 37 |
NRXN3,EDIL3 |
3.704e-02 | -3.30 | endometrioid_carcinoma | COSMIC cancer mutations | endometrioid_carcinoma | 15690 | 47 | 16828 | 47 |
GRIN2B,NRG3,VSNL1,GRM5,CACNA1E,RYR2,NRXN3,RIMS1,CACNA1A,PCLO,RASGRF1,DLGAP2,CELF5,CACNA1G,ABLIM1,SPTBN4,CAMKV,PPFIA3,CPLX1,CAMK2B,EDIL3,CACNA1C,SLC4A10,SPTBN2,CELF3,SLC8A3,CCDC136,SYT1,L1CAM,CACNA2D1,GRIN1,DLG4,MCF2L2,STX1A,LRRC7,GABRB2,CAMK2A,EPHA6,IQSEC2,FGF14,PPFIA2,NRXN2,SNAP25,HCN1,MYT1L,DNM1,SCN8A |
3.727e-02 | -3.29 | dopamine receptor binding | molecular function | GO:0050780 | 14 | 1 | 18094 | 49 |
DLG4 |
3.727e-02 | -3.29 | protein kinase A catalytic subunit binding | molecular function | GO:0034236 | 14 | 1 | 18094 | 49 |
RYR2 |
3.727e-02 | -3.29 | endometrium | COSMIC cancer mutations | endometrium | 15692 | 47 | 16828 | 47 |
SPTBN4,CAMKV,PPFIA3,DLGAP2,CELF5,CACNA1G,ABLIM1,CACNA1E,RYR2,NRXN3,CACNA1A,RIMS1,PCLO,RASGRF1,GRIN2B,NRG3,VSNL1,GRM5,SNAP25,HCN1,MYT1L,DNM1,SCN8A,STX1A,LRRC7,GABRB2,CAMK2A,EPHA6,FGF14,IQSEC2,PPFIA2,NRXN2,SYT1,L1CAM,CACNA2D1,MCF2L2,GRIN1,DLG4,CPLX1,CAMK2B,EDIL3,CACNA1C,SLC4A10,SPTBN2,CELF3,SLC8A3,CCDC136 |
3.745e-02 | -3.28 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 7 | 16828 | 47 |
CACNA1C,SLC4A10,RYR2,CACNA1E,LRRC7,L1CAM,GRIN2B |
3.759e-02 | -3.28 | human chr12p13.1 | chromosome location | human chr12p13.1 | 20 | 1 | 26134 | 50 |
GRIN2B |
3.764e-02 | -3.28 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 20 |
SLC4A10 |
3.764e-02 | -3.28 | NACHANNEL | prints domains | PR00170 | 10 | 1 | 5227 | 20 |
SCN8A |
3.766e-02 | -3.28 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 36 | 16828 | 47 |
SYT1,RYR2,CACNA2D1,NRXN3,RIMS1,PCLO,RASGRF1,DLG4,MCF2L2,GRIN1,CPLX1,CAMK2B,CACNA1C,EDIL3,SPTBN2,CELF3,GRIN2B,NRG3,SLC8A3,VSNL1,CCDC136,SNAP25,SPTBN4,HCN1,MYT1L,PPFIA3,SCN8A,DLGAP2,GABRB2,LRRC7,CELF5,CAMK2A,FGF14,PPFIA2,NRXN2,ABLIM1 |
3.776e-02 | -3.28 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 4 | 18521 | 49 |
CAMK2A,CAMKV,EPHA6,CAMK2B |
3.788e-02 | -3.27 | Cep85l (centrosomal protein 85-like) | protein interactions | 100038725 | 15 | 1 | 19454 | 50 |
BRINP1 |
3.788e-02 | -3.27 | ADGRB2 (adhesion G protein-coupled receptor B2) | protein interactions | 576 | 15 | 1 | 19454 | 50 |
DLG4 |
3.788e-02 | -3.27 | ASCL4 (achaete-scute family bHLH transcription factor 4) | protein interactions | 121549 | 15 | 1 | 19454 | 50 |
DNM1 |
3.788e-02 | -3.27 | Sgo1 (shugoshin 1) | protein interactions | 72415 | 15 | 1 | 19454 | 50 |
RIMS1 |
3.788e-02 | -3.27 | RGS9 (regulator of G protein signaling 9) | protein interactions | 8787 | 15 | 1 | 19454 | 50 |
GRIN1 |
3.788e-02 | -3.27 | PRR16 (proline rich 16) | protein interactions | 51334 | 15 | 1 | 19454 | 50 |
DLG4 |
3.788e-02 | -3.27 | BSN (bassoon presynaptic cytomatrix protein) | protein interactions | 8927 | 15 | 1 | 19454 | 50 |
RIMS1 |
3.788e-02 | -3.27 | GPR88 (G protein-coupled receptor 88) | protein interactions | 54112 | 15 | 1 | 19454 | 50 |
GRIN1 |
3.788e-02 | -3.27 | DEFB123 (defensin beta 123) | protein interactions | 245936 | 15 | 1 | 19454 | 50 |
CACNA2D1 |
3.788e-02 | -3.27 | FZD1 (frizzled class receptor 1) | protein interactions | 8321 | 15 | 1 | 19454 | 50 |
DLG4 |
3.788e-02 | -3.27 | MEGF6 (multiple EGF like domains 6) | protein interactions | 1953 | 15 | 1 | 19454 | 50 |
CACNA1A |
3.788e-02 | -3.27 | AARD (alanine and arginine rich domain containing protein) | protein interactions | 441376 | 15 | 1 | 19454 | 50 |
STX1A |
3.799e-02 | -3.27 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 4 | 16828 | 47 |
CAMK2B,CAMK2A,CAMKV,EPHA6 |
3.802e-02 | -3.27 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 3 | 16828 | 47 |
CACNA1E,SLC4A10,PCLO |
3.805e-02 | -3.27 | neurotransmitter receptor internalization | biological process | GO:0099590 | 15 | 1 | 18204 | 47 |
SNAP25 |
3.805e-02 | -3.27 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 47 |
SLC4A10 |
3.805e-02 | -3.27 | endosome to plasma membrane protein transport | biological process | GO:0099638 | 15 | 1 | 18204 | 47 |
LRRC7 |
3.805e-02 | -3.27 | atrial cardiac muscle cell to AV node cell communication | biological process | GO:0086066 | 15 | 1 | 18204 | 47 |
CACNA1C |
3.805e-02 | -3.27 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 47 |
RYR2 |
3.805e-02 | -3.27 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 47 |
DLG4 |
3.805e-02 | -3.27 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 47 |
RYR2 |
3.805e-02 | -3.27 | apical protein localization | biological process | GO:0045176 | 15 | 1 | 18204 | 47 |
HCN1 |
3.814e-02 | -3.27 | ELP3 (elongator acetyltransferase complex subunit 3) | protein interactions | 55140 | 120 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
3.830e-02 | -3.26 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 21 | 18204 | 47 |
RYR2,LRRC7,CAMK2B,GRIN1,STX1A,IQSEC2,L1CAM,VSNL1,CAMK2A,EDIL3,GRM5,RASGRF1,SYT1,SNAP25,RIMS1,GRIN2B,DLG4,BRINP1,SLC8A3,CACNA2D1,CELF3 |
3.851e-02 | -3.26 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 4 | 16828 | 47 |
EPHA6,CAMK2B,CAMK2A,CAMKV |
3.855e-02 | -3.26 | BLOC-1 complex | cellular component | GO:0031083 | 15 | 1 | 19108 | 50 |
SNAP25 |
3.872e-02 | -3.25 | HASPIN (histone H3 associated protein kinase) | protein interactions | 83903 | 121 | 2 | 19454 | 50 |
CACNA2D1,SPTBN2 |
3.878e-02 | -3.25 | G_PROTEIN_RECEP_F3_2 | prosite domains | PS00980 | 13 | 1 | 12186 | 37 |
GRM5 |
3.891e-02 | -3.25 | Dynamin_N | pfam domains | PF00350 | 15 | 1 | 17795 | 47 |
DNM1 |
3.891e-02 | -3.25 | CRAL_TRIO_2 | pfam domains | PF13716 | 15 | 1 | 17795 | 47 |
MCF2L2 |
3.891e-02 | -3.25 | Sec7 | pfam domains | PF01369 | 15 | 1 | 17795 | 47 |
IQSEC2 |
3.897e-02 | -3.24 | Sec7_dom_sf | interpro domains | IPR035999 | 15 | 1 | 18521 | 49 |
IQSEC2 |
3.897e-02 | -3.24 | Sec7_C_sf | interpro domains | IPR023394 | 15 | 1 | 18521 | 49 |
IQSEC2 |
3.897e-02 | -3.24 | Dynamin_N | interpro domains | IPR045063 | 15 | 1 | 18521 | 49 |
DNM1 |
3.897e-02 | -3.24 | Syntaxin/epimorphin_CS | interpro domains | IPR006012 | 15 | 1 | 18521 | 49 |
STX1A |
3.898e-02 | -3.24 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 2 | 7161 | 30 |
CAMK2B,CAMK2A |
3.898e-02 | -3.24 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 2 | 7161 | 30 |
CAMK2A,CAMK2B |
3.900e-02 | -3.24 | chloride transport | biological process | GO:0006821 | 121 | 2 | 18204 | 47 |
SLC4A10,GABRB2 |
3.915e-02 | -3.24 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 4 | 18204 | 47 |
DNM1,SPTBN2,SPTBN4,L1CAM |
3.930e-02 | -3.24 | A2ML1 (alpha-2-macroglobulin like 1) | protein interactions | 144568 | 122 | 2 | 19454 | 50 |
HCN1,SPTBN4 |
3.930e-02 | -3.24 | BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex) | protein interactions | 55845 | 122 | 2 | 19454 | 50 |
PPFIA2,PPFIA3 |
3.939e-02 | -3.23 | endocytosis | biological process | GO:0006897 | 499 | 4 | 18204 | 47 |
DNM1,SYT1,SNAP25,STX1A |
3.943e-02 | -3.23 | human chr10q23.1 | chromosome location | human chr10q23.1 | 21 | 1 | 26134 | 50 |
NRG3 |
3.950e-02 | -3.23 | basal plasma membrane | cellular component | GO:0009925 | 288 | 3 | 19108 | 50 |
SLC4A10,LRRC7,DLG4 |
3.955e-02 | -3.23 | EGF | smart domains | SM00181 | 184 | 3 | 9717 | 40 |
NRXN2,NRXN3,EDIL3 |
3.970e-02 | -3.23 | regulation of cellular localization | biological process | GO:0060341 | 983 | 6 | 18204 | 47 |
SNAP25,VSNL1,CPLX1,IQSEC2,STX1A,GRIN1 |
3.988e-02 | -3.22 | transmembrane-ephrin receptor activity | molecular function | GO:0005005 | 15 | 1 | 18094 | 49 |
EPHA6 |
3.988e-02 | -3.22 | EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma) | protein interactions | 8891 | 123 | 2 | 19454 | 50 |
SYT1,FGF14 |
3.988e-02 | -3.22 | HMOX1 (heme oxygenase 1) | protein interactions | 3162 | 123 | 2 | 19454 | 50 |
HCN1,STX1A |
4.006e-02 | -3.22 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 11 | 18204 | 47 |
CAMK2A,CACNA1A,GRIN1,HCN1,GABRB2,RYR2,CACNA2D1,SLC8A3,BRINP1,DLG4,SYT1 |
4.009e-02 | -3.22 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 4 | 16828 | 47 |
EPHA6,CAMK2A,CAMKV,CAMK2B |
4.014e-02 | -3.22 | Primary Focal Segmental Glomerulosclerosis FSGS | WikiPathways | WP2572 | 74 | 2 | 5310 | 23 |
CAMK2B,DNM1 |
4.035e-02 | -3.21 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 2 | 16828 | 47 |
SLC4A10,SPTBN2 |
4.035e-02 | -3.21 | SLC6A9 (solute carrier family 6 member 9) | protein interactions | 6536 | 16 | 1 | 19454 | 50 |
STX1A |
4.035e-02 | -3.21 | FZD4 (frizzled class receptor 4) | protein interactions | 8322 | 16 | 1 | 19454 | 50 |
DLG4 |
4.035e-02 | -3.21 | Ostm1 (osteopetrosis associated transmembrane protein 1) | protein interactions | 14628 | 16 | 1 | 19454 | 50 |
CAMK2A |
4.035e-02 | -3.21 | SYT9 (synaptotagmin 9) | protein interactions | 143425 | 16 | 1 | 19454 | 50 |
SNAP25 |
4.035e-02 | -3.21 | CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1) | protein interactions | 782 | 16 | 1 | 19454 | 50 |
CACNA1A |
4.035e-02 | -3.21 | KCNJ4 (potassium inwardly rectifying channel subfamily J member 4) | protein interactions | 3761 | 16 | 1 | 19454 | 50 |
DLG4 |
4.035e-02 | -3.21 | CNTNAP2 (contactin associated protein 2) | protein interactions | 26047 | 16 | 1 | 19454 | 50 |
DLG4 |
4.035e-02 | -3.21 | GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3) | protein interactions | 2562 | 16 | 1 | 19454 | 50 |
GABRB2 |
4.035e-02 | -3.21 | AKAP6 (A-kinase anchoring protein 6) | protein interactions | 9472 | 16 | 1 | 19454 | 50 |
RYR2 |
4.035e-02 | -3.21 | GMPR2 (guanosine monophosphate reductase 2) | protein interactions | 51292 | 16 | 1 | 19454 | 50 |
DNM1 |
4.035e-02 | -3.21 | RBM18 (RNA binding motif protein 18) | protein interactions | 92400 | 16 | 1 | 19454 | 50 |
SYT1 |
4.035e-02 | -3.21 | ZFAND3 (zinc finger AN1-type containing 3) | protein interactions | 60685 | 16 | 1 | 19454 | 50 |
DNM1 |
4.035e-02 | -3.21 | DUS1L (dihydrouridine synthase 1 like) | protein interactions | 64118 | 16 | 1 | 19454 | 50 |
CAMK2B |
4.037e-02 | -3.21 | protein phosphorylation | biological process | GO:0006468 | 503 | 4 | 18204 | 47 |
CAMK2A,EPHA6,CAMK2B,CAMKV |
4.043e-02 | -3.21 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 40 |
RYR2 |
4.054e-02 | -3.21 | angiotensin-activated signaling pathway | biological process | GO:0038166 | 16 | 1 | 18204 | 47 |
CAMK2A |
4.054e-02 | -3.21 | mitochondrial calcium ion transmembrane transport | biological process | GO:0006851 | 16 | 1 | 18204 | 47 |
SLC8A3 |
4.054e-02 | -3.21 | desensitization of G protein-coupled receptor signaling pathway | biological process | GO:0002029 | 16 | 1 | 18204 | 47 |
GRM5 |
4.054e-02 | -3.21 | cardiac left ventricle morphogenesis | biological process | GO:0003214 | 16 | 1 | 18204 | 47 |
RYR2 |
4.054e-02 | -3.21 | regulation of postsynaptic specialization assembly | biological process | GO:0099150 | 16 | 1 | 18204 | 47 |
SPTBN2 |
4.055e-02 | -3.21 | Cellular response to heat stress | REACTOME pathways | R-HSA-3371556 | 89 | 2 | 10285 | 37 |
CAMK2B,CAMK2A |
4.077e-02 | -3.20 | regulation of protein-containing complex disassembly | biological process | GO:0043244 | 124 | 2 | 18204 | 47 |
SPTBN4,SPTBN2 |
4.087e-02 | -3.20 | response to inorganic substance | biological process | GO:0010035 | 505 | 4 | 18204 | 47 |
CACNA1G,SYT1,RYR2,DLG4 |
4.106e-02 | -3.19 | STXBP1 (syntaxin binding protein 1) | protein interactions | 6812 | 125 | 2 | 19454 | 50 |
STX1A,SNAP25 |
4.106e-02 | -3.19 | CBLN4 (cerebellin 4 precursor) | protein interactions | 140689 | 125 | 2 | 19454 | 50 |
NRXN3,L1CAM |
4.106e-02 | -3.19 | ZNF250 (zinc finger protein 250) | protein interactions | 58500 | 125 | 2 | 19454 | 50 |
CCDC136,STX1A |
4.110e-02 | -3.19 | Galactose-binding domain-like | gene3d domains | 2.60.120.260 | 97 | 2 | 14470 | 48 |
EPHA6,EDIL3 |
4.127e-02 | -3.19 | chloride transmembrane transporter activity | molecular function | GO:0015108 | 119 | 2 | 18094 | 49 |
GABRB2,SLC4A10 |
4.127e-02 | -3.19 | human chr12q21.31 | chromosome location | human chr12q21.31 | 22 | 1 | 26134 | 50 |
PPFIA2 |
4.127e-02 | -3.19 | human chr5p12 | chromosome location | human chr5p12 | 22 | 1 | 26134 | 50 |
HCN1 |
4.145e-02 | -3.18 | EF-hand_1 | pfam domains | PF00036 | 16 | 1 | 17795 | 47 |
VSNL1 |
4.152e-02 | -3.18 | Sec7_dom | interpro domains | IPR000904 | 16 | 1 | 18521 | 49 |
IQSEC2 |
4.152e-02 | -3.18 | Guanylate_kinase_CS | interpro domains | IPR020590 | 16 | 1 | 18521 | 49 |
DLG4 |
4.152e-02 | -3.18 | cNMP-bd_CS | interpro domains | IPR018488 | 16 | 1 | 18521 | 49 |
HCN1 |
4.152e-02 | -3.18 | Syntaxin | interpro domains | IPR045242 | 16 | 1 | 18521 | 49 |
STX1A |
4.170e-02 | -3.18 | EPH_LBD | prosite domains | PS51550 | 14 | 1 | 12186 | 37 |
EPHA6 |
4.170e-02 | -3.18 | RECEPTOR_TYR_KIN_V_2 | prosite domains | PS00791 | 14 | 1 | 12186 | 37 |
EPHA6 |
4.170e-02 | -3.18 | G_DYNAMIN_2 | prosite domains | PS51718 | 14 | 1 | 12186 | 37 |
DNM1 |
4.170e-02 | -3.18 | RECEPTOR_TYR_KIN_V_1 | prosite domains | PS00790 | 14 | 1 | 12186 | 37 |
EPHA6 |
4.170e-02 | -3.18 | RASGEF | prosite domains | PS00720 | 14 | 1 | 12186 | 37 |
RASGRF1 |
4.197e-02 | -3.17 | response to ethanol | biological process | GO:0045471 | 126 | 2 | 18204 | 47 |
GRIN2B,GRIN1 |
4.219e-02 | -3.17 | HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) | protein interactions | 9146 | 512 | 4 | 19454 | 50 |
EPHA6,DLG4,CCDC136,SNAP25 |
4.229e-02 | -3.16 | central_nervous_system-brain-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligoastrocytoma_Grade_III | 117 | 2 | 16828 | 47 |
HCN1,RYR2 |
4.229e-02 | -3.16 | iswi atpase | gene3d domains | 1.20.5.1190 | 13 | 1 | 14470 | 48 |
SCN8A |
4.229e-02 | -3.16 | - | gene3d domains | 1.20.58.70 | 13 | 1 | 14470 | 48 |
STX1A |
4.229e-02 | -3.16 | GPCR, family 3, nine cysteines domain | gene3d domains | 2.10.50.30 | 13 | 1 | 14470 | 48 |
GRM5 |
4.231e-02 | -3.16 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 6 | 16828 | 47 |
MCF2L2,RASGRF1,NRXN3,CACNA2D1,SPTBN2,SYT1 |
4.235e-02 | -3.16 | Activation of Ca-permeable Kainate Receptor | REACTOME pathways | R-HSA-451308 | 12 | 1 | 10285 | 37 |
DLG4 |
4.235e-02 | -3.16 | Ionotropic activity of Kainate Receptors | REACTOME pathways | R-HSA-451306 | 12 | 1 | 10285 | 37 |
DLG4 |
4.244e-02 | -3.16 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 46 | 16828 | 47 |
HCN1,SNAP25,MYT1L,DNM1,SCN8A,CAMK2A,STX1A,GABRB2,LRRC7,EPHA6,NRXN2,PPFIA2,IQSEC2,FGF14,SYT1,L1CAM,CACNA2D1,MCF2L2,DLG4,GRIN1,EDIL3,CACNA1C,SLC4A10,CAMK2B,CELF3,SPTBN2,SLC8A3,CCDC136,CAMKV,SPTBN4,PPFIA3,CELF5,DLGAP2,CACNA1G,ABLIM1,RYR2,CACNA1E,NRXN3,RASGRF1,PCLO,CACNA1A,RIMS1,NRG3,GRIN2B,GRM5,VSNL1 |
4.248e-02 | -3.16 | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | molecular function | GO:0099507 | 16 | 1 | 18094 | 49 |
GRIN2B |
4.257e-02 | -3.16 | organelle fusion | biological process | GO:0048284 | 127 | 2 | 18204 | 47 |
SNAP25,STX1A |
4.282e-02 | -3.15 | ZNF12 (zinc finger protein 12) | protein interactions | 7559 | 17 | 1 | 19454 | 50 |
STX1A |
4.282e-02 | -3.15 | ZNF557 (zinc finger protein 557) | protein interactions | 79230 | 17 | 1 | 19454 | 50 |
STX1A |
4.282e-02 | -3.15 | BMP8A (bone morphogenetic protein 8a) | protein interactions | 353500 | 17 | 1 | 19454 | 50 |
BRINP1 |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NRXN3 |
4.282e-02 | -3.15 | ZNF559-ZNF177 (ZNF559-ZNF177 readthrough) | protein interactions | 100529215 | 17 | 1 | 19454 | 50 |
SNAP25 |
4.282e-02 | -3.15 | FAM163B (family with sequence similarity 163 member B) | protein interactions | 642968 | 17 | 1 | 19454 | 50 |
CAMK2B |
4.282e-02 | -3.15 | CLEC1A (C-type lectin domain family 1 member A) | protein interactions | 51267 | 17 | 1 | 19454 | 50 |
STX1A |
4.282e-02 | -3.15 | SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) | protein interactions | 51091 | 17 | 1 | 19454 | 50 |
ABLIM1 |
4.282e-02 | -3.15 | IL13RA1 (interleukin 13 receptor subunit alpha 1) | protein interactions | 3597 | 17 | 1 | 19454 | 50 |
DLG4 |
4.282e-02 | -3.15 | CNTN2 (contactin 2) | protein interactions | 6900 | 17 | 1 | 19454 | 50 |
L1CAM |
4.282e-02 | -3.15 | FAM131C (family with sequence similarity 131 member C) | protein interactions | 348487 | 17 | 1 | 19454 | 50 |
VSNL1 |
4.282e-02 | -3.15 | Aurkb (aurora kinase B) | protein interactions | 20877 | 17 | 1 | 19454 | 50 |
SPTBN2 |
4.286e-02 | -3.15 | HOMER3 (homer scaffold protein 3) | protein interactions | 9454 | 128 | 2 | 19454 | 50 |
LRRC7,GRM5 |
4.286e-02 | -3.15 | SYT2 (synaptotagmin 2) | protein interactions | 127833 | 128 | 2 | 19454 | 50 |
CAMKV,SYT1 |
4.286e-02 | -3.15 | EIF2B2 (eukaryotic translation initiation factor 2B subunit beta) | protein interactions | 8892 | 128 | 2 | 19454 | 50 |
FGF14,SYT1 |
4.297e-02 | -3.15 | signaling receptor activity | molecular function | GO:0038023 | 1474 | 8 | 18094 | 49 |
GRM5,EPHA6,NRXN2,NRXN3,GRIN2B,GRIN1,L1CAM,GABRB2 |
4.297e-02 | -3.15 | molecular transducer activity | molecular function | GO:0060089 | 1474 | 8 | 18094 | 49 |
L1CAM,GABRB2,GRM5,EPHA6,NRXN3,NRXN2,GRIN2B,GRIN1 |
4.301e-02 | -3.15 | positive regulation of cardiac muscle cell apoptotic process | biological process | GO:0010666 | 17 | 1 | 18204 | 47 |
CAMK2A |
4.301e-02 | -3.15 | positive regulation of sequestering of calcium ion | biological process | GO:0051284 | 17 | 1 | 18204 | 47 |
RYR2 |
4.301e-02 | -3.15 | adaptation of signaling pathway | biological process | GO:0023058 | 17 | 1 | 18204 | 47 |
GRM5 |
4.301e-02 | -3.15 | negative adaptation of signaling pathway | biological process | GO:0022401 | 17 | 1 | 18204 | 47 |
GRM5 |
4.301e-02 | -3.15 | positive regulation of striated muscle cell apoptotic process | biological process | GO:0010663 | 17 | 1 | 18204 | 47 |
CAMK2A |
4.301e-02 | -3.15 | negative regulation of receptor internalization | biological process | GO:0002091 | 17 | 1 | 18204 | 47 |
DLG4 |
4.301e-02 | -3.15 | nuclear body organization | biological process | GO:0030575 | 17 | 1 | 18204 | 47 |
CELF3 |
4.311e-02 | -3.14 | human chr3q11.2 | chromosome location | human chr3q11.2 | 23 | 1 | 26134 | 50 |
EPHA6 |
4.311e-02 | -3.14 | human chr2p25.3 | chromosome location | human chr2p25.3 | 23 | 1 | 26134 | 50 |
MYT1L |
4.316e-02 | -3.14 | skin-malignant_melanoma | COSMIC cancer mutations | skin-malignant_melanoma | 15741 | 47 | 16828 | 47 |
SCN8A,DNM1,MYT1L,SNAP25,HCN1,PPFIA2,FGF14,IQSEC2,NRXN2,EPHA6,LRRC7,GABRB2,STX1A,CAMK2A,MCF2L2,DLG4,GRIN1,CACNA2D1,L1CAM,SYT1,CCDC136,SLC8A3,SPTBN2,CELF3,CAMK2B,CPLX1,EDIL3,SLC4A10,CACNA1C,PPFIA3,SPTBN4,CAMKV,ABLIM1,CACNA1G,DLGAP2,CELF5,CACNA1A,RIMS1,RASGRF1,PCLO,NRXN3,CACNA1E,RYR2,GRM5,VSNL1,GRIN2B,NRG3 |
4.317e-02 | -3.14 | potassium channel activity | molecular function | GO:0005267 | 122 | 2 | 18094 | 49 |
HCN1,SNAP25 |
4.317e-02 | -3.14 | myelination | biological process | GO:0042552 | 128 | 2 | 18204 | 47 |
SLC8A3,SCN8A |
4.320e-02 | -3.14 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 3 | 16828 | 47 |
SLC8A3,PCLO,EPHA6 |
4.346e-02 | -3.14 | EIF2B4 (eukaryotic translation initiation factor 2B subunit delta) | protein interactions | 8890 | 129 | 2 | 19454 | 50 |
FGF14,SYT1 |
4.346e-02 | -3.14 | PNKP (polynucleotide kinase 3'-phosphatase) | protein interactions | 11284 | 129 | 2 | 19454 | 50 |
CAMK2A,CAMK2B |
4.350e-02 | -3.14 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 4 | 18094 | 49 |
RASGRF1,IQSEC2,RIMS1,MCF2L2 |
4.350e-02 | -3.14 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 4 | 18094 | 49 |
MCF2L2,RIMS1,IQSEC2,RASGRF1 |
4.358e-02 | -3.13 | apical dendrite | cellular component | GO:0097440 | 17 | 1 | 19108 | 50 |
SLC4A10 |
4.406e-02 | -3.12 | Synaptotagmin | interpro domains | IPR001565 | 17 | 1 | 18521 | 49 |
SYT1 |
4.418e-02 | -3.12 | peptidyl-amino acid modification | biological process | GO:0018193 | 518 | 4 | 18204 | 47 |
CAMKV,STX1A,CAMK2A,CAMK2B |
4.440e-02 | -3.11 | ensheathment of neurons | biological process | GO:0007272 | 130 | 2 | 18204 | 47 |
SCN8A,SLC8A3 |
4.440e-02 | -3.11 | axon ensheathment | biological process | GO:0008366 | 130 | 2 | 18204 | 47 |
SCN8A,SLC8A3 |
4.448e-02 | -3.11 | cytoskeleton | cellular component | GO:0005856 | 2412 | 11 | 19108 | 50 |
RIMS1,CAMK2B,SPTBN4,DNM1,DLG4,PCLO,DLGAP2,SNAP25,SPTBN2,ABLIM1,GRIN2B |
4.461e-02 | -3.11 | SEC7 | prosite domains | PS50190 | 15 | 1 | 12186 | 37 |
IQSEC2 |
4.461e-02 | -3.11 | SYNTAXIN | prosite domains | PS00914 | 15 | 1 | 12186 | 37 |
STX1A |
4.468e-02 | -3.11 | KRTAP4-2 (keratin associated protein 4-2) | protein interactions | 85291 | 131 | 2 | 19454 | 50 |
DLGAP2,CELF5 |
4.476e-02 | -3.11 | Interferon gamma signaling | REACTOME pathways | R-HSA-877300 | 94 | 2 | 10285 | 37 |
CAMK2B,CAMK2A |
4.484e-02 | -3.10 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 50 |
SPTBN2,SPTBN4,LRRC7,DLG4 |
4.499e-02 | -3.10 | NRP1 (neuropilin 1) | protein interactions | 8829 | 309 | 3 | 19454 | 50 |
CAMKV,ABLIM1,L1CAM |
4.501e-02 | -3.10 | EAGCHANLFMLY | prints domains | PR01463 | 12 | 1 | 5227 | 20 |
HCN1 |
4.501e-02 | -3.10 | response to calcium ion | biological process | GO:0051592 | 131 | 2 | 18204 | 47 |
SYT1,RYR2 |
4.507e-02 | -3.10 | ephrin receptor activity | molecular function | GO:0005003 | 17 | 1 | 18094 | 49 |
EPHA6 |
4.509e-02 | -3.10 | protein tyrosine kinase binding | molecular function | GO:1990782 | 125 | 2 | 18094 | 49 |
NRG3,GRM5 |
4.529e-02 | -3.09 | GRIK5 (glutamate ionotropic receptor kainate type subunit 5) | protein interactions | 2901 | 18 | 1 | 19454 | 50 |
DLG4 |
4.529e-02 | -3.09 | CTSE (cathepsin E) | protein interactions | 1510 | 18 | 1 | 19454 | 50 |
L1CAM |
4.529e-02 | -3.09 | Ccdc77 (coiled-coil domain containing 77) | protein interactions | 67200 | 18 | 1 | 19454 | 50 |
CACNA2D1 |
4.529e-02 | -3.09 | DAPK2 (death associated protein kinase 2) | protein interactions | 23604 | 18 | 1 | 19454 | 50 |
CAMK2A |
4.529e-02 | -3.09 | RYR3 (ryanodine receptor 3) | protein interactions | 6263 | 18 | 1 | 19454 | 50 |
RYR2 |
4.529e-02 | -3.09 | KLHL1 (kelch like family member 1) | protein interactions | 57626 | 18 | 1 | 19454 | 50 |
CACNA1A |
4.530e-02 | -3.09 | INA (internexin neuronal intermediate filament protein alpha) | protein interactions | 9118 | 132 | 2 | 19454 | 50 |
GRIN1,CAMK2A |
4.535e-02 | -3.09 | response to chemical | biological process | GO:0042221 | 3743 | 15 | 18204 | 47 |
GRIN2B,SYT1,NRG3,BRINP1,DLG4,CACNA2D1,SLC8A3,CACNA1G,RYR2,L1CAM,CACNA1A,CAMK2A,HCN1,GABRB2,GRIN1 |
4.546e-02 | -3.09 | organelle organization | biological process | GO:0006996 | 3091 | 13 | 18204 | 47 |
SNAP25,DNM1,CELF3,DLG4,NRXN2,SPTBN4,PCLO,CCDC136,SPTBN2,STX1A,ABLIM1,CAMK2A,IQSEC2 |
4.547e-02 | -3.09 | ephrin a2 ectodomain | gene3d domains | 2.60.40.1770 | 14 | 1 | 14470 | 48 |
EPHA6 |
4.549e-02 | -3.09 | regulation of calcium ion transport into cytosol | biological process | GO:0010522 | 18 | 1 | 18204 | 47 |
GRIN1 |
4.549e-02 | -3.09 | regulation of skeletal muscle contraction | biological process | GO:0014819 | 18 | 1 | 18204 | 47 |
SLC8A3 |
4.549e-02 | -3.09 | positive regulation of dendritic spine morphogenesis | biological process | GO:0061003 | 18 | 1 | 18204 | 47 |
CAMK2B |
4.549e-02 | -3.09 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 47 |
DLG4 |
4.549e-02 | -3.09 | clathrin coat assembly | biological process | GO:0048268 | 18 | 1 | 18204 | 47 |
DNM1 |
4.549e-02 | -3.09 | type B pancreatic cell proliferation | biological process | GO:0044342 | 18 | 1 | 18204 | 47 |
RASGRF1 |
4.563e-02 | -3.09 | regulation of mRNA processing | biological process | GO:0050684 | 132 | 2 | 18204 | 47 |
CELF5,CELF3 |
4.580e-02 | -3.08 | GABA A receptor activation | REACTOME pathways | R-HSA-977441 | 13 | 1 | 10285 | 37 |
GABRB2 |
4.580e-02 | -3.08 | Sodium/Calcium exchangers | REACTOME pathways | R-HSA-425561 | 13 | 1 | 10285 | 37 |
SLC8A3 |
4.580e-02 | -3.08 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 37 |
NRG3 |
4.582e-02 | -3.08 | Taste transduction | KEGG pathways | ko04742 | 82 | 2 | 7161 | 30 |
CACNA1A,CACNA1C |
4.582e-02 | -3.08 | Taste transduction | KEGG pathways | hsa04742 | 82 | 2 | 7161 | 30 |
CACNA1A,CACNA1C |
4.591e-02 | -3.08 | PTPRS (protein tyrosine phosphatase receptor type S) | protein interactions | 5802 | 133 | 2 | 19454 | 50 |
PPFIA3,PPFIA2 |
4.609e-02 | -3.08 | calyx of Held | cellular component | GO:0044305 | 18 | 1 | 19108 | 50 |
CPLX1 |
4.625e-02 | -3.07 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 2 | 18204 | 47 |
RYR2,CACNA1C |
4.627e-02 | -3.07 | basal part of cell | cellular component | GO:0045178 | 307 | 3 | 19108 | 50 |
DLG4,LRRC7,SLC4A10 |
4.627e-02 | -3.07 | bone-humerus-chondrosarcoma | COSMIC cancer mutations | bone-humerus-chondrosarcoma | 123 | 2 | 16828 | 47 |
PCLO,RYR2 |
4.653e-02 | -3.07 | EPHB4 (EPH receptor B4) | protein interactions | 2050 | 134 | 2 | 19454 | 50 |
EPHA6,GRIN1 |
4.659e-02 | -3.07 | SNARE | interpro domains | IPR010989 | 18 | 1 | 18521 | 49 |
STX1A |
4.661e-02 | -3.07 | Neurotrophic factor-mediated Trk receptor signaling | Pathway Interaction DB | trkrpathway | 56 | 2 | 2226 | 14 |
RASGRF1,DNM1 |
4.667e-02 | -3.06 | Serotonin Transporter Activity | WikiPathways | WP1455 | 11 | 1 | 5310 | 23 |
STX1A |
4.672e-02 | -3.06 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 4 | 19108 | 50 |
ABLIM1,SPTBN2,SNAP25,SPTBN4 |
4.677e-02 | -3.06 | human chr5q34 | chromosome location | human chr5q34 | 25 | 1 | 26134 | 50 |
GABRB2 |
4.677e-02 | -3.06 | exocytic vesicle membrane | cellular component | GO:0099501 | 132 | 2 | 19108 | 50 |
SYT1,STX1A |
4.677e-02 | -3.06 | synaptic vesicle membrane | cellular component | GO:0030672 | 132 | 2 | 19108 | 50 |
STX1A,SYT1 |
4.679e-02 | -3.06 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 4 | 16828 | 47 |
SLC4A10,RYR2,GRIN2B,L1CAM |
4.688e-02 | -3.06 | regulation of actin filament polymerization | biological process | GO:0030833 | 134 | 2 | 18204 | 47 |
SPTBN2,SPTBN4 |
4.688e-02 | -3.06 | vesicle-mediated transport to the plasma membrane | biological process | GO:0098876 | 134 | 2 | 18204 | 47 |
SNAP25,LRRC7 |
4.716e-02 | -3.05 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 50 |
SPTBN2,ABLIM1 |
4.737e-02 | -3.05 | regulation of establishment of protein localization | biological process | GO:0070201 | 530 | 4 | 18204 | 47 |
VSNL1,CPLX1,SNAP25,STX1A |
4.752e-02 | -3.05 | FA58C_2 | prosite domains | PS01286 | 16 | 1 | 12186 | 37 |
EDIL3 |
4.752e-02 | -3.05 | GUANYLATE_KINASE_1 | prosite domains | PS00856 | 16 | 1 | 12186 | 37 |
DLG4 |
4.752e-02 | -3.05 | CNMP_BINDING_1 | prosite domains | PS00888 | 16 | 1 | 12186 | 37 |
HCN1 |
4.763e-02 | -3.04 | knee | COSMIC cancer mutations | knee | 125 | 2 | 16828 | 47 |
EPHA6,RYR2 |
4.766e-02 | -3.04 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 49 |
RYR2 |
4.766e-02 | -3.04 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 49 |
NRG3 |
4.766e-02 | -3.04 | adrenergic receptor binding | molecular function | GO:0031690 | 18 | 1 | 18094 | 49 |
DLG4 |
4.774e-02 | -3.04 | TTC7A (tetratricopeptide repeat domain 7A) | protein interactions | 57217 | 19 | 1 | 19454 | 50 |
CAMKV |
4.774e-02 | -3.04 | NANOS1 (nanos C2HC-type zinc finger 1) | protein interactions | 340719 | 19 | 1 | 19454 | 50 |
GRIN1 |
4.774e-02 | -3.04 | RAB26 (RAB26, member RAS oncogene family) | protein interactions | 25837 | 19 | 1 | 19454 | 50 |
RIMS1 |
4.774e-02 | -3.04 | LRRTM3 (leucine rich repeat transmembrane neuronal 3) | protein interactions | 347731 | 19 | 1 | 19454 | 50 |
NRXN3 |
4.774e-02 | -3.04 | CCL19 (C-C motif chemokine ligand 19) | protein interactions | 6363 | 19 | 1 | 19454 | 50 |
CACNA2D1 |
4.774e-02 | -3.04 | CACNA1B (calcium voltage-gated channel subunit alpha1 B) | protein interactions | 774 | 19 | 1 | 19454 | 50 |
RIMS1 |
4.774e-02 | -3.04 | ANKRD13C (ankyrin repeat domain 13C) | protein interactions | 81573 | 19 | 1 | 19454 | 50 |
GRIN1 |
4.774e-02 | -3.04 | CRIM1 (cysteine rich transmembrane BMP regulator 1) | protein interactions | 51232 | 19 | 1 | 19454 | 50 |
CACNA1A |
4.774e-02 | -3.04 | FAM170A (family with sequence similarity 170 member A) | protein interactions | 340069 | 19 | 1 | 19454 | 50 |
CAMK2B |
4.774e-02 | -3.04 | SYT7 (synaptotagmin 7) | protein interactions | 9066 | 19 | 1 | 19454 | 50 |
STX1A |
4.774e-02 | -3.04 | ETNK2 (ethanolamine kinase 2) | protein interactions | 55224 | 19 | 1 | 19454 | 50 |
STX1A |
4.774e-02 | -3.04 | ZNF197 (zinc finger protein 197) | protein interactions | 10168 | 19 | 1 | 19454 | 50 |
CCDC136 |
4.774e-02 | -3.04 | TEX13B (testis expressed 13B) | protein interactions | 56156 | 19 | 1 | 19454 | 50 |
VSNL1 |
4.774e-02 | -3.04 | Cep76 (centrosomal protein 76) | protein interactions | 225659 | 19 | 1 | 19454 | 50 |
CACNA2D1 |
4.795e-02 | -3.04 | positive regulation of Ras protein signal transduction | biological process | GO:0046579 | 19 | 1 | 18204 | 47 |
RASGRF1 |
4.795e-02 | -3.04 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | biological process | GO:1902514 | 19 | 1 | 18204 | 47 |
CACNA2D1 |
4.795e-02 | -3.04 | presynapse assembly | biological process | GO:0099054 | 19 | 1 | 18204 | 47 |
PCLO |
4.795e-02 | -3.04 | response to potassium ion | biological process | GO:0035864 | 19 | 1 | 18204 | 47 |
DLG4 |
4.795e-02 | -3.04 | excitatory synapse assembly | biological process | GO:1904861 | 19 | 1 | 18204 | 47 |
NRXN2 |
4.795e-02 | -3.04 | cerebellar Purkinje cell layer morphogenesis | biological process | GO:0021692 | 19 | 1 | 18204 | 47 |
SPTBN2 |
4.795e-02 | -3.04 | positive regulation of reactive oxygen species biosynthetic process | biological process | GO:1903428 | 19 | 1 | 18204 | 47 |
GRIN1 |
4.814e-02 | -3.03 | cell-matrix adhesion | biological process | GO:0007160 | 136 | 2 | 18204 | 47 |
PPFIA2,L1CAM |
4.832e-02 | -3.03 | MACPF | smart domains | SM00457 | 12 | 1 | 9717 | 40 |
BRINP1 |
4.859e-02 | -3.02 | GABA-A receptor complex | cellular component | GO:1902711 | 19 | 1 | 19108 | 50 |
GABRB2 |
4.859e-02 | -3.02 | astrocyte projection | cellular component | GO:0097449 | 19 | 1 | 19108 | 50 |
GRM5 |
4.859e-02 | -3.02 | human chr14q24.2 | chromosome location | human chr14q24.2 | 26 | 1 | 26134 | 50 |
SLC8A3 |
4.859e-02 | -3.02 | human chr15q24.2 | chromosome location | human chr15q24.2 | 26 | 1 | 26134 | 50 |
TMEM266 |
4.864e-02 | -3.02 | Arf Nucleotide-binding Site Opener,domain 2 | gene3d domains | 1.10.1000.11 | 15 | 1 | 14470 | 48 |
IQSEC2 |
4.910e-02 | -3.01 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 4 | 18521 | 49 |
CAMK2B,EPHA6,CAMKV,CAMK2A |
4.923e-02 | -3.01 | Retrograde neurotrophin signalling | REACTOME pathways | R-HSA-177504 | 14 | 1 | 10285 | 37 |
DNM1 |
4.923e-02 | -3.01 | Reduction of cytosolic Ca++ levels | REACTOME pathways | R-HSA-418359 | 14 | 1 | 10285 | 37 |
SLC8A3 |
4.923e-02 | -3.01 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 1 | 10285 | 37 |
NRG3 |
4.923e-02 | -3.01 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 37 |
ABLIM1 |
4.930e-02 | -3.01 | EphrinA-EPHA pathway | Pathway Interaction DB | ephrina_ephapathway | 8 | 1 | 2226 | 14 |
EPHA6 |
4.941e-02 | -3.01 | regulation of protein localization to cell periphery | biological process | GO:1904375 | 138 | 2 | 18204 | 47 |
CPLX1,IQSEC2 |
4.947e-02 | -3.01 | positive regulation of signal transduction | biological process | GO:0009967 | 1593 | 8 | 18204 | 47 |
GRIN2B,RASGRF1,RIMS1,CAMK2A,GRM5,DLG4,STX1A,GRIN1 |
4.968e-02 | -3.00 | ERG28 (ergosterol biosynthesis 28 homolog) | protein interactions | 11161 | 139 | 2 | 19454 | 50 |
CELF3,STX1A |
4.968e-02 | -3.00 | EXOC3 (exocyst complex component 3) | protein interactions | 11336 | 139 | 2 | 19454 | 50 |
GRIN2B,CCDC136 |
4.971e-02 | -3.00 | protein kinase activator activity | molecular function | GO:0030295 | 132 | 2 | 18094 | 49 |
GRM5,NRG3 |